
<html lang="en"     class="pb-page"  data-request-id="cb0a8e67-b5ac-424b-8082-31c73eae5d73"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2021.64.issue-11;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.1c00294;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="The Expanding Role of Chemistry in Optimizing Proteins for Human Health Applications" /></meta><meta name="dc.Creator" content="Bart I.  Roman" /></meta><meta name="dc.Description" content="Over the past decades, therapeutics based on biological macromolecules and cells have successfully entered the clinical arena and progressively occupied an increasing share of what once was almost ..." /></meta><meta name="Description" content="Over the past decades, therapeutics based on biological macromolecules and cells have successfully entered the clinical arena and progressively occupied an increasing share of what once was almost ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 20, 2021" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00294" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00294" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00294" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00294" /></link>
        
    
    

<title>The Expanding Role of Chemistry in Optimizing Proteins for Human Health Applications | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00294" /></meta><meta property="og:title" content="The Expanding Role of Chemistry in Optimizing Proteins for Human Health Applications" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/large/jm1c00294_0003.jpeg" /></meta><meta property="og:description" content="Over the past decades, therapeutics based on biological macromolecules and cells have successfully entered the clinical arena and progressively occupied an increasing share of what once was almost exclusively small molecule territory. This perspective explores the opportunities for chemists at the interface between biologics and small molecule-based products. It provides concrete examples by zooming in on the area of post-translational protein modification. The conclusion is that, rather than diminishing the relevance of chemistry in the pharmaceutical enterprise, the advent of the biologics has provided an additional playing field for synthetic and medicinal chemists, where they can contribute to the efficacy and scope of applicability of biological entities in a collaborative effort to transformatively address unmet medical needs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00294"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00294">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00294&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00294&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00294&amp;href=/doi/10.1021/acs.jmedchem.1c00294" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 7179-7188</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00261" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.1c00415" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Expanding Role of Chemistry in Optimizing Proteins for Human Health Applications</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Bart I. Roman</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bart I. Roman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Group SynBioC, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Universiteit Gent, Coupure Links 653, 9000 Gent, Belgium</div><div class="loa-info-affiliations-info">Cancer Research Institute Ghent (CRIG), Corneel Heymanslaan 10, 9000 Gent, Belgium</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#4123203335706f332e2c202f013426242f356f2324"><span class="__cf_email__" data-cfemail="f092918284c1de829f9d919eb08597959e84de9295">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bart+I.++Roman">Bart I. Roman</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-9407-6721" title="Orcid link">https://orcid.org/0000-0002-9407-6721</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00294&amp;href=/doi/10.1021%2Facs.jmedchem.1c00294" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 7179–7188</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 20, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 February 2021</li><li><span class="item_label"><b>Published</b> online</span>20 May 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 June 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00294" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00294</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7179%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBart%2BI.%2BRoman%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D11%26contentID%3Dacs.jmedchem.1c00294%26title%3DThe%2BExpanding%2BRole%2Bof%2BChemistry%2Bin%2BOptimizing%2BProteins%2Bfor%2BHuman%2BHealth%2BApplications%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7188%26publicationDate%3DJune%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00294"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3615</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00294" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Expanding Role of Chemistry in Optimizing Proteins for Human Health Applications&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Bart&quot;,&quot;last_name&quot;:&quot;I. Roman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;7179-7188&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00294&quot;},&quot;abstract&quot;:&quot;Over the past decades, therapeutics based on biological macromolecules and cells have successfully entered the clinical arena and progressively occupied an increasing share of what once was almost exclusively small molecule territory. This perspective explores the opportunities for chemists at the interface between biologics and small molecule-based products. It provides concrete examples by zooming in on the area of post-translational protein modification. The conclusion is that, rather than diminishing the relevance of chemistry in the pharmaceutical enterprise, the advent of the biologics has provided an additional playing field for synthetic and medicinal chemists, where they can contribute to the efficacy and scope of applicability of biological entities in a collaborative effort to transformatively address unmet medical needs.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00294&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00294" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00294&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00294" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00294&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00294" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00294&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00294&amp;href=/doi/10.1021/acs.jmedchem.1c00294" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00294" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00294" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00294%26sid%3Dliteratum%253Aachs%26pmid%3D34014084%26genre%3Darticle%26aulast%3DRoman%26date%3D2021%26atitle%3DThe%2BExpanding%2BRole%2Bof%2BChemistry%2Bin%2BOptimizing%2BProteins%2Bfor%2BHuman%2BHealth%2BApplications%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D11%26spage%3D7179%26epage%3D7188%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292161" title="Modification">Modification</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292276" title="Small molecules">Small molecules</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/jmcmar.2021.64.issue-11/20210610/jmcmar.2021.64.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/medium/jm1c00294_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/large/jm1c00294_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00294&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Over the past decades, therapeutics based on biological macromolecules and cells have successfully entered the clinical arena and progressively occupied an increasing share of what once was almost exclusively small molecule territory. This perspective explores the opportunities for chemists at the interface between biologics and small molecule-based products. It provides concrete examples by zooming in on the area of post-translational protein modification. The conclusion is that, rather than diminishing the relevance of chemistry in the pharmaceutical enterprise, the advent of the biologics has provided an additional playing field for synthetic and medicinal chemists, where they can contribute to the efficacy and scope of applicability of biological entities in a collaborative effort to transformatively address unmet medical needs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><p class="first">When Wöhler successfully prepared urea from inorganic reagents in 1828,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and Kolbe converted carbon disulfide to acetic acid 17 years later,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> they not only contributed to the downfall of vitalism. Their feats also heralded the age of modern organic chemistry: given skill and effort, scientific progress would eventually enable the synthesis of any molecule, be it natural or designed (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). By the end of the 19th century, the chemical industry produced a whole array of dyes and other chemicals, and also introduced what would become the world’s first blockbuster drug: acetylsalicylic acid (Aspirin, Bayer, 1899).<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> (In which Kolbe also played an important role by determining the structure and developing a synthesis of salicylic acid in 1859.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a>) Add another 70 years, and the field of synthetic organic chemistry came to full maturity with the preparation of vitamin B12 by Woodward and Eschenmoser.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a> Enter the blockbuster era during which pharmaceutical companies and research institutions successfully developed an armamentarium of small molecule drugs that have provided options to increase our wellbeing and live longer lives.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></p><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/medium/jm1c00294_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/large/jm1c00294_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Milestone achievements in small molecules synthesis and drug development,<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref6 ref7 ref8 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref6 ref7 ref8 ref10 ref11 ref12 ref13">(1−4,6−8,10−13)</a> and likewise transformative events in molecular biology and biotechnological therapeutics.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18 ref19 ref20">(14−20)</a> Graphical illustration of human insulin was generated using data of Timofeev et al. (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7Y">3E7Y</a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/large/jm1c00294_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00294&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>Looking beyond chemistry, the achievements of Wöhler and Kolbe come forth from the ancient human desire to be able to fully characterize, understand, and create all molecules of life, and ultimately living systems.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22−24)</a> A second scientific discipline—with remarkable parallels to chemistry—that came forth from this desire is molecular biology. Inevitably, given the greater complexity of the systems under study, molecular (and ultimately synthetic) biology came to maturation later than chemistry. Since the 1980s, however, synthetic biology has achieved pinnacles equivalent to those in total chemical synthesis with the preparation of natural and engineered biological macromolecules, up to the level of fully functional proteins and genomes, from simple chemical building blocks (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref22 ref23 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref25">(22,23,25)</a> This has enabled the biotechnological industry to generate a continuous output of innovative therapeutic approaches employing oligonucleotides, proteins, cells, and genetic engineering, among others, over the past decades.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Biologics have been developed against targets that were challenging or impossible to manipulate with small molecules and have brought benefit in previously unmet medical needs such as psoriasis, Crohn’s disease, and rheumatoid arthritis.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a> They have enabled the introduction of new treatment paradigms and were also more frequently first-in-class agents. The absolute and relative increase in the number of regulatory approvals for biologics<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> is, in some ways, still an underestimation of the true impact that these agents have made. (Although cost-effectiveness is worthy of a debate on its own, the higher economic valuation of biologics may to a certain extent be a better measure of their importance.) The <i>biotech revolution</i> is still in full swing, and its products are continuing to gain pharmaceutical market share.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31−33)</a> Small molecules are no longer the rule, and biologics no longer the exception.</p><p>Medicinal chemists, then, have perceived this evolution in diverging ways.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Part of the community has felt threatened in terms of long-term employment perspectives or has experienced an impact on morale due the effectiveness of biologics in indications where small molecules had previously failed. Others have downplayed the rise of biologics and point toward their high cost, lack of oral availability, and distribution to target organs, or other disadvantages, perhaps in search of confirmation of the continued relevance of their own field.</p><p>Rather than <i>fearing</i> or <i>playing down</i> the biotech revolution, however, chemists should <i>play along</i> and see the opportunities rather than the threats. Small molecule drugs and medicinal chemistry as we know them will remain relevant as such, but more importantly, there is a new and creative role for chemists in biologics development as well. We must move past the classical view of small molecules and biologics as separate, or worse, competing technologies: biotechnology and chemistry are at their most powerful when they labor hand in hand in search of the best possible medicinal products.</p><p>There are many precedents: fermentation has long helped chemists to produce high-value small molecules, and increasingly chemistry helps to modify biologics to make them better fit for purpose.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Especially in the field of protein modification, chemistry has a lot to offer.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Notable examples of engineered protein-based products already in the market or in advanced development stages include synthetic glycoprotein vaccines for which a chemical step is used to conjugate the carbohydrate antigen to a carrier protein.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> Other well-known examples are chemically modified protein drugs with improved pharmacokinetics or lowered immunogenicity, antibody conjugates for the targeted delivery of therapeutics, and labeled macromolecules for imaging applications.<a onclick="showRef(event, 'ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41">(39−41)</a></p><p>Despite the successful infiltration of these and many related products in the pharmaceutical market, much of the potential of protein-based pharmaceuticals remains untapped due to the inadequacy of current chemical methodology to modify proteins in a highly controlled fashion. In small molecule drug discovery, hit expansion and lead optimization involve the synthesis of large libraries of analogues to determine structure–activity relationships and to optimize potency, safety, and pharmacokinetics. These synthesis campaigns have greatly benefited from enabling technologies such as late-stage modification strategies, combinatorial chemistry, and high-throughput chemistry, which deliver homogeneous products of well-defined structure in a time- and cost-efficient manner.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> Likewise, peptides and proteins make use of structural modification strategies to enhance developability.<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44−46)</a> In contrast to small molecules, however, library synthesis can be less straightforward here, both in terms of the modification of specific residues (e.g., when requiring resynthesis, designed mutations, or directed evolution) and with regard to conjugation strategies (e.g., site-specific PEGylation).<a onclick="showRef(event, 'ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50">(47−50)</a> These efforts would greatly benefit from additional site-specific “late-stage” peptide and protein modification strategies facilitating high-throughput library synthesis.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a></p><p>The large and unmet need for new and improved chemical technologies for post-translational protein modification constitutes an exciting opportunity for synthetic and medicinal chemists.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> In the following paragraphs, a few unanswered challenges and opportunities in this area will be discussed. This perspective focuses on methods that directly modify native (and not engineered) proteins, as it may be argued that native protein modification bears more intrinsic potential for approximating the “ideal” route toward a target protein product. This is reflected in the growing interest in native protein modification by synthetic organic chemists that have previously focused on small molecules, and in their intensive collaborations with protein chemistry laboratories.<a onclick="showRef(event, 'ref53 ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55 ref56 ref57">(53−57)</a> Of course, methods based on the modification of unnatural amino acids inserted via genetic engineering will remain of high utility as well, as will enzymatic methods.<a onclick="showRef(event, 'ref58 ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref58 ref59 ref60">(58−60)</a></p><p>For any protein modification technology to be valuable, the first and foremost condition is that it does not negatively affect the intended protein function. As that function is determined by shape and hence by chemical structure, any method will therefore primarily be judged by its ability to deliver site-specific modifications resulting in a homogeneous product of defined (primary) structure. It is important to realize that site-specific, in this context, refers to the modification of a single instance of a particular amino acid, thus implying chemoselectivity not only toward one amino acid type (in this context termed “site-selectivity”), but also toward a particular occurrence of that amino acid in the sequence.</p><p>Achieving a high degree of site-specificity directly depends on the ability to identify and exploit the particularities of the microenvironment of a candidate target residue, in terms of chemical nature and/or spatial characteristics. A successful strategy in this context has been to target the N- or C-termini. These are mostly accessible, often not implicated in protein function, and allow for steric and electronic differentiation. Recently, for example, MacMillan and co-workers have developed a site-specific decarboxylative alkylation at the C-terminus of native proteins (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> For human insulin, exclusive modification of the A-chain C-terminus was achieved. The transformation proceeds via a visible-light-mediated single-electron transfer (SET) mechanism. The observed specificity for the C-terminal carboxylate with respect to aspartic and glutamic acid residues was anticipated because of their inherently different oxidation potentials, due to the respective formation of a heteroatom-stabilized α-amino radical and a nonstabilized carbon-centered primary radical. The fundamental insights and intuition of synthetic organic chemists, developed by working on small molecules, are thus of direct value in solving problems of site-specificity (and, more general, site-selectivity) in protein modification.</p><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/medium/jm1c00294_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/large/jm1c00294_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical post-translational modification strategies targeting native protein residues: advantages, disadvantages, and examples of validated substrates illustrating the scope of use. Left: commonly used methods from the realm of “classical”, closed-shell chemistry.<a onclick="showRef(event, 'ref36 ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref36 ref61 ref62 ref63">(36,61−63)</a> Right: examples of emerging strategies using novel, “open-shell” technology.<a onclick="showRef(event, 'ref54 ref55 ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref64 ref65 ref66">(54,55,64−66)</a> (The protein depicted in the center is a gelsolin nanobody, (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4S11">4S11</a>) and is used for graphical purposes only.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> We do not suggest that the displayed reactions will be successful on this substrate.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/large/jm1c00294_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00294&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p>Whereas C-terminal and N-terminal modifications have logically focused on decarboxylation and amine chemistry, respectively, a larger pool of functional groups and reaction types can be exploited when targeting native in-chain residues (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). An informative overview of recent advances in the field, structured per residue and accessible to the organic chemist, was compiled by Baran and co-workers.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Two main points of inspiration for chemists can be drawn from this and other review papers.<a onclick="showRef(event, 'ref36 ref52 ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref36 ref52 ref68 ref69 ref70">(36,52,68−70)</a> First, an outstanding challenge is to find effective ways to modify underserved canonical amino acids, notably the aliphatic, carboxylate, aliphatic alcohol, and histidine residues. Second, for residues that at first sight can be targeted by a myriad of existing methods, reactions with enhanced site-specificity remain in demand. Lysine modification chemistry, for example, often lacks sufficient control to select between the various ε-amino groups of in-chain residues (and to a lesser extent the N-terminal α-amino group). Cysteine thiol modification methods are abundant, but the formed adducts frequently display suboptimal stability.</p><p>Cys and Lys modification are cornerstone strategies in the production of biologics, and the properties of the resulting linkage directly impact the clinical success or failure of the resulting products, as can be illustrated for antibody–drug conjugates (ADCs).<a onclick="showRef(event, 'ref40 ref71'); return false;" href="javascript:void(0);" class="ref ref40 ref71">(40,71)</a> Most ADCs—FDA-approved or in advanced clinical development—are essentially produced using one of two “classic” linker technologies: amide bond formation by conjugation to native lysine residues or Michael addition of a cysteine thiol to a maleimide (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Accessible Lys residues are relatively abundant in monoclonal antibodies (mAbs). Because current lysine modification chemistries are not site-specific, conjugation processes are of stochastic nature and produce heterogeneous products in terms of site of attachment and drug loading (drug–antibody ratio, DAR). This is problematic in production and formulation, and negatively affects the pharmacokinetics and the therapeutic index of the drug product. The impact of these issues became clear with the first marketed ADC, Gemtuzumab ozogamicin (Mylotarg, Wyeth), an anti-CD33 monoclonal antibody–calicheamicin construct for the treatment of acute myeloid leukemia. It is produced via random lysine conjugation and used as a heterogeneous mixture with a broad drug loading distribution (1–8 per molecule) and contains 50% of unconjugated mAb. These deficiencies contributed to off-target effects and serious toxicity issues, which led to market withdrawal of the product in 2010 (it was later reapproved).<a onclick="showRef(event, 'ref18 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref18 ref71 ref72">(18,71,72)</a> Significant improvements in lysine-based ADC construction meanwhile have enabled the introduction and safe use of several lysine-conjugated ADCs, but the technology remains random in nature. Cysteine conjugation techniques can display superior site-specificity (e.g., at interchain thiols) and may deliver better DAR control, but chiefly use maleimide-type chemistry that is slowly reversible under physiological conditions causing off-target toxicity.<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> New techniques for in-chain residue modification with improved site-specificity as well as reduced deconjugation rates have meanwhile been developed, but of these, the chemical methods remain focused on thiol-maleimide or similar reactions.<a onclick="showRef(event, 'ref71 ref75 ref76 ref77 ref78 ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref71 ref75 ref76 ref77 ref78 ref79 ref80 ref81">(71,75−81)</a></p><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. FDA-Approved Antibody–Drug Conjugates Up to and Including 2020, Sorted by Bioconjugation Methodology and Year of Approval<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><a onclick="showRef(event, 'ref82 ref83 ref84 ref85 ref86 ref87 ref88 ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref82 ref83 ref84 ref85 ref86 ref87 ref88 ref89 ref90">()</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/medium/jm1c00294_0006.gif" alt="" id="GRAPHIC-d7e418-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations and compound code names used in this table: ALCL, anaplastic large cell lymphoma; AML, acute myeloid leukemia; BC, breast cancer BCMA, B-cell maturation antigen; BCP-ALL, B-cell precursor acute lymphoblastic leukemia; CTCL, cutaneous T-cell lymphoma; DLBCL, diffuse large B-cell lymphoma; DM1, mertansine, thiol-containing maytansinoid; HCL, Hairy cell leukemia; HL, Hodgkin lymphoma; la, locally advanced; m, metastatic; mcMMAF, maleimidocaproyl monomethyl auristatin F; MMAE, monomethyl auristatin E; MM, multiple myeloma; PE, 38 kDa fragment of Pseudomonas exotoxin A; PTCL, peripheral T-cell lymphoma; R/R, relapsed/refractory; s, systemic; SN-38, active metabolite of irinotecan; TNBC, triple negative breast cancer.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Gemtuzumab ozogamicin was withdrawn from the market in 2010 and reapproved in 2017.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Trastuzumab deruxtecan received FDA approval for unresectable and/or metastatic breast cancer and locally advanced or metastatic HER2-positive gastric adenocarcinomas.</p></div></div><div></div></div><p>This underlines the unmet need for fundamentally novel post-translational protein modification chemistry, both for commonly targeted residues and for underserved residues. Current transformations of native residues are chiefly situated in the realm of “classical”, ionic (and cycloaddition) chemistry.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Variations on such closed-shell transformations are seldomly able to provide disruptive advances in site-selectivity and site-specificity: they all share fundamental issues of chemo- and regioselectivity, since protein residues (amines, thiols, alcohols, carboxylic acids, and amides) readily engage in similar ionic transformations. Many procedures and reagents commonly employed in synthetic closed-shell reactions are, moreover, not compatible with biologically ambient conditions (e.g., due to trapping of cationic or anionic intermediates in an aqueous environment, attenuated nucleophilicity, poor kinetics at room temperature). There are notable exceptions, however, where “classical” methods display remarkable reactivity under mild conditions. Ball, for example, has developed a site-selective, Cu(II)-mediated backbone N–H modification in peptides and proteins, which is directed by a neighboring histidine residue and proceeds under ambient and aqueous conditions (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Another instance is Pentelute’s cysteine conjugation chemistry, which enables the introduction of probes and proteins using a perfluoroaryl linker.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Although this method is able to site-specifically target one cysteine residue in a protein, it requires the presence or engineering of a four-amino-acid sequence (Phe-Cys-Pro-Phe, called the “π-clamp”).</p><p>A wealth of novel reactivity (for producing biological therapeutics, but also for bioconjugation in general) can come from complementing, fundamentally different chemistry using open-shell mechanisms.<a onclick="showRef(event, 'ref54 ref70 ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref54 ref70 ref92 ref93">(54,70,92,93)</a> Contrary to the general notion, radical chemistry can afford selectivity and complexity in a controlled fashion. It can be run in open flasks and is generally inert to the wealth of functionalities present in biologics. Radicals enable otherwise inaccessible chemistry because of reactivity umpolung and insensitivity to steric crowding. Closed-shell reactions have low to moderate rate constants ranging from 10<sup>–3</sup> (Staudinger) to 10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup> (cycloadditions). Thus, relatively high concentrations of reagents are required to obtain meaningful reaction yields, causing solubility and (in bioconjugation applications in living systems) toxicity problems.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> The rate constants of transformations involving open-shell intermediates are several orders of magnitude higher (10<sup>5</sup>–10<sup>9</sup> M<sup>–1</sup> s<sup>–1</sup>) and limit the concentration issue.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Open-shell reactions thus possess unique innate properties that render them kinetically and thermodynamically superior to classical modification techniques in terms of fundamental and application potential in post-translational protein modification.</p><p>Small-molecule synthesis has recently witnessed a renaissance of radical chemistry, and enabling technologies such as electrochemistry and photoredox catalysis concomitantly have come (back) to the forefront.<a onclick="showRef(event, 'ref93 ref96 ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref93 ref96 ref97 ref98">(93,96−98)</a> Chemists with interest in drug discovery must fully exploit this momentum and grasp the opportunity to apply this wealth of new technology to the modification of (therapeutically relevant) biological macromolecules. Reports providing proof-of-principle have recently emerged (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Besides the previously described site-specific decarboxylative alkylation at the C-terminus of insulin using photoredox chemistry by MacMillan et al., the groups of Gouverneur and Davis have demonstrated the applicability of chemically initiated radical reactions in native protein modification. In an extension of the scope of Baran’s sulfinate-based radical chemistry, they realized a chemoselective trifluoromethylation of tryptophan residues in proteins such as myoglobin on a preparative (mg) scale.<a onclick="showRef(event, 'ref55 ref99'); return false;" href="javascript:void(0);" class="ref ref55 ref99">(55,99)</a> This modification was, moreover, accomplished at buried Trp sites, thereby displaying compatibility with other approaches that for steric reasons target accessible surface Trp residues.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> “Classical” electrophilic approaches, also reported by Davis and Gouverneur et al., had directed trifluoromethylation toward cysteine residues, further illustrating the fundamentally different selectivity that can be obtained using open-shell mechanisms.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> The need for organic chemists in fine-tuning reaction conditions for particular protein scaffolds and applications is further evidenced by earlier reports on the photochemically induced radical trifluoromethylations of peptides and proteins, which noted yet different selectivities.<a onclick="showRef(event, 'ref102 ref103 ref104'); return false;" href="javascript:void(0);" class="ref ref102 ref103 ref104">(102−104)</a> The residue tunability by sulfinates continues to be developed: different alkyl sulfinates were recently used to leverage the innate reactivity of protonated His residues (at the C2 position) in unprotected, complex, bioactive peptides.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The broad scope of the sulfinate technology and other innovative protein modification methods will greatly facilitate the production of libraries for structure–activity and safety studies and pharmacological optimization, similar to what has long been possible for small molecules.</p><p>Evidence of the potential of electrochemistry in radical post-translational modification of native protein residues was provided by Song et al. in their direct, site-selective selective bioconjugation of tyrosine residues in insulin and myoglobin using phenotiazines (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Initial progress toward the site-selective targeting of in-chain carboxylate residues can be found in the photoinduced reaction of tetrazoles with surface-exposed glutamic acid residues in myoglobin, as reported by Luo et al. (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> All of the above transformations proceed under (near)-biologically ambient conditions and can be considered early successes in what we believe to become enabling technologies in translational research.</p><p>Realistically, new methods will first have to prove their merits on small molecules before their scope will be extended to peptides and proteins. Some transformations will only be applicable to a subset of proteins but may still be of great translational value. Smaller vectors, for example, currently receive great attention as a substitute to full-length antibodies in certain applications because of superior tissue targeting.<a onclick="showRef(event, 'ref105 ref106 ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref105 ref106 ref107 ref108">(105−108)</a> These entities may tolerate greater insults in terms of reaction conditions, as has been demonstrated for nanobodies with respect to full monoclonal antibodies.<a onclick="showRef(event, 'ref109 ref110'); return false;" href="javascript:void(0);" class="ref ref109 ref110">(109,110)</a> In addition, the development of high-value biomaterials often relies on the modification of more “robust” peptides and proteins like gelatin.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></p><p>Medicinal chemists may also contribute to the field of biological therapeutics through their experience in computational drug discovery. Calculations, modeling, structure-based design, and virtual screening techniques, common in small molecule drug discovery, can be adapted to solve problems in the structural modification of biologics, in terms of both reagent and residue selection and target structure design. Such tools are increasingly popular in post-translational protein modification, where they offer information on the orthogonality of reactions, and the location and chemical potential of hyperreactive instances of a particular amino acid that may engage in a site-specific modification.<a onclick="showRef(event, 'ref112 ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref112 ref113 ref114">(112−114)</a> Still more refined techniques are needed, however, to accurately model these complex phenomena. Returning to the C-terminal modification of the A-chain of insulin by MacMillan, for example, a different but related set of conditions later unexpectedly led to selective modification of the B-chain C-terminus, for reasons that remain to be understood.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></p><p class="last">This perspective has focused on the expanding role of chemists in optimizing protein therapeutics and in broadening their scope of application. Besides therapeutics, also the development of synthetic vaccines,<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> diagnostics,<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117,118)</a> theranostics,<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> and biomaterials,<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> among others, increasingly relies on the chemical modification of (native) proteins. Myriad opportunities for organic and medicinal chemists exist for other classes of biologics as well. These include, for example, modifications of oligonucleotides or in CRISPR-Cas9-associated base editing that increase stability or enable targeted delivery.<a onclick="showRef(event, 'ref120 ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref120 ref121 ref122">(120−122)</a> Another opportunity for the enhancement of advanced therapeutics (e.g., CAR T cells and CRISPR-Cas9-based therapies) is the development of chemically gated <i>in vivo</i> control systems.<a onclick="showRef(event, 'ref123 ref124 ref125'); return false;" href="javascript:void(0);" class="ref ref123 ref124 ref125">(123−125)</a> Regardless of the exact nature of the substrate, the point remains that chemistry and biology in the future will increasingly work together to provide better solutions to unmet medical needs. I wish to end by speculating that this collaboration will be an enabling factor in the maturation of precision medicine: a stratified approach with tailor-made products for narrow patient populations, providing real cure instead of disease control. Perhaps the true change in landscape for medicinal chemists lies there: not the era of chemistry is over, but rather the era of “one size fits all” blockbuster drugs.</p><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00294" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25547" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25547" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bart I. Roman</span> - <span class="hlFld-Affiliation affiliation">Research Group SynBioC, Department
of Green Chemistry and Technology, Faculty of Bioscience Engineering, Universiteit Gent, Coupure Links 653, 9000 Gent, Belgium</span>; 
    <span class="hlFld-Affiliation affiliation">Cancer Research Institute
Ghent (CRIG), Corneel
Heymanslaan 10, 9000 Gent, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-9407-6721" title="Orcid link">https://orcid.org/0000-0002-9407-6721</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7517140701445b071a18141b350012101b015b1710"><span class="__cf_email__" data-cfemail="8fedeefdfbbea1fde0e2eee1cffae8eae1fba1edea">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The author declares no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Biography</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57024" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57024" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Bart I. Roman</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00294&amp;id=BIO-d7e757-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last">Bart I. Roman received his master’s degree in Engineering Technology in Chemical Sciences from Ghent University (2006), where he also obtained his Ph.D. in Applied Biological Sciences (Chemistry) under the supervision of Professors Christian V. Stevens and Marc E. Bracke (2012). In 2014, he conducted a postdoctoral stay in the lab of Phil S. Baran at the Department of Chemistry of the Scripps Research Institute. Bart is currently working as a senior postdoctoral researcher at the research group SynBioC (director: Christian V. Stevens) at the Department of Green Chemistry of Ghent University. His research interests lie in the discovery and development of therapeutics to tackle metastatic cancer, and in the development of new chemical methodology to modify biological macromolecules towards use in human health applications.</p></figure></div><table summary="" class="NLM_def-list" id="DEF-LIST-d7e587-autogenerated"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ADC</td><td class="NLM_def"><p class="first last">antibody–drug conjugate</p></td></tr><tr><td class="NLM_term">ALCL</td><td class="NLM_def"><p class="first last">anaplastic large cell lymphoma</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">BCMA</td><td class="NLM_def"><p class="first last">B-cell maturation antigen</p></td></tr><tr><td class="NLM_term">BCP-ALL</td><td class="NLM_def"><p class="first last">B-cell precursor acute lymphoblastic leukemia</p></td></tr><tr><td class="NLM_term">CAR T cells</td><td class="NLM_def"><p class="first last">chimeric antigen receptor T Cells</p></td></tr><tr><td class="NLM_term">CDX</td><td class="NLM_def"><p class="first last">cluster of differentiation-X (X= number)</p></td></tr><tr><td class="NLM_term">CRISR</td><td class="NLM_def"><p class="first last">clustered regularly interspaced short palindromic repeats</p></td></tr><tr><td class="NLM_term">CTCL</td><td class="NLM_def"><p class="first last">cutaneous T-cell lymphoma</p></td></tr><tr><td class="NLM_term">DAR</td><td class="NLM_def"><p class="first last">drug–antibody ratio</p></td></tr><tr><td class="NLM_term">DLBCL</td><td class="NLM_def"><p class="first last">diffuse large B-cell lymphoma</p></td></tr><tr><td class="NLM_term">DM1</td><td class="NLM_def"><p class="first last">mertansine, thiol-containing maytansinoid</p></td></tr><tr><td class="NLM_term">HCL</td><td class="NLM_def"><p class="first last">Hairy cell leukemia</p></td></tr><tr><td class="NLM_term">HER2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2</p></td></tr><tr><td class="NLM_term">HL</td><td class="NLM_def"><p class="first last">Hodgkin lymphoma</p></td></tr><tr><td class="NLM_term">la</td><td class="NLM_def"><p class="first last">locally advance</p></td></tr><tr><td class="NLM_term">m</td><td class="NLM_def"><p class="first last">metastatic</p></td></tr><tr><td class="NLM_term">mAb</td><td class="NLM_def"><p class="first last">monoclonal antibody</p></td></tr><tr><td class="NLM_term">mcMMAF</td><td class="NLM_def"><p class="first last">maleimidocaproyl monomethyl auristatin F</p></td></tr><tr><td class="NLM_term">MMAE</td><td class="NLM_def"><p class="first last">monomethyl auristatin E</p></td></tr><tr><td class="NLM_term">MM</td><td class="NLM_def"><p class="first last">multiple myeloma</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">38 kDa fragment of Pseudomonas exotoxin A</p></td></tr><tr><td class="NLM_term">R/R</td><td class="NLM_def"><p class="first last">relapsed/refractory</p></td></tr><tr><td class="NLM_term">s</td><td class="NLM_def"><p class="first last">systemic</p></td></tr><tr><td class="NLM_term">SN-38</td><td class="NLM_def"><p class="first last">active metabolite of irinotecan</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple negative breast cancer</p></td></tr><tr><td class="NLM_term">Trop-2</td><td class="NLM_def"><p class="first last">tumor-associated calcium signal transducer 2</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81682" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81682" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 125 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wöhler, F.</span></span> <span> </span><span class="NLM_article-title">Ueber Künstliche Bildung des Harnstoffs</span>. <i>Ann. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1828</span>,  <span class="NLM_volume"><i>88</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1002/andp.18280880206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fandp.18280880206" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1828&pages=253-256&issue=2&author=F.+W%C3%B6hler&title=Ueber+K%C3%BCnstliche+Bildung+des+Harnstoffs&doi=10.1002%2Fandp.18280880206"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fandp.18280880206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fandp.18280880206%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25B6hler%26aufirst%3DF.%26atitle%3DUeber%2520K%25C3%25BCnstliche%2520Bildung%2520des%2520Harnstoffs%26jtitle%3DAnn.%2520Phys.%26date%3D1828%26volume%3D88%26issue%3D2%26spage%3D253%26epage%3D256%26doi%3D10.1002%2Fandp.18280880206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolbe, H.</span></span> <span> </span><span class="NLM_article-title">Beiträge zur Kenntniss der Gepaarten Verbindungen</span>. <i>Ann. der Chemie und Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1845</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1002/jlac.18450540202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fjlac.18450540202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1845&pages=145-188&issue=2&author=H.+Kolbe&title=Beitr%C3%A4ge+zur+Kenntniss+der+Gepaarten+Verbindungen&doi=10.1002%2Fjlac.18450540202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fjlac.18450540202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.18450540202%26sid%3Dliteratum%253Aachs%26aulast%3DKolbe%26aufirst%3DH.%26atitle%3DBeitr%25C3%25A4ge%2520zur%2520Kenntniss%2520der%2520Gepaarten%2520Verbindungen%26jtitle%3DAnn.%2520der%2520Chemie%2520und%2520Pharm.%26date%3D1845%26volume%3D54%26issue%3D2%26spage%3D145%26epage%3D188%26doi%3D10.1002%2Fjlac.18450540202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aftalion, F.</span></span> <i>History of the International Chemical Industry</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Chemical Heritage Foundation</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=F.+Aftalion&title=History+of+the+International+Chemical+Industry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAftalion%26aufirst%3DF.%26btitle%3DHistory%2520of%2520the%2520International%2520Chemical%2520Industry%26pub%3DChemical%2520Heritage%2520Foundation%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jack, D. B.</span></span> <span> </span><span class="NLM_article-title">One Hundred Years of Aspirin</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>350</i></span> (<span class="NLM_issue">9075</span>),  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(97)07087-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS0140-6736%2897%2907087-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=9259670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A280%3ADyaK2svgs1ajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1997&pages=437-439&issue=9075&author=D.+B.+Jack&title=One+Hundred+Years+of+Aspirin&doi=10.1016%2FS0140-6736%2897%2907087-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">One hundred years of aspirin</span></div><div class="casAuthors">Jack D B</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">9075</span>),
    <span class="NLM_cas:pages">437-9</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTk-z6HyUUaGNbHMBt0mMIXfW6udTcc2eazx_cPnxQG1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2svgs1ajtQ%253D%253D&md5=97a39f30327b2b083f15310dd7c0c266</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2897%2907087-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252897%252907087-6%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DD.%2BB.%26atitle%3DOne%2520Hundred%2520Years%2520of%2520Aspirin%26jtitle%3DLancet%26date%3D1997%26volume%3D350%26issue%3D9075%26spage%3D437%26epage%3D439%26doi%3D10.1016%2FS0140-6736%2897%2907087-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolbe, H.</span></span> <span> </span><span class="NLM_article-title">Ueber Synthese der Salicylsäure</span>. <i>Ann. der Chemie und Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1860</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1002/jlac.18601130120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fjlac.18601130120" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1860&pages=125-127&issue=1&author=H.+Kolbe&title=Ueber+Synthese+der+Salicyls%C3%A4ure&doi=10.1002%2Fjlac.18601130120"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fjlac.18601130120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.18601130120%26sid%3Dliteratum%253Aachs%26aulast%3DKolbe%26aufirst%3DH.%26atitle%3DUeber%2520Synthese%2520der%2520Salicyls%25C3%25A4ure%26jtitle%3DAnn.%2520der%2520Chemie%2520und%2520Pharm.%26date%3D1860%26volume%3D113%26issue%3D1%26spage%3D125%26epage%3D127%26doi%3D10.1002%2Fjlac.18601130120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, R. B.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in the Chemistry of Natural Products</span>. <i>Pure Appl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1351/pac196817030519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1351%2Fpac196817030519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=5729287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaE3cXktFCksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1968&pages=519-547&issue=3%E2%80%934&author=R.+B.+Woodward&title=Recent+Advances+in+the+Chemistry+of+Natural+Products&doi=10.1351%2Fpac196817030519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry of natural products</span></div><div class="casAuthors">Woodward, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Pure and Applied Chemistry</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">519-47</span>CODEN:
                <span class="NLM_cas:coden">PACHAS</span>;
        ISSN:<span class="NLM_cas:issn">0033-4545</span>.
    </div><div class="casAbstract">A review of the current state of research in the synthesis of vitamin B12 with 1 ref.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUA2YUJjo-1LVg90H21EOLACvtfcHk0lhX9cWBXQFMkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXktFCksb4%253D&md5=d657880d680dc964900bbeff91343cdf</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1351%2Fpac196817030519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac196817030519%26sid%3Dliteratum%253Aachs%26aulast%3DWoodward%26aufirst%3DR.%2BB.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Chemistry%2520of%2520Natural%2520Products%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D1968%26volume%3D17%26issue%3D3%25E2%2580%25934%26spage%3D519%26epage%3D547%26doi%3D10.1351%2Fpac196817030519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eschenmoser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wintner, C.</span></span> <span> </span><span class="NLM_article-title">Natural Product Synthesis and Vitamin B12</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>196</i></span> (<span class="NLM_issue">4297</span>),  <span class="NLM_fpage">1410</span>– <span class="NLM_lpage">1420</span>, <span class="refDoi"> DOI: 10.1126/science.867037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1126%2Fscience.867037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=867037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaE2sXlvVCgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=1977&pages=1410-1420&issue=4297&author=A.+Eschenmoserauthor=C.+Wintner&title=Natural+Product+Synthesis+and+Vitamin+B12&doi=10.1126%2Fscience.867037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product synthesis and vitamin B12</span></div><div class="casAuthors">Eschenmoser, Albert; Wintner, Claude E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">4297</span>),
    <span class="NLM_cas:pages">1410-20</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 54 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpVOu70RpD2rVg90H21EOLACvtfcHk0lhX9cWBXQFMkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXlvVCgurk%253D&md5=687c932371867890753555ca177ef64a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.867037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.867037%26sid%3Dliteratum%253Aachs%26aulast%3DEschenmoser%26aufirst%3DA.%26aulast%3DWintner%26aufirst%3DC.%26atitle%3DNatural%2520Product%2520Synthesis%2520and%2520Vitamin%2520B12%26jtitle%3DScience%26date%3D1977%26volume%3D196%26issue%3D4297%26spage%3D1410%26epage%3D1420%26doi%3D10.1126%2Fscience.867037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marko, I. E.</span></span> <span> </span><span class="NLM_article-title">Natural Product Synthesis: The Art of Total Synthesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">5548</span>),  <span class="NLM_fpage">1842</span>– <span class="NLM_lpage">1843</span>, <span class="refDoi"> DOI: 10.1126/science.1067545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1126%2Fscience.1067545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=11729290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFSqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=1842-1843&issue=5548&author=I.+E.+Marko&title=Natural+Product+Synthesis%3A+The+Art+of+Total+Synthesis&doi=10.1126%2Fscience.1067545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product synthesis: the art of total synthesis</span></div><div class="casAuthors">Marko, Istvan E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">5548</span>),
    <span class="NLM_cas:pages">1842-1843</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review on the prepn. of complex natural products.  Emphasis is on Hirama's prepn. of ciguatoxin CTX3C in 77% yield via the selective acetalization of the two halves followed by a challenging metathesis reaction to install the final C-C bond and complete the whole skeleton of ciguatoxin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGRGB7W8uLf7Vg90H21EOLACvtfcHk0lg4RbtB5a3J6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFSqt7w%253D&md5=671388b5b9b2f516eabe010776c7f8bf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1067545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1067545%26sid%3Dliteratum%253Aachs%26aulast%3DMarko%26aufirst%3DI.%2BE.%26atitle%3DNatural%2520Product%2520Synthesis%253A%2520The%2520Art%2520of%2520Total%2520Synthesis%26jtitle%3DScience%26date%3D2001%26volume%3D294%26issue%3D5548%26spage%3D1842%26epage%3D1843%26doi%3D10.1126%2Fscience.1067545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, W. R.</span></span> <span> </span><span class="NLM_article-title">In Praise of Remarkably Powerful Centamolecular Therapeutic Agents</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1094</span>– <span class="NLM_lpage">1097</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlylsL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1094-1097&issue=8&author=N.+A.+Meanwellauthor=W.+R.+Ewing&title=In+Praise+of+Remarkably+Powerful+Centamolecular+Therapeutic+Agents&doi=10.1021%2Facsmedchemlett.9b00286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">In Praise of Remarkably Powerful Centamolecular Therapeutic Agents</span></div><div class="casAuthors">Meanwell, Nicholas A.; Ewing, William R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1094-1097</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  While biol. medications have addressed many challenging therapeutic targets, the pharmacopeia is still dominated by centamols.  In this viewpoint, we illustrate the impact of centamol. drugs on mortality and morbidity due to chronic viral infections and present select examples from other disease areas that highlight some of their remarkably powerful biochem. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofRNASt4Snv7Vg90H21EOLACvtfcHk0lg4RbtB5a3J6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlylsL3F&md5=16a78cfdc956392783a087a86bec8888</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00286%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26atitle%3DIn%2520Praise%2520of%2520Remarkably%2520Powerful%2520Centamolecular%2520Therapeutic%2520Agents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26issue%3D8%26spage%3D1094%26epage%3D1097%26doi%3D10.1021%2Facsmedchemlett.9b00286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicolaou, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nantermet, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claiborne, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couladouros, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulvannan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, E. J.</span></span> <span> </span><span class="NLM_article-title">Total Synthesis of Taxol</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>367</i></span> (<span class="NLM_issue">6464</span>),  <span class="NLM_fpage">630</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1038/367630a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2F367630a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=7906395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaK2cXksFOksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=1994&pages=630-634&issue=6464&author=K.+C.+Nicolaouauthor=Z.+Yangauthor=J.+J.+Liuauthor=H.+Uenoauthor=P.+G.+Nantermetauthor=R.+K.+Guyauthor=C.+F.+Claiborneauthor=J.+Renaudauthor=E.+A.+Couladourosauthor=K.+Paulvannanauthor=E.+J.+Sorensen&title=Total+Synthesis+of+Taxol&doi=10.1038%2F367630a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Total synthesis of taxol</span></div><div class="casAuthors">Nicolaou, K. C.; Yang, Z.; Liu, J. J.; Ueno, H.; Nantermet, P. G.; Guy, R. K.; Claiborne, C. F.; Renaud, J.; Couladouros, E. A.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">6464</span>),
    <span class="NLM_cas:pages">630-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The total synthesis of taxol (I) from the benzofuranone II by a convergent strategy, which opens a chem. pathway for the prodn. of both I and a variety of designed taxoids is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpntORbDeDdrbVg90H21EOLACvtfcHk0lg4RbtB5a3J6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFOksLc%253D&md5=d5ac12f78c2b2d62f145f25258961a2f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F367630a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F367630a0%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26aulast%3DClaiborne%26aufirst%3DC.%2BF.%26aulast%3DRenaud%26aufirst%3DJ.%26aulast%3DCouladouros%26aufirst%3DE.%2BA.%26aulast%3DPaulvannan%26aufirst%3DK.%26aulast%3DSorensen%26aufirst%3DE.%2BJ.%26atitle%3DTotal%2520Synthesis%2520of%2520Taxol%26jtitle%3DNature%26date%3D1994%26volume%3D367%26issue%3D6464%26spage%3D630%26epage%3D634%26doi%3D10.1038%2F367630a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marks, L.</span></span> <i>Sexual Chemistry: A History of the Contraceptive Pill</i>; <span class="NLM_publisher-name">Yale University Press</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=L.+Marks&title=Sexual+Chemistry%3A+A+History+of+the+Contraceptive+Pill"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DL.%26btitle%3DSexual%2520Chemistry%253A%2520A%2520History%2520of%2520the%2520Contraceptive%2520Pill%26pub%3DYale%2520University%2520Press%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denis, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueritte-Voegelein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangatal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, P.</span></span> <span> </span><span class="NLM_article-title">Highly Efficient, Practical Approach to Natural Taxol</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">5917</span>– <span class="NLM_lpage">5919</span>, <span class="refDoi"> DOI: 10.1021/ja00225a063</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00225a063" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaL1cXkvFegtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=5917-5919&issue=17&author=J.+N.+Denisauthor=A.+E.+Greeneauthor=D.+Guenardauthor=F.+Gueritte-Voegeleinauthor=L.+Mangatalauthor=P.+Potier&title=Highly+Efficient%2C+Practical+Approach+to+Natural+Taxol&doi=10.1021%2Fja00225a063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Highly efficient, practical approach to natural taxol</span></div><div class="casAuthors">Denis, Jean Noel; Greene, Andrew E.; Guenard, Daniel; Gueritte-Voegelein, Francoise; Mangatal, Lydie; Potier, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5917-19</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Taxol (I), a promising but difficultly accessible cancer chemotherapeutic agent isolated from yew bark, was efficiently synthesized in 4 steps from readily available congener II.  The synthesis should alleviate the current shortage and provide a reliable future source of this natural product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLI98SsnXembVg90H21EOLACvtfcHk0lh1Ov8Ubae6qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXkvFegtL0%253D&md5=df78d2b2fddae985c666f836e19208e4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fja00225a063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00225a063%26sid%3Dliteratum%253Aachs%26aulast%3DDenis%26aufirst%3DJ.%2BN.%26aulast%3DGreene%26aufirst%3DA.%2BE.%26aulast%3DGuenard%26aufirst%3DD.%26aulast%3DGueritte-Voegelein%26aufirst%3DF.%26aulast%3DMangatal%26aufirst%3DL.%26aulast%3DPotier%26aufirst%3DP.%26atitle%3DHighly%2520Efficient%252C%2520Practical%2520Approach%2520to%2520Natural%2520Taxol%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26issue%3D17%26spage%3D5917%26epage%3D5919%26doi%3D10.1021%2Fja00225a063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holton, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biediger, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boatman, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span> <span> </span><span class="NLM_article-title">First Total Synthesis of Taxol. 1. Functionalization of the B Ring</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1597</span>– <span class="NLM_lpage">1598</span>, <span class="refDoi"> DOI: 10.1021/ja00083a066</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00083a066" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaK2cXhtlCrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=1597-1598&issue=4&author=R.+A.+Holtonauthor=C.+Somozaauthor=H.+B.+Kimauthor=F.+Liangauthor=R.+J.+Biedigerauthor=P.+D.+Boatmanauthor=M.+Shindoauthor=C.+C.+Smithauthor=S.+Kim&title=First+Total+Synthesis+of+Taxol.+1.+Functionalization+of+the+B+Ring&doi=10.1021%2Fja00083a066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">First total synthesis of taxol. 1. Functionalization of the B ring</span></div><div class="casAuthors">Holton, Robert A.; Somoza, Carmen; Kim, Hyeong Baik; Liang, Feng; Biediger, Ronald J.; Boatman, P. Douglas; Shindo, Mitsuru; Smith, Chase C.; Kim, Soekchan; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1597-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Beginning stages of a total synthesis of the anti-tumor agent taxol were described.  These stages result in the prepn. of an intermediate having three rings in which 6 stereocenters of the natural product are set.  The key feature of this part of the total synthesis is control of conformation and reactivity in the bicyclo[5.3.1]undecane ring system.  Thus, the diol I, a taxusin intermediate readily available from camphor, was transformed to the lactone carbonate II in 12 steps and 40% overall yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0YnV7x4JcZrVg90H21EOLACvtfcHk0lh1Ov8Ubae6qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtlCrtLs%253D&md5=ff0f016854e9d02e755c7f053fe668ab</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fja00083a066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00083a066%26sid%3Dliteratum%253Aachs%26aulast%3DHolton%26aufirst%3DR.%2BA.%26aulast%3DSomoza%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DH.%2BB.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DBiediger%26aufirst%3DR.%2BJ.%26aulast%3DBoatman%26aufirst%3DP.%2BD.%26aulast%3DShindo%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DC.%2BC.%26aulast%3DKim%26aufirst%3DS.%26atitle%3DFirst%2520Total%2520Synthesis%2520of%2520Taxol.%25201.%2520Functionalization%2520of%2520the%2520B%2520Ring%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1994%26volume%3D116%26issue%3D4%26spage%3D1597%26epage%3D1598%26doi%3D10.1021%2Fja00083a066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, P.</span></span> <span> </span><span class="NLM_article-title">Biochemical Method for Inserting New Genetic Information into DNA of Simian Virus 40: Circular SV40 DNA Molecules Containing Lambda Phage Genes and the Galactose Operon of Escherichia Coli</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2904</span>– <span class="NLM_lpage">2909</span>, <span class="refDoi"> DOI: 10.1073/pnas.69.10.2904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1073%2Fpnas.69.10.2904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=4342968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaE3sXhslCh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1972&pages=2904-2909&issue=10&author=D.+A.+Jacksonauthor=R.+H.+Symonsauthor=P.+Berg&title=Biochemical+Method+for+Inserting+New+Genetic+Information+into+DNA+of+Simian+Virus+40%3A+Circular+SV40+DNA+Molecules+Containing+Lambda+Phage+Genes+and+the+Galactose+Operon+of+Escherichia+Coli&doi=10.1073%2Fpnas.69.10.2904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical method for inserting new genetic information into DNA of Simian Virus 40.  Circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli</span></div><div class="casAuthors">Jackson, David A.; Symons, Robert H.; Berg, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2904-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Methods for covalently joining duplex DNA mols. to one another have been developed and used to construct circular dimers of SV40 DNA and to insert a DNA segment contg. λ-phage genes and the galactose operon of E. coli into SV40 DNA.  The method involves:  (a) converting circular SV40 DNA to a linear form, (b) adding single-stranded homodeoxypolymeric extensions of defined compn. and length to the 3' ends of 1 of the DNA strands with the enzyme terminal deoxynucleotidyl transferase, (c) adding complementary homodeoxypolymeric extensions to the other DNA strand, (d) annealing the 2 DNA mols. to form a circular duplex structure, and (e) filling the gaps and sealing nicks in this structure with E. coli DNA polymerase and DNA ligase to form a covalently closed-circular DNA mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoslA6E7DpaFLVg90H21EOLACvtfcHk0lh1Ov8Ubae6qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhslCh&md5=4afd92e56449c5d8cced628f9e174429</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.69.10.2904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.69.10.2904%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DD.%2BA.%26aulast%3DSymons%26aufirst%3DR.%2BH.%26aulast%3DBerg%26aufirst%3DP.%26atitle%3DBiochemical%2520Method%2520for%2520Inserting%2520New%2520Genetic%2520Information%2520into%2520DNA%2520of%2520Simian%2520Virus%252040%253A%2520Circular%2520SV40%2520DNA%2520Molecules%2520Containing%2520Lambda%2520Phage%2520Genes%2520and%2520the%2520Galactose%2520Operon%2520of%2520Escherichia%2520Coli%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1972%26volume%3D69%26issue%3D10%26spage%3D2904%26epage%3D2909%26doi%3D10.1073%2Fpnas.69.10.2904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nadler, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stashenko, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Button, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufe, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antman, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlossman, S. F.</span></span> <span> </span><span class="NLM_article-title">Serotherapy of a Patient with a Monoclonal Antibody Directed against a Human Lymphoma-Associated Antigen</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3147</span>– <span class="NLM_lpage">3154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=7427932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A280%3ADyaL3M%252Fkt1SlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1980&pages=3147-3154&issue=9&author=L.+M.+Nadlerauthor=P.+Stashenkoauthor=R.+Hardyauthor=W.+D.+Kaplanauthor=L.+N.+Buttonauthor=D.+W.+Kufeauthor=K.+H.+Antmanauthor=S.+F.+Schlossman&title=Serotherapy+of+a+Patient+with+a+Monoclonal+Antibody+Directed+against+a+Human+Lymphoma-Associated+Antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen</span></div><div class="casAuthors">Nadler L M; Stashenko P; Hardy R; Kaplan W D; Button L N; Kufe D W; Antman K H; Schlossman S F</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3147-54</span>
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">A preliminary serotherapeutic trial was undertaken with a monoclonal antibody designated antibody 89 (Ab 89) directed against a lymphoma-associated antigen.  In vitro studies demonstrated that Ab 89 could mediate complement-dependent lysis and macrophage adherence but not antibody-dependent cell-mediated cytotoxicity.  To evaluate toxicity and therapeutic efficacy, two courses of Ab 89 were administered to a patient with an Ab 89-reactive tumor.  Transient decreases in the number of circulating tumor cells and the appearance of circulating dead cells were noted with the infusion of Ab 89.  Following administration of 150 mg or more of Ab 89, small amounts of antibody could be demonstrated on circulating tumor cells at a time when no free antibody was found in the serum.  The inability to deliver a significant amount of Ab 89 to tumor cells in vivo is thought to be secondary to a circulating tumor antigen.  Following each infusion, the amount of this blocking antigen decreased but could not be entirely cleared from the serum.  This study provides preliminary evidence for the lack of clinical toxicity of a monoclonal antibody and identifies circulating blocking antigens as a significant obstacle to serotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPNHhFXNucGe98rul4nhSdfW6udTcc2eaCveuEwv1Nobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3M%252Fkt1SlsA%253D%253D&md5=3490ac2a7f42fb531ecfc19bcb5fa649</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNadler%26aufirst%3DL.%2BM.%26aulast%3DStashenko%26aufirst%3DP.%26aulast%3DHardy%26aufirst%3DR.%26aulast%3DKaplan%26aufirst%3DW.%2BD.%26aulast%3DButton%26aufirst%3DL.%2BN.%26aulast%3DKufe%26aufirst%3DD.%2BW.%26aulast%3DAntman%26aufirst%3DK.%2BH.%26aulast%3DSchlossman%26aufirst%3DS.%2BF.%26atitle%3DSerotherapy%2520of%2520a%2520Patient%2520with%2520a%2520Monoclonal%2520Antibody%2520Directed%2520against%2520a%2520Human%2520Lymphoma-Associated%2520Antigen%26jtitle%3DCancer%2520Res.%26date%3D1980%26volume%3D40%26issue%3D9%26spage%3D3147%26epage%3D3154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span> </span><span class="NLM_article-title">Human Insulin Receives FDA Approval</span>.  <i>FDA
Drug Bull.</i>, <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume">12</span> (<span class="NLM_issue">3</span>)  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">19</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=6762312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A280%3ADyaL3s7lvVGqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Human+Insulin+Receives+FDA+Approval.+FDA%0ADrug+Bull.%2C+1982%2C+12+%283%29+18%E2%80%9319."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Human insulin receives FDA approval</span></div><div class="casAuthors">Anonymous</div><div class="citationInfo"><span class="NLM_cas:title">FDA drug bulletin</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">18-9</span>
        ISSN:<span class="NLM_cas:issn">0361-4344</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9uBV65_Tx8Djk2McQZ6XmfW6udTcc2eaCveuEwv1Nobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s7lvVGqsg%253D%253D&md5=217b5e4f1f31b5988da77d3a5734fb5d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DHuman%2520Insulin%2520Receives%2520FDA%2520Approval%26jtitle%3DFDA%250ADrug%2520Bull.%26date%3D1982%26volume%3D12%26issue%3D3%26spage%3D18%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span> </span><span class="NLM_article-title">Rapid-Acting Insulin Approved for Marketing</span>.  <i>Am. J. Health-Syst. Pharm.</i>, <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume">53</span> (<span class="NLM_issue">19</span>)  <span class="NLM_fpage">2250</span>. <span class="refDoi"> DOI: 10.1093/ajhp/53.19.2250</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1093%2Fajhp%2F53.19.2250a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Rapid-Acting+Insulin+Approved+for+Marketing.+Am.+J.+Health-Syst.+Pharm.%2C+1996%2C+53+%2819%29+2250.+10.1093%2Fajhp%2F53.19.2250."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fajhp%2F53.19.2250a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajhp%252F53.19.2250a%26sid%3Dliteratum%253Aachs%26atitle%3DRapid-Acting%2520Insulin%2520Approved%2520for%2520Marketing%26jtitle%3DAm.%2520J.%2520Health-Syst.%2520Pharm.%26date%3D1996%26volume%3D53%26issue%3D19%26spage%3D2250%26doi%3D10.1093%2Fajhp%2F53.19.2250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bross, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beitz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridhara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdur, R.</span></span> <span> </span><span class="NLM_article-title">Approval Summary: Gemtuzumab Ozogamicin in Relapsed Acute Myeloid Leukemia</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1490</span>– <span class="NLM_lpage">1496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=11410481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltV2iu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=1490-1496&issue=6&author=P.+F.+Brossauthor=J.+Beitzauthor=G.+Chenauthor=X.+H.+Chenauthor=E.+Duffyauthor=L.+Kiefferauthor=S.+Royauthor=R.+Sridharaauthor=A.+Rahmanauthor=G.+Williamsauthor=R.+Pazdur&title=Approval+Summary%3A+Gemtuzumab+Ozogamicin+in+Relapsed+Acute+Myeloid+Leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Approval summary: Gemtuzumab ozogamicin in relapsed acute myeloid leukemia</span></div><div class="casAuthors">Bross, Peter F.; Beitz, Julie; Chen, Gang; Chen, Xiao Hong; Duffy, Eric; Kieffer, Lydia; Roy, Sandip; Sridhara, Rajeshwari; Rahman, Atiqur; Williams, Grant; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1490-1496</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review with refs.  Gemtuzumab ozogamicin (Mylotarg; Wyeth Labs., Philadelphia, PA) consists of a semisynthetic deriv. of calicheamicin, a cytotoxic antibiotic linked to a recombinant monoclonal antibody directed against the CD33 antigen present on leukemic myeloblasts in most patients with acute myeloid leukemia (AML).  In this study, we review the preclin. and clin. profiles of this immuno-conjugate and the regulatory review that led to marketing approval by the United States Food and Drug Administration.  From the literature and manufacturer's data, we review the activity, tolerability, and pharmacokinetics of gemtuzumab ozogamicin in preclin. and Phase I studies and its activity, efficacy, and side effects in three Phase 2 trials of 142 patients with relapsed AML.  In Phase I studies, the major toxicity was myelosuppression, esp. neutropenia and thrombocytopenia, resulting from the expression of CD33 on myeloid progenitor cells.  The Phase 2 dose was 9 mg/m2 infused i.v. over 4 h, repeated on day 14.  A minority of patients experienced acute infusion-related symptoms, usually transient and occasionally requiring hospitalization.  The complete response (CR) rate with full recovery of hematopoiesis was 16%.  A subset of patients [CRs with incomplete platelet recovery (CRps)] was identified with blast clearance and neutrophil recovery but incomplete platelet recovery.  The duration of responses of CRps appeared to be similar to those of the CRs, although the nos. were small.  The question of the equivalence of these response groups was a central issue in the review of this new drug application (NDA).  After considerable discussion, the Oncol. Drugs Advisory Committee recommended allowing inclusion of CRps resulting in an overall response rate in the Phase 2 studies of 30%.  In the subgroup of patients over 60 yr of age, the overall response rate was 26%.  Response duration was difficult to establish because of the high prevalence of postremission therapies.  Tolerability and ease of administration may be improved compared with conventional chemotherapy, except for hepatotoxicity, with 31% of patients exhibiting abnormal liver enzymes.  One patient died of liver failure in the Phase 2 trials.  Marketing approval of gemtuzumab ozogamicin was granted on May 17, 2000 by the United States Food and Drug Administration under the Accelerated Approval regulations.  Gemtuzumab ozogamicin is indicated for the treatment of patients with CD33 pos. AML in first relapse who are 60 yr of age or older and who are not considered candidates for cytotoxic chemotherapy.  The approved dose was 9 mg/m2 i.v. over 4 h and repeated in 14 days.  Completion of the ongoing studies of gemtuzumab ozogamicin in relapsed AML and initiation of randomized clin. trials comparing the effects of gemtuzumab ozogamicin in combination with conventional induction chemotherapy to conventional chemotherapy alone on survival are mandated to confirm clin. benefit under the accelerated approval Subpart H regulations.  Postmarketing reports of fatal anaphylaxis, adult respiratory distress syndrome (ARDS), and hepatotoxicity, esp. venoocclusive disease (VOD) in patients treated with gemtuzumab ozogamicin, with and without assocd. hematopoietic stem cell transplantation (HSCT), have required labeling revisions and the initiation of a registration surveillance program.  Tumor lysis and ARDS have been reported in patients with leukocytes above 30,000/mL treated with gemtuzumab ozogamicin; therefore, the redn. of leukocyte counts to below 30,000/mL is recommended prior to treatment.  Patients should be carefully monitored for acute hypersensitivity, hypoxia, and delayed hepatotoxicity following treatment with gemtuzumab ozogamicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxE3VNYYST67Vg90H21EOLACvtfcHk0lgkK9PgmiFcAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltV2iu78%253D&md5=8a85e32e3113034e98f05dfbd119110b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBross%26aufirst%3DP.%2BF.%26aulast%3DBeitz%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DX.%2BH.%26aulast%3DDuffy%26aufirst%3DE.%26aulast%3DKieffer%26aufirst%3DL.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DSridhara%26aufirst%3DR.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DApproval%2520Summary%253A%2520Gemtuzumab%2520Ozogamicin%2520in%2520Relapsed%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26issue%3D6%26spage%3D1490%26epage%3D1496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">The
Lancet</span> <span> </span><span class="NLM_article-title">CAR T-Cells: An Exciting
Frontier in Cancer Therapy</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span> (<span class="NLM_issue">10099</span>),  <span class="NLM_fpage">1006</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(17)32395-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS0140-6736%2817%2932395-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=1006&issue=10099&author=The%0ALancet&title=CAR+T-Cells%3A+An+Exciting%0AFrontier+in+Cancer+Therapy&doi=10.1016%2FS0140-6736%2817%2932395-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2932395-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252932395-4%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DCAR%2520T-Cells%253A%2520An%2520Exciting%250AFrontier%2520in%2520Cancer%2520Therapy%26jtitle%3DLancet%26date%3D2017%26volume%3D390%26issue%3D10099%26spage%3D1006%26doi%3D10.1016%2FS0140-6736%2817%2932395-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gargano, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClung, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos-Outcalt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mbaeyi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dooling, K.</span></span> <span> </span><span class="NLM_article-title">The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020</span>. <i>MMWR. Morb. Mortal. Wkly. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">50</span>),  <span class="NLM_fpage">1922</span>– <span class="NLM_lpage">1924</span>, <span class="refDoi"> DOI: 10.15585/mmwr.mm6950e2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.15585%2Fmmwr.mm6950e2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=33332292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3MXltF2nuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2020&pages=1922-1924&issue=50&author=S.+E.+Oliverauthor=J.+W.+Garganoauthor=M.+Marinauthor=M.+Wallaceauthor=K.+G.+Curranauthor=M.+Chamberlandauthor=N.+McClungauthor=D.+Campos-Outcaltauthor=R.+L.+Morganauthor=S.+Mbaeyiauthor=J.+R.+Romeroauthor=H.+K.+Talbotauthor=G.+M.+Leeauthor=B.+P.+Bellauthor=K.+Dooling&title=The+Advisory+Committee+on+Immunization+Practices%E2%80%99+Interim+Recommendation+for+Use+of+Pfizer-BioNTech+COVID-19+Vaccine+-+United+States%2C+December+2020&doi=10.15585%2Fmmwr.mm6950e2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The advisory committee on immunization practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine - United States, December 2020</span></div><div class="casAuthors">Oliver, Sara E.; Gargano, Julia W.; Marin, Mona; Wallace, Megan; Curran, Kathryn G.; Chamberland, Mary; McClung, Nancy; Campos-Outcalt, Doug; Morgan, Rebecca L.; Mbaeyi, Sarah; Romero, Jose R.; Talbot, H. Keipp; Lee, Grace M.; Bell, Beth P.; Dooling, Kathleen</div><div class="citationInfo"><span class="NLM_cas:title">Morbidity and Mortality Weekly Report</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">1922-1924</span>CODEN:
                <span class="NLM_cas:coden">MMWRC7</span>;
        ISSN:<span class="NLM_cas:issn">1545-861X</span>.
    
            (<span class="NLM_cas:orgname">Centers for Disease Control and Prevention</span>)
        </div><div class="casAbstract">What is already known about this topic.  On Dec. 11, 2020, the Food and Drug Administration issued an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine.  What is added by this report.  On Dec. 12, 2020, after an explicit, evidence-based review of all available data, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years for the prevention of COVID-19.  What are the implications for public health practice.  The recommendation for the Pfizer-BioNTech COVID-19 vaccine should be implemented in conjunction with ACIP's interim recommendation for allocating initial supplies of COVID-19 vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj4Zl10Ay0TbVg90H21EOLACvtfcHk0lgkK9PgmiFcAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXltF2nuw%253D%253D&md5=c155ec652cf8d1bfa3a3faaef9e35cdd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.15585%2Fmmwr.mm6950e2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15585%252Fmmwr.mm6950e2%26sid%3Dliteratum%253Aachs%26aulast%3DOliver%26aufirst%3DS.%2BE.%26aulast%3DGargano%26aufirst%3DJ.%2BW.%26aulast%3DMarin%26aufirst%3DM.%26aulast%3DWallace%26aufirst%3DM.%26aulast%3DCurran%26aufirst%3DK.%2BG.%26aulast%3DChamberland%26aufirst%3DM.%26aulast%3DMcClung%26aufirst%3DN.%26aulast%3DCampos-Outcalt%26aufirst%3DD.%26aulast%3DMorgan%26aufirst%3DR.%2BL.%26aulast%3DMbaeyi%26aufirst%3DS.%26aulast%3DRomero%26aufirst%3DJ.%2BR.%26aulast%3DTalbot%26aufirst%3DH.%2BK.%26aulast%3DLee%26aufirst%3DG.%2BM.%26aulast%3DBell%26aufirst%3DB.%2BP.%26aulast%3DDooling%26aufirst%3DK.%26atitle%3DThe%2520Advisory%2520Committee%2520on%2520Immunization%2520Practices%25E2%2580%2599%2520Interim%2520Recommendation%2520for%2520Use%2520of%2520Pfizer-BioNTech%2520COVID-19%2520Vaccine%2520-%2520United%2520States%252C%2520December%25202020%26jtitle%3DMMWR.%2520Morb.%2520Mortal.%2520Wkly.%2520Rep.%26date%3D2020%26volume%3D69%26issue%3D50%26spage%3D1922%26epage%3D1924%26doi%3D10.15585%2Fmmwr.mm6950e2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Timofeev, V. I.</span>; <span class="NLM_string-name">Baidus, A. N.</span>; <span class="NLM_string-name">Kislitsyn, Y. A.</span>; <span class="NLM_string-name">Kuranova, I. P.</span></span> <span> </span><span class="NLM_article-title">Structure of Human Insulin (PDB ID: 3E7Y); RSC PDB,</span> <span class="NLM_year" style="font-weight: bold;">2008</span>. <span class="refDoi"> DOI: 10.2210/pdb3E7Y/pdb</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.2210%2Fpdb3E7Y%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=V.+I.+Timofeev&author=A.+N.+Baidus&author=Y.+A.+Kislitsyn&author=I.+P.+Kuranova&title=Structure+of+Human+Insulin+%28PDB+ID%3A+3E7Y%29%3B+RSC+PDB%2C&doi=10.2210%2Fpdb3E7Y%2Fpdb"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2210%2Fpdb3E7Y%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2210%252Fpdb3E7Y%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DTimofeev%26aufirst%3DV.%2BI.%26atitle%3DStructure%2520of%2520Human%2520Insulin%2520%2528PDB%2520ID%253A%25203E7Y%2529%253B%2520RSC%2520PDB%252C%26date%3D2008%26doi%3D10.2210%2Fpdb3E7Y%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lartigue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noskov, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, R.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algire, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benders, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montague, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moodie, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merryman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vashee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnakumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assad-Garcia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews-Pfannkoch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denisova, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Z.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segall-Shapiro, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvey, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchison, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venter, J. C.</span></span> <span> </span><span class="NLM_article-title">Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>329</i></span> (<span class="NLM_issue">5987</span>),  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1126/science.1190719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1126%2Fscience.1190719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=20488990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVeqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2010&pages=52-56&issue=5987&author=D.+G.+Gibsonauthor=J.+I.+Glassauthor=C.+Lartigueauthor=V.+N.+Noskovauthor=R.-Y.+Chuangauthor=M.+A.+Algireauthor=G.+A.+Bendersauthor=M.+G.+Montagueauthor=L.+Maauthor=M.+M.+Moodieauthor=C.+Merrymanauthor=S.+Vasheeauthor=R.+Krishnakumarauthor=N.+Assad-Garciaauthor=C.+Andrews-Pfannkochauthor=E.+A.+Denisovaauthor=L.+Youngauthor=Z.-Q.+Qiauthor=T.+H.+Segall-Shapiroauthor=C.+H.+Calveyauthor=P.+P.+Parmarauthor=C.+A.+Hutchisonauthor=H.+O.+Smithauthor=J.+C.+Venter&title=Creation+of+a+Bacterial+Cell+Controlled+by+a+Chemically+Synthesized+Genome&doi=10.1126%2Fscience.1190719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Creation of a bacterial cell controlled by a chemically synthesized genome</span></div><div class="casAuthors">Gibson, Daniel G.; Glass, John I.; Lartigue, Carole; Noskov, Vladimir N.; Chuang, Ray-Yuan; Algire, Mikkel A.; Benders, Gwynedd A.; Montague, Michael G.; Ma, Li; Moodie, Monzia M.; Merryman, Chuck; Vashee, Sanjay; Krishnakumar, Radha; Assad-Garcia, Nacyra; Andrews-Pfannkoch, Cynthia; Denisova, Evgeniya A.; Young, Lei; Qi, Zhi-Qing; Segall-Shapiro, Thomas H.; Calvey, Christopher H.; Parmar, Prashanth P.; Hutchison, Clyde A., III; Smith, Hamilton O.; Venter, J. Craig</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">5987</span>),
    <span class="NLM_cas:pages">52-56</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We report the design, synthesis, and assembly of the 1.08-mega-base pair Mycoplasma mycoides JCVI-syn1.0 genome starting from digitized genome sequence information and its transplantation into a M. capricolum recipient cell to create new M. mycoides cells that are controlled only by the synthetic chromosome.  The only DNA in the cells is the designed synthetic DNA sequence, including "watermark" sequences and other designed gene deletions and polymorphisms, and mutations acquired during the building process.  The new cells have expected phenotypic properties and are capable of continuous self-replication.  The complete, annotated synthetic genome sequence is deposited in GenBank/EMBL/DDBJ with accession no. CP002027.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPBfMgKBs4-7Vg90H21EOLACvtfcHk0li6SA2FnqoVzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVeqsLg%253D&md5=f978c98f3e5c3c9b14bd4c7d8a1eecc7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscience.1190719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1190719%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DD.%2BG.%26aulast%3DGlass%26aufirst%3DJ.%2BI.%26aulast%3DLartigue%26aufirst%3DC.%26aulast%3DNoskov%26aufirst%3DV.%2BN.%26aulast%3DChuang%26aufirst%3DR.-Y.%26aulast%3DAlgire%26aufirst%3DM.%2BA.%26aulast%3DBenders%26aufirst%3DG.%2BA.%26aulast%3DMontague%26aufirst%3DM.%2BG.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DMoodie%26aufirst%3DM.%2BM.%26aulast%3DMerryman%26aufirst%3DC.%26aulast%3DVashee%26aufirst%3DS.%26aulast%3DKrishnakumar%26aufirst%3DR.%26aulast%3DAssad-Garcia%26aufirst%3DN.%26aulast%3DAndrews-Pfannkoch%26aufirst%3DC.%26aulast%3DDenisova%26aufirst%3DE.%2BA.%26aulast%3DYoung%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DZ.-Q.%26aulast%3DSegall-Shapiro%26aufirst%3DT.%2BH.%26aulast%3DCalvey%26aufirst%3DC.%2BH.%26aulast%3DParmar%26aufirst%3DP.%2BP.%26aulast%3DHutchison%26aufirst%3DC.%2BA.%26aulast%3DSmith%26aufirst%3DH.%2BO.%26aulast%3DVenter%26aufirst%3DJ.%2BC.%26atitle%3DCreation%2520of%2520a%2520Bacterial%2520Cell%2520Controlled%2520by%2520a%2520Chemically%2520Synthesized%2520Genome%26jtitle%3DScience%26date%3D2010%26volume%3D329%26issue%3D5987%26spage%3D52%26epage%3D56%26doi%3D10.1126%2Fscience.1190719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malyshev, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavergne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrêa, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romesberg, F. E.</span></span> <span> </span><span class="NLM_article-title">A Semi-Synthetic Organism with an Expanded Genetic Alphabet</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>509</i></span> (<span class="NLM_issue">7500</span>),  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1038/nature13314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnature13314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=24805238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVyqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=509&publication_year=2014&pages=385-388&issue=7500&author=D.+A.+Malyshevauthor=K.+Dhamiauthor=T.+Lavergneauthor=T.+Chenauthor=N.+Daiauthor=J.+M.+Fosterauthor=I.+R.+Corr%C3%AAaauthor=F.+E.+Romesberg&title=A+Semi-Synthetic+Organism+with+an+Expanded+Genetic+Alphabet&doi=10.1038%2Fnature13314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A semi-synthetic organism with an expanded genetic alphabet</span></div><div class="casAuthors">Malyshev, Denis A.; Dhami, Kirandeep; Lavergne, Thomas; Chen, Tingjian; Dai, Nan; Foster, Jeremy M.; Correa, Ivan R.; Romesberg, Floyd E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">509</span>
        (<span class="NLM_cas:issue">7500</span>),
    <span class="NLM_cas:pages">385-388</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Organisms are defined by the information encoded in their genomes, and since the origin of life this information has been encoded using a two-base-pair genetic alphabet (A-T and G-C).  In vitro, the alphabet has been expanded to include several unnatural base pairs (UBPs).  We have developed a class of UBPs formed between nucleotides bearing hydrophobic nucleobases, exemplified by the pair formed between d5SICS and dNaM (d5SICS-dNaM), which is efficiently PCR-amplified and transcribed in vitro, and whose unique mechanism of replication has been characterized.  However, expansion of an organism's genetic alphabet presents new and unprecedented challenges: the unnatural nucleoside triphosphates must be available inside the cell; endogenous polymerases must be able to use the unnatural triphosphates to faithfully replicate DNA contg. the UBP within the complex cellular milieu; and finally, the UBP must be stable in the presence of pathways that maintain the integrity of DNA.  Here we show that an exogenously expressed algal nucleotide triphosphate transporter efficiently imports the triphosphates of both d5SICS and dNaM (d5SICSTP and dNaMTP) into Escherichia coli, and that the endogenous replication machinery uses them to accurately replicate a plasmid contg. d5SICS-dNaM.  Neither the presence of the unnatural triphosphates nor the replication of the UBP introduces a notable growth burden.  Lastly, we find that the UBP is not efficiently excised by DNA repair pathways.  Thus, the resulting bacterium is the first organism to propagate stably an expanded genetic alphabet.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgwP1p83TK1LVg90H21EOLACvtfcHk0ljFGTBg2QXQAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVyqtb8%253D&md5=97b4b184cda52cc809b1705e5e88ad8e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature13314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13314%26sid%3Dliteratum%253Aachs%26aulast%3DMalyshev%26aufirst%3DD.%2BA.%26aulast%3DDhami%26aufirst%3DK.%26aulast%3DLavergne%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DN.%26aulast%3DFoster%26aufirst%3DJ.%2BM.%26aulast%3DCorr%25C3%25AAa%26aufirst%3DI.%2BR.%26aulast%3DRomesberg%26aufirst%3DF.%2BE.%26atitle%3DA%2520Semi-Synthetic%2520Organism%2520with%2520an%2520Expanded%2520Genetic%2520Alphabet%26jtitle%3DNature%26date%3D2014%26volume%3D509%26issue%3D7500%26spage%3D385%26epage%3D388%26doi%3D10.1038%2Fnature13314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Powell, K.</span></span> <span> </span><span class="NLM_article-title">How Biologists Are Creating Life-like Cells from Scratch</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>563</i></span> (<span class="NLM_issue">7730</span>),  <span class="NLM_fpage">172</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1038/d41586-018-07289-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fd41586-018-07289-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=30405232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFejsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=563&publication_year=2018&pages=172-175&issue=7730&author=K.+Powell&title=How+Biologists+Are+Creating+Life-like+Cells+from+Scratch&doi=10.1038%2Fd41586-018-07289-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">How biologists are creating life-like cells from scratch</span></div><div class="casAuthors">Powell, Kendall</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">563</span>
        (<span class="NLM_cas:issue">7730</span>),
    <span class="NLM_cas:pages">172-175</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Built from the bottom up, synthetic cells and other creations are starting to come together and could soon test the boundaries of life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMM6QE2kl8ErVg90H21EOLACvtfcHk0ljFGTBg2QXQAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFejsbbF&md5=43ad5b99be3137e9bae225f6a88c031e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fd41586-018-07289-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fd41586-018-07289-x%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DK.%26atitle%3DHow%2520Biologists%2520Are%2520Creating%2520Life-like%2520Cells%2520from%2520Scratch%26jtitle%3DNature%26date%3D2018%26volume%3D563%26issue%3D7730%26spage%3D172%26epage%3D175%26doi%3D10.1038%2Fd41586-018-07289-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, M. H.</span></span> <span> </span><span class="NLM_article-title">A Completely De Novo ATPase from Combinatorial Protein Design</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">15230</span>– <span class="NLM_lpage">15234</span>, <span class="refDoi"> DOI: 10.1021/jacs.0c02954</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.0c02954" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1GrsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2020&pages=15230-15234&issue=36&author=M.+S.+Wangauthor=M.+H.+Hecht&title=A+Completely+De+Novo+ATPase+from+Combinatorial+Protein+Design&doi=10.1021%2Fjacs.0c02954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A completely de novo ATPase from combinatorial protein design</span></div><div class="casAuthors">Wang, Michael S.; Hecht, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">15230-15234</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Our understanding of biol. chem. is shaped by the observation that all life comes from other life-as Pasteur put it, omne vivum ex vivo.  A key step in expanding our biochem. vocabulary is to recapitulate biogenic catalysis using non-natural sequences that did not arise from common ancestry.  Here we describe an enzyme designed completely de novo that hydrolyzes ATP.  This protein was designed to lack β-sheet structure and is competitively inhibited by magnesium, two traits that are unlike natural ATPases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtlrIZve8BA7Vg90H21EOLACvtfcHk0ljFGTBg2QXQAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1GrsLjE&md5=976aa54a0e80422b8a195c50a0ee2010</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjacs.0c02954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.0c02954%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%2BS.%26aulast%3DHecht%26aufirst%3DM.%2BH.%26atitle%3DA%2520Completely%2520De%2520Novo%2520ATPase%2520from%2520Combinatorial%2520Protein%2520Design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2020%26volume%3D142%26issue%3D36%26spage%3D15230%26epage%3D15234%26doi%3D10.1021%2Fjacs.0c02954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, D.</span>; <span class="NLM_string-name">Pazdernik, N.</span></span> <i>Biotechnology</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Academic Cell</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+Clark&author=N.+Pazdernik&title=Biotechnology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%26btitle%3DBiotechnology%26pub%3DAcademic%2520Cell%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maini, R. N.</span></span> <span> </span><span class="NLM_article-title">TNF Defined as a Therapeutic Target for Rheumatoid Arthritis and Other Autoimmune Diseases</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1245</span>– <span class="NLM_lpage">1250</span>, <span class="refDoi"> DOI: 10.1038/nm939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnm939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=14520364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1Cksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=1245-1250&issue=10&author=M.+Feldmannauthor=R.+N.+Maini&title=TNF+Defined+as+a+Therapeutic+Target+for+Rheumatoid+Arthritis+and+Other+Autoimmune+Diseases&doi=10.1038%2Fnm939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases</span></div><div class="casAuthors">Feldmann, Marc; Maini, Ravinder N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1245-1250</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVrPP8cx-5NrVg90H21EOLACvtfcHk0ljFGTBg2QXQAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1Cksr0%253D&md5=5a47a0d9196b0be19eb25cdab5d17b9e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnm939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm939%26sid%3Dliteratum%253Aachs%26aulast%3DFeldmann%26aufirst%3DM.%26aulast%3DMaini%26aufirst%3DR.%2BN.%26atitle%3DTNF%2520Defined%2520as%2520a%2520Therapeutic%2520Target%2520for%2520Rheumatoid%2520Arthritis%2520and%2520Other%2520Autoimmune%2520Diseases%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26issue%3D10%26spage%3D1245%26epage%3D1250%26doi%3D10.1038%2Fnm939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Regulation of Tumour Necrosis Factor Signalling: Live or Let Die</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1038/nri3834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnri3834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26008591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=362-374&issue=6&author=D.+Brennerauthor=H.+Blaserauthor=T.+W.+Mak&title=Regulation+of+Tumour+Necrosis+Factor+Signalling%3A+Live+or+Let+Die&doi=10.1038%2Fnri3834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of tumour necrosis factor signalling: live or let die</span></div><div class="casAuthors">Brenner, Dirk; Blaser, Heiko; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">362-374</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is a pro-inflammatory cytokine that has important roles in mammalian immunity and cellular homeostasis.  Deregulation of TNF receptor (TNFR) signalling is assocd. with many inflammatory disorders, including various types of arthritis and inflammatory bowel disease, and targeting TNF has been an effective therapeutic strategy in these diseases.  This Review focuses on the recent advances that have been made in understanding TNFR signalling and the consequences of its deregulation for cellular survival, apoptosis and regulated necrosis.  We discuss how TNF-induced survival signals are distinguished from those that lead to cell death.  Finally, we provide a brief overview of the role of TNF in inflammatory and autoimmune diseases, and we discuss up-to-date and future treatment strategies for these disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwd5YDL8raprVg90H21EOLACvtfcHk0lh9WF0N319C1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7jJ&md5=adc251b8af3f6e4d5fc04262c597f67f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnri3834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3834%26sid%3Dliteratum%253Aachs%26aulast%3DBrenner%26aufirst%3DD.%26aulast%3DBlaser%26aufirst%3DH.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DRegulation%2520of%2520Tumour%2520Necrosis%2520Factor%2520Signalling%253A%2520Live%2520or%2520Let%2520Die%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26issue%3D6%26spage%3D362%26epage%3D374%26doi%3D10.1038%2Fnri3834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinarello, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Meer, J. W. M.</span></span> <span> </span><span class="NLM_article-title">Treating Inflammation by Blocking Interleukin-1 in a Broad Spectrum of Diseases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1038/nrd3800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnrd3800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=22850787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=633-652&issue=8&author=C.+A.+Dinarelloauthor=A.+Simonauthor=J.+W.+M.+van+der+Meer&title=Treating+Inflammation+by+Blocking+Interleukin-1+in+a+Broad+Spectrum+of+Diseases&doi=10.1038%2Fnrd3800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases</span></div><div class="casAuthors">Dinarello, Charles A.; Simon, Anna; van der Meer, Jos W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">633-652</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Interleukin-1 (IL-1) is a highly active pro-inflammatory cytokine that lowers pain thresholds and damages tissues.  Monotherapy blocking IL-1 activity in autoinflammatory syndromes results in a rapid and sustained redn. in disease severity, including reversal of inflammation-mediated loss of sight, hearing and organ function.  This approach can therefore be effective in treating common conditions such as post-infarction heart failure, and trials targeting a broad spectrum of new indications are underway.  So far, three IL-1-targeted agents have been approved: the IL-1 receptor antagonist anakinra, the sol. decoy receptor rilonacept and the neutralizing monoclonal anti-IL-1β antibody canakinumab.  In addn., a monoclonal antibody directed against the IL-1 receptor and a neutralizing anti-IL-1α antibody are in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6wcqDUVKRhLVg90H21EOLACvtfcHk0lh9WF0N319C1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmtrfJ&md5=9297c8530f9d2c75da0880a7df7c1fe2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnrd3800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3800%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%2BM.%26atitle%3DTreating%2520Inflammation%2520by%2520Blocking%2520Interleukin-1%2520in%2520a%2520Broad%2520Spectrum%2520of%2520Diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26issue%3D8%26spage%3D633%26epage%3D652%26doi%3D10.1038%2Fnrd3800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.9b01285</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.9b01285" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXks1Cmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2020&pages=770-803&issue=3&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+Products+as+Sources+of+New+Drugs+over+the+Nearly+Four+Decades+from+01%2F1981+to+09%2F2019&doi=10.1021%2Facs.jnatprod.9b01285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">770-803</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">This review is an updated and expanded version of the five prior reviews that were published in this journal in 1997, 2003, 2007, 2012, and 2016.  For all approved therapeutic agents, the time frame has been extended to cover the almost 39 years from the first of Jan. 1981 to the 30th of Sept. 2019 for all diseases worldwide and from ∼1946 (earliest so far identified) to the 30th of Sept. 2019 for all approved antitumor drugs worldwide.  As in earlier reviews, only the first approval of any drug is counted, irresp. of how many "biosimilars" or added approvals were subsequently identified.  As in the 2012 and 2016 reviews, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions, and the designation "natural product botanical", or "NB", to cover those botanical "defined mixts." now recognized as drug entities by the FDA (and similar organizations).  From the data presented in this review, the utilization of natural products and/or synthetic variations using their novel structures, in order to discover and develop the final drug entity, is still alive and well.  For example, in the area of cancer, over the time frame from 1946 to 1980, of the 75 small mols., 40, or 53.3%, are N or ND.  In the 1981 to date time frame the equiv. figures for the N* compds. of the 185 small mols. are 62, or 33.5%, though to these can be added the 58 S* and S*/NMs, bringing the figure to 64.9%.  In other areas, the influence of natural product structures is quite marked with, as expected from prior information, the anti-infective area being dependent on natural products and their structures, though as can be seen in the review there are still disease areas (shown in Table 2) for which there are no drugs derived from natural products.  Although combinatorial chem. techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are still able to identify only two de novo combinatorial compds. (one of which is a little speculative) approved as drugs in this 39-yr time frame, though there is also one drug that was developed using the "fragment-binding methodol." and approved in 2012.  We have also added a discussion of candidate drug entities currently in clin. trials as "warheads" and some very interesting preliminary reports on sources of novel antibiotics from Nature due to the abs. requirement for new agents to combat plasmid-borne resistance genes now in the general populace.  We continue to draw the attention of readers to the recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated"; thus we consider that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9vVZR4nleEbVg90H21EOLACvtfcHk0lh9WF0N319C1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXks1Cmsrw%253D&md5=2c10c2aef98042d8bd772b6280b51d2b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.9b01285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.9b01285%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520Products%2520as%2520Sources%2520of%2520New%2520Drugs%2520over%2520the%2520Nearly%2520Four%2520Decades%2520from%252001%252F1981%2520to%252009%252F2019%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2020%26volume%3D83%26issue%3D3%26spage%3D770%26epage%3D803%26doi%3D10.1021%2Facs.jnatprod.9b01285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIsaac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wren, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. T.</span></span> <span> </span><span class="NLM_article-title">Market Share and Costs of Biologic Therapies for Inflammatory Bowel Disease in the USA</span>. <i>Aliment. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.1111/apt.14430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1111%2Fapt.14430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=29164650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmt1elsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=364-370&issue=3&author=H.+Yuauthor=D.+MacIsaacauthor=J.+J.+Wongauthor=Z.+M.+Sellersauthor=A.+A.+Wrenauthor=R.+Bensenauthor=C.+Kinauthor=K.+T.+Park&title=Market+Share+and+Costs+of+Biologic+Therapies+for+Inflammatory+Bowel+Disease+in+the+USA&doi=10.1111%2Fapt.14430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Market share and costs of biologic therapies for inflammatory bowel disease in the USA</span></div><div class="casAuthors">Yu, H.; MacIsaac, D.; Wong, J. J.; Sellers, Z. M.; Wren, A. A.; Bensen, R.; Kin, C.; Park, K. T.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">364-370</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Background : Real-world data quantifying the costs of increasing use of biologics in inflammatory bowel disease (IBD) are unknown.  Aim : To det. the outpatient IBD drug utilization trends, relative market share, and costs in the USA during a 9-yr period.  Methods : The Truven MarketScan Database was analyzed for patients with Crohn's disease (CD) and ulcerative colitis (UC) during 2007-2015.  National drug codes were used to identify prescription drugs; Healthcare Common Procedure Coding System J-codes were used to capture biol. out-patient infusions.  Proportion of drug usage, relative market share and per-member per-yr (PMPY) costs were analyzed for biologics, immunomodulators, 5-ASAs and corticosteroids.  Results : In 415 405 patients (188 842 CD; 195 183 UC; 31 380 indeterminate colitis; 54.67% female), utilization trends show a consistent rise in the market share of biologics during the 9-yr study period.  The proportion of patients using biologics increased from 21.8% to 43.8% for CD and 5.1%-16.2% for UC.  This contrasts a small decrease in immunomodulator and 5-ASA use for CD and relative constancy of other classes including corticosteroids-only use as primary IBD medication from 2007 to 2015.  The av. biol.-taking patient accounted for 25 275 PMPY in 2007 and 36 051 PMPY in 2015.  The av. paediatric biol.-taking patient accounted for 23 616 PMPY in 2007 and 41 109 PMPY in 2015.  In all patients, the share of costs for biologics increased from 72.9% in 2007 to 85.7% in 2015 (81.7% in 2007 to 94.9% in 2015 in paediatrics).  Conclusion : The vast majority of costs allocated to out-patient IBD medications in the USA is attributed to increasing use of biol. therapies despite the relative minority of biol.-taking patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdJoBG67JeN7Vg90H21EOLACvtfcHk0lhfLfYlySM3Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmt1elsg%253D%253D&md5=bc8bb2062cef56a3c2b6ec7343060353</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fapt.14430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fapt.14430%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DMacIsaac%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DJ.%2BJ.%26aulast%3DSellers%26aufirst%3DZ.%2BM.%26aulast%3DWren%26aufirst%3DA.%2BA.%26aulast%3DBensen%26aufirst%3DR.%26aulast%3DKin%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DK.%2BT.%26atitle%3DMarket%2520Share%2520and%2520Costs%2520of%2520Biologic%2520Therapies%2520for%2520Inflammatory%2520Bowel%2520Disease%2520in%2520the%2520USA%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2018%26volume%3D47%26issue%3D3%26spage%3D364%26epage%3D370%26doi%3D10.1111%2Fapt.14430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulman, K. A.</span></span> <span> </span><span class="NLM_article-title">The Impact Of Specialty Pharmaceuticals As Drivers Of Health Care Costs</span>. <i>Health Aff.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1714</span>– <span class="NLM_lpage">1720</span>, <span class="refDoi"> DOI: 10.1377/hlthaff.2014.0558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1377%2Fhlthaff.2014.0558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A280%3ADC%252BC2M7otVKjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=1714-1720&issue=10&author=B.+R.+Hirschauthor=S.+Baluauthor=K.+A.+Schulman&title=The+Impact+Of+Specialty+Pharmaceuticals+As+Drivers+Of+Health+Care+Costs&doi=10.1377%2Fhlthaff.2014.0558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of specialty pharmaceuticals as drivers of health care costs</span></div><div class="casAuthors">Hirsch Bradford R; Balu Suresh; Schulman Kevin A</div><div class="citationInfo"><span class="NLM_cas:title">Health affairs (Project Hope)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1714-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pharmaceutical industry is shifting its focus from blockbuster small molecules to specialty pharmaceuticals.  Specialty pharmaceuticals are novel drugs and biologic agents that require special handling and ongoing monitoring, are administered by injection or infusion, and are sold in the marketplace by a small number of distributors.  They are frequently identified by having a cost to payers and patients of $600 or more per treatment.  The total costs of the new agents are likely to have a substantial impact on overall health care costs and on patients during the next decade, unless steps are taken to align competing interests.  We examine the economic and policy issues related to specialty pharmaceuticals, taking care to consider the impact on patients.  We assess the role of cost-sharing provisions, legislation that is promoting realignment within the market, the role of biosimilars in price competition, and the potential for novel drug development paradigms to help bend the cost curve.  The economic aspects of this analysis highlight the need for a far-reaching discussion of potential novel approaches to innovation pathways in our quest for both affordability and new technology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRjBxt52rBKcJZoeNcnHOQ9fW6udTcc2eaZXKH-IKi7Obntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7otVKjug%253D%253D&md5=1cecaafff39d7069104b734d5f06f6cc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1377%2Fhlthaff.2014.0558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1377%252Fhlthaff.2014.0558%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch%26aufirst%3DB.%2BR.%26aulast%3DBalu%26aufirst%3DS.%26aulast%3DSchulman%26aufirst%3DK.%2BA.%26atitle%3DThe%2520Impact%2520Of%2520Specialty%2520Pharmaceuticals%2520As%2520Drivers%2520Of%2520Health%2520Care%2520Costs%26jtitle%3DHealth%2520Aff.%26date%3D2014%26volume%3D33%26issue%3D10%26spage%3D1714%26epage%3D1720%26doi%3D10.1377%2Fhlthaff.2014.0558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespi-Lofton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skelton, J. B.</span></span> <span> </span><span class="NLM_article-title">The Growing Role of Biologics and Biosimilars in the United States: Perspectives from the APhA Biologics and Biosimilars Stakeholder Conference</span>. <i>J. Am. Pharm. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">e15</span>– <span class="NLM_lpage">e27</span>, <span class="refDoi"> DOI: 10.1016/j.japh.2017.05.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.japh.2017.05.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=e15-e27&issue=5&author=J.+Crespi-Loftonauthor=J.+B.+Skelton&title=The+Growing+Role+of+Biologics+and+Biosimilars+in+the+United+States%3A+Perspectives+from+the+APhA+Biologics+and+Biosimilars+Stakeholder+Conference&doi=10.1016%2Fj.japh.2017.05.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.japh.2017.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.japh.2017.05.014%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi-Lofton%26aufirst%3DJ.%26aulast%3DSkelton%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520Growing%2520Role%2520of%2520Biologics%2520and%2520Biosimilars%2520in%2520the%2520United%2520States%253A%2520Perspectives%2520from%2520the%2520APhA%2520Biologics%2520and%2520Biosimilars%2520Stakeholder%2520Conference%26jtitle%3DJ.%2520Am.%2520Pharm.%2520Assoc.%26date%3D2017%26volume%3D57%26issue%3D5%26spage%3De15%26epage%3De27%26doi%3D10.1016%2Fj.japh.2017.05.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D.</span></span> <span> </span><span class="NLM_article-title">Rise of the Biologics</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1039/C7MD90046E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC7MD90046E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=30108898" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=10-11&issue=1&author=D.+Lowe&title=Rise+of+the+Biologics&doi=10.1039%2FC7MD90046E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2FC7MD90046E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD90046E%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DD.%26atitle%3DRise%2520of%2520the%2520Biologics%26jtitle%3DMedChemComm%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D10%26epage%3D11%26doi%3D10.1039%2FC7MD90046E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span> <i>Principles and Applications of Fermentation Technology</i>, <span class="NLM_contrib-group"><span class="NLM_string-name">Kuila, A.</span>; <span class="NLM_string-name">Sharma, V.</span></span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ, USA</span>, <span class="NLM_year">2018</span>. <span class="refDoi"> DOI: 10.1002/9781119460381</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2F9781119460381" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=A.+Kuila&author=V.+Sharma&title=Principles+and+Applications+of+Fermentation+Technology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2F9781119460381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781119460381%26sid%3Dliteratum%253Aachs%26btitle%3DPrinciples%2520and%2520Applications%2520of%2520Fermentation%2520Technology%26aulast%3DKuila%26aufirst%3DA.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2018%26doi%3D10.1002%2F9781119460381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Cruz, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutureira, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, G. J. L.</span></span> <span> </span><span class="NLM_article-title">Site-Selective Protein-Modification Chemistry for Basic Biology and Drug Development</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1038/nchem.2393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnchem.2393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26791892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFemsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=103-113&issue=2&author=N.+Krallauthor=F.+P.+da+Cruzauthor=O.+Boutureiraauthor=G.+J.+L.+Bernardes&title=Site-Selective+Protein-Modification+Chemistry+for+Basic+Biology+and+Drug+Development&doi=10.1038%2Fnchem.2393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Site-selective protein-modification chemistry for basic biology and drug development</span></div><div class="casAuthors">Krall, Nikolaus; da Cruz, Filipa P.; Boutureira, Omar; Bernardes, Goncalo J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">103-113</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nature has produced intricate machinery to covalently diversify the structure of proteins after their synthesis in the ribosome.  In an attempt to mimic nature, chemists have developed a large set of reactions that enable post-expression modification of proteins at pre-detd. sites.  These reactions are now used to selectively install particular modifications on proteins for many biol. and therapeutic applications.  For example, they provide an opportunity to install post-translational modifications on proteins to det. their exact biol. roles.  Labeling of proteins in live cells with fluorescent dyes allows protein uptake and intracellular trafficking to be tracked and also enables physiol. parameters to be measured optically.  Through the conjugation of potent cytotoxicants to antibodies, novel anti-cancer drugs with improved efficacy and reduced side effects may be obtained.  In this Perspective, we highlight the most exciting current and future applications of chem. site-selective protein modification and consider which hurdles still need to be overcome for more widespread use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCXe9yoL2S-bVg90H21EOLACvtfcHk0li1ZiYPXrbR-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFemsbrI&md5=9a8f675a512f1286c5d88c6692d8773c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2393%26sid%3Dliteratum%253Aachs%26aulast%3DKrall%26aufirst%3DN.%26aulast%3Dda%2BCruz%26aufirst%3DF.%2BP.%26aulast%3DBoutureira%26aufirst%3DO.%26aulast%3DBernardes%26aufirst%3DG.%2BJ.%2BL.%26atitle%3DSite-Selective%2520Protein-Modification%2520Chemistry%2520for%2520Basic%2520Biology%2520and%2520Drug%2520Development%26jtitle%3DNat.%2520Chem.%26date%3D2016%26volume%3D8%26issue%3D2%26spage%3D103%26epage%3D113%26doi%3D10.1038%2Fnchem.2393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adamo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutureira, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, G. J. L.</span></span> <span> </span><span class="NLM_article-title">Synthetically Defined Glycoprotein Vaccines: Current Status and Future Directions</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2995</span>– <span class="NLM_lpage">3008</span>, <span class="refDoi"> DOI: 10.1039/c3sc50862e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2Fc3sc50862e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=25893089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVehs7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2995-3008&issue=8&author=R.+Adamoauthor=A.+Niloauthor=B.+Castagnerauthor=O.+Boutureiraauthor=F.+Bertiauthor=G.+J.+L.+Bernardes&title=Synthetically+Defined+Glycoprotein+Vaccines%3A+Current+Status+and+Future+Directions&doi=10.1039%2Fc3sc50862e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetically defined glycoprotein vaccines: current status and future directions</span></div><div class="casAuthors">Adamo, Roberto; Nilo, Alberto; Castagner, Bastien; Boutureira, Omar; Berti, Francesco; Bernardes, Goncalo J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2995-3008</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Primary examples in vaccine design have shown good levels of carbohydrate-specific antibody generation when raised using extd. or fully synthetic capsular polysaccharide glycans covalently coupled to a protein carrier.  Herein, the authors cover recent clin. developments of carbohydrate-based vaccines and describe how novel cutting-edge methodol. for the total synthesis of oligosaccharides and for the precise placement of carbohydrates at pre-detd. sites within a protein may be used to further improve the safety and efficacy of glycovaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhC--VhdicaLVg90H21EOLACvtfcHk0li1ZiYPXrbR-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVehs7jN&md5=eb09336f0a6302efb364de7539fd94a4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2Fc3sc50862e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3sc50862e%26sid%3Dliteratum%253Aachs%26aulast%3DAdamo%26aufirst%3DR.%26aulast%3DNilo%26aufirst%3DA.%26aulast%3DCastagner%26aufirst%3DB.%26aulast%3DBoutureira%26aufirst%3DO.%26aulast%3DBerti%26aufirst%3DF.%26aulast%3DBernardes%26aufirst%3DG.%2BJ.%2BL.%26atitle%3DSynthetically%2520Defined%2520Glycoprotein%2520Vaccines%253A%2520Current%2520Status%2520and%2520Future%2520Directions%26jtitle%3DChem.%2520Sci.%26date%3D2013%26volume%3D4%26issue%3D8%26spage%3D2995%26epage%3D3008%26doi%3D10.1039%2Fc3sc50862e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span></span> <span> </span><span class="NLM_article-title">From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">836</span>– <span class="NLM_lpage">863</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(20000303)39:5<836::AID-ANIE836>3.0.CO;2-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2F%28SICI%291521-3773%2820000303%2939%3A5%3C836%3A%3AAID-ANIE836%3E3.0.CO%3B2-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFSns7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=836-863&issue=5&author=S.+J.+Danishefskyauthor=J.+R.+Allen&title=From+the+Laboratory+to+the+Clinic%3A+A+Retrospective+on+Fully+Synthetic+Carbohydrate-Based+Anticancer+Vaccines&doi=10.1002%2F%28SICI%291521-3773%2820000303%2939%3A5%3C836%3A%3AAID-ANIE836%3E3.0.CO%3B2-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">From the laboratory to the clinic: a retrospective on fully synthetic carbohydrate-based anticancer vaccines</span></div><div class="casAuthors">Danishefsky, Samuel J.; Allen, Jennifer R.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">836-863</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A review with many refs. on authors' explorations into oligosaccharide and glycoconjugate construction for the creation and evaluation of vaccines based on carbohydrate-centered tumor antigens.  The starting point was the known tendency of transformed cells to express selective carbohydrate motifs in the form of glycoproteins or glycolipids.  Anticancer vaccines derived from carbohydrate-based antigens could be effective targets for immune recognition and attack.  Obtaining significant quantities of such structures from natural sources is extremely difficult.  With the total synthesis of tumor-assocd. carbohydrate antigens accomplished, the evaluation at the clin. level was initiated whether the human immune system can respond to such fully synthetic antigens in a focused and useful way.  Toward this goal the resources of chem. and immunol. in an attack on the problem were merged.  The synthesis and immunoconjugation of various tumor-assocd. carbohydrate antigens and the results of such constructs in mice vaccinations are described.  For fashioning an effective vaccine, conjugation to a suitable immunogenic carrier was necessary and conjugates of keyhole limpet cyanin have consistently demonstrated the relevant immunogenicity.  Preclin. and clin. studies with synthetic conjugate carbohydrate vaccines show induction of IgM- and IgG-antibody responses.  Another approach to anticancer vaccines involves the use of clustered glycopeptides as targets for immune attack.  Initial attention has been directed to mucin-related O-linked glycopeptides.  Synthetic trimeric clusters of glycoepitopes derived from the Tn-, TF- and Lewisy-antigens, appropriately bioconjugated, have been demonstrated to be immunogenic.  The hope is that patients immunized in an adjuvant manner with synthetic carbohydrate vaccines would produce antibodies reactive with cancer cells and that the prodn. of such antibodies would mitigate against tumor spread, thereby enabling a more favorable survival and "quality of life" prognosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj1D_JGqYFi7Vg90H21EOLACvtfcHk0li1ZiYPXrbR-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFSns7s%253D&md5=0a800658fba553abe968b57db53ce28e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2820000303%2939%3A5%3C836%3A%3AAID-ANIE836%3E3.0.CO%3B2-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252820000303%252939%253A5%253C836%253A%253AAID-ANIE836%253E3.0.CO%253B2-I%26sid%3Dliteratum%253Aachs%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DFrom%2520the%2520Laboratory%2520to%2520the%2520Clinic%253A%2520A%2520Retrospective%2520on%2520Fully%2520Synthetic%2520Carbohydrate-Based%2520Anticancer%2520Vaccines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2000%26volume%3D39%26issue%3D5%26spage%3D836%26epage%3D863%26doi%3D10.1002%2F%28SICI%291521-3773%2820000303%2939%3A5%3C836%3A%3AAID-ANIE836%3E3.0.CO%3B2-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelegri-O’Day, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, E.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maynard, H. D.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Protein-Polymer Conjugates: Advancing Beyond PEGylation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">14323</span>– <span class="NLM_lpage">14332</span>, <span class="refDoi"> DOI: 10.1021/ja504390x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja504390x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFCjsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=14323-14332&issue=41&author=E.+M.+Pelegri-O%E2%80%99Dayauthor=E.-W.+Linauthor=H.+D.+Maynard&title=Therapeutic+Protein-Polymer+Conjugates%3A+Advancing+Beyond+PEGylation&doi=10.1021%2Fja504390x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Protein-Polymer Conjugates: Advancing Beyond PEGylation</span></div><div class="casAuthors">Pelegri-O'Day, Emma M.; Lin, En-Wei; Maynard, Heather D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">14323-14332</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Protein-polymer conjugates are widely used as therapeutics.  All Food and Drug Administration (FDA)-approved protein conjugates are covalently linked to poly(ethylene glycol) (PEG).  These PEGylated drugs have longer half-lives in the bloodstream, leading to less frequent dosing, which is a significant advantage for patients.  However, there are some potential drawbacks to PEG that are driving the development of alternatives.  Polymers that display enhanced pharmacokinetic properties along with addnl. advantages such as improved stability or degradability will be important to advance the field of protein therapeutics.  This perspective presents a summary of protein-PEG conjugates for therapeutic use and alternative technologies in various stages of development as well as suggestions for future directions.  Established methods of producing protein-PEG conjugates and new approaches utilizing controlled radical polymn. are also covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO4BZRwq_slrVg90H21EOLACvtfcHk0lhdFexvr40suw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCjsLfI&md5=784f96a81f2c6f6bfba8b4dadb31bdcb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja504390x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja504390x%26sid%3Dliteratum%253Aachs%26aulast%3DPelegri-O%25E2%2580%2599Day%26aufirst%3DE.%2BM.%26aulast%3DLin%26aufirst%3DE.-W.%26aulast%3DMaynard%26aufirst%3DH.%2BD.%26atitle%3DTherapeutic%2520Protein-Polymer%2520Conjugates%253A%2520Advancing%2520Beyond%2520PEGylation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26issue%3D41%26spage%3D14323%26epage%3D14332%26doi%3D10.1021%2Fja504390x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkenblit, A.</span></span> <span> </span><span class="NLM_article-title">Antibody-Drug Conjugates for Cancer Treatment</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1146/annurev-med-061516-121357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1146%2Fannurev-med-061516-121357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=29414262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVCns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2018&pages=191-207&issue=1&author=J.+M.+Lambertauthor=A.+Berkenblit&title=Antibody-Drug+Conjugates+for+Cancer+Treatment&doi=10.1146%2Fannurev-med-061516-121357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-Drug Conjugates for Cancer Treatment</span></div><div class="casAuthors">Lambert, John M.; Berkenblit, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191-207</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The concept of exploiting the specific binding properties of monoclonal antibodies as a mechanism for selective delivery of cytotoxic agents to tumor cells is an attractive soln. to the challenge of increasing the therapeutic index of cell-killing agents for treating cancer.  All three parts of an antibody-drug conjugate (ADC)-the antibody, the cytotoxic payload, and the linker chem. that joins them together-as well as the biol. properties of the cell-surface target antigen are important in designing an effective anticancer agent.  The approval of brentuximab vedotin in 2011 for treating relapsed Hodgkin's lymphoma and systemic anaplastic large cell lymphoma, and the approval of ado-trastuzumab emtansine in 2013 for treating HER2-pos. metastatic breast cancer, have sparked vigorous research in the field, with >65 ADCs currently in clin. evaluation.  This review highlights the ADCs that are approved for marketing, in pivotal clin. trials, or in at least phase II clin. development for treating both hematol. malignancies and solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_IOG6MLM3DbVg90H21EOLACvtfcHk0lhdFexvr40suw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVCns7o%253D&md5=2b1ef573a3a0949af32103053bb71be2</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-061516-121357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-061516-121357%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DJ.%2BM.%26aulast%3DBerkenblit%26aufirst%3DA.%26atitle%3DAntibody-Drug%2520Conjugates%2520for%2520Cancer%2520Treatment%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2018%26volume%3D69%26issue%3D1%26spage%3D191%26epage%3D207%26doi%3D10.1146%2Fannurev-med-061516-121357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choyke, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span> <span> </span><span class="NLM_article-title">New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2620</span>– <span class="NLM_lpage">2640</span>, <span class="refDoi"> DOI: 10.1021/cr900263j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900263j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGhtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=2620-2640&issue=5&author=H.+Kobayashiauthor=M.+Ogawaauthor=R.+Alfordauthor=P.+L.+Choykeauthor=Y.+Urano&title=New+Strategies+for+Fluorescent+Probe+Design+in+Medical+Diagnostic+Imaging&doi=10.1021%2Fcr900263j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging</span></div><div class="casAuthors">Kobayashi, Hisataka; Ogawa, Mikako; Alford, Raphael; Choyke, Peter L.; Urano, Yasuteru</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2620-2640</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review including major sections entitled Introduction, History of Fluorescent Probes in Medical Imaging, General Requirements for Fluorescent Probes in Medical Imaging, Classification of Fluorophores, Advanced Applications of Fluorescent Probes in Medical Imaging, and Addnl. Signaling Mechanisms Using Fluorescent Probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPWrMbju05UrVg90H21EOLACvtfcHk0lglIy14es4Xfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGhtbzP&md5=af8dc6331e8d0e311e8fc5cb5c1d6736</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fcr900263j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900263j%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DAlford%26aufirst%3DR.%26aulast%3DChoyke%26aufirst%3DP.%2BL.%26aulast%3DUrano%26aufirst%3DY.%26atitle%3DNew%2520Strategies%2520for%2520Fluorescent%2520Probe%2520Design%2520in%2520Medical%2520Diagnostic%2520Imaging%26jtitle%3DChem.%2520Rev.%26date%3D2010%26volume%3D110%26issue%3D5%26spage%3D2620%26epage%3D2640%26doi%3D10.1021%2Fcr900263j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykstra, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagarajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S. W.</span></span> <span> </span><span class="NLM_article-title">The Medicinal Chemist’s Toolbox for Late Stage Functionalization of Drug-like Molecules</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1039/C5CS00628G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC5CS00628G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26507237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslams7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=546-576&issue=3&author=T.+Cernakauthor=K.+D.+Dykstraauthor=S.+Tyagarajanauthor=P.+Vachalauthor=S.+W.+Krska&title=The+Medicinal+Chemist%E2%80%99s+Toolbox+for+Late+Stage+Functionalization+of+Drug-like+Molecules&doi=10.1039%2FC5CS00628G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The medicinal chemist's toolbox for late stage functionalization of drug-like molecules</span></div><div class="casAuthors">Cernak, Tim; Dykstra, Kevin D.; Tyagarajan, Sriram; Vachal, Petr; Krska, Shane W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">546-576</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The advent of modern C-H functionalization chemistries has enabled medicinal chemists to consider a synthetic strategy, late stage functionalization (LSF), which utilizes the C-H bonds of drug leads as points of diversification for generating new analogs.  LSF approaches offer the promise of rapid exploration of structure activity relationships (SAR), the generation of oxidized metabolites, the blocking of metabolic hot spots and the prepn. of biol. probes.  This review details a toolbox of intermol. C-H functionalization chemistries with proven applicability to drug-like mols., classified by regioselectivity patterns, and gives guidance on how to systematically develop LSF strategies using these patterns and other considerations.  In addn., a no. of examples illustrate how LSF approaches have been used to impact actual drug discovery and chem. biol. efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7N9sPaaVAQbVg90H21EOLACvtfcHk0lglIy14es4Xfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslams7nN&md5=a52fc5692f5515e5cadab0f2746fd6f7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2FC5CS00628G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00628G%26sid%3Dliteratum%253Aachs%26aulast%3DCernak%26aufirst%3DT.%26aulast%3DDykstra%26aufirst%3DK.%2BD.%26aulast%3DTyagarajan%26aufirst%3DS.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DKrska%26aufirst%3DS.%2BW.%26atitle%3DThe%2520Medicinal%2520Chemist%25E2%2580%2599s%2520Toolbox%2520for%2520Late%2520Stage%2520Functionalization%2520of%2520Drug-like%2520Molecules%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26issue%3D3%26spage%3D546%26epage%3D576%26doi%3D10.1039%2FC5CS00628G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mennen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhambra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barberis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berritt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castañón, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damon, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eugenio
de Diego, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Cerrada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Losada, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitch, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobben, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacMillan, D. W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInturff, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monfette, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitter, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strambeanu, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twilton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zajac, M. A.</span></span> <span> </span><span class="NLM_article-title">The Evolution of High-Throughput Experimentation in Pharmaceutical Development and Perspectives on the Future</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1213</span>– <span class="NLM_lpage">1242</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.9b00140</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.9b00140" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptFyhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2019&pages=1213-1242&issue=6&author=S.+M.+Mennenauthor=C.+Alhambraauthor=C.+L.+Allenauthor=M.+Barberisauthor=S.+Berrittauthor=T.+A.+Brandtauthor=A.+D.+Campbellauthor=J.+Casta%C3%B1%C3%B3nauthor=A.+H.+Cherneyauthor=M.+Christensenauthor=D.+B.+Damonauthor=J.+Eugenio%0Ade+Diegoauthor=S.+Garc%C3%ADa-Cerradaauthor=P.+Garc%C3%ADa-Losadaauthor=R.+Haroauthor=J.+Janeyauthor=D.+C.+Leitchauthor=L.+Liauthor=F.+Liuauthor=P.+C.+Lobbenauthor=D.+W.+C.+MacMillanauthor=J.+Maganoauthor=E.+McInturffauthor=S.+Monfetteauthor=R.+J.+Postauthor=D.+Schultzauthor=B.+J.+Sitterauthor=J.+M.+Stevensauthor=I.+I.+Strambeanuauthor=J.+Twiltonauthor=K.+Wangauthor=M.+A.+Zajac&title=The+Evolution+of+High-Throughput+Experimentation+in+Pharmaceutical+Development+and+Perspectives+on+the+Future&doi=10.1021%2Facs.oprd.9b00140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Evolution of High-Throughput Experimentation in Pharmaceutical Development and Perspectives on the Future</span></div><div class="casAuthors">Mennen, Steven M.; Alhambra, Carolina; Allen, C. Liana; Barberis, Mario; Berritt, Simon; Brandt, Thomas A.; Campbell, Andrew D.; Castanon, Jesus; Cherney, Alan H.; Christensen, Melodie; Damon, David B.; Eugenio de Diego, J.; Garcia-Cerrada, Susana; Garcia-Losada, Pablo; Haro, Ruben; Janey, Jacob; Leitch, David C.; Li, Ling; Liu, Fangfang; Lobben, Paul C.; MacMillan, David W. C.; Magano, Javier; McInturff, Emma; Monfette, Sebastien; Post, Ronald J.; Schultz, Danielle; Sitter, Barbara J.; Stevens, Jason M.; Strambeanu, Iulia I.; Twilton, Jack; Wang, Ke; Zajac, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1213-1242</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  High-throughput experimentation (HTE) has revolutionized the pharmaceutical industry, most notably allowing for rapid screening of compd. libraries against therapeutic targets.  The past decade has also witnessed the extension of HTE principles toward the realm of small-mol. process chem.  Today, most major pharmaceutical companies have created dedicated HTE groups within their process development teams, invested in automation technol. to accelerate screening, or both.  The industry's commitment to accelerating process development has led to rapid innovations in the HTE space.  This review will deliver an overview of the latest best practices currently taking place within our teams in process chem. by sharing frequently studied transformations, our perspective for the next several years in the field, and manual and automated tools to enable experimentation.  A series of case studies are presented to exemplify state-of-the-art workflows developed within our labs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGv9Mgw1B12bVg90H21EOLACvtfcHk0ljBy6nrHa3bSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptFyhsrc%253D&md5=e00d87520ba1f3498e3667e25c62dfe4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.9b00140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.9b00140%26sid%3Dliteratum%253Aachs%26aulast%3DMennen%26aufirst%3DS.%2BM.%26aulast%3DAlhambra%26aufirst%3DC.%26aulast%3DAllen%26aufirst%3DC.%2BL.%26aulast%3DBarberis%26aufirst%3DM.%26aulast%3DBerritt%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DT.%2BA.%26aulast%3DCampbell%26aufirst%3DA.%2BD.%26aulast%3DCasta%25C3%25B1%25C3%25B3n%26aufirst%3DJ.%26aulast%3DCherney%26aufirst%3DA.%2BH.%26aulast%3DChristensen%26aufirst%3DM.%26aulast%3DDamon%26aufirst%3DD.%2BB.%26aulast%3DEugenio%2Bde%2BDiego%26aufirst%3DJ.%26aulast%3DGarc%25C3%25ADa-Cerrada%26aufirst%3DS.%26aulast%3DGarc%25C3%25ADa-Losada%26aufirst%3DP.%26aulast%3DHaro%26aufirst%3DR.%26aulast%3DJaney%26aufirst%3DJ.%26aulast%3DLeitch%26aufirst%3DD.%2BC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DLobben%26aufirst%3DP.%2BC.%26aulast%3DMacMillan%26aufirst%3DD.%2BW.%2BC.%26aulast%3DMagano%26aufirst%3DJ.%26aulast%3DMcInturff%26aufirst%3DE.%26aulast%3DMonfette%26aufirst%3DS.%26aulast%3DPost%26aufirst%3DR.%2BJ.%26aulast%3DSchultz%26aufirst%3DD.%26aulast%3DSitter%26aufirst%3DB.%2BJ.%26aulast%3DStevens%26aufirst%3DJ.%2BM.%26aulast%3DStrambeanu%26aufirst%3DI.%2BI.%26aulast%3DTwilton%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DZajac%26aufirst%3DM.%2BA.%26atitle%3DThe%2520Evolution%2520of%2520High-Throughput%2520Experimentation%2520in%2520Pharmaceutical%2520Development%2520and%2520Perspectives%2520on%2520the%2520Future%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2019%26volume%3D23%26issue%3D6%26spage%3D1213%26epage%3D1242%26doi%3D10.1021%2Facs.oprd.9b00140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanathan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, C. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Peptides: Technological Advances Driving Peptides into Development</span>. <i>Curr. Opin. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.1016/j.copbio.2006.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.copbio.2006.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=17049837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eqs7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=638-642&issue=6&author=A.+K.+Satoauthor=M.+Viswanathanauthor=R.+B.+Kentauthor=C.+R.+Wood&title=Therapeutic+Peptides%3A+Technological+Advances+Driving+Peptides+into+Development&doi=10.1016%2Fj.copbio.2006.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic peptides: Technological advances driving peptides into development</span></div><div class="casAuthors">Sato, Aaron K.; Viswanathan, Malini; Kent, Rachel B.; Wood, Clive R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">638-642</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  As potential therapeutics, peptides offer several advantages over small mols. (increased specificity) and antibodies (small size).  Nevertheless, a no. of key issues have hampered their use as drug candidates.  A series of new technologies have recently been developed that allow peptides to be viable drug candidates in areas usually restricted to protein therapeutics, such as monoclonal antibodies.  These include the development of various types of peptide-conjugates that have lower rates of clearance and hence the potential to increase the exposure of peptide drug candidates in chronic diseases.  Structural addns. were also made to peptides, including the use of unnatural amino acids, main-chain modifications, and other novel substitutions, which have helped to improve peptide stability and further their therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiwe4yE4GqUbVg90H21EOLACvtfcHk0ljBy6nrHa3bSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eqs7zL&md5=c29eae8a5bbf2e0bb5fb3c67211be0d5</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2006.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2006.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DA.%2BK.%26aulast%3DViswanathan%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DR.%2BB.%26aulast%3DWood%26aufirst%3DC.%2BR.%26atitle%3DTherapeutic%2520Peptides%253A%2520Technological%2520Advances%2520Driving%2520Peptides%2520into%2520Development%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2006%26volume%3D17%26issue%3D6%26spage%3D638%26epage%3D642%26doi%3D10.1016%2Fj.copbio.2006.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Strategic Approaches to Optimizing Peptide ADME Properties</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">143</span>, <span class="refDoi"> DOI: 10.1208/s12248-014-9687-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1208%2Fs12248-014-9687-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=25366889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSnurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=134-143&issue=1&author=L.+Di&title=Strategic+Approaches+to+Optimizing+Peptide+ADME+Properties&doi=10.1208%2Fs12248-014-9687-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Strategic Approaches to Optimizing Peptide ADME Properties</span></div><div class="casAuthors">Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-143</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Development of peptide drugs is challenging but also quite rewarding.  Five blockbuster peptide drugs are currently on the market, and six new peptides received first marketing approval as new mol. entities in 2012.  Although peptides only represent 2% of the drug market, the market is growing twice as quickly and might soon occupy a larger niche.  Natural peptides typically have poor absorption, distribution, metab., and excretion (ADME) properties with rapid clearance, short half-life, low permeability, and sometimes low soly.  Strategies have been developed to improve peptide drugability through enhancing permeability, reducing proteolysis and renal clearance, and prolonging half-life.  In vivo, in vitro, and in silico tools are available to evaluate ADME properties of peptides, and structural modification strategies are in place to improve peptide developability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDLDsR-Zk0OLVg90H21EOLACvtfcHk0ljBy6nrHa3bSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSnurvJ&md5=530597d3719d65509105096f433fee0a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1208%2Fs12248-014-9687-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-014-9687-3%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26atitle%3DStrategic%2520Approaches%2520to%2520Optimizing%2520Peptide%2520ADME%2520Properties%26jtitle%3DAAPS%2520J.%26date%3D2015%26volume%3D17%26issue%3D1%26spage%3D134%26epage%3D143%26doi%3D10.1208%2Fs12248-014-9687-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Werle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernkop-Schnürch, A.</span></span> <span> </span><span class="NLM_article-title">Strategies to Improve Plasma Half Life Time of Peptide and Protein Drugs</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1007/s00726-005-0289-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1007%2Fs00726-005-0289-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=16622600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD28Xls1egsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=351-367&issue=4&author=M.+Werleauthor=A.+Bernkop-Schn%C3%BCrch&title=Strategies+to+Improve+Plasma+Half+Life+Time+of+Peptide+and+Protein+Drugs&doi=10.1007%2Fs00726-005-0289-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies to improve plasma half life time of peptide and protein drugs</span></div><div class="casAuthors">Werle, M.; Bernkop-Schnuerch, A.</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">Springer Wien</span>)
        </div><div class="casAbstract">A review.  Due to the obvious advantages of long-acting peptide and protein drugs, strategies to prolong blood plasma half life time of such compds. are highly on demand.  Short plasma half life times are commonly due to fast renal clearance as well as to enzymic degrdn. occurring during systemic circulation.  Modifications of the peptide/protein can lead to prolonged plasma half life times.  By shortening the overall amino acid amt. of somatostatin and replacing L-analog amino acids with D-amino acids, plasma half life time of the derivate octreotide was 1.5 h in comparison to only few minutes of somatostatin.  A PEG2,40K conjugate of INF-α-2b exhibited a 330-fold prolonged plasma half life time compared to the native protein.  It was the aim of this review to provide an overview of possible strategies to prolong plasma half life time such as modification of N- and C-terminus or PEGylation as well as methods to evaluate the effectiveness of drug modifications.  Furthermore, fundamental data about most important proteolytic enzymes of human blood, liver, and kidney as well as their cleavage specificity and inhibitors for them are provided to predict enzymic cleavage of peptide and protein drugs during systemic circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovVKc2VODC97Vg90H21EOLACvtfcHk0liw0UeFA3YsqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xls1egsrw%253D&md5=2e286c53028f38cfe33deef26bb160d0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs00726-005-0289-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-005-0289-3%26sid%3Dliteratum%253Aachs%26aulast%3DWerle%26aufirst%3DM.%26aulast%3DBernkop-Schn%25C3%25BCrch%26aufirst%3DA.%26atitle%3DStrategies%2520to%2520Improve%2520Plasma%2520Half%2520Life%2520Time%2520of%2520Peptide%2520and%2520Protein%2520Drugs%26jtitle%3DAmino%2520Acids%26date%3D2006%26volume%3D30%26issue%3D4%26spage%3D351%26epage%3D367%26doi%3D10.1007%2Fs00726-005-0289-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rand, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khunte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiowetz, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span> <span> </span><span class="NLM_article-title">Optimizing PK Properties of Cyclic Peptides: The Effect of Side Chain Substitutions on Permeability and Clearance</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1282</span>– <span class="NLM_lpage">1289</span>, <span class="refDoi"> DOI: 10.1039/C2MD20203D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC2MD20203D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=23133740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWns7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1282-1289&issue=10&author=A.+C.+Randauthor=S.+S.+F.+Leungauthor=H.+Engauthor=C.+J.+Rotterauthor=R.+Sharmaauthor=A.+S.+Kalgutkarauthor=Y.+Zhangauthor=M.+V.+Varmaauthor=K.+A.+Farleyauthor=B.+Khunteauthor=C.+Limberakisauthor=D.+A.+Priceauthor=S.+Lirasauthor=A.+M.+Mathiowetzauthor=M.+P.+Jacobsonauthor=R.+S.+Lokey&title=Optimizing+PK+Properties+of+Cyclic+Peptides%3A+The+Effect+of+Side+Chain+Substitutions+on+Permeability+and+Clearance&doi=10.1039%2FC2MD20203D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance</span></div><div class="casAuthors">Rand, Arthur C.; Leung, Siegfried S. F.; Eng, Heather; Rotter, Charles J.; Sharma, Raman; Kalgutkar, Amit S.; Zhang, Yizhong; Varma, Manthena V.; Farley, Kathleen A.; Khunte, Bhagyashree; Limberakis, Chris; Price, David A.; Liras, Spiros; Mathiowetz, Alan M.; Jacobson, Matthew P.; Lokey, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1282-1289</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of cyclic peptides were designed and prepd. to investigate the physicochem. properties that affect oral bioavailability of this chemotype in rats.  In particular, the ionization state of the peptide was examd. by the incorporation of naturally occurring amino acid residues that are charged in differing regions of the gut.  In addn., data was generated in a variety of in vitro assays and the usefulness of this data in predicting the subsequent oral bioavailability obsd. in the rat is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr-tYW5ziK7bVg90H21EOLACvtfcHk0liw0UeFA3YsqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWns7%252FM&md5=fe1c9f3c7c3e6d48e4e11ee4b5818ef7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1039%2FC2MD20203D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2MD20203D%26sid%3Dliteratum%253Aachs%26aulast%3DRand%26aufirst%3DA.%2BC.%26aulast%3DLeung%26aufirst%3DS.%2BS.%2BF.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DRotter%26aufirst%3DC.%2BJ.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DFarley%26aufirst%3DK.%2BA.%26aulast%3DKhunte%26aufirst%3DB.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DMathiowetz%26aufirst%3DA.%2BM.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26atitle%3DOptimizing%2520PK%2520Properties%2520of%2520Cyclic%2520Peptides%253A%2520The%2520Effect%2520of%2520Side%2520Chain%2520Substitutions%2520on%2520Permeability%2520and%2520Clearance%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26issue%3D10%26spage%3D1282%26epage%3D1289%26doi%3D10.1039%2FC2MD20203D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. J.</span></span> <span> </span><span class="NLM_article-title">Potent Antibody Therapeutics by Design</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1038/nri1837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnri1837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=16622479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslOhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=343-357&issue=5&author=P.+J.+Carter&title=Potent+Antibody+Therapeutics+by+Design&doi=10.1038%2Fnri1837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Potent antibody therapeutics by design</span></div><div class="casAuthors">Carter, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">343-357</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibodies constitute the most rapidly growing class of human therapeutics and the second largest class of drugs after vaccines.  The generation of potent antibody therapeutics, reviewed here by the author, is an iterative design process that involves the generation and optimization of antibodies to improve their clin. potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnBlEa3XkH-rVg90H21EOLACvtfcHk0livwX7HgvRaGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslOhu7o%253D&md5=e7d506c0300d3700aefe04f2336878e2</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnri1837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1837%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DP.%2BJ.%26atitle%3DPotent%2520Antibody%2520Therapeutics%2520by%2520Design%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2006%26volume%3D6%26issue%3D5%26spage%3D343%26epage%3D357%26doi%3D10.1038%2Fnri1837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vasserot, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huse, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchester, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, J. D.</span></span> <span> </span><span class="NLM_article-title">Optimization of Protein Therapeutics by Directed Evolution</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(02)02590-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS1359-6446%2802%2902590-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=12568781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlyhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=118-126&issue=3&author=A.+P.+Vasserotauthor=C.+D.+Dickinsonauthor=Y.+Tangauthor=W.+D.+Huseauthor=K.+S.+Manchesterauthor=J.+D.+Watkins&title=Optimization+of+Protein+Therapeutics+by+Directed+Evolution&doi=10.1016%2FS1359-6446%2802%2902590-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of protein therapeutics by directed evolution</span></div><div class="casAuthors">Vasserot, Alain P.; Dickinson, Craig D.; Tang, Ying; Huse, William D.; Manchester, Keith S.; Watkins, Jeffry D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">118-126</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Directed evolution is a broadly applicable technol. platform that is ideally suited to address the need for protein optimization and to fully exploit the therapeutic potential of biologics.  The approach takes advantage of the remarkable structural and functional plasticity of proteins and permits the rapid remodeling of biologics into new entities with improved functions.  The ability to ameliorate virtually any characteristic of a protein can translate into significant clin. benefits, including decreased immunogenicity, higher potency, greater efficacy and improved safety profile, and can considerably increase the probability of successfully developing and commercializing biotherapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGritEbuoIROIrVg90H21EOLACvtfcHk0lhitNplFOtrzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlyhsg%253D%253D&md5=fc95c8f73ca12de4355a1cc9f55e29a8</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2802%2902590-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252802%252902590-4%26sid%3Dliteratum%253Aachs%26aulast%3DVasserot%26aufirst%3DA.%2BP.%26aulast%3DDickinson%26aufirst%3DC.%2BD.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DHuse%26aufirst%3DW.%2BD.%26aulast%3DManchester%26aufirst%3DK.%2BS.%26aulast%3DWatkins%26aufirst%3DJ.%2BD.%26atitle%3DOptimization%2520of%2520Protein%2520Therapeutics%2520by%2520Directed%2520Evolution%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26issue%3D3%26spage%3D118%26epage%3D126%26doi%3D10.1016%2FS1359-6446%2802%2902590-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaberc-Porekar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zore, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podobnik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menart, V.</span></span> <span> </span><span class="NLM_article-title">Obstacles and Pitfalls in the PEGylation of Therapeutic Proteins</span>. <i>Curr. Opin. Drug Discovery Devel.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">242</span>– <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=18283612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFektr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=242-250&issue=2&author=V.+Gaberc-Porekarauthor=I.+Zoreauthor=B.+Podobnikauthor=V.+Menart&title=Obstacles+and+Pitfalls+in+the+PEGylation+of+Therapeutic+Proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Obstacles and pitfalls in the PEGylation of therapeutic proteins</span></div><div class="casAuthors">Gaberc-Porekar, Vladka; Zore, Irena; Podobnik, Barbara; Menart, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">242-250</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  In recent years, PEGylation has become widely used as a post-prodn. modification methodol. for improving the biomedical efficacy and physicochem. properties of therapeutic proteins.  Several marketed drugs that have already been in use for more than a decade have proved the applicability and safety of this technol. and, with the successes already achieved, it is expected that PEGylation will be applied to other potential therapeutic proteins.  The non-biodegradable nature of PEG, however, may become a limiting factor for the next generation of protein pharmaceuticals, for which use in high concns. and in the long term is the aim, esp. considering the trend for the use of branched and high mol. mass PEGs.  This review addresses various obstacles and pitfalls in the prodn. of PEGylated biopharmaceuticals, in particular, the specificity of PEGylation reactions, sepn. and purifn. issues, the anal. of inherently polydisperse PEG reagents and PEGylated products, the consistency of products and processes, and the accurate detn. of pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzMDn_6Ri_tLVg90H21EOLACvtfcHk0lhitNplFOtrzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFektr8%253D&md5=01d9ff6b0f69299ea8cf1ed2b2db74a7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaberc-Porekar%26aufirst%3DV.%26aulast%3DZore%26aufirst%3DI.%26aulast%3DPodobnik%26aufirst%3DB.%26aulast%3DMenart%26aufirst%3DV.%26atitle%3DObstacles%2520and%2520Pitfalls%2520in%2520the%2520PEGylation%2520of%2520Therapeutic%2520Proteins%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Devel.%26date%3D2008%26volume%3D11%26issue%3D2%26spage%3D242%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dozier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distefano, M.</span></span> <span> </span><span class="NLM_article-title">Site-Specific PEGylation of Therapeutic Proteins</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">25831</span>– <span class="NLM_lpage">25864</span>, <span class="refDoi"> DOI: 10.3390/ijms161025831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.3390%2Fijms161025831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26516849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFaltrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=25831-25864&issue=10&author=J.+Dozierauthor=M.+Distefano&title=Site-Specific+PEGylation+of+Therapeutic+Proteins&doi=10.3390%2Fijms161025831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific pegylation of therapeutic proteins</span></div><div class="casAuthors">Dozier, Jonathan K.; Distefano, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">25831-25864</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The use of proteins as therapeutics has a long history and is becoming ever more common in modern medicine.  While the no. of protein-based drugs is growing every year, significant problems still remain with their use.  Among these problems are rapid degrdn. and excretion from patients, thus requiring frequent dosing, which in turn increases the chances for an immunol. response as well as increasing the cost of therapy.  One of the main strategies to alleviate these problems is to link a polyethylene glycol (PEG) group to the protein of interest.  This process, called PEGylation, has grown dramatically in recent years resulting in several approved drugs.  Installing a single PEG chain at a defined site in a protein is challenging.  Recently, there is has been considerable research into various methods for the site-specific PEGylation of proteins.  This review seeks to summarize that work and provide background and context for how site-specific PEGylation is performed.  After introducing the topic of site-specific PEGylation, recent developments using chem. methods are described.  That is followed by a more extensive discussion of bioorthogonal reactions and enzymic labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqamy1V2rUeIbVg90H21EOLACvtfcHk0lhitNplFOtrzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFaltrfF&md5=e07d153e16a67da1e929964ec7ba01bf</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3390%2Fijms161025831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms161025831%26sid%3Dliteratum%253Aachs%26aulast%3DDozier%26aufirst%3DJ.%26aulast%3DDistefano%26aufirst%3DM.%26atitle%3DSite-Specific%2520PEGylation%2520of%2520Therapeutic%2520Proteins%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2015%26volume%3D16%26issue%3D10%26spage%3D25831%26epage%3D25864%26doi%3D10.3390%2Fijms161025831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cal, P. M. S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, G. J. L.</span></span> <span> </span><span class="NLM_article-title">Contemporary Approaches to Site-Selective Protein Modification</span>. <i>Nat. Rev. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1038/s41570-019-0079-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fs41570-019-0079-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsFCks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2019&pages=147-171&issue=3&author=E.+A.+Hoytauthor=P.+M.+S.+D.+Calauthor=B.+L.+Oliveiraauthor=G.+J.+L.+Bernardes&title=Contemporary+Approaches+to+Site-Selective+Protein+Modification&doi=10.1038%2Fs41570-019-0079-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Contemporary approaches to site-selective protein modification</span></div><div class="casAuthors">Hoyt, Emily A.; Cal, Pedro M. S. D.; Oliveira, Bruno L.; Bernardes, Goncalo J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">147-171</span>CODEN:
                <span class="NLM_cas:coden">NRCAF7</span>;
        ISSN:<span class="NLM_cas:issn">2397-3358</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Proteins constitute the majority of nature's worker biomols.  Designed for specific functions, complex tertiary structures make proteins ideal candidates for analyzing natural systems and creating novel biol. tools.  Owing to both their large size and the need for proper folding, de novo synthesis of proteins has been quite a challenge, leading scientists to focus on modifying protein templates already provided by nature.  Recently developed methods for protein modification fall into two broad categories: those that can modify the natural protein template directly and those that require genetic manipulation of the amino acid sequence before modification.  The goal of this Review is not only to provide a window through which to view the many opportunities created by novel protein modification techniques, but also to act as an initial guide to help scientists find direction and form ideas in an ever-growing field.  In addn. to highlighting methods reported in the past 5 years, we aim to provide a broader sense of the goals and outcomes of protein modification and bioconjugation in general.  While the main body of this paper comprises reactions involving the direct modification of expressed proteins, some further functionalization strategies as well as biol. applications are also acknowledged.  The discussion concludes by speculating which trends and discoveries will most likely come next in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt5DtfV3-IWbVg90H21EOLACvtfcHk0ljRq26uuUSfvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsFCks7o%253D&md5=b08dabd1a572061e988c0ee1d64d71d2</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fs41570-019-0079-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41570-019-0079-1%26sid%3Dliteratum%253Aachs%26aulast%3DHoyt%26aufirst%3DE.%2BA.%26aulast%3DCal%26aufirst%3DP.%2BM.%2BS.%2BD.%26aulast%3DOliveira%26aufirst%3DB.%2BL.%26aulast%3DBernardes%26aufirst%3DG.%2BJ.%2BL.%26atitle%3DContemporary%2520Approaches%2520to%2520Site-Selective%2520Protein%2520Modification%26jtitle%3DNat.%2520Rev.%2520Chem.%26date%3D2019%26volume%3D3%26issue%3D3%26spage%3D147%26epage%3D171%26doi%3D10.1038%2Fs41570-019-0079-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">deGruyter, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malins, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Residue-Specific Peptide Modification: A Chemist’s Guide</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">30</span>),  <span class="NLM_fpage">3863</span>– <span class="NLM_lpage">3873</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.7b00536</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.7b00536" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKisLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=3863-3873&issue=30&author=J.+N.+deGruyterauthor=L.+R.+Malinsauthor=P.+S.+Baran&title=Residue-Specific+Peptide+Modification%3A+A+Chemist%E2%80%99s+Guide&doi=10.1021%2Facs.biochem.7b00536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Residue-Specific Peptide Modification: A Chemist's Guide</span></div><div class="casAuthors">deGruyter, Justine N.; Malins, Lara R.; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">3863-3873</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Advances in bioconjugation and native protein modification are appearing at a blistering pace, making it increasingly time consuming for practitioners to identify the best chem. method to modify a specific amino acid residue in a complex setting.  The purpose of this perspective is to provide an informative, graphically rich manual highlighting significant advances in the field over the past decade.  This guide will help triage candidate methods for peptide alteration, and will serve as a starting point for those seeking to solve longstanding challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqGLA9b0u-FbVg90H21EOLACvtfcHk0ljRq26uuUSfvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKisLfK&md5=cb0a794b5077461762fd9fa43f4f39c2</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.7b00536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.7b00536%26sid%3Dliteratum%253Aachs%26aulast%3DdeGruyter%26aufirst%3DJ.%2BN.%26aulast%3DMalins%26aufirst%3DL.%2BR.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DResidue-Specific%2520Peptide%2520Modification%253A%2520A%2520Chemist%25E2%2580%2599s%2520Guide%26jtitle%3DBiochemistry%26date%3D2017%26volume%3D56%26issue%3D30%26spage%3D3863%26epage%3D3873%26doi%3D10.1021%2Facs.biochem.7b00536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kölmel, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacMillan, D. W. C.</span></span> <span> </span><span class="NLM_article-title">Decarboxylative Alkylation for Site-Selective Bioconjugation of Native Proteins via Oxidation Potentials</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1038/nchem.2888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnchem.2888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=29359756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=205-211&issue=2&author=S.+Bloomauthor=C.+Liuauthor=D.+K.+K%C3%B6lmelauthor=J.+X.+Qiaoauthor=Y.+Zhangauthor=M.+A.+Possauthor=W.+R.+Ewingauthor=D.+W.+C.+MacMillan&title=Decarboxylative+Alkylation+for+Site-Selective+Bioconjugation+of+Native+Proteins+via+Oxidation+Potentials&doi=10.1038%2Fnchem.2888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Decarboxylative alkylation for site-selective bioconjugation of native proteins via oxidation potentials</span></div><div class="casAuthors">Bloom, Steven; Liu, Chun; Kolmel, Dominik K.; Qiao, Jennifer X.; Zhang, Yong; Poss, Michael A.; Ewing, William R.; MacMillan, David W. C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-211</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The advent of antibody-drug conjugates as pharmaceuticals has fueled a need for reliable methods of site-selective protein modification that furnish homogeneous adducts.  Although bioorthogonal methods that use engineered amino acids often provide an elegant soln. to the question of selective functionalization, achieving homogeneity using native amino acids remains a challenge.  Here, the authors explore visible-light-mediated single-electron transfer as a mechanism towards enabling site- and chemoselective bioconjugation.  Specifically, the authors demonstrate the use of photoredox catalysis as a platform to selectivity wherein the discrepancy in oxidn. potentials between internal vs. C-terminal carboxylates can be exploited towards obtaining C-terminal functionalization exclusively.  This oxidn. potential-gated technol. is amenable to endogenous peptides and has been successfully demonstrated on the protein insulin.  As a fundamentally new approach to bioconjugation this methodol. provides a blueprint toward the development of photoredox catalysis as a generic platform to target other redox-active side chains for native conjugation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiy7-ViSoLeLVg90H21EOLACvtfcHk0ljcaShW6VV0VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsrjJ&md5=a5f8b7f701329a625221c77280243746</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2888%26sid%3Dliteratum%253Aachs%26aulast%3DBloom%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DK%25C3%25B6lmel%26aufirst%3DD.%2BK.%26aulast%3DQiao%26aufirst%3DJ.%2BX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26aulast%3DMacMillan%26aufirst%3DD.%2BW.%2BC.%26atitle%3DDecarboxylative%2520Alkylation%2520for%2520Site-Selective%2520Bioconjugation%2520of%2520Native%2520Proteins%2520via%2520Oxidation%2520Potentials%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26issue%3D2%26spage%3D205%26epage%3D211%26doi%3D10.1038%2Fnchem.2888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imiołek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karunanithy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouverneur, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span> <span> </span><span class="NLM_article-title">Selective Radical Trifluoromethylation of Native Residues in Proteins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1568</span>– <span class="NLM_lpage">1571</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b10230</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b10230" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksVOitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=1568-1571&issue=5&author=M.+Imio%C5%82ekauthor=G.+Karunanithyauthor=W.-L.+Ngauthor=A.+J.+Baldwinauthor=V.+Gouverneurauthor=B.+G.+Davis&title=Selective+Radical+Trifluoromethylation+of+Native+Residues+in+Proteins&doi=10.1021%2Fjacs.7b10230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Radical Trifluoromethylation of Native Residues in Proteins</span></div><div class="casAuthors">Imiolek, Mateusz; Karunanithy, Gogulan; Ng, Wai-Lung; Baldwin, Andrew J.; Gouverneur, Veronique; Davis, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1568-1571</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The incorporation of fluorine can not only significantly facilitate the study of proteins but also potentially modulate their function.  Though some biosynthetic methods allow global residue-replacement, post-translational fluorine incorporation would constitute a fast and efficient alternative.  Here, the authors reveal a mild method for direct protein radical trifluoromethylation at native residues as a strategy for sym.-multifluorine incorporation on mg scales with high recoveries.  High selectivity toward tryptophan residues enhanced the utility of this direct trifluoromethylation technique allowing ready study of fluorinated protein constructs using 19F-NMR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh-m_zVIPb8bVg90H21EOLACvtfcHk0ljcaShW6VV0VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksVOitQ%253D%253D&md5=87aeeae802829e661c71ab37374edda4</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b10230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b10230%26sid%3Dliteratum%253Aachs%26aulast%3DImio%25C5%2582ek%26aufirst%3DM.%26aulast%3DKarunanithy%26aufirst%3DG.%26aulast%3DNg%26aufirst%3DW.-L.%26aulast%3DBaldwin%26aufirst%3DA.%2BJ.%26aulast%3DGouverneur%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DB.%2BG.%26atitle%3DSelective%2520Radical%2520Trifluoromethylation%2520of%2520Native%2520Residues%2520in%2520Proteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D5%26spage%3D1568%26epage%3D1571%26doi%3D10.1021%2Fjacs.7b10230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vantourout, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adusumalli, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knouse, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flood, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padial, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istrate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maziarz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGruyter, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deery, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastgate, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, G. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Serine-Selective Bioconjugation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">17236</span>– <span class="NLM_lpage">17242</span>, <span class="refDoi"> DOI: 10.1021/jacs.0c05595</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.0c05595" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvV2ns7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2020&pages=17236-17242&issue=41&author=J.+C.+Vantouroutauthor=S.+R.+Adusumalliauthor=K.+W.+Knouseauthor=D.+T.+Floodauthor=A.+Ramirezauthor=N.+M.+Padialauthor=A.+Istrateauthor=K.+Maziarzauthor=J.+N.+DeGruyterauthor=R.+R.+Merchantauthor=J.+X.+Qiaoauthor=M.+A.+Schmidtauthor=M.+J.+Deeryauthor=M.+D.+Eastgateauthor=P.+E.+Dawsonauthor=G.+J.+L.+Bernardesauthor=P.+S.+Baran&title=Serine-Selective+Bioconjugation&doi=10.1021%2Fjacs.0c05595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Serine-Selective Bioconjugation</span></div><div class="casAuthors">Vantourout, Julien C.; Adusumalli, Srinivasa Rao; Knouse, Kyle W.; Flood, Dillon T.; Ramirez, Antonio; Padial, Natalia M.; Istrate, Alena; Maziarz, Katarzyna; deGruyter, Justine N.; Merchant, Rohan R.; Qiao, Jennifer X.; Schmidt, Michael A.; Deery, Michael J.; Eastgate, Martin D.; Dawson, Philip E.; Bernardes, Goncalo J. L.; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">17236-17242</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This Communication reports the first general method for rapid, chemoselective, and modular functionalization of serine residues in native polypeptides, which uses a reagent platform based on the P(V) oxidn. state.  This redox-economical approach can be used to append nearly any kind of cargo onto serine, generating a stable, benign, and hydrophilic phosphorothioate linkage.  The method tolerates all other known nucleophilic functional groups of naturally occurring proteinogenic amino acids.  A variety of applications can be envisaged by this expansion of the toolbox of site-selective bioconjugation methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolJdbCZc8hFrVg90H21EOLACvtfcHk0lgWu5xWkuJ-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvV2ns7%252FF&md5=82cfa0521bc91128872572324af57553</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjacs.0c05595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.0c05595%26sid%3Dliteratum%253Aachs%26aulast%3DVantourout%26aufirst%3DJ.%2BC.%26aulast%3DAdusumalli%26aufirst%3DS.%2BR.%26aulast%3DKnouse%26aufirst%3DK.%2BW.%26aulast%3DFlood%26aufirst%3DD.%2BT.%26aulast%3DRamirez%26aufirst%3DA.%26aulast%3DPadial%26aufirst%3DN.%2BM.%26aulast%3DIstrate%26aufirst%3DA.%26aulast%3DMaziarz%26aufirst%3DK.%26aulast%3DDeGruyter%26aufirst%3DJ.%2BN.%26aulast%3DMerchant%26aufirst%3DR.%2BR.%26aulast%3DQiao%26aufirst%3DJ.%2BX.%26aulast%3DSchmidt%26aufirst%3DM.%2BA.%26aulast%3DDeery%26aufirst%3DM.%2BJ.%26aulast%3DEastgate%26aufirst%3DM.%2BD.%26aulast%3DDawson%26aufirst%3DP.%2BE.%26aulast%3DBernardes%26aufirst%3DG.%2BJ.%2BL.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DSerine-Selective%2520Bioconjugation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2020%26volume%3D142%26issue%3D41%26spage%3D17236%26epage%3D17242%26doi%3D10.1021%2Fjacs.0c05595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhanjee, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buslov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windsor, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raines, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentelute, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">Palladium-Protein Oxidative Addition Complexes by Amine-Selective Acylation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">21237</span>– <span class="NLM_lpage">21242</span>, <span class="refDoi"> DOI: 10.1021/jacs.0c09180</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.0c09180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFOmurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2020&pages=21237-21242&issue=51&author=H.+H.+Dhanjeeauthor=I.+Buslovauthor=I.+W.+Windsorauthor=R.+T.+Rainesauthor=B.+L.+Penteluteauthor=S.+L.+Buchwald&title=Palladium-Protein+Oxidative+Addition+Complexes+by+Amine-Selective+Acylation&doi=10.1021%2Fjacs.0c09180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Protein Oxidative Addition Complexes by Amine-Selective Acylation</span></div><div class="casAuthors">Dhanjee, Heemal H.; Buslov, Ivan; Windsor, Ian W.; Raines, Ronald T.; Pentelute, Bradley L.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">21237-21242</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Palladium oxidative addn. complexes (OACs) are traditionally accessed by treating an aryl halide-contg. substrate with a palladium(0) source.  Here, a new strategy to selectively prep. stable OACs from amino groups on native proteins is presented.  The approach relies on an amine-selective acylation reaction that occurs without modification of a preformed palladium(II)-aryl group.  Once transferred onto a protein substrate, the palladium(II)-aryl group facilitates conjugation by undergoing reaction with a second, cysteine-contg. protein.  This operationally simple method is applicable to native, nonengineered enzymes as well as antibodies and is carried out in an aq. setting and open to air.  The resulting Pd-protein OACs are stable, storable reagents that retain biol. activity and can be used to achieve protein-protein cross-coupling at nanomolar concns. within hours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8uh91DRqw-LVg90H21EOLACvtfcHk0lgWu5xWkuJ-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFOmurvK&md5=290e986b0af0ed723d03bf24f29a3ce9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjacs.0c09180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.0c09180%26sid%3Dliteratum%253Aachs%26aulast%3DDhanjee%26aufirst%3DH.%2BH.%26aulast%3DBuslov%26aufirst%3DI.%26aulast%3DWindsor%26aufirst%3DI.%2BW.%26aulast%3DRaines%26aufirst%3DR.%2BT.%26aulast%3DPentelute%26aufirst%3DB.%2BL.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-Protein%2520Oxidative%2520Addition%2520Complexes%2520by%2520Amine-Selective%2520Acylation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2020%26volume%3D142%26issue%3D51%26spage%3D21237%26epage%3D21242%26doi%3D10.1021%2Fjacs.0c09180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
la Torre, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J. W.</span></span> <span> </span><span class="NLM_article-title">Reprogramming the Genetic Code</span>. <i>Nat. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1038/s41576-020-00307-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fs41576-020-00307-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=33318706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXis1SgsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2021&pages=169-184&issue=3&author=D.+de%0Ala+Torreauthor=J.+W.+Chin&title=Reprogramming+the+Genetic+Code&doi=10.1038%2Fs41576-020-00307-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Reprogramming the genetic code</span></div><div class="casAuthors">de la Torre, Daniel; Chin, Jason W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-184</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The encoded biosynthesis of proteins provides the ultimate paradigm for high-fidelity synthesis of long polymers of defined sequence and compn., but it is limited to polymg. the canonical amino acids.  Recent advances have built on genetic code expansion - which commonly permits the cellular incorporation of one type of non-canonical amino acid into a protein - to enable the encoded incorporation of several distinct non-canonical amino acids.  Developments include strategies to read quadruplet codons, use non-natural DNA base pairs, synthesize completely recoded genomes and create orthogonal translational components with reprogrammed specificities.  These advances may enable the genetically encoded synthesis of non-canonical biopolymers and provide a platform for transforming the discovery and evolution of new materials and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJFC6TSU507rVg90H21EOLACvtfcHk0lhcn0OS16eO-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXis1SgsrfF&md5=a39d44aec6176822c98b73c20053d0f6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fs41576-020-00307-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41576-020-00307-7%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Bla%2BTorre%26aufirst%3DD.%26aulast%3DChin%26aufirst%3DJ.%2BW.%26atitle%3DReprogramming%2520the%2520Genetic%2520Code%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2021%26volume%3D22%26issue%3D3%26spage%3D169%26epage%3D184%26doi%3D10.1038%2Fs41576-020-00307-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J. W.</span></span> <span> </span><span class="NLM_article-title">Cellular Incorporation of Unnatural Amino Acids and Bioorthogonal Labeling of Proteins</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4764</span>– <span class="NLM_lpage">4806</span>, <span class="refDoi"> DOI: 10.1021/cr400355w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400355w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslamtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=4764-4806&issue=9&author=K.+Langauthor=J.+W.+Chin&title=Cellular+Incorporation+of+Unnatural+Amino+Acids+and+Bioorthogonal+Labeling+of+Proteins&doi=10.1021%2Fcr400355w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Incorporation of Unnatural Amino Acids and Bioorthogonal Labeling of Proteins</span></div><div class="casAuthors">Lang, Kathrin; Chin, Jason W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4764-4806</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A range of bioorthogonal reactions are described and methods discussed include the cellular cotranslational incorporation of unnatural amino acids bearing bioorthogonal functionalities into proteins via residue-specific or site-specific approaches.  Applications of residue-specific incorporation and labeling and developments of site-specific incorporation and labeling are outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf78CtJ7B0jbVg90H21EOLACvtfcHk0lhcn0OS16eO-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslamtrY%253D&md5=bbb5b3099d3fccf801262e6b0d51676b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fcr400355w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400355w%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DK.%26aulast%3DChin%26aufirst%3DJ.%2BW.%26atitle%3DCellular%2520Incorporation%2520of%2520Unnatural%2520Amino%2520Acids%2520and%2520Bioorthogonal%2520Labeling%2520of%2520Proteins%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26issue%3D9%26spage%3D4764%26epage%3D4806%26doi%3D10.1021%2Fcr400355w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suazo, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distefano, M. D.</span></span> <span> </span><span class="NLM_article-title">Recent Progress in Enzymatic Protein Labelling Techniques and Their Applications</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">9106</span>– <span class="NLM_lpage">9136</span>, <span class="refDoi"> DOI: 10.1039/C8CS00537K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC8CS00537K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=30259933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWhur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=9106-9136&issue=24&author=Y.+Zhangauthor=K.-Y.+Parkauthor=K.+F.+Suazoauthor=M.+D.+Distefano&title=Recent+Progress+in+Enzymatic+Protein+Labelling+Techniques+and+Their+Applications&doi=10.1039%2FC8CS00537K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in enzymatic protein labelling techniques and their applications</span></div><div class="casAuthors">Zhang, Yi; Park, Keun-Young; Suazo, Kiall F.; Distefano, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9106-9136</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Protein-based conjugates are valuable constructs for a variety of applications.  Conjugation of proteins to fluorophores is commonly used to study their cellular localization and the protein-protein interactions.  Modification of therapeutic proteins with either polymers or cytotoxic moieties greatly enhances their pharmacokinetics or potency.  To label a protein of interest, conventional direct chem. reaction with the side-chains of native amino acids often yields heterogeneously modified products.  This renders their characterization complicated, requires difficult sepn. steps and may impact protein function.  Although modification can also be achieved via the insertion of unnatural amino acids bearing bioorthogonal functional groups, these methods can have lower protein expression yields, limiting large scale prodn.  As a site-specific modification method, enzymic protein labeling is highly efficient and robust under mild reaction conditions.  Significant progress has been made over the last five years in modifying proteins using enzymic methods for numerous applications, including the creation of clin. relevant conjugates with polymers, cytotoxins or imaging agents, fluorescent or affinity probes to study complex protein interaction networks, and protein-linked materials for biosensing.  This review summarizes developments in enzymic protein labeling over the last five years for a panel of ten enzymes, including sortase A, subtiligase, microbial transglutaminase, farnesyltransferase, N-myristoyltransferase, phosphopantetheinyl transferases, tubulin tyrosin ligase, lipoic acid ligase, biotin ligase and formylglycine generating enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSxSaDWbYK87Vg90H21EOLACvtfcHk0lj4K9FpQzroEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWhur7L&md5=4b7ebe718b06c70590cbeb8e96819a72</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1039%2FC8CS00537K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CS00537K%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DK.-Y.%26aulast%3DSuazo%26aufirst%3DK.%2BF.%26aulast%3DDistefano%26aufirst%3DM.%2BD.%26atitle%3DRecent%2520Progress%2520in%2520Enzymatic%2520Protein%2520Labelling%2520Techniques%2520and%2520Their%2520Applications%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2018%26volume%3D47%26issue%3D24%26spage%3D9106%26epage%3D9136%26doi%3D10.1039%2FC8CS00537K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disotuar, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, D. H.-C.</span></span> <span> </span><span class="NLM_article-title">Selective N-Terminal Functionalization of Native Peptides and Proteins</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">2717</span>– <span class="NLM_lpage">2722</span>, <span class="refDoi"> DOI: 10.1039/C6SC04744K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC6SC04744K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=28553506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltlCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=2717-2722&issue=4&author=D.+Chenauthor=M.+M.+Disotuarauthor=X.+Xiongauthor=Y.+Wangauthor=D.+H.-C.+Chou&title=Selective+N-Terminal+Functionalization+of+Native+Peptides+and+Proteins&doi=10.1039%2FC6SC04744K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Selective N-terminal functionalization of native peptides and proteins</span></div><div class="casAuthors">Chen, Diao; Disotuar, Maria M.; Xiong, Xiaochun; Wang, Yuanxiang; Chou, Danny Hung-Chieh</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2717-2722</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report an efficient, highly selective modification on the N-terminal amines of peptides and proteins using aldehyde derivs. via reductive alkylation.  After modification of a library of unprotected peptides XYSKEASAL (X varies over 20 natural amino acids) by benzaldehyde at room temp., pH 6.1 resulted in excellent N-terminal selectivity (α-amino/ε-amino: >99 : 1) and high reaction conversion for 19 out of the 20 peptides.  Under similar conditions, highly selective N-terminal modifications were achieved with a variety of aldehydes.  Furthermore, N-termini of native peptides and proteins could be selectively modified under the same conditions to introduce bioorthogonal functional groups.  Using human insulin as an example, we further demonstrated that preserving the pos. charge in the N-terminus using reductive alkylation instead of acylation leads to a 5-fold increase in bioactivity.  In summary, our reported method provides a universal strategy for site-selective N-terminal functionalization in native peptides and proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomrguLnvsfDbVg90H21EOLACvtfcHk0lj4K9FpQzroEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltlCgtQ%253D%253D&md5=3d3b5a3c8b73f72d0526fda0145a78f0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1039%2FC6SC04744K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC04744K%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DDisotuar%26aufirst%3DM.%2BM.%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChou%26aufirst%3DD.%2BH.-C.%26atitle%3DSelective%2520N-Terminal%2520Functionalization%2520of%2520Native%2520Peptides%2520and%2520Proteins%26jtitle%3DChem.%2520Sci.%26date%3D2017%26volume%3D8%26issue%3D4%26spage%3D2717%26epage%3D2722%26doi%3D10.1039%2FC6SC04744K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petter, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arduini, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brickelmaier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepinsky, R. B.</span></span> <span> </span><span class="NLM_article-title">N-Terminally PEGylated Human Interferon-β-1a with Improved Pharmacokinetic Properties and in Vivo Efficacy in a Melanoma Angiogenesis Model</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1021/bc050237q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc050237q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1KktrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=179-188&issue=1&author=D.+P.+Bakerauthor=E.+Y.+Linauthor=K.+Linauthor=M.+Pellegriniauthor=R.+C.+Petterauthor=L.+L.+Chenauthor=R.+M.+Arduiniauthor=M.+Brickelmaierauthor=D.+Wenauthor=D.+M.+Hessauthor=L.+Chenauthor=D.+Grantauthor=A.+Whittyauthor=A.+Gillauthor=D.+J.+Lindnerauthor=R.+B.+Pepinsky&title=N-Terminally+PEGylated+Human+Interferon-%CE%B2-1a+with+Improved+Pharmacokinetic+Properties+and+in+Vivo+Efficacy+in+a+Melanoma+Angiogenesis+Model&doi=10.1021%2Fbc050237q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">N-Terminally PEGylated Human Interferon-β-1a with Improved Pharmacokinetic Properties and in Vivo Efficacy in a Melanoma Angiogenesis Model</span></div><div class="casAuthors">Baker, Darren P.; Lin, Edward Y.; Lin, KoChung; Pellegrini, Maria; Petter, Russell C.; Chen, Ling Ling; Arduini, Robert M.; Brickelmaier, Margot; Wen, Dingyi; Hess, Donna M.; Chen, Liqing; Grant, Donna; Whitty, Adrian; Gill, Alan; Lindner, Daniel J.; Pepinsky, R. Blake</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-188</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PEGylation of IFN-α has been used successfully to improve the pharmacokinetic properties and efficacy of the drug.  To prep. a PEGylated form of human interferon-β-1a (IFN-β-1a) suitable for testing in vivo, the authors have synthesized 20 kDa mPEG-O-2-methylpropionaldehyde and used it to modify the N-terminal α-amino group of the cytokine.  The PEGylated protein retained ∼50% of the activity of the unmodified protein and had significantly improved pharmacokinetic properties following i.v. administration in rats.  The clearance and vol. of distribution at steady state were reduced ∼30-fold and ∼4-fold, resp., resulting in a significant increase in systemic exposure as detd. by the area under the curve.  The elimination half-life of the PEGylated protein was ∼13-fold greater than for the unmodified protein.  The unmodified and PEGylated proteins were tested for their ability to inhibit the formation of radially oriented blood vessels entering the periphery of human SK-MEL-1 melanoma tumors in athymic nude homozygous (nu/nu) mice.  In a single dose comparison study, administration of 1×106 units of unmodified IFN-β-1a resulted in a 29% redn. in vessel no., while 1×106 units of PEGylated IFN-β-1a resulted in a 58% redn.  Both treatments resulted in statistically significant redns. in mean vessel no. as compared to the vehicle (control)-treated mice, with the PEGylated IFN-β-1a-treated mice showing a statistically significantly greater redn. in mean vessel no. as compared to the unmodified IFN-β-1a-treated mice.  In a multiple vs. single dose comparison study, daily administration of 1×106 units of unmodified IFN-β-1a for 9 days resulted in a 51% redn. in vessel no., while a single dose of 1×106 units of the PEGylated protein resulted in a 66% redn.  Both treatments resulted in statistically significant redns. in mean vessel no. as compared to the vehicle-treated mice, with the PEGylated IFN-β-1a-treated mice showing a statistically significantly greater redn. in mean vessel no. as compared to the unmodified IFN-β-1a-treated mice.  Therefore, the improved pharmacokinetic properties of the modified protein translated into improved efficacy.  Since unmodified IFN-β is used for the treatment of multiple sclerosis and hepatitis C virus infection, a PEGylated form of the protein such as 20 kDa mPEG-O-2-methylpropionaldehyde-modified IFN-β-1a may serve as a useful adjunct for the treatment of these diseases.  In addn., the antiangiogenic effects of PEGylated IFN-β-1a may be harnessed for the treatment of certain cancers, either as a sole agent or in combination with other antitumor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBICklCkZ7QLVg90H21EOLACvtfcHk0lj4K9FpQzroEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1KktrrM&md5=20ca130e0d26f9f2b484379f4d870eef</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fbc050237q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc050237q%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DD.%2BP.%26aulast%3DLin%26aufirst%3DE.%2BY.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DPellegrini%26aufirst%3DM.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DChen%26aufirst%3DL.%2BL.%26aulast%3DArduini%26aufirst%3DR.%2BM.%26aulast%3DBrickelmaier%26aufirst%3DM.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DHess%26aufirst%3DD.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrant%26aufirst%3DD.%26aulast%3DWhitty%26aufirst%3DA.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DLindner%26aufirst%3DD.%2BJ.%26aulast%3DPepinsky%26aufirst%3DR.%2BB.%26atitle%3DN-Terminally%2520PEGylated%2520Human%2520Interferon-%25CE%25B2-1a%2520with%2520Improved%2520Pharmacokinetic%2520Properties%2520and%2520in%2520Vivo%2520Efficacy%2520in%2520a%2520Melanoma%2520Angiogenesis%2520Model%26jtitle%3DBioconjugate%2520Chem.%26date%3D2006%26volume%3D17%26issue%3D1%26spage%3D179%26epage%3D188%26doi%3D10.1021%2Fbc050237q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minus, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abernathy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, Z. T.</span></span> <span> </span><span class="NLM_article-title">Histidine-Directed Arylation/Alkenylation of Backbone N-H Bonds Mediated by Copper(II)</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7472</span>– <span class="NLM_lpage">7475</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b03390</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b03390" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVKrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=7472-7475&issue=24&author=J.+Ohataauthor=M.+B.+Minusauthor=M.+E.+Abernathyauthor=Z.+T.+Ball&title=Histidine-Directed+Arylation%2FAlkenylation+of+Backbone+N-H+Bonds+Mediated+by+Copper%28II%29&doi=10.1021%2Fjacs.6b03390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Histidine-directed arylation/alkenylation of backbone N-H bonds mediated by copper(II)</span></div><div class="casAuthors">Ohata, Jun; Minus, Matthew B.; Abernathy, Morgan E.; Ball, Zachary T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7472-7475</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chem. modification of proteins and peptides represents a challenge of reaction design as well as an important biol. tool.  In contrast to side-chain modification, synthetic methods to alter backbone structure are extremely limited.  In this communication, copper-mediated backbone N-alkenylation or N-arylation of peptides and proteins by direct modification of natural sequences is described.  Histidine residues direct oxidative coupling of boronic acids at the backbone NH of a neighboring amino acid.  The mild reaction conditions in common physiol. buffers, at ambient temp., are compatible with proteins and biol. systems.  This simple reaction demonstrates the potential for directed reactions in complex systems to allow modification of N-H bonds that directly affect polypeptide structure, stability, and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXQ-5qVYtGZ7Vg90H21EOLACvtfcHk0lj1aZvdUhgqlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVKrur4%253D&md5=fe5570c124808c522ec7fc886763c945</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b03390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b03390%26sid%3Dliteratum%253Aachs%26aulast%3DOhata%26aufirst%3DJ.%26aulast%3DMinus%26aufirst%3DM.%2BB.%26aulast%3DAbernathy%26aufirst%3DM.%2BE.%26aulast%3DBall%26aufirst%3DZ.%2BT.%26atitle%3DHistidine-Directed%2520Arylation%252FAlkenylation%2520of%2520Backbone%2520N-H%2520Bonds%2520Mediated%2520by%2520Copper%2528II%2529%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26issue%3D24%26spage%3D7472%26epage%3D7475%26doi%3D10.1021%2Fjacs.6b03390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, T.</span></span> <span> </span><span class="NLM_article-title">Photo-Induced Coupling Reactions of Tetrazoles with Carboxylic Acids in Aqueous Solution: Application in Protein Labelling</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">4702</span>– <span class="NLM_lpage">4705</span>, <span class="refDoi"> DOI: 10.1039/C5CC10445A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC5CC10445A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26953773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1ejs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=4702-4705&issue=25&author=S.+Zhaoauthor=J.+Daiauthor=M.+Huauthor=C.+Liuauthor=R.+Mengauthor=X.+Liuauthor=C.+Wangauthor=T.+Luo&title=Photo-Induced+Coupling+Reactions+of+Tetrazoles+with+Carboxylic+Acids+in+Aqueous+Solution%3A+Application+in+Protein+Labelling&doi=10.1039%2FC5CC10445A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Photo-induced coupling reactions of tetrazoles with carboxylic acids in aqueous solution: application in protein labeling</span></div><div class="casAuthors">Zhao, Shan; Dai, Jianye; Hu, Mo; Liu, Chang; Meng, Rong; Liu, Xiaoyun; Wang, Chu; Luo, Tuoping</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4702-4705</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The photo-induced reactions of diaryltetrazoles with carboxylic acids in aq. soln. were studied.  Besides measuring the apparent second-order rate const. and evaluating the functional group compatibility of these reactions, the authors further incorporated the tetrazoles into SAHA, leading to a new active-site-directed probe for labeling HDACs in both cell lysates and living cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF0HDgo-LCF7Vg90H21EOLACvtfcHk0lj1aZvdUhgqlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1ejs78%253D&md5=09c69da8265c035f3dcd8000d298c0b8</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1039%2FC5CC10445A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC10445A%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMeng%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DT.%26atitle%3DPhoto-Induced%2520Coupling%2520Reactions%2520of%2520Tetrazoles%2520with%2520Carboxylic%2520Acids%2520in%2520Aqueous%2520Solution%253A%2520Application%2520in%2520Protein%2520Labelling%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26issue%3D25%26spage%3D4702%26epage%3D4705%26doi%3D10.1039%2FC5CC10445A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, A.</span></span> <span> </span><span class="NLM_article-title">Electrochemical Oxidation Induced Selective Tyrosine Bioconjugation for the Modification of Biomolecules</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">7982</span>– <span class="NLM_lpage">7987</span>, <span class="refDoi"> DOI: 10.1039/C9SC02218J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC9SC02218J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31673320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlaltrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=7982-7987&issue=34&author=C.+Songauthor=K.+Liuauthor=Z.+Wangauthor=B.+Dingauthor=S.+Wangauthor=Y.+Wengauthor=C.-W.+Chiangauthor=A.+Lei&title=Electrochemical+Oxidation+Induced+Selective+Tyrosine+Bioconjugation+for+the+Modification+of+Biomolecules&doi=10.1039%2FC9SC02218J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Electrochemical oxidation induced selective tyrosine bioconjugation for the modification of biomolecules</span></div><div class="casAuthors">Song, Chunlan; Liu, Kun; Wang, Zhongjie; Ding, Bo; Wang, Shengchun; Weng, Yue; Chiang, Chien-Wei; Lei, Aiwen</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7982-7987</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Directly introducing a beneficial functional group into biomols. under mild, clean and easy-to-handle conditions is of great importance in the field of chem. biol. and pharmacol.  Herein, we described an electrochem. strategy to perform the bioconjugation of tyrosine residues with phenothiazine derivs. in a rapid and simple manner.  In this electrochem. system, various polypeptides and proteins were successfully labeled with excellent site- and chemo-selectivity, and metals, oxidants or additives were also avoided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpARru4dpklgrVg90H21EOLACvtfcHk0lisHoTOuafXNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlaltrrJ&md5=cceaefba850ea224cdff9a6276faedf8</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1039%2FC9SC02218J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9SC02218J%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWeng%26aufirst%3DY.%26aulast%3DChiang%26aufirst%3DC.-W.%26aulast%3DLei%26aufirst%3DA.%26atitle%3DElectrochemical%2520Oxidation%2520Induced%2520Selective%2520Tyrosine%2520Bioconjugation%2520for%2520the%2520Modification%2520of%2520Biomolecules%26jtitle%3DChem.%2520Sci.%26date%3D2019%26volume%3D10%26issue%3D34%26spage%3D7982%26epage%3D7987%26doi%3D10.1039%2FC9SC02218J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noisier, A. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knerr, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drury, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valeur, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malins, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalakrishnan, R.</span></span> <span> </span><span class="NLM_article-title">Late-Stage Functionalization of Histidine in Unprotected Peptides</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">52</span>),  <span class="NLM_fpage">19096</span>– <span class="NLM_lpage">19102</span>, <span class="refDoi"> DOI: 10.1002/anie.201910888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fanie.201910888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFant7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=19096-19102&issue=52&author=A.+F.+M.+Noisierauthor=M.+J.+Johanssonauthor=L.+Knerrauthor=M.+A.+Hayesauthor=W.+J.+Druryauthor=E.+Valeurauthor=L.+R.+Malinsauthor=R.+Gopalakrishnan&title=Late-Stage+Functionalization+of+Histidine+in+Unprotected+Peptides&doi=10.1002%2Fanie.201910888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Late-stage functionalization of histidine in unprotected peptides</span></div><div class="casAuthors">Noisier, Anais F. M.; Johansson, Magnus J.; Knerr, Laurent; Hayes, Martin A.; Drury, William J. III; Valeur, Eric; Malins, Lara R.; Gopalakrishnan, Ranganath</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">19096-19102</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The late-stage functionalization (LSF) of peptides represents a valuable strategy for the design of potent peptide pharmaceuticals by enabling rapid exploration of chem. diversity and offering novel opportunities for peptide conjugation.  While the C(sp2)-H activation of tryptophan (Trp) is well documented, the resurgence of radical chem. is opening new avenues for the C-H functionalization of other arom. side-chains.  Herein, we report the first example of LSF at C2 of histidine (His) utilizing a broad scope of aliph. sulfinate salts as radical precursors.  In this work, the exquisite selectivity for histidine functionalization was demonstrated through the alkylation of complex unprotected peptides in aq. media.  Finally, this methodol. was extended for the installation of a ketone handle, providing an unprecedented anchor for selective oxime/hydrazone conjugation at histidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXni3z_Jrfe7Vg90H21EOLACvtfcHk0lisHoTOuafXNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFant7vE&md5=76bd2c854dfe039f866e87ee9aed69ff</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fanie.201910888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201910888%26sid%3Dliteratum%253Aachs%26aulast%3DNoisier%26aufirst%3DA.%2BF.%2BM.%26aulast%3DJohansson%26aufirst%3DM.%2BJ.%26aulast%3DKnerr%26aufirst%3DL.%26aulast%3DHayes%26aufirst%3DM.%2BA.%26aulast%3DDrury%26aufirst%3DW.%2BJ.%26aulast%3DValeur%26aufirst%3DE.%26aulast%3DMalins%26aufirst%3DL.%2BR.%26aulast%3DGopalakrishnan%26aufirst%3DR.%26atitle%3DLate-Stage%2520Functionalization%2520of%2520Histidine%2520in%2520Unprotected%2520Peptides%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26issue%3D52%26spage%3D19096%26epage%3D19102%26doi%3D10.1002%2Fanie.201910888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Overbeke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongsantichon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everaert, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwaenepoel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loonchanta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burtnick, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Ganck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochepied, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haigh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuvelier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derave, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettemans, J.</span></span> <span> </span><span class="NLM_article-title">An ER-Directed Gelsolin Nanobody Targets the First Step in Amyloid Formation in a Gelsolin Amyloidosis Mouse Model</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2492</span>– <span class="NLM_lpage">2507</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddv010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1093%2Fhmg%2Fddv010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=25601851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVyltLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=2492-2507&issue=9&author=W.+Van%0AOverbekeauthor=J.+Wongsantichonauthor=I.+Everaertauthor=A.+Verhelleauthor=O.+Zwaenepoelauthor=A.+Loonchantaauthor=L.+D.+Burtnickauthor=A.+De+Ganckauthor=T.+Hochepiedauthor=J.+Haighauthor=C.+Cuvelierauthor=W.+Deraveauthor=R.+C.+Robinsonauthor=J.+Gettemans&title=An+ER-Directed+Gelsolin+Nanobody+Targets+the+First+Step+in+Amyloid+Formation+in+a+Gelsolin+Amyloidosis+Mouse+Model&doi=10.1093%2Fhmg%2Fddv010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">An ER-directed gelsolin nanobody targets the first step in amyloid formation in a gelsolin amyloidosis mouse model</span></div><div class="casAuthors">Van Overbeke, Wouter; Wongsantichon, Jantana; Everaert, Inge; Verhelle, Adriaan; Zwaenepoel, Olivier; Loonchanta, Anantasak; Burtnick, Leslie D.; De Ganck, Ariane; Hochepied, Tino; Haigh, Jody; Cuvelier, Claude; Derave, Wim; Robinson, Robert C.; Gettemans, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2492-2507</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Hereditary gelsolin amyloidosis is an autosomal dominantly inherited amyloid disorder.  A point mutation in the GSN gene (G654A being the most common one) results in disturbed calcium binding by the second gelsolin domain (G2).  As a result, the folding of G2 is hampered, rendering the mutant plasma gelsolin susceptible to a proteolytic cascade.  Consecutive cleavage by furin and MT1-MMP-like proteases generates 8 and 5 kDa amyloidogenic peptides that cause neurol., ophthalmol. and dermatol. findings.  To this day, no specific treatment is available to counter the pathogenesis.  Using GSN nanobody 11 as a mol. chaperone, we aimed to protect mutant plasma gelsolin from furin proteolysis in the trans-Golgi network.  We report a transgenic, GSN nanobody 11 secreting mouse that was used for crossbreeding with gelsolin amyloidosis mice.  Insertion of the therapeutic nanobody gene into the gelsolin amyloidosis mouse genome resulted in improved muscle contractility.  X-ray crystal structure detn. of the gelsolin G2:Nb11 complex revealed that Nb11 does not directly block the furin cleavage site.  We conclude that nanobodies can be used to shield substrates from aberrant proteolysis and this approach might establish a novel therapeutic strategy in amyloid diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-aY9pOJNQxbVg90H21EOLACvtfcHk0liOYgllFUyscQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVyltLfI&md5=46d05bff0cd01f07e0c075fc684c2816</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddv010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddv010%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BOverbeke%26aufirst%3DW.%26aulast%3DWongsantichon%26aufirst%3DJ.%26aulast%3DEveraert%26aufirst%3DI.%26aulast%3DVerhelle%26aufirst%3DA.%26aulast%3DZwaenepoel%26aufirst%3DO.%26aulast%3DLoonchanta%26aufirst%3DA.%26aulast%3DBurtnick%26aufirst%3DL.%2BD.%26aulast%3DDe%2BGanck%26aufirst%3DA.%26aulast%3DHochepied%26aufirst%3DT.%26aulast%3DHaigh%26aufirst%3DJ.%26aulast%3DCuvelier%26aufirst%3DC.%26aulast%3DDerave%26aufirst%3DW.%26aulast%3DRobinson%26aufirst%3DR.%2BC.%26aulast%3DGettemans%26aufirst%3DJ.%26atitle%3DAn%2520ER-Directed%2520Gelsolin%2520Nanobody%2520Targets%2520the%2520First%2520Step%2520in%2520Amyloid%2520Formation%2520in%2520a%2520Gelsolin%2520Amyloidosis%2520Mouse%2520Model%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2015%26volume%3D24%26issue%3D9%26spage%3D2492%26epage%3D2507%26doi%3D10.1093%2Fhmg%2Fddv010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spicer, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span> <span> </span><span class="NLM_article-title">Selective Chemical Protein Modification</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">4740</span>, <span class="refDoi"> DOI: 10.1038/ncomms5740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fncomms5740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=25190082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVeksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4740&issue=1&author=C.+D.+Spicerauthor=B.+G.+Davis&title=Selective+Chemical+Protein+Modification&doi=10.1038%2Fncomms5740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Selective chemical protein modification</span></div><div class="casAuthors">Spicer, Christopher D.; Davis, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4740</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The chem. modification of proteins is an important tool for probing natural systems and synthesizing novel conjugates.  Here, Spicer and Davis review the merits and limitations of the most useful methods for selective modification at both natural and unnatural amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZgjVcXZmMGbVg90H21EOLACvtfcHk0liOYgllFUyscQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVeksb4%253D&md5=055c882ff0405b0bbb91edca3bcef8cb</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fncomms5740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms5740%26sid%3Dliteratum%253Aachs%26aulast%3DSpicer%26aufirst%3DC.%2BD.%26aulast%3DDavis%26aufirst%3DB.%2BG.%26atitle%3DSelective%2520Chemical%2520Protein%2520Modification%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26issue%3D1%26spage%3D4740%26doi%3D10.1038%2Fncomms5740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boutureira, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, G. J. L.</span></span> <span> </span><span class="NLM_article-title">Advances in Chemical Protein Modification</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2174</span>– <span class="NLM_lpage">2195</span>, <span class="refDoi"> DOI: 10.1021/cr500399p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500399p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtV2nu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=2174-2195&issue=5&author=O.+Boutureiraauthor=G.+J.+L.+Bernardes&title=Advances+in+Chemical+Protein+Modification&doi=10.1021%2Fcr500399p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Chemical Protein Modification</span></div><div class="casAuthors">Boutureira, Omar; Bernardes, Goncalo J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2174-2195</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Transition metal-free and -mediated approaches are covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptimHDGRGsWLVg90H21EOLACvtfcHk0lhK_V_UmHVIoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtV2nu7k%253D&md5=d21a5407a59a7e12346c16e5db75ab91</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fcr500399p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500399p%26sid%3Dliteratum%253Aachs%26aulast%3DBoutureira%26aufirst%3DO.%26aulast%3DBernardes%26aufirst%3DG.%2BJ.%2BL.%26atitle%3DAdvances%2520in%2520Chemical%2520Protein%2520Modification%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26issue%3D5%26spage%3D2174%26epage%3D2195%26doi%3D10.1021%2Fcr500399p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isenegger, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span> <span> </span><span class="NLM_article-title">Concepts of Catalysis in Site-Selective Protein Modifications</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>141</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8005</span>– <span class="NLM_lpage">8013</span>, <span class="refDoi"> DOI: 10.1021/jacs.8b13187</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b13187" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntlehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2019&pages=8005-8013&issue=20&author=P.+G.+Iseneggerauthor=B.+G.+Davis&title=Concepts+of+Catalysis+in+Site-Selective+Protein+Modifications&doi=10.1021%2Fjacs.8b13187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Concepts of Catalysis in Site-Selective Protein Modifications</span></div><div class="casAuthors">Isenegger, Patrick G.; Davis, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8005-8013</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The manipulation and modulation of biomols. has the potential to herald new modes of Biol. and Medicine through chem. "editing".  Key to the success of such processes will be the selectivities, reactivities and efficiencies that may be brought to bear in bond-formation and bond-cleavage in a benign manner.  In this Perspective, we use select examples, primarily from our own research, to examine the current opportunities, limitations and the particular potential of metal-mediated processes as exemplars of possible alternative catalytic modes and manifolds to those already found in nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq44tDJIQ-GT7Vg90H21EOLACvtfcHk0lhK_V_UmHVIoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntlehsb8%253D&md5=37e790585ed0d73fec6ab1303358abd0</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b13187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b13187%26sid%3Dliteratum%253Aachs%26aulast%3DIsenegger%26aufirst%3DP.%2BG.%26aulast%3DDavis%26aufirst%3DB.%2BG.%26atitle%3DConcepts%2520of%2520Catalysis%2520in%2520Site-Selective%2520Protein%2520Modifications%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2019%26volume%3D141%26issue%3D20%26spage%3D8005%26epage%3D8013%26doi%3D10.1021%2Fjacs.8b13187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetsch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumontet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvaïa, N.</span></span> <span> </span><span class="NLM_article-title">Strategies and Challenges for the next Generation of Antibody-Drug Conjugates</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnrd.2016.268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=28303026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1Onsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=315-337&issue=5&author=A.+Beckauthor=L.+Goetschauthor=C.+Dumontetauthor=N.+Corva%C3%AFa&title=Strategies+and+Challenges+for+the+next+Generation+of+Antibody-Drug+Conjugates&doi=10.1038%2Fnrd.2016.268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies and challenges for the next generation of antibody-drug conjugates</span></div><div class="casAuthors">Beck, Alain; Goetsch, Liliane; Dumontet, Charles; Corvaia, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">315-337</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibody-drug conjugates (ADCs) are one of the fastest growing classes of oncol. therapeutics.  After half a century of research, the approvals of brentuximab vedotin (in 2011) and trastuzumab emtansine (in 2013) have paved the way for ongoing clin. trials that are evaluating more than 60 further ADC candidates.  The limited success of first-generation ADCs (developed in the early 2000s) informed strategies to bring second-generation ADCs to the market, which have higher levels of cytotoxic drug conjugation, lower levels of naked antibodies and more-stable linkers between the drug and the antibody.  Furthermore, lessons learned during the past decade are now being used in the development of third-generation ADCs.  In this Review, we discuss strategies to select the best target antigens as well as suitable cytotoxic drugs; the design of optimized linkers; the discovery of bioorthogonal conjugation chemistries; and toxicity issues.  The selection and engineering of antibodies for site-specific drug conjugation, which will result in higher homogeneity and increased stability, as well as the quest for new conjugation chemistries and mechanisms of action, are priorities in ADC research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP7lV63Ws8rbVg90H21EOLACvtfcHk0lhK_V_UmHVIoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1Onsbc%253D&md5=7358b6080dd1aed1d21e98c078cd9ef1</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.268%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DA.%26aulast%3DGoetsch%26aufirst%3DL.%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DCorva%25C3%25AFa%26aufirst%3DN.%26atitle%3DStrategies%2520and%2520Challenges%2520for%2520the%2520next%2520Generation%2520of%2520Antibody-Drug%2520Conjugates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26issue%3D5%26spage%3D315%26epage%3D337%26doi%3D10.1038%2Fnrd.2016.268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labrijn, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buijsse, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den
Bremer, E. T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verwilligen, A. Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleeker, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killestein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polman, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aalberse, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuurman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Winkel, J. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parren, P. W. H. I.</span></span> <span> </span><span class="NLM_article-title">Therapeutic IgG4 Antibodies Engage in Fab-Arm Exchange with Endogenous Human IgG4 in Vivo</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">771</span>, <span class="refDoi"> DOI: 10.1038/nbt.1553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnbt.1553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=19620983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD1MXoslymt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=767-771&issue=8&author=A.+F.+Labrijnauthor=A.+O.+Buijsseauthor=E.+T.+J.+van+den%0ABremerauthor=A.+Y.+W.+Verwilligenauthor=W.+K.+Bleekerauthor=S.+J.+Thorpeauthor=J.+Killesteinauthor=C.+H.+Polmanauthor=R.+C.+Aalberseauthor=J.+Schuurmanauthor=J.+G.+J.+van+de+Winkelauthor=P.+W.+H.+I.+Parren&title=Therapeutic+IgG4+Antibodies+Engage+in+Fab-Arm+Exchange+with+Endogenous+Human+IgG4+in+Vivo&doi=10.1038%2Fnbt.1553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo</span></div><div class="casAuthors">Labrijn, Aran F.; Buijsse, Antonio Ortiz; van den Bremer, Ewald T. J.; Verwilligen, Annemiek Y. W.; Bleeker, Wim K.; Thorpe, Susan J.; Killestein, Joep; Polman, Chris H.; Aalberse, Rob C.; Schuurman, Janine; van de Winkel, Jan G. J.; Parren, Paul W. H. I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">767-771</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Two humanized IgG4 antibodies, natalizumab and gemtuzumab, are approved for human use, and several others, like TGN1412, are or have been in clin. development.  Although IgG4 antibodies can dynamically exchange half-mols., Fab-arm exchange with therapeutic antibodies has not been demonstrated in humans.  Here, the authors show that natalizumab exchanges Fab arms with endogenous human IgG4 in natalizumab-treated individuals.  Gemtuzumab, in contrast, contains an IgG4 core-hinge mutation that blocks Fab-arm exchange to undetectable levels both in vitro and in a mouse model.  The ability of IgG4 therapeutics to recombine with endogenous IgG4 may affect their pharmacokinetics and pharmacodynamics.  Although pharmacokinetic modeling lessens concerns about undesired crosslinking under normal conditions, unpredictability remains and mutations that completely prevent Fab-arm exchange in vivo should be considered when designing therapeutic IgG4 antibodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGn4nvTCj3-LVg90H21EOLACvtfcHk0liLm6xArlAu6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXoslymt7Y%253D&md5=c758d687c55c60f4dd18be713be8f892</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1553%26sid%3Dliteratum%253Aachs%26aulast%3DLabrijn%26aufirst%3DA.%2BF.%26aulast%3DBuijsse%26aufirst%3DA.%2BO.%26aulast%3Dvan%2Bden%2BBremer%26aufirst%3DE.%2BT.%2BJ.%26aulast%3DVerwilligen%26aufirst%3DA.%2BY.%2BW.%26aulast%3DBleeker%26aufirst%3DW.%2BK.%26aulast%3DThorpe%26aufirst%3DS.%2BJ.%26aulast%3DKillestein%26aufirst%3DJ.%26aulast%3DPolman%26aufirst%3DC.%2BH.%26aulast%3DAalberse%26aufirst%3DR.%2BC.%26aulast%3DSchuurman%26aufirst%3DJ.%26aulast%3Dvan%2Bde%2BWinkel%26aufirst%3DJ.%2BG.%2BJ.%26aulast%3DParren%26aufirst%3DP.%2BW.%2BH.%2BI.%26atitle%3DTherapeutic%2520IgG4%2520Antibodies%2520Engage%2520in%2520Fab-Arm%2520Exchange%2520with%2520Endogenous%2520Human%2520IgG4%2520in%2520Vivo%26jtitle%3DNat.%2520Biotechnol.%26date%3D2009%26volume%3D27%26issue%3D8%26spage%3D767%26epage%3D771%26doi%3D10.1038%2Fnbt.1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C. R.</span></span> <span> </span><span class="NLM_article-title">Site-Specific Antibody-Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1021/bc5004982</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc5004982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=176-192&issue=2&author=P.+Agarwalauthor=C.+R.+Bertozzi&title=Site-Specific+Antibody-Drug+Conjugates%3A+The+Nexus+of+Bioorthogonal+Chemistry%2C+Protein+Engineering%2C+and+Drug+Development&doi=10.1021%2Fbc5004982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Site-Specific Antibody-Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development</span></div><div class="casAuthors">Agarwal, Paresh; Bertozzi, Carolyn R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">176-192</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Antibody-drug conjugates (ADCs) combine the specificity of antibodies with the potency of small mols. to create targeted drugs.  Despite the simplicity of this concept, generation of clin. successful ADCs has been very difficult.  Over the past several decades, scientists have learned a great deal about the constraints on antibodies, linkers, and drugs as they relate to successful construction of ADCs.  Once these components are in hand, most ADCs are prepd. by nonspecific modification of antibody lysine or cysteine residues with drug-linker reagents, which results in heterogeneous product mixts. that cannot be further purified.  With advances in the fields of bioorthogonal chem. and protein engineering, there is growing interest in producing ADCs by site-specific conjugation to the antibody, yielding more homogeneous products that have demonstrated benefits over their heterogeneous counterparts in vivo.  Here, we chronicle the development of a multitude of site-specific conjugation strategies for assembly of ADCs and provide a comprehensive account of key advances and their roots in the fields of bioorthogonal chem. and protein engineering.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOcb0A3dT72bVg90H21EOLACvtfcHk0liCbJ4Rrd_POA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrsrfK&md5=c3d822b0e53e5cdb074e5b63b8060ccf</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fbc5004982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc5004982%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DP.%26aulast%3DBertozzi%26aufirst%3DC.%2BR.%26atitle%3DSite-Specific%2520Antibody-Drug%2520Conjugates%253A%2520The%2520Nexus%2520of%2520Bioorthogonal%2520Chemistry%252C%2520Protein%2520Engineering%252C%2520and%2520Drug%2520Development%26jtitle%3DBioconjugate%2520Chem.%26date%3D2015%26volume%3D26%26issue%3D2%26spage%3D176%26epage%3D192%26doi%3D10.1021%2Fbc5004982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovee, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doronina, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duniho, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiske, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senter, P. D.</span></span> <span> </span><span class="NLM_article-title">Self-Hydrolyzing Maleimides Improve the Stability and Pharmacological Properties of Antibody-Drug Conjugates</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1059</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.1038/nbt.2968</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnbt.2968" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=25194818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKms7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=1059-1062&issue=10&author=R.+P.+Lyonauthor=J.+R.+Setterauthor=T.+D.+Boveeauthor=S.+O.+Doroninaauthor=J.+H.+Hunterauthor=M.+E.+Andersonauthor=C.+L.+Balasubramanianauthor=S.+M.+Dunihoauthor=C.+I.+Leiskeauthor=F.+Liauthor=P.+D.+Senter&title=Self-Hydrolyzing+Maleimides+Improve+the+Stability+and+Pharmacological+Properties+of+Antibody-Drug+Conjugates&doi=10.1038%2Fnbt.2968"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates</span></div><div class="casAuthors">Lyon, Robert P.; Setter, Jocelyn R.; Bovee, Tim D.; Doronina, Svetlana O.; Hunter, Joshua H.; Anderson, Martha E.; Balasubramanian, Cindy L.; Duniho, Steven M.; Leiske, Chris I.; Li, Fu; Senter, Peter D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1059-1062</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many antibody-drug conjugates (ADCs) are unstable in vivo because they are formed from maleimide-contg. components conjugated to reactive thiols.  These thiosuccinimide linkages undergo two competing reactions in plasma: elimination of the maleimide through a retro-Michael reaction, which results in loss of drug-linker from the ADC, and hydrolysis of the thiosuccinimide ring, which results in a deriv. that is resistant to the elimination reaction.  In an effort to create linker technologies with improved stability characteristics, we used diaminopropionic acid (DPR) to prep. a drug-linker incorporating a basic amino group adjacent to the maleimide, positioned to provide intramol. catalysis of thiosuccinimide ring hydrolysis.  This basic group induces the thiosuccinimide to undergo rapid hydrolysis at neutral pH and room temp.  Once hydrolyzed, the drug-linker is no longer subject to maleimide elimination reactions, preventing nonspecific deconjugation.  In vivo studies demonstrate that the increased stability characteristics can lead to improved ADC antitumor activity and reduced neutropenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOKvXMGRGxEbVg90H21EOLACvtfcHk0liCbJ4Rrd_POA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKms7jN&md5=96c3b19b856cc9c685cbdc704a842797</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2968%26sid%3Dliteratum%253Aachs%26aulast%3DLyon%26aufirst%3DR.%2BP.%26aulast%3DSetter%26aufirst%3DJ.%2BR.%26aulast%3DBovee%26aufirst%3DT.%2BD.%26aulast%3DDoronina%26aufirst%3DS.%2BO.%26aulast%3DHunter%26aufirst%3DJ.%2BH.%26aulast%3DAnderson%26aufirst%3DM.%2BE.%26aulast%3DBalasubramanian%26aufirst%3DC.%2BL.%26aulast%3DDuniho%26aufirst%3DS.%2BM.%26aulast%3DLeiske%26aufirst%3DC.%2BI.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DSenter%26aufirst%3DP.%2BD.%26atitle%3DSelf-Hydrolyzing%2520Maleimides%2520Improve%2520the%2520Stability%2520and%2520Pharmacological%2520Properties%2520of%2520Antibody-Drug%2520Conjugates%26jtitle%3DNat.%2520Biotechnol.%26date%3D2014%26volume%3D32%26issue%3D10%26spage%3D1059%26epage%3D1062%26doi%3D10.1038%2Fnbt.2968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strop, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaria, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foletti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witt, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasa-Moreno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorywalska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farias, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pios, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dushin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navaratnam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pons, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajpal, A.</span></span> <span> </span><span class="NLM_article-title">Site-Specific Conjugation Improves Therapeutic Index of Antibody Drug Conjugates with High Drug Loading</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">694</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1038/nbt.3274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnbt.3274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26154005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ensLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=694-696&issue=7&author=P.+Stropauthor=K.+Delariaauthor=D.+Folettiauthor=J.+M.+Wittauthor=A.+Hasa-Morenoauthor=K.+Poulsenauthor=M.+G.+Casasauthor=M.+Dorywalskaauthor=S.+Fariasauthor=A.+Piosauthor=V.+Luiauthor=R.+Dushinauthor=D.+Zhouauthor=T.+Navaratnamauthor=T.-T.+Tranauthor=J.+Suttonauthor=K.+C.+Lindquistauthor=B.+Hanauthor=S.-H.+Liuauthor=D.+L.+Sheltonauthor=J.+Ponsauthor=A.+Rajpal&title=Site-Specific+Conjugation+Improves+Therapeutic+Index+of+Antibody+Drug+Conjugates+with+High+Drug+Loading&doi=10.1038%2Fnbt.3274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loading</span></div><div class="casAuthors">Strop, Pavel; Delaria, Kathy; Foletti, Davide; Witt, Jody Melton; Hasa-Moreno, Adela; Poulsen, Kris; Casas, Meritxell Galindo; Dorywalska, Magdalena; Farias, Santiago; Pios, Ariel; Lui, Victor; Dushin, Russell; Zhou, Dahui; Navaratnam, Thayalan; Tran, Thomas-Toan; Sutton, Janette; Lindquist, Kevin C.; Han, Bora; Liu, Shu-Hui; Shelton, David L.; Pons, Jaume; Rajpal, Arvind</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">694-696</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt9y4CtErWAbVg90H21EOLACvtfcHk0liBoXfhVgOKjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ensLbK&md5=43b6c9f702e02a91887c3f27a5ab7353</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fnbt.3274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.3274%26sid%3Dliteratum%253Aachs%26aulast%3DStrop%26aufirst%3DP.%26aulast%3DDelaria%26aufirst%3DK.%26aulast%3DFoletti%26aufirst%3DD.%26aulast%3DWitt%26aufirst%3DJ.%2BM.%26aulast%3DHasa-Moreno%26aufirst%3DA.%26aulast%3DPoulsen%26aufirst%3DK.%26aulast%3DCasas%26aufirst%3DM.%2BG.%26aulast%3DDorywalska%26aufirst%3DM.%26aulast%3DFarias%26aufirst%3DS.%26aulast%3DPios%26aufirst%3DA.%26aulast%3DLui%26aufirst%3DV.%26aulast%3DDushin%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DTran%26aufirst%3DT.-T.%26aulast%3DSutton%26aufirst%3DJ.%26aulast%3DLindquist%26aufirst%3DK.%2BC.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DS.-H.%26aulast%3DShelton%26aufirst%3DD.%2BL.%26aulast%3DPons%26aufirst%3DJ.%26aulast%3DRajpal%26aufirst%3DA.%26atitle%3DSite-Specific%2520Conjugation%2520Improves%2520Therapeutic%2520Index%2520of%2520Antibody%2520Drug%2520Conjugates%2520with%2520High%2520Drug%2520Loading%26jtitle%3DNat.%2520Biotechnol.%26date%3D2015%26volume%3D33%26issue%3D7%26spage%3D694%26epage%3D696%26doi%3D10.1038%2Fnbt.3274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christie, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezabeh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimasi, N.</span></span> <span> </span><span class="NLM_article-title">Stabilization of Cysteine-Linked Antibody Drug Conjugates with N-Aryl Maleimides</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>220</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2015.09.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.jconrel.2015.09.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26387744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1SiurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=2015&pages=660-670&author=R.+J.+Christieauthor=R.+Flemingauthor=B.+Bezabehauthor=R.+Woodsauthor=S.+Maoauthor=J.+Harperauthor=A.+Josephauthor=Q.+Wangauthor=Z.-Q.+Xuauthor=H.+Wuauthor=C.+Gaoauthor=N.+Dimasi&title=Stabilization+of+Cysteine-Linked+Antibody+Drug+Conjugates+with+N-Aryl+Maleimides&doi=10.1016%2Fj.jconrel.2015.09.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides</span></div><div class="casAuthors">Christie, R. James; Fleming, Ryan; Bezabeh, Binyam; Woods, Rob; Mao, Shenlan; Harper, Jay; Joseph, Augustine; Wang, Qianli; Xu, Ze-Qi; Wu, Herren; Gao, Changshou; Dimasi, Nazzareno</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">660-670</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Maleimides are often used to covalently attach drugs to cysteine thiols for prodn. of antibody-drug conjugates (ADCs).  However, ADCs formed with traditional N-alkyl maleimides have variable stability in the bloodstream leading to loss of drug.  Here, we report that N-aryl maleimides form stable antibody conjugates under very mild conditions while also maintaining high conjugation efficiency.  Thiol-maleimide coupling and ADC stabilization via thiosuccinimide hydrolysis were accelerated by addn. of N-Ph or N-fluorophenyl groups to the ring-head nitrogen.  Cysteine-linked ADCs prepd. with N-aryl maleimides exhibited less than 20% deconjugation in both thiol-contg. buffer and serum when incubated at 37 °C over a period of 7 days, whereas the analogous ADCs prepd. with N-alkyl maleimides showed 35-67% deconjugation under the same conditions.  ADCs prepd. with the anticancer drug N-Ph maleimide monomethyl-auristatin-E (MMAE) maintained high cytotoxicity following long-term exposure to serum whereas the N-alkyl maleimide MMAE ADC lost potency over time.  These data demonstrate that N-aryl maleimides are a convenient and flexible platform to improve the stability of ADCs through manipulation of functional groups attached to the maleimide ring-head nitrogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP7jfO1qLzB7Vg90H21EOLACvtfcHk0liBoXfhVgOKjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1SiurbK&md5=0d689828ce8d888cead593ff0dc3423f</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2015.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2015.09.032%26sid%3Dliteratum%253Aachs%26aulast%3DChristie%26aufirst%3DR.%2BJ.%26aulast%3DFleming%26aufirst%3DR.%26aulast%3DBezabeh%26aufirst%3DB.%26aulast%3DWoods%26aufirst%3DR.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DHarper%26aufirst%3DJ.%26aulast%3DJoseph%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DZ.-Q.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DC.%26aulast%3DDimasi%26aufirst%3DN.%26atitle%3DStabilization%2520of%2520Cysteine-Linked%2520Antibody%2520Drug%2520Conjugates%2520with%2520N-Aryl%2520Maleimides%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2015%26volume%3D220%26spage%3D660%26epage%3D670%26doi%3D10.1016%2Fj.jconrel.2015.09.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolodych, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koniev, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baatarkhuu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debaene, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianférani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dorsselaer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A.</span></span> <span> </span><span class="NLM_article-title">CBTF: New Amine-to-Thiol Coupling Reagent for Preparation of Antibody Conjugates with Increased Plasma Stability</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1021/bc500610g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc500610g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=197-200&issue=2&author=S.+Kolodychauthor=O.+Konievauthor=Z.+Baatarkhuuauthor=J.-Y.+Bonnefoyauthor=F.+Debaeneauthor=S.+Cianf%C3%A9raniauthor=A.+Van+Dorsselaerauthor=A.+Wagner&title=CBTF%3A+New+Amine-to-Thiol+Coupling+Reagent+for+Preparation+of+Antibody+Conjugates+with+Increased+Plasma+Stability&doi=10.1021%2Fbc500610g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">CBTF: New Amine-to-Thiol Coupling Reagent for Preparation of Antibody Conjugates with Increased Plasma Stability</span></div><div class="casAuthors">Kolodych, Sergii; Koniev, Oleksandr; Baatarkhuu, Zoljargal; Bonnefoy, Jean-Yves; Debaene, Francois; Cianferani, Sarah; Van Dorsselaer, Alain; Wagner, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-200</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amine-to-thiol coupling is the most common route for the prepn. of antibody-drug conjugates (ADC).  It is usually achieved by using heterobifunctional reagents possessing an activated ester at one end and a maleimide group at the other.  However, maleimide-based conjugates were recently revealed to have limited stability in blood circulation, which can compromise therapeutic efficacy of the conjugate.  To address this issue, we have developed a heterobifunctional reagent, sodium 4-((4-(cyanoethynyl)benzoyl)oxy)-2,3,5,6-tetrafluorobenzenesulfonate (CBTF), for amine-to-thiol coupling.  It comprises a recently described 3-arylpropionitrile (APN) function in replacement of maleimide and allows for the prepn. of remarkably stable conjugates.  A series of antibody-dye conjugates have been prepd. using this reagent and shown superior stability in human blood plasma compared to maleimide-derived conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTbOZ8qNf8brVg90H21EOLACvtfcHk0lg0mVD0AgfTpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWgu7w%253D&md5=1b3c24d458a79fe4c9d5b30a606c9248</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fbc500610g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc500610g%26sid%3Dliteratum%253Aachs%26aulast%3DKolodych%26aufirst%3DS.%26aulast%3DKoniev%26aufirst%3DO.%26aulast%3DBaatarkhuu%26aufirst%3DZ.%26aulast%3DBonnefoy%26aufirst%3DJ.-Y.%26aulast%3DDebaene%26aufirst%3DF.%26aulast%3DCianf%25C3%25A9rani%26aufirst%3DS.%26aulast%3DVan%2BDorsselaer%26aufirst%3DA.%26aulast%3DWagner%26aufirst%3DA.%26atitle%3DCBTF%253A%2520New%2520Amine-to-Thiol%2520Coupling%2520Reagent%2520for%2520Preparation%2520of%2520Antibody%2520Conjugates%2520with%2520Increased%2520Plasma%2520Stability%26jtitle%3DBioconjugate%2520Chem.%26date%3D2015%26volume%3D26%26issue%3D2%26spage%3D197%26epage%3D200%26doi%3D10.1021%2Fbc500610g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dovgan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolodych, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koniev, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A.</span></span> <span> </span><span class="NLM_article-title">2-(Maleimidomethyl)-1,3-Dioxanes (MD): A Serum-Stable Self-Hydrolysable Hydrophilic Alternative to Classical Maleimide Conjugation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">30835</span>, <span class="refDoi"> DOI: 10.1038/srep30835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fsrep30835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=27501860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCisbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=30835&issue=1&author=I.+Dovganauthor=S.+Kolodychauthor=O.+Konievauthor=A.+Wagner&title=2-%28Maleimidomethyl%29-1%2C3-Dioxanes+%28MD%29%3A+A+Serum-Stable+Self-Hydrolysable+Hydrophilic+Alternative+to+Classical+Maleimide+Conjugation&doi=10.1038%2Fsrep30835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">2-(Maleimidomethyl)-1,3-Dioxanes (MD): a Serum-Stable Self-hydrolysable Hydrophilic Alternative to Classical Maleimide Conjugation</span></div><div class="casAuthors">Dovgan, Igor; Kolodych, Sergii; Koniev, Oleksandr; Wagner, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30835</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The vast majority of antibody-drug conjugates (ADC) are prepd. through amine-to-thiol conjugation.  To date, N-Succinimidyl-4-(maleimidomethyl) cyclohexanecarboxylate (SMCC) has been one of the most frequently applied reagents for the prepn. of ADC and other functional conjugates.  However, SMCC-based conjugates suffer from limited stability in blood circulation and from a hydrophobic character of the linker, which may give rise to major pharmacokinetic implications.  To address this issue, we have developed a heterobifunctional analog of a SMCC reagent, i.e., sodium 4-((maleimidomethyl-1,3-dioxane-5-carbonyl)oxy)-2,3,5,6- tetrafluorobenzenesulfonate (MDTF) for amine-to-thiol conjugation.  By replacing the cyclohexyl ring in the SMCC structure with the 1,3-dioxane, we increased the hydrophilicity of the linker.  A FRET probe based on MD linker was prepd. and showed superior stability compared to the MCC linker in human plasma, as well as in a variety of aq. buffers.  A detailed investigation demonstrated an accelerated succinimide ring opening for MD linker, resulting in stabilized conjugates.  Finally, the MDTF reagent was applied for the prepn. of serum stable antibody-dye conjugate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwsmWEmS006LVg90H21EOLACvtfcHk0lg0mVD0AgfTpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCisbbO&md5=6be2bf9187983ec52f6650841df724e3</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fsrep30835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep30835%26sid%3Dliteratum%253Aachs%26aulast%3DDovgan%26aufirst%3DI.%26aulast%3DKolodych%26aufirst%3DS.%26aulast%3DKoniev%26aufirst%3DO.%26aulast%3DWagner%26aufirst%3DA.%26atitle%3D2-%2528Maleimidomethyl%2529-1%252C3-Dioxanes%2520%2528MD%2529%253A%2520A%2520Serum-Stable%2520Self-Hydrolysable%2520Hydrophilic%2520Alternative%2520to%2520Classical%2520Maleimide%2520Conjugation%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26issue%3D1%26spage%3D30835%26doi%3D10.1038%2Fsrep30835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span>; <span class="NLM_string-name">Moore, K. N.</span>; <span class="NLM_string-name">Wang, J. S.</span>; <span class="NLM_string-name">Patel, M.</span>; <span class="NLM_string-name">Birrer, M. J.</span>; <span class="NLM_string-name">Hamilton, E.</span>; <span class="NLM_string-name">Barroilhet, L.</span>; <span class="NLM_string-name">Flanagan, W. M.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Garg, A.</span>; <span class="NLM_string-name">Lu, X.</span>; <span class="NLM_string-name">Vaze, A.</span>; <span class="NLM_string-name">Amin, D.</span>; <span class="NLM_string-name">Leipold, D.</span>; <span class="NLM_string-name">Commerford, S. R.</span>; <span class="NLM_string-name">Humke, E. W.</span>; <span class="NLM_string-name">Burris, H. A.</span></span> <span> </span><span class="NLM_article-title">Abstract CT009: Targeting MUC16 with the THIOMAB TM -Drug Conjugate DMUC4064A in Patients with Platinum-Resistant Ovarian Cancer: A Phase I Escalation Study</span>. In  <i>Clinical Trials</i>; <span class="NLM_publisher-name">American Association for Cancer Research</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">CT009</span>– <span class="NLM_lpage">CT009</span>. <span class="refDoi"> DOI: 10.1158/1538-7445.AM2017-CT009</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1158%2F1538-7445.AM2017-CT009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=CT009-CT009&author=J.+F.+Liu&author=K.+N.+Moore&author=J.+S.+Wang&author=M.+Patel&author=M.+J.+Birrer&author=E.+Hamilton&author=L.+Barroilhet&author=W.+M.+Flanagan&author=Y.+Wang&author=A.+Garg&author=X.+Lu&author=A.+Vaze&author=D.+Amin&author=D.+Leipold&author=S.+R.+Commerford&author=E.+W.+Humke&author=H.+A.+Burris&title=Clinical+Trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2017-CT009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1158%252F1538-7445.AM2017-CT009%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26atitle%3DAbstract%2520CT009%253A%2520Targeting%2520MUC16%2520with%2520the%2520THIOMAB%2520TM%2520-Drug%2520Conjugate%2520DMUC4064A%2520in%2520Patients%2520with%2520Platinum-Resistant%2520Ovarian%2520Cancer%253A%2520A%2520Phase%2520I%2520Escalation%2520Study%26btitle%3DClinical%2520Trials%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%26date%3D2017%26spage%3DCT009%26epage%3DCT009%26doi%3D10.1158%2F1538-7445.AM2017-CT009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erba, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Advani, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancet, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacsovics, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelo, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bixby, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faderl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jillella, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biddle-Snead, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, A. S.</span></span> <span> </span><span class="NLM_article-title">A Phase 1 Trial of Vadastuximab Talirine as Monotherapy in Patients with CD33-Positive Acute Myeloid Leukemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1182/blood-2017-06-789800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1182%2Fblood-2017-06-789800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=29196412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1CqsLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2018&pages=387-396&issue=4&author=E.+M.+Steinauthor=R.+B.+Walterauthor=H.+P.+Erbaauthor=A.+T.+Fathiauthor=A.+S.+Advaniauthor=J.+E.+Lancetauthor=F.+Ravandiauthor=T.+Kovacsovicsauthor=D.+J.+DeAngeloauthor=D.+Bixbyauthor=S.+Faderlauthor=A.+P.+Jillellaauthor=P.+A.+Hoauthor=M.+M.+O%E2%80%99Mearaauthor=B.+Zhaoauthor=C.+Biddle-Sneadauthor=A.+S.+Stein&title=A+Phase+1+Trial+of+Vadastuximab+Talirine+as+Monotherapy+in+Patients+with+CD33-Positive+Acute+Myeloid+Leukemia&doi=10.1182%2Fblood-2017-06-789800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia</span></div><div class="casAuthors">Stein, Eytan M.; Walter, Roland B.; Erba, Harry P.; Fathi, Amir T.; Advani, Anjali S.; Lancet, Jeffrey E.; Ravandi, Farhad; Kovacsovics, Tibor; DeAngelo, Daniel J.; Bixby, Dale; Faderl, Stefan; Jillella, Anand P.; Ho, Phoenix A.; O'Meara, Megan M.; Zhao, Baiteng; Biddle-Snead, Charles; Stein, Anthony S.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-396</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Vadastuximab talirine (SGN-CD33A, 33A) is an antibody-drug conjugate consisting of pyrrolobenzodiazepine dimers linked to a monoclonal antibody targeting CD33, which is expressed in the majority of acute myeloid leukemia (AML) patients.  This phase 1 study evaluated the safety, pharmacokinetics, and preliminary activity of vadastuximab talirine and detd. the recommended monotherapy dose in patients with relapsed or refractory AML.  Addnl. expansion cohorts tested vadastuximab talirine in specific subpopulations of relapsed AML, and in a cohort of older, treatment-naive patients.  Patients received vadastuximab talirine IV on day 1 (5-60μg/kg) or on days 1 and 4 (20μg/kg) of 21-day cycles.  A total of 131 patients (median age, 73 years [range, 26-89 years]) had intermediate I-II (48%) or adverse (34%) risk by European LeukemiaNet classification; 50% of patients had underlying myelodysplasia.  Two dose-limiting toxicities (grade 2 pulmonary embolism and grade 4 hypocellular marrow) occurred during dose finding.  Most adverse events (AEs) were consistent with myelosuppression; nonhematol. AEs included fatigue, nausea, and diarrhea.  The 30-day mortality was 8%.  At the recommended monotherapy dose of 40μg/kg, the complete remission + CRi rate was 28% (5 of 18 patients); 50% of patients who responded achieved minimal residual disease negativity.  In patients across dose levels who achieved CR or CRi, the median time to full count recovery was 6.4 wk for neutrophils (≥1000/mL) and 10.6 wk for platelets (≥100 × 109/L).  Vadastuximab talirine demonstrates activity and a tolerable safety profile as a single agent in patients with AML.  The recommended monotherapy dose of vadastuximab talirine is 40μg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrINNKMO7kyLLVg90H21EOLACvtfcHk0ljqm2M-XF79Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1CqsLvN&md5=31b796f7bf19c07dc37b88c6935308ee</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1182%2Fblood-2017-06-789800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2017-06-789800%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DE.%2BM.%26aulast%3DWalter%26aufirst%3DR.%2BB.%26aulast%3DErba%26aufirst%3DH.%2BP.%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DAdvani%26aufirst%3DA.%2BS.%26aulast%3DLancet%26aufirst%3DJ.%2BE.%26aulast%3DRavandi%26aufirst%3DF.%26aulast%3DKovacsovics%26aufirst%3DT.%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DBixby%26aufirst%3DD.%26aulast%3DFaderl%26aufirst%3DS.%26aulast%3DJillella%26aufirst%3DA.%2BP.%26aulast%3DHo%26aufirst%3DP.%2BA.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%2BM.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DBiddle-Snead%26aufirst%3DC.%26aulast%3DStein%26aufirst%3DA.%2BS.%26atitle%3DA%2520Phase%25201%2520Trial%2520of%2520Vadastuximab%2520Talirine%2520as%2520Monotherapy%2520in%2520Patients%2520with%2520CD33-Positive%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DBlood%26date%3D2018%26volume%3D131%26issue%3D4%26spage%3D387%26epage%3D396%26doi%3D10.1182%2Fblood-2017-06-789800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strop, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorywalska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaria, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dushin, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, W.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farias, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdiche, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekaran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samain, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaparro-Riggers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pons, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajpal, A.</span></span> <span> </span><span class="NLM_article-title">Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2013.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.chembiol.2013.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=23438745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=161-167&issue=2&author=P.+Stropauthor=S.-H.+Liuauthor=M.+Dorywalskaauthor=K.+Delariaauthor=R.+G.+Dushinauthor=T.-T.+Tranauthor=W.-H.+Hoauthor=S.+Fariasauthor=M.+G.+Casasauthor=Y.+Abdicheauthor=D.+Zhouauthor=R.+Chandrasekaranauthor=C.+Samainauthor=C.+Looauthor=A.+Rossiauthor=M.+Rickertauthor=S.+Krimmauthor=T.+Wongauthor=S.+M.+Chinauthor=J.+Yuauthor=J.+Dilleyauthor=J.+Chaparro-Riggersauthor=G.+F.+Filzenauthor=C.+J.+O%E2%80%99Donnellauthor=F.+Wangauthor=J.+S.+Myersauthor=J.+Ponsauthor=D.+L.+Sheltonauthor=A.+Rajpal&title=Location+Matters%3A+Site+of+Conjugation+Modulates+Stability+and+Pharmacokinetics+of+Antibody+Drug+Conjugates&doi=10.1016%2Fj.chembiol.2013.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates</span></div><div class="casAuthors">Strop, Pavel; Liu, Shu-Hui; Dorywalska, Magdalena; Delaria, Kathy; Dushin, Russell G.; Tran, Thomas-Toan; Ho, Wei-Hsien; Farias, Santiago; Casas, Meritxell Galindo; Abdiche, Yasmina; Zhou, Dahui; Chandrasekaran, Ramalakshmi; Samain, Caroline; Loo, Carole; Rossi, Andrea; Rickert, Mathias; Krimm, Stellanie; Wong, Teresa; Chin, Sherman Michael; Yu, Jessica; Dilley, Jeanette; Chaparro-Riggers, Javier; Filzen, Gary F.; O'Donnell, Christopher J.; Wang, Fang; Myers, Jeremy S.; Pons, Jaume; Shelton, David L.; Rajpal, Arvind</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-167</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Antibody drug conjugates (ADCs) are a therapeutic class offering promise for cancer therapy.  The attachment of cytotoxic drugs to antibodies can result in an effective therapy with better safety potential than nontargeted cytotoxics.  To understand the role of conjugation site, we developed an enzymic method for site-specific antibody drug conjugation using microbial transglutaminase.  This allowed us to attach diverse compds. at multiple positions and investigate how the site influences stability, toxicity, and efficacy.  We show that the conjugation site has significant impact on ADC stability and pharmacokinetics in a species-dependent manner.  These differences can be directly attributed to the position of the linkage rather than the chem. instability, as was obsd. with a maleimide linkage.  With this method, it is possible to produce homogeneous ADCs and tune their properties to maximize the therapeutic window.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIo4ZEVMFX2LVg90H21EOLACvtfcHk0liF334VM39UQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWht74%253D&md5=0b419848b5fd4dfa4863a29de0555cf4</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DStrop%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DS.-H.%26aulast%3DDorywalska%26aufirst%3DM.%26aulast%3DDelaria%26aufirst%3DK.%26aulast%3DDushin%26aufirst%3DR.%2BG.%26aulast%3DTran%26aufirst%3DT.-T.%26aulast%3DHo%26aufirst%3DW.-H.%26aulast%3DFarias%26aufirst%3DS.%26aulast%3DCasas%26aufirst%3DM.%2BG.%26aulast%3DAbdiche%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DChandrasekaran%26aufirst%3DR.%26aulast%3DSamain%26aufirst%3DC.%26aulast%3DLoo%26aufirst%3DC.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DKrimm%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DT.%26aulast%3DChin%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DDilley%26aufirst%3DJ.%26aulast%3DChaparro-Riggers%26aufirst%3DJ.%26aulast%3DFilzen%26aufirst%3DG.%2BF.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DMyers%26aufirst%3DJ.%2BS.%26aulast%3DPons%26aufirst%3DJ.%26aulast%3DShelton%26aufirst%3DD.%2BL.%26aulast%3DRajpal%26aufirst%3DA.%26atitle%3DLocation%2520Matters%253A%2520Site%2520of%2520Conjugation%2520Modulates%2520Stability%2520and%2520Pharmacokinetics%2520of%2520Antibody%2520Drug%2520Conjugates%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26issue%3D2%26spage%3D161%26epage%3D167%26doi%3D10.1016%2Fj.chembiol.2013.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ricart, A. D.</span></span> <span> </span><span class="NLM_article-title">Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6417</span>– <span class="NLM_lpage">6427</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-0486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1158%2F1078-0432.CCR-11-0486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=22003069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSksrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6417-6427&issue=20&author=A.+D.+Ricart&title=Antibody-Drug+Conjugates+of+Calicheamicin+Derivative%3A+Gemtuzumab+Ozogamicin+and+Inotuzumab+Ozogamicin&doi=10.1158%2F1078-0432.CCR-11-0486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin</span></div><div class="casAuthors">Ricart, Alejandro D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6417-6427</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Antibody-drug conjugates (ADC) are an attractive approach for the treatment of acute myeloid leukemia and non-Hodgkin lymphomas, which in most cases, are inherently sensitive to cytotoxic agents.  CD33 and CD22 are specific markers of myeloid leukemias and B-cell malignancies, resp.  These endocytic receptors are ideal for an ADC strategy because they can effectively carry the cytotoxic payload into the cell.  Gemtuzumab ozogamicin (GO, Mylotarg) and inotuzumab ozogamicin consist of a deriv. of calicheamicin (a potent DNA-binding cytotoxic antibiotic) linked to a humanized monoclonal IgG4 antibody directed against CD33 or CD22, resp.  Both of these ADCs have a target-mediated pharmacokinetic disposition.  GO was the first drug to prove the ADC concept in the clinic, specifically in phase II studies that included substantial proportions of older patients with relapsed acute myeloid leukemia.  In contrast, in phase III studies, it has thus far failed to show clin. benefit in first-line treatment in combination with std. chemotherapy.  Inotuzumab ozogamicin has shown remarkable clin. activity in relapsed/refractory B-cell non-Hodgkin lymphoma, and it has started phase III evaluation.  The safety profile of these ADCs includes reversible myelosuppression (esp. neutropenia and thrombocytopenia), elevated hepatic transaminases, and hyperbilirubinemia.  There have been postmarketing reports of hepatotoxicity, esp. veno-occlusive disease, assocd. with GO.  The incidence is ∼2%, but patients who undergo hematopoietic stem cell transplantation have an increased risk.  As we steadily move toward the goal of personalized medicine, these kinds of agents will provide a unique opportunity to treat selected patient subpopulations based on the expression of their specific tumor targets.  Clin Cancer Res; 17(20); 6417-27.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXhh65029iwbVg90H21EOLACvtfcHk0lh_6ZF4mNI9ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSksrzF&md5=103b40cfe49632a86367414e0e97c011</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-0486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-0486%26sid%3Dliteratum%253Aachs%26aulast%3DRicart%26aufirst%3DA.%2BD.%26atitle%3DAntibody-Drug%2520Conjugates%2520of%2520Calicheamicin%2520Derivative%253A%2520Gemtuzumab%2520Ozogamicin%2520and%2520Inotuzumab%2520Ozogamicin%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26issue%3D20%26spage%3D6417%26epage%3D6427%26doi%3D10.1158%2F1078-0432.CCR-11-0486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krop, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welslau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baselga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diéras, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guardino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwell, K.</span></span> <span> </span><span class="NLM_article-title">Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">1783</span>– <span class="NLM_lpage">1791</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1209124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1056%2FNEJMoa1209124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=23020162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=1783-1791&issue=19&author=S.+Vermaauthor=D.+Milesauthor=L.+Gianniauthor=I.+E.+Kropauthor=M.+Welslauauthor=J.+Baselgaauthor=M.+Pegramauthor=D.-Y.+Ohauthor=V.+Di%C3%A9rasauthor=E.+Guardinoauthor=L.+Fangauthor=M.+W.+Luauthor=S.+Olsenauthor=K.+Blackwell&title=Trastuzumab+Emtansine+for+HER2-Positive+Advanced+Breast+Cancer&doi=10.1056%2FNEJMoa1209124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Trastuzumab emtansine for HER2-positive advanced breast cancer</span></div><div class="casAuthors">Verma, Sunil; Miles, David; Gianni, Luca; Krop, Ian E.; Welslau, Manfred; Baselga, Jose; Pegram, Mark; Oh, Do-Youn; Dieras, Veronique; Guardino, Ellie; Fang, Liang; Lu, Michael W.; Olsen, Steven; Blackwell, Kim</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1783-1791</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate incorporating the human epidermal growth factor receptor 2 (HER2)-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.  The antibody and the cytotoxic agent are conjugated by means of a stable linker.  METHODS: We randomly assigned patients with HER2-pos. advanced breast cancer, who had previously been treated with trastuzumab and a taxane, to T-DM1 or lapatinib plus capecitabine.  The primary end points were progression-free survival (as assessed by independent review), overall survival, and safety.  Secondary end points included progression-free survival (investigator-assessed), the objective response rate, and the time to symptom progression.  Two interim analyses of overall survival were conducted.  RESULTS: Among 991 randomly assigned patients, median progression-free survival as assessed by independent review was 9.6 mo with T-DM1 vs. 6.4 mo with lapatinib plus capecitabine (hazard ratio for progression or death from any cause, 0.65; 95% confidence interval [CI], 0.55 to 0.77; P<0.001), and median overall survival at the second interim anal. crossed the stopping boundary for efficacy (30.9 mo vs. 25.1 mo; hazard ratio for death from any cause, 0.68; 95% CI, 0.55 to 0.85; P<0.001).  The objective response rate was higher with T-DM1 (43.6%, vs. 30.8% with lapatinib plus capecitabine; P<0.001); results for all addnl. secondary end points favored T-DM1.  Rates of grade 3 or above were higher with lapatinib plus capecitabine than with T-DM1 (57% vs. 41%).  The incidences of thrombocytopenia and increased serum aminotransferase levels were higher with T-DM1, whereas the incidences of diarrhea, nausea, vomiting, and palmar-plantar erythrodysesthesia were higher with lapatinib plus capecitabine.  CONCLUSIONS: T-DM1 significantly prolonged progression-free and overall survival with less toxicity than lapatinib plus capecitabine in patients with HER2-pos. advanced breast cancer previously treated with trastuzumab and a taxane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGRhxRQ7JSJrVg90H21EOLACvtfcHk0lh_6ZF4mNI9ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt73M&md5=3be5bac27a81b530442dc8a6b4a1f82e</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1209124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1209124%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DS.%26aulast%3DMiles%26aufirst%3DD.%26aulast%3DGianni%26aufirst%3DL.%26aulast%3DKrop%26aufirst%3DI.%2BE.%26aulast%3DWelslau%26aufirst%3DM.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DPegram%26aufirst%3DM.%26aulast%3DOh%26aufirst%3DD.-Y.%26aulast%3DDi%25C3%25A9ras%26aufirst%3DV.%26aulast%3DGuardino%26aufirst%3DE.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DS.%26aulast%3DBlackwell%26aufirst%3DK.%26atitle%3DTrastuzumab%2520Emtansine%2520for%2520HER2-Positive%2520Advanced%2520Breast%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26issue%3D19%26spage%3D1783%26epage%3D1791%26doi%3D10.1056%2FNEJMoa1209124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bardia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vahdat, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolaney, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isakoff, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shaughnessy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroose, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santin, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramson, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugo, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenberg, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweidan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iannone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washkowitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharkey, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegener, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinsky, K.</span></span> <span> </span><span class="NLM_article-title">Sacituzumab Govitecan-Hziy in Refractory Metastatic Triple-Negative Breast Cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>380</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1814213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1056%2FNEJMoa1814213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=30786188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvVSjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2019&pages=741-751&issue=8&author=A.+Bardiaauthor=I.+A.+Mayerauthor=L.+T.+Vahdatauthor=S.+M.+Tolaneyauthor=S.+J.+Isakoffauthor=J.+R.+Diamondauthor=J.+O%E2%80%99Shaughnessyauthor=R.+L.+Morooseauthor=A.+D.+Santinauthor=V.+G.+Abramsonauthor=N.+C.+Shahauthor=H.+S.+Rugoauthor=D.+M.+Goldenbergauthor=A.+M.+Sweidanauthor=R.+Iannoneauthor=S.+Washkowitzauthor=R.+M.+Sharkeyauthor=W.+A.+Wegenerauthor=K.+Kalinsky&title=Sacituzumab+Govitecan-Hziy+in+Refractory+Metastatic+Triple-Negative+Breast+Cancer&doi=10.1056%2FNEJMoa1814213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer</span></div><div class="casAuthors">Bardia, A.; Mayer, I. A.; Vahdat, L. T.; Tolaney, S. M.; Isakoff, S. J.; Diamond, J. R.; O'Shaughnessy, J.; Moroose, R. L.; Santin, A. D.; Abramson, V. G.; Shah, N. C.; Rugo, H. S.; Goldenberg, D. M.; Sweidan, A. M.; Iannone, R.; Washkowitz, S.; Sharkey, R. M.; Wegener, W. A.; Kalinsky, K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">741-751</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background Std. chemotherapy is assocd. with low response rates and short progression-free survival among patients with pretreated metastatic triple-neg. breast cancer.  Sacituzumab govitecan-hziy is an antibody-drug conjugate that combines a humanized monoclonal antibody, which targets the human trophoblast cell-surface antigen 2 (Trop-2), with SN-38, which is conjugated to the antibody by a cleavable linker.  Sacituzumab govitecan-hziy enables delivery of high concns. of SN-38 to tumors.  Methods We conducted a phase 1/2 single-group, multicenter trial involving patients with advanced epithelial cancers who received sacituzumab govitecan-hziy i.v. on days 1 and 8 of each 21-day cycle until disease progression or unacceptable toxic effects.  A total of 108 patients received sacituzumab govitecan-hziy at a dose of 10 mg per kg of body wt. after receiving at least two previous anticancer therapies for metastatic triple-neg. breast cancer.  The end points included safety; the objective response rate (according to Response Evaluation Criteria in Solid Tumors, version 1.1), which was assessed locally; the duration of response; the clin. benefit rate (defined as a complete or partial response or stable disease for at least 6 mo); progression-free survival; and overall survival.  Post hoc analyses detd. the response rate and duration, which were assessed by blinded independent central review. results The 108 patients with triple-neg. breast cancer had received a median of 3 previous therapies (range, 2 to 10).  Four deaths occurred during treatment; 3 patients (2.8%) discontinued treatment because of adverse events.  Grade 3 or 4 adverse events (in ≥10% of the patients) included anemia and neutropenia; 10 patients (9.3%) had febrile neutropenia.  The response rate (3 complete and 33 partial responses) was 33.3% (95% confidence interval [CI], 24.6 to 43.1), and the median duration of response was 7.7 mo (95% CI, 4.9 to 10.8); as assessed by independent central review, these values were 34.3% and 9.1 mo, resp.  The clin. benefit rate was 45.4%.  Median progression-free survival was 5.5 mo (95% CI, 4.1 to 6.3), and overall survival was 13.0 mo (95% CI, 11.2 to 13.7).  Conclusions Sacituzumab govitecan-hziy was assocd. with durable objective responses in patients with heavily pretreated metastatic triple-neg. breast cancer.  Myelotoxic effects were the main adverse reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAgQWEPOcqfrVg90H21EOLACvtfcHk0lgf3_0JH7IuPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvVSjs7w%253D&md5=75edc2c274aef0ab90dd2aaf230dabac</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1814213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1814213%26sid%3Dliteratum%253Aachs%26aulast%3DBardia%26aufirst%3DA.%26aulast%3DMayer%26aufirst%3DI.%2BA.%26aulast%3DVahdat%26aufirst%3DL.%2BT.%26aulast%3DTolaney%26aufirst%3DS.%2BM.%26aulast%3DIsakoff%26aufirst%3DS.%2BJ.%26aulast%3DDiamond%26aufirst%3DJ.%2BR.%26aulast%3DO%25E2%2580%2599Shaughnessy%26aufirst%3DJ.%26aulast%3DMoroose%26aufirst%3DR.%2BL.%26aulast%3DSantin%26aufirst%3DA.%2BD.%26aulast%3DAbramson%26aufirst%3DV.%2BG.%26aulast%3DShah%26aufirst%3DN.%2BC.%26aulast%3DRugo%26aufirst%3DH.%2BS.%26aulast%3DGoldenberg%26aufirst%3DD.%2BM.%26aulast%3DSweidan%26aufirst%3DA.%2BM.%26aulast%3DIannone%26aufirst%3DR.%26aulast%3DWashkowitz%26aufirst%3DS.%26aulast%3DSharkey%26aufirst%3DR.%2BM.%26aulast%3DWegener%26aufirst%3DW.%2BA.%26aulast%3DKalinsky%26aufirst%3DK.%26atitle%3DSacituzumab%2520Govitecan-Hziy%2520in%2520Refractory%2520Metastatic%2520Triple-Negative%2520Breast%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2019%26volume%3D380%26issue%3D8%26spage%3D741%26epage%3D751%26doi%3D10.1056%2FNEJMoa1814213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lonial, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trudel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nooka, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdallah, A.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callander, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lendvai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sborov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suvannasankha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libby, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnulf, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortüm, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Otero, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usmani, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quach, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voorhees, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piontek, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewell, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dettman, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposti, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opalinska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, A. D.</span></span> <span> </span><span class="NLM_article-title">Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma (DREAMM-2): A Two-Arm, Randomised, Open-Label, Phase 2 Study</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(19)30788-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS1470-2045%2819%2930788-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31859245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVajtLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=207-221&issue=2&author=S.+Lonialauthor=H.+C.+Leeauthor=A.+Badrosauthor=S.+Trudelauthor=A.+K.+Nookaauthor=A.+Chariauthor=A.-O.+Abdallahauthor=N.+Callanderauthor=N.+Lendvaiauthor=D.+Sborovauthor=A.+Suvannasankhaauthor=K.+Weiselauthor=L.+Karlinauthor=E.+Libbyauthor=B.+Arnulfauthor=T.+Faconauthor=C.+Hulinauthor=K.+M.+Kort%C3%BCmauthor=P.+Rodr%C3%ADguez-Oteroauthor=S.+Z.+Usmaniauthor=P.+Hariauthor=R.+Bazauthor=H.+Quachauthor=P.+Moreauauthor=P.+M.+Voorheesauthor=I.+Guptaauthor=A.+Hoosauthor=E.+Zhiauthor=J.+Baronauthor=T.+Piontekauthor=E.+Lewisauthor=R.+C.+Jewellauthor=E.+J.+Dettmanauthor=R.+Popatauthor=S.+D.+Espostiauthor=J.+Opalinskaauthor=P.+Richardsonauthor=A.+D.+Cohen&title=Belantamab+Mafodotin+for+Relapsed+or+Refractory+Multiple+Myeloma+%28DREAMM-2%29%3A+A+Two-Arm%2C+Randomised%2C+Open-Label%2C+Phase+2+Study&doi=10.1016%2FS1470-2045%2819%2930788-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study</span></div><div class="casAuthors">Lonial, Sagar; Lee, Hans C.; Badros, Ashraf; Trudel, Suzanne; Nooka, Ajay K.; Chari, Ajai; Abdallah, Al-Ola; Callander, Natalie; Lendvai, Nikoletta; Sborov, Douglas; Suvannasankha, Attaya; Weisel, Katja; Karlin, Lionel; Libby, Edward; Arnulf, Bertrand; Facon, Thierry; Hulin, Cyrille; Kortum, K. Martin; Rodriguez-Otero, Paula; Usmani, Saad Z.; Hari, Parameswaran; Baz, Rachid; Quach, Hang; Moreau, Philippe; Voorhees, Peter M.; Gupta, Ira; Hoos, Axel; Zhi, Eric; Baron, January; Piontek, Trisha; Lewis, Eric; Jewell, Roxanne C.; Dettman, Elisha J.; Popat, Rakesh; Esposti, Simona Degli; Opalinska, Joanna; Richardson, Paul; Cohen, Adam D.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-221</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Belantamab mafodotin (GSK2857916), an immunoconjugate targeting B-cell maturation antigen, showed single-agent activity in the phase 1 DREAMM-1 study in heavily pre-treated patients with relapsed or refractory multiple myeloma.  We further investigated the safety and activity of belantamab mafodotin in the DREAMM-2 study.  DREAMM-2 is an open-label, two-arm, phase 2 study done at 58 multiple myeloma specialty centers in eight countries.  Patients (aged ≥18 years) with relapsed or refractory multiple myeloma with disease progression after three or more lines of therapy and who were refractory to immunomodulatory drugs and proteasome inhibitors, and refractory or intolerant (or both) to an anti-CD38 monoclonal antibody with an Eastern Cooperative Oncol. Group performance status of 0-2 were recruited, centrally randomly assigned (1:1) with permuted blocks (block size 4), and stratified by previous lines of therapy (≤4 vs >4) and cytogenetic features to receive 2·5 mg/kg or 3·4 mg/kg belantamab mafodotin via i.v. infusion every 3 wk on day 1 of each cycle until disease progression or unacceptable toxicity.  The intention-to-treat population comprised all randomised patients, regardless of treatment administration.  The safety population comprised all patients who received at least one dose of belantamab mafodotin.  The primary outcome was the proportion of randomly assigned patients in the intention-to-treat population who achieved an overall response, as assessed by an independent review committee.  This study is registered with ClinicalTrials.gov, NCT03525678, and is ongoing.  Between June 18, 2018, and Jan 2, 2019, 293 patients were screened and 196 were included in the intention-to-treat population (97 in the 2·5 mg/kg cohort and 99 in the 3·4 mg/kg cohort).  As of June 21, 2019 (the primary anal. data cutoff date), 30 (31%; 97·5% CI 20·8-42·6) of 97 patients in the 2·5 mg/kg cohort and 34 (34%; 23·9-46·0) of 99 patients in the 3·4 mg/kg cohort achieved an overall response.  The most common grade 3-4 adverse events in the safety population were keratopathy (in 26 [27%] of 95 patients in the 2·5 mg/kg cohort and 21 [21%] of 99 patients in the 3·4 mg/kg cohort), thrombocytopenia (19 [20%] and 33 [33%]), and anemia (19 [20%] and 25 [25%]); 38 (40%) of 95 patients in the 2·5 mg/kg cohort and 47 (47%) of 99 in the 3·4 mg/kg cohort reported serious adverse events.  Two deaths were potentially treatment related (one case of sepsis in the 2·5 mg/kg cohort and one case of haemophagocytic lymphohistiocytosis in the 3·4 mg/kg cohort).  Single-agent belantamab mafodotin shows anti-myeloma activity with a manageable safety profile in patients with relapsed or refractory multiple myeloma.GlaxoSmithKline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX5xuk-7bebbVg90H21EOLACvtfcHk0lgf3_0JH7IuPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVajtLjN&md5=cef83b6e32d56ef8410f339855314db1</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2819%2930788-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252819%252930788-0%26sid%3Dliteratum%253Aachs%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DH.%2BC.%26aulast%3DBadros%26aufirst%3DA.%26aulast%3DTrudel%26aufirst%3DS.%26aulast%3DNooka%26aufirst%3DA.%2BK.%26aulast%3DChari%26aufirst%3DA.%26aulast%3DAbdallah%26aufirst%3DA.-O.%26aulast%3DCallander%26aufirst%3DN.%26aulast%3DLendvai%26aufirst%3DN.%26aulast%3DSborov%26aufirst%3DD.%26aulast%3DSuvannasankha%26aufirst%3DA.%26aulast%3DWeisel%26aufirst%3DK.%26aulast%3DKarlin%26aufirst%3DL.%26aulast%3DLibby%26aufirst%3DE.%26aulast%3DArnulf%26aufirst%3DB.%26aulast%3DFacon%26aufirst%3DT.%26aulast%3DHulin%26aufirst%3DC.%26aulast%3DKort%25C3%25BCm%26aufirst%3DK.%2BM.%26aulast%3DRodr%25C3%25ADguez-Otero%26aufirst%3DP.%26aulast%3DUsmani%26aufirst%3DS.%2BZ.%26aulast%3DHari%26aufirst%3DP.%26aulast%3DBaz%26aufirst%3DR.%26aulast%3DQuach%26aufirst%3DH.%26aulast%3DMoreau%26aufirst%3DP.%26aulast%3DVoorhees%26aufirst%3DP.%2BM.%26aulast%3DGupta%26aufirst%3DI.%26aulast%3DHoos%26aufirst%3DA.%26aulast%3DZhi%26aufirst%3DE.%26aulast%3DBaron%26aufirst%3DJ.%26aulast%3DPiontek%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DE.%26aulast%3DJewell%26aufirst%3DR.%2BC.%26aulast%3DDettman%26aufirst%3DE.%2BJ.%26aulast%3DPopat%26aufirst%3DR.%26aulast%3DEsposti%26aufirst%3DS.%2BD.%26aulast%3DOpalinska%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DCohen%26aufirst%3DA.%2BD.%26atitle%3DBelantamab%2520Mafodotin%2520for%2520Relapsed%2520or%2520Refractory%2520Multiple%2520Myeloma%2520%2528DREAMM-2%2529%253A%2520A%2520Two-Arm%252C%2520Randomised%252C%2520Open-Label%252C%2520Phase%25202%2520Study%26jtitle%3DLancet%2520Oncol.%26date%3D2020%26volume%3D21%26issue%3D2%26spage%3D207%26epage%3D221%26doi%3D10.1016%2FS1470-2045%2819%2930788-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Modi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsurutani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denduluri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aogi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, S.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurvitz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahidi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yver, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krop, I.</span></span> <span> </span><span class="NLM_article-title">Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>382</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">610</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1914510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1056%2FNEJMoa1914510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31825192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtlChur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2020&pages=610-621&issue=7&author=S.+Modiauthor=C.+Sauraauthor=T.+Yamashitaauthor=Y.+H.+Parkauthor=S.-B.+Kimauthor=K.+Tamuraauthor=F.+Andreauthor=H.+Iwataauthor=Y.+Itoauthor=J.+Tsurutaniauthor=J.+Sohnauthor=N.+Denduluriauthor=C.+Perrinauthor=K.+Aogiauthor=E.+Tokunagaauthor=S.-A.+Imauthor=K.+S.+Leeauthor=S.+A.+Hurvitzauthor=J.+Cortesauthor=C.+Leeauthor=S.+Chenauthor=L.+Zhangauthor=J.+Shahidiauthor=A.+Yverauthor=I.+Krop&title=Trastuzumab+Deruxtecan+in+Previously+Treated+HER2-Positive+Breast+Cancer&doi=10.1056%2FNEJMoa1914510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Trastuzumab deruxtecan in previously treated HER2-positive breast cancer</span></div><div class="casAuthors">Modi, S.; Saura, C.; Yamashita, T.; Park, Y. H.; Kim, S.-B.; Tamura, K.; Andre, F.; Iwata, H.; Ito, Y.; Tsurutani, J.; Sohn, J.; Denduluri, N.; Perrin, C.; Aogi, K.; Tokunaga, E.; Im, S.-A.; Lee, K. S.; Hurvitz, S. A.; Cortes, J.; Lee, C.; Chen, S.; Zhang, L.; Shahidi, J.; Yver, A.; Krop, I.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">610-621</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">In this two-part, open-label, single-group, multicenter, phase 2 study, we evaluated trastuzumab deruxtecan in adults with pathol. documented HER2-pos. metastatic breast cancer who had received previous treatment with trastuzumab emtansine.  In the first part of the study, we evaluated three different doses of trastuzumab deruxtecan to establish a recommended dose; in the second part, we evaluated the efficacy and safety of the recommended dose.  Key secondary end points were the disease-control rate, clin.-benefit rate, duration of response and progression-free survival, and safety. results Overall, 184 patients who had undergone a median of six previous treatments received the recommended dose of trastuzumab deruxtecan (5.4 mg per kg of body wt.).  During the study, the most common adverse events of grade 3 or higher were a decreased neutrophil count (in 20.7% of the patients), anemia (in 8.7%), and nausea (in 7.6%).  On independent adjudication, the trial drug was assocd. with interstitial lung disease in 13.6% of the patients (grade 1 or 2, 10.9%; grade 3 or 4, 0.5%; and grade 5, 2.2%). conclusions Trastuzumab deruxtecan showed durable antitumor activity in a pretreated patient population with HER2-pos. metastatic breast cancer.  In addn. to nausea and myelosuppression, interstitial lung disease was obsd. in a subgroup of patients and requires attention to pulmonary symptoms and careful monitoring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Uc2NDB76h7Vg90H21EOLACvtfcHk0lj4iisUXOvpQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtlChur8%253D&md5=0b142802a47c4f50f0b2cdc82f22ce87</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1914510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1914510%26sid%3Dliteratum%253Aachs%26aulast%3DModi%26aufirst%3DS.%26aulast%3DSaura%26aufirst%3DC.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DY.%2BH.%26aulast%3DKim%26aufirst%3DS.-B.%26aulast%3DTamura%26aufirst%3DK.%26aulast%3DAndre%26aufirst%3DF.%26aulast%3DIwata%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DTsurutani%26aufirst%3DJ.%26aulast%3DSohn%26aufirst%3DJ.%26aulast%3DDenduluri%26aufirst%3DN.%26aulast%3DPerrin%26aufirst%3DC.%26aulast%3DAogi%26aufirst%3DK.%26aulast%3DTokunaga%26aufirst%3DE.%26aulast%3DIm%26aufirst%3DS.-A.%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DHurvitz%26aufirst%3DS.%2BA.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DShahidi%26aufirst%3DJ.%26aulast%3DYver%26aufirst%3DA.%26aulast%3DKrop%26aufirst%3DI.%26atitle%3DTrastuzumab%2520Deruxtecan%2520in%2520Previously%2520Treated%2520HER2-Positive%2520Breast%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2020%26volume%3D382%26issue%3D7%26spage%3D610%26epage%3D621%26doi%3D10.1056%2FNEJMoa1914510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balar, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galsky, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gartner, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinelli, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melhem-Bertrandt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrylak, D. P.</span></span> <span> </span><span class="NLM_article-title">Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">2592</span>– <span class="NLM_lpage">2600</span>, <span class="refDoi"> DOI: 10.1200/JCO.19.01140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1200%2FJCO.19.01140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31356140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovVSitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=2592-2600&issue=29&author=J.+E.+Rosenbergauthor=P.+H.+O%E2%80%99Donnellauthor=A.+V.+Balarauthor=B.+A.+McGregorauthor=E.+I.+Heathauthor=E.+Y.+Yuauthor=M.+D.+Galskyauthor=N.+M.+Hahnauthor=E.+M.+Gartnerauthor=J.+M.+Pinelliauthor=S.-Y.+Liangauthor=A.+Melhem-Bertrandtauthor=D.+P.+Petrylak&title=Pivotal+Trial+of+Enfortumab+Vedotin+in+Urothelial+Carcinoma+After+Platinum+and+Anti-Programmed+Death+1%2FProgrammed+Death+Ligand+1+Therapy&doi=10.1200%2FJCO.19.01140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Pivotal trial of enfortumab vedotin in urothelial carcinoma after platinum and anti-programmed death 1/programmed death ligand 1 therapy</span></div><div class="casAuthors">Rosenberg, Jonathan E.; O'Donnell, Peter H.; Balar, Arjun V.; McGregor, Bradley A.; Heath, Elisabeth I.; Yu, Evan Y.; Galsky, Matthew D.; Hahn, Noah M.; Gartner, Elaina M.; Pinelli, Juan M.; Liang, Shang-Ying; Melhem-Bertrandt, Amal; Petrylak, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">2592-2613</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">1527-7755</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">PURPOSE Locally advanced or metastatic urothelial carcinoma is an incurable disease with limited treatment options, esp. for patients who were previously treated with platinum and anti-programmed death 1 or anti-programmed death ligand 1 (PD-1/L1) therapy.  Enfortumab vedotin is an antibody-drug conjugate that targets Nectin-4, which is highly expressed in urothelial carcinoma.  METHODS EV-201 is a global, phase II, single-arm study of enfortumab vedotin 1.25mg/kg (i.v. on days 1, 8, and 15 of every 28-day cycle) in patients with locally advanced or metastatic urothelial carcinoma who were previously treated with platinum chemotherapy and anti-PD-1/L1 therapy.  The primary end point was objective response rate per Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 by blinded independent central review.  Key secondary end points were duration of response, progression-free survival, overall survival, safety, and tolerability.  RESULTS Enfortumab vedotin was administered to 125 patients with metastatic urothelial carcinoma.  Median follow-up was 10.2 mo (range, 0.5 to 16.5 mo).  Confirmed objective response rate was 44% (95% CI, 35.1% to 53.2%), including 12% complete responses.  Similar responses were obsd. in prespecified subgroups, such as those patients with liver metastases and those with no response to prior anti-PD-1/L1 therapy.  Median duration of response was 7.6 mo (range, 0.95 to 11.301 mo).  The most common treatment-related adverse events were fatigue (50%), any peripheral neuropathy (50%), alopecia (49%), any rash (48%), decreased appetite (44%), and dysgeusia (40%).  No single treatment-related adverse events grade 3 or greater occurred in 10% or more of patients.  CONCLUSION Enfortumab vedotin demonstrated a clin. meaningful response rate with a manageable and tolerable safety profile in patients with locally advanced or metastatic urothelial carcinoma who were previously treated with platinum and anti-PD-1/L1 therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSAj5iZGBZybVg90H21EOLACvtfcHk0lib_Sg9BsqP5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovVSitrc%253D&md5=01f8e50e459d254f0a687abc479da014</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1200%2FJCO.19.01140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.19.01140%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DP.%2BH.%26aulast%3DBalar%26aufirst%3DA.%2BV.%26aulast%3DMcGregor%26aufirst%3DB.%2BA.%26aulast%3DHeath%26aufirst%3DE.%2BI.%26aulast%3DYu%26aufirst%3DE.%2BY.%26aulast%3DGalsky%26aufirst%3DM.%2BD.%26aulast%3DHahn%26aufirst%3DN.%2BM.%26aulast%3DGartner%26aufirst%3DE.%2BM.%26aulast%3DPinelli%26aufirst%3DJ.%2BM.%26aulast%3DLiang%26aufirst%3DS.-Y.%26aulast%3DMelhem-Bertrandt%26aufirst%3DA.%26aulast%3DPetrylak%26aufirst%3DD.%2BP.%26atitle%3DPivotal%2520Trial%2520of%2520Enfortumab%2520Vedotin%2520in%2520Urothelial%2520Carcinoma%2520After%2520Platinum%2520and%2520Anti-Programmed%2520Death%25201%252FProgrammed%2520Death%2520Ligand%25201%2520Therapy%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2019%26volume%3D37%26issue%3D29%26spage%3D2592%26epage%3D2600%26doi%3D10.1200%2FJCO.19.01140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sehn, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flowers, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamdar, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMillan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assouline, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozcan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penuel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulson, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matasar, M. J.</span></span> <span> </span><span class="NLM_article-title">Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1200/JCO.19.00172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1200%2FJCO.19.00172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31693429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslSktb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2020&pages=155-165&issue=2&author=L.+H.+Sehnauthor=A.+F.+Herreraauthor=C.+R.+Flowersauthor=M.+K.+Kamdarauthor=A.+McMillanauthor=M.+Hertzbergauthor=S.+Assoulineauthor=T.+M.+Kimauthor=W.+S.+Kimauthor=M.+Ozcanauthor=J.+Hirataauthor=E.+Penuelauthor=J.+N.+Paulsonauthor=J.+Chengauthor=G.+Kuauthor=M.+J.+Matasar&title=Polatuzumab+Vedotin+in+Relapsed+or+Refractory+Diffuse+Large+B-Cell+Lymphoma&doi=10.1200%2FJCO.19.00172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma</span></div><div class="casAuthors">Sehn, Laurie H.; Herrera, Alex F.; Flowers, Christopher R.; Kaar, Manali K.; McMillan, Andrew; Hertzberg, Mark; Assouline, Sarit; Kim, Tae Min; Kim, Won Seog; Ozcan, Muhit; Hirata, Jamie; Penuel, Elicia; Paulson, Joseph N.; Cheng, Ji; Ku, Grace; Matasar, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-176</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">1527-7755</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Patients with transplantation-ineligible relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) fare poorly, with limited treatment options.  The antibody-drug conjugate polatuzumab vedotin targets CD79b, a B-cell receptor component.  Safety and efficacy of polatuzumab vedotin with bendamustine and obinutuzumab (pola-BG) was evaluated in a single-arm cohort.  Polatuzumab vedotin combined with bendamustine and rituximab (pola-BR) was compared with bendamustine and rituximab (BR) in a randomly assigned cohort of patients with transplantation-ineligible R/R DLBCL (primary end point: independent review committee [IRC] assessed complete response [CR] rate at the end of treatment).  Duration of response, progression-free survival (PFS), and overall survival (OS) were analyzed using Kaplan-Meier and Cox regression methods.  Pola-BG and pola-BR had a tolerable safety profile.  The phase Ib/II pola-BG cohort (n = 27) had a CR rate of 29.6% and a median OS of 10.8 mo (median follow-up, 27.0 mo).  In the randomly assigned cohort (n = 80; 40 per arm), pola-BR patients had a significantly higher IRC-assessed CR rate (40.0% v 17.5%; P = .026) and longer IRC-assessed PFS (median, 9.5 v 3.7 mo; hazard ratio [HR], 0.36, 95% CI, 0.21 to 0.63; P < .001) and OS (median, 12.4 v 4.7 mo; HR, 0.42; 95% CI, 0.24 to 0.75; P = .002; median follow-up, 22.3 mo).  Pola-BR patients had higher rates of grade 3-4 neutropenia (46.2% v 33.3%), anemia (28.2% v 17.9%), and thrombocytopenia (41% v 23.1%), but similar grade 3-4 infections (23.1% v 20.5%), vs. the BR group.  Peripheral neuropathy assocd. with polatuzumab vedotin (43.6% of patients) was grade 1-2 and resolved in most patients.  Polatuzumab vedotin combined with BR resulted in a significantly higher CR rate and reduced the risk of death by 58% compared with BR in patients with transplantation-ineligible R/R DLBCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUa_nOL1QFFLVg90H21EOLACvtfcHk0lib_Sg9BsqP5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslSktb3L&md5=3e8d91c5458d187b189615090441f029</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1200%2FJCO.19.00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.19.00172%26sid%3Dliteratum%253Aachs%26aulast%3DSehn%26aufirst%3DL.%2BH.%26aulast%3DHerrera%26aufirst%3DA.%2BF.%26aulast%3DFlowers%26aufirst%3DC.%2BR.%26aulast%3DKamdar%26aufirst%3DM.%2BK.%26aulast%3DMcMillan%26aufirst%3DA.%26aulast%3DHertzberg%26aufirst%3DM.%26aulast%3DAssouline%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DT.%2BM.%26aulast%3DKim%26aufirst%3DW.%2BS.%26aulast%3DOzcan%26aufirst%3DM.%26aulast%3DHirata%26aufirst%3DJ.%26aulast%3DPenuel%26aufirst%3DE.%26aulast%3DPaulson%26aufirst%3DJ.%2BN.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DKu%26aufirst%3DG.%26aulast%3DMatasar%26aufirst%3DM.%2BJ.%26atitle%3DPolatuzumab%2520Vedotin%2520in%2520Relapsed%2520or%2520Refractory%2520Diffuse%2520Large%2520B-Cell%2520Lymphoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2020%26volume%3D38%26issue%3D2%26spage%3D155%26epage%3D165%26doi%3D10.1200%2FJCO.19.00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Younes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sievers, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forero-Torres, A.</span></span> <span> </span><span class="NLM_article-title">Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>363</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">1812</span>– <span class="NLM_lpage">1821</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1002965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1056%2FNEJMoa1002965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=21047225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2gsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1812-1821&issue=19&author=A.+Younesauthor=N.+L.+Bartlettauthor=J.+P.+Leonardauthor=D.+A.+Kennedyauthor=C.+M.+Lynchauthor=E.+L.+Sieversauthor=A.+Forero-Torres&title=Brentuximab+Vedotin+%28SGN-35%29+for+Relapsed+CD30-Positive+Lymphomas&doi=10.1056%2FNEJMoa1002965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Brentuximab vedotin (SGN-35) for relapsed Cd30-positive lymphomas</span></div><div class="casAuthors">Younes, Anas; Bartlett, Nancy L.; Leonard, John P.; Kennedy, Dana A.; Lynch, Carmel M.; Sievers, Eric L.; Forero-Torres, Andres</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1812-1821</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Hodgkin's lymphoma and anaplastic large-cell lymphoma are the two most common tumors expressing CD30.  Previous attempts to target the CD30 antigen with monoclonal-based therapies have shown minimal activity.  To enhance the antitumor activity of CD30-directed therapy, the antitubulin agent monomethyl auristatin E (MMAE) was attached to a CD30-specific monoclonal antibody by an enzyme-cleavable linker, producing the antibody-drug conjugate brentuximab vedotin (SGN-35).  METHODS: In this phase 1, open-label, multicenter dose-escalation study, we administered brentuximab vedotin (at a dose of 0.1 to 3.6 mg per kg of body wt.) every 3 wk to 45 patients with relapsed or refractory CD30-pos. hematol.  Cancers, primarily Hodgkin's lymphoma and anaplastic large-cell lymphoma.  Patients had received a median of three previous chemotherapy regimens (range, one to seven), and 73% had undergone autologous stem-cell transplantation.  RESULTS: The max. tolerated dose was 1.8 mg per kg, administered every 3 wk.  Objective responses, including 11 complete remissions, were obsd. in 17 patients.  Of 12 patients who received the 1.8-mg-per-kilogram dose, 6 (50%) had an objective response.  The median duration of response was at least 9.7 mo.  Tumor regression was obsd. in 36 of 42 patients who could be evaluated (86%).  The most common adverse events were fatigue, pyrexia, diarrhea, nausea, neutropenia, and peripheral neuropathy.  CONCLUSIONS: Brentuximab vedotin induced durable objective responses and resulted in tumor regression for most patients with relapsed or refractory CD30-pos. lymphomas in this phase 1 study.  Treatment was assocd. primarily with grade 1 or 2 (mild-to-moderate) toxic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS4GvKk2Sw7bVg90H21EOLACvtfcHk0lib_Sg9BsqP5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2gsbbE&md5=d27d22f971143a6c5415090ab57fe01a</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1002965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1002965%26sid%3Dliteratum%253Aachs%26aulast%3DYounes%26aufirst%3DA.%26aulast%3DBartlett%26aufirst%3DN.%2BL.%26aulast%3DLeonard%26aufirst%3DJ.%2BP.%26aulast%3DKennedy%26aufirst%3DD.%2BA.%26aulast%3DLynch%26aufirst%3DC.%2BM.%26aulast%3DSievers%26aufirst%3DE.%2BL.%26aulast%3DForero-Torres%26aufirst%3DA.%26atitle%3DBrentuximab%2520Vedotin%2520%2528SGN-35%2529%2520for%2520Relapsed%2520CD30-Positive%2520Lymphomas%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26issue%3D19%26spage%3D1812%26epage%3D1821%26doi%3D10.1056%2FNEJMoa1002965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kreitman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dearden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinzani, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gladstone, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">le Coutre, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larratt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swords, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouabdallah, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breems, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortelezzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doubek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gjertsen, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepretre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloisel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousselot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadmor, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troussard, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saglio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roboz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balic, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standifer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, F.</span></span> <span> </span><span class="NLM_article-title">Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1768</span>– <span class="NLM_lpage">1777</span>, <span class="refDoi"> DOI: 10.1038/s41375-018-0210-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fs41375-018-0210-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=30030507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2jsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=1768-1777&issue=8&author=R.+J.+Kreitmanauthor=C.+Deardenauthor=P.+L.+Zinzaniauthor=J.+Delgadoauthor=L.+Karlinauthor=T.+Robakauthor=D.+E.+Gladstoneauthor=P.+le+Coutreauthor=S.+Dietrichauthor=M.+Goticauthor=L.+Larrattauthor=F.+Offnerauthor=G.+Schillerauthor=R.+Swordsauthor=L.+Baconauthor=M.+Bocchiaauthor=K.+Bouabdallahauthor=D.+A.+Breemsauthor=A.+Cortelezziauthor=S.+Dinnerauthor=M.+Doubekauthor=B.+T.+Gjertsenauthor=M.+Gobbiauthor=A.+Hellmannauthor=S.+Lepretreauthor=F.+Maloiselauthor=F.+Ravandiauthor=P.+Rousselotauthor=M.+Rummelauthor=T.+Siddiqiauthor=T.+Tadmorauthor=X.+Troussardauthor=C.+A.+Yiauthor=G.+Saglioauthor=G.+J.+Robozauthor=K.+Balicauthor=N.+Standiferauthor=P.+Heauthor=S.+Marshallauthor=W.+Wilsonauthor=I.+Pastanauthor=N.-S.+Yaoauthor=F.+Giles&title=Moxetumomab+Pasudotox+in+Relapsed%2FRefractory+Hairy+Cell+Leukemia&doi=10.1038%2Fs41375-018-0210-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia</span></div><div class="casAuthors">Kreitman, Robert J.; Dearden, Claire; Zinzani, Pier Luigi; Delgado, Julio; Karlin, Lionel; Robak, Tadeusz; Gladstone, Douglas E.; le Coutre, Philipp; Dietrich, Sascha; Gotic, Mirjana; Larratt, Loree; Offner, Fritz; Schiller, Gary; Swords, Ronan; Bacon, Larry; Bocchia, Monica; Bouabdallah, Krimo; Breems, Dimitri A.; Cortelezzi, Agostino; Dinner, Shira; Doubek, Michael; Gjertsen, Bjorn Tore; Gobbi, Marco; Hellmann, Andrzej; Lepretre, Stephane; Maloisel, Frederic; Ravandi, Farhad; Rousselot, Philippe; Rummel, Mathias; Siddiqi, Tanya; Tadmor, Tamar; Troussard, Xavier; Yi, Cecilia Arana; Saglio, Giuseppe; Roboz, Gail J.; Balic, Kemal; Standifer, Nathan; He, Peng; Marshall, Shannon; Wilson, Wyndham; Pastan, Ira; Yao, Nai-Shun; Giles, Francis</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1768-1777</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">This is a pivotal, multicenter, open-label study of moxetumomab pasudotox, a recombinant CD22-targeting immunotoxin, in hairy cell leukemia (HCL), a rare B cell malignancy with high CD22 expression.  The study enrolled patients with relapsed/refractory HCL who had ≥2 prior systemic therapies, including ≥1 purine nucleoside analog.  Patients received moxetumomab pasudotox 40μg/kg i.v. on days 1, 3, and 5 every 28 days for ≤6 cycles.  Blinded independent central review detd. disease response and minimal residual disease (MRD) status.  Among 80 patients (79% males; median age, 60.0 years), durable complete response (CR) rate was 30%, CR rate was 41%, and objective response rate (CR and partial response) was 75%; 64 patients (80%) achieved hematol. remission.  Among complete responders, 27 (85%) achieved MRD negativity by immunohistochem.  The most frequent adverse events (AEs) were peripheral edema (39%), nausea (35%), fatigue (34%), and headache (33%).  Treatment-related serious AEs of hemolytic uremic syndrome (7.5%) and capillary leak syndrome (5%) were reversible and generally manageable with supportive care and treatment discontinuation (6 patients; 7.5%).  Moxetumomab pasudotox treatment achieved a high rate of independently assessed durable response and MRD eradication in heavily pretreated patients with HCL, with acceptable tolerability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeY1R3pFu2G7Vg90H21EOLACvtfcHk0lgux_o6pojMtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2jsLfF&md5=99d890861536dbea09c65e49da58bfdd</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1038%2Fs41375-018-0210-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41375-018-0210-1%26sid%3Dliteratum%253Aachs%26aulast%3DKreitman%26aufirst%3DR.%2BJ.%26aulast%3DDearden%26aufirst%3DC.%26aulast%3DZinzani%26aufirst%3DP.%2BL.%26aulast%3DDelgado%26aufirst%3DJ.%26aulast%3DKarlin%26aufirst%3DL.%26aulast%3DRobak%26aufirst%3DT.%26aulast%3DGladstone%26aufirst%3DD.%2BE.%26aulast%3Dle%2BCoutre%26aufirst%3DP.%26aulast%3DDietrich%26aufirst%3DS.%26aulast%3DGotic%26aufirst%3DM.%26aulast%3DLarratt%26aufirst%3DL.%26aulast%3DOffner%26aufirst%3DF.%26aulast%3DSchiller%26aufirst%3DG.%26aulast%3DSwords%26aufirst%3DR.%26aulast%3DBacon%26aufirst%3DL.%26aulast%3DBocchia%26aufirst%3DM.%26aulast%3DBouabdallah%26aufirst%3DK.%26aulast%3DBreems%26aufirst%3DD.%2BA.%26aulast%3DCortelezzi%26aufirst%3DA.%26aulast%3DDinner%26aufirst%3DS.%26aulast%3DDoubek%26aufirst%3DM.%26aulast%3DGjertsen%26aufirst%3DB.%2BT.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DHellmann%26aufirst%3DA.%26aulast%3DLepretre%26aufirst%3DS.%26aulast%3DMaloisel%26aufirst%3DF.%26aulast%3DRavandi%26aufirst%3DF.%26aulast%3DRousselot%26aufirst%3DP.%26aulast%3DRummel%26aufirst%3DM.%26aulast%3DSiddiqi%26aufirst%3DT.%26aulast%3DTadmor%26aufirst%3DT.%26aulast%3DTroussard%26aufirst%3DX.%26aulast%3DYi%26aufirst%3DC.%2BA.%26aulast%3DSaglio%26aufirst%3DG.%26aulast%3DRoboz%26aufirst%3DG.%2BJ.%26aulast%3DBalic%26aufirst%3DK.%26aulast%3DStandifer%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DMarshall%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DW.%26aulast%3DPastan%26aufirst%3DI.%26aulast%3DYao%26aufirst%3DN.-S.%26aulast%3DGiles%26aufirst%3DF.%26atitle%3DMoxetumomab%2520Pasudotox%2520in%2520Relapsed%252FRefractory%2520Hairy%2520Cell%2520Leukemia%26jtitle%3DLeukemia%26date%3D2018%26volume%3D32%26issue%3D8%26spage%3D1768%26epage%3D1777%26doi%3D10.1038%2Fs41375-018-0210-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welborn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentelute, B. L.</span></span> <span> </span><span class="NLM_article-title">π-Clamp-Mediated Cysteine Conjugation</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1038/nchem.2413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnchem.2413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26791894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVygurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=120-128&issue=2&author=C.+Zhangauthor=M.+Welbornauthor=T.+Zhuauthor=N.+J.+Yangauthor=M.+S.+Santosauthor=T.+Van+Voorhisauthor=B.+L.+Pentelute&title=%CF%80-Clamp-Mediated+Cysteine+Conjugation&doi=10.1038%2Fnchem.2413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">π-Clamp-mediated cysteine conjugation</span></div><div class="casAuthors">Zhang, Chi; Welborn, Matthew; Zhu, Tianyu; Yang, Nicole J.; Santos, Michael S.; Van Voorhis, Troy; Pentelute, Bradley L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-128</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Site-selective functionalization of complex mols. is one of the most significant challenges in chem.  Typically, protecting groups or catalysts must be used to enable the selective modification of one site among many that are similarly reactive, and general strategies that selectively tune the local chem. environment around a target site are rare.  Here, the authors show a four-amino-acid sequence (Phe-Cys-Pro-Phe), which the authors call the π-clamp, that tunes the reactivity of its cysteine thiol for site-selective conjugation with perfluoroarom. reagents.  The authors use the π-clamp to selectively modify one cysteine site in proteins contg. multiple endogenous cysteine residues.  These examples include antibodies and cysteine-based enzymes that would be difficult to modify selectively using std. cysteine-based methods.  Antibodies modified using the π-clamp retained binding affinity to their targets, enabling the synthesis of site-specific antibody-drug conjugates for selective killing of HER2-pos. breast cancer cells.  The π-clamp is an unexpected approach to mediate site-selective chem. and provides new avenues to modify biomols. for research and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN7ymIedFQd7Vg90H21EOLACvtfcHk0lgux_o6pojMtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVygurzE&md5=8c3c367f6fd7c64237bd0ba3e9bd40b4</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2413%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWelborn%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DN.%2BJ.%26aulast%3DSantos%26aufirst%3DM.%2BS.%26aulast%3DVan%2BVoorhis%26aufirst%3DT.%26aulast%3DPentelute%26aufirst%3DB.%2BL.%26atitle%3D%25CF%2580-Clamp-Mediated%2520Cysteine%2520Conjugation%26jtitle%3DNat.%2520Chem.%26date%3D2016%26volume%3D8%26issue%3D2%26spage%3D120%26epage%3D128%26doi%3D10.1038%2Fnchem.2413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garbaccio, R. M.</span></span> <span> </span><span class="NLM_article-title">9.17 Chemistry of Antibody-Small Molecule Drug Conjugates</span>. In  <i>Comprehensive Organic Synthesis II</i>; <span class="NLM_publisher-name">Elsevier</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">462</span>. <span class="refDoi"> DOI: 10.1016/B978-0-08-097742-3.00942-3</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FB978-0-08-097742-3.00942-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=438-462&author=R.+M.+Garbaccio&title=Comprehensive+Organic+Synthesis+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2FB978-0-08-097742-3.00942-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-08-097742-3.00942-3%26sid%3Dliteratum%253Aachs%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26atitle%3D9.17%2520Chemistry%2520of%2520Antibody-Small%2520Molecule%2520Drug%2520Conjugates%26btitle%3DComprehensive%2520Organic%2520Synthesis%2520II%26pub%3DElsevier%26date%3D2014%26spage%3D438%26epage%3D462%26doi%3D10.1016%2FB978-0-08-097742-3.00942-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Radicals: Reactive Intermediates with Translational Potential</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">12692</span>– <span class="NLM_lpage">12714</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b08856</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b08856" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWqsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=12692-12714&issue=39&author=M.+Yanauthor=J.+C.+Loauthor=J.+T.+Edwardsauthor=P.+S.+Baran&title=Radicals%3A+Reactive+Intermediates+with+Translational+Potential&doi=10.1021%2Fjacs.6b08856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Radicals: Reactive Intermediates with Translational Potential</span></div><div class="casAuthors">Yan, Ming; Lo, Julian C.; Edwards, Jacob T.; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">12692-12714</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This Perspective illustrates the defining characteristics of free radical chem., beginning with its rich and storied history.  Studies from our lab. are discussed along with recent developments emanating from others in this burgeoning area.  The practicality and chemoselectivity of radical reactions enable rapid access to mols. of relevance to drug discovery, agrochem., material science, and other disciplines.  Thus, these reactive intermediates possess inherent translational potential, as they can be widely used to expedite scientific endeavors for the betterment of humankind.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4oRSlR3ztW7Vg90H21EOLACvtfcHk0lgzDgOMvoICNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWqsbvM&md5=15c5593913c703235d22a5681ebd8413</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b08856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b08856%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DJ.%2BC.%26aulast%3DEdwards%26aufirst%3DJ.%2BT.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DRadicals%253A%2520Reactive%2520Intermediates%2520with%2520Translational%2520Potential%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26issue%3D39%26spage%3D12692%26epage%3D12714%26doi%3D10.1021%2Fjacs.6b08856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sletten, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C. R.</span></span> <span> </span><span class="NLM_article-title">Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">6974</span>– <span class="NLM_lpage">6998</span>, <span class="refDoi"> DOI: 10.1002/anie.200900942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fanie.200900942" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2ltrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6974-6998&issue=38&author=E.+M.+Slettenauthor=C.+R.+Bertozzi&title=Bioorthogonal+Chemistry%3A+Fishing+for+Selectivity+in+a+Sea+of+Functionality&doi=10.1002%2Fanie.200900942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality</span></div><div class="casAuthors">Sletten, Ellen M.; Bertozzi, Carolyn R.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">6974-6998</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The study of biomols. in their native environments is a challenging task because of the vast complexity of cellular systems.  Technologies developed in the last few years for the selective modification of biol. species in living systems have yielded new insights into cellular processes.  Key to these new techniques are bioorthogonal chem. reactions, whose components must react rapidly and selectively with each other under physiol. conditions in the presence of the plethora of functionality necessary to sustain life.  Herein the authors describe the bioorthogonal chem. reactions developed to date and how they can be used to study biomols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJibJXpsfxW7Vg90H21EOLACvtfcHk0lgrtIOocVyqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2ltrvK&md5=993199cb4deabc186848bae6fe81f605</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1002%2Fanie.200900942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200900942%26sid%3Dliteratum%253Aachs%26aulast%3DSletten%26aufirst%3DE.%2BM.%26aulast%3DBertozzi%26aufirst%3DC.%2BR.%26atitle%3DBioorthogonal%2520Chemistry%253A%2520Fishing%2520for%2520Selectivity%2520in%2520a%2520Sea%2520of%2520Functionality%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26issue%3D38%26spage%3D6974%26epage%3D6998%26doi%3D10.1002%2Fanie.200900942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walling, C.</span></span> <span> </span><span class="NLM_article-title">Some Properties of Radical Reactions Important in Synthesis</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">3887</span>– <span class="NLM_lpage">3900</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)97172-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS0040-4020%2801%2997172-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaL28Xit1Cgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1985&pages=3887-3900&issue=19&author=C.+Walling&title=Some+Properties+of+Radical+Reactions+Important+in+Synthesis&doi=10.1016%2FS0040-4020%2801%2997172-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Some properties of radical reactions important in synthesis</span></div><div class="casAuthors">Walling, Cheves</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3887-900</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">Properties of radical chain reactions are reviewed including propagating steps, lifetimes of chains, and choices of initiators.  Structure and reactivity relations in chain-propagation steps and their effects on regio- and stereochem. are discussed.  The utility of redox chains involving transition metal ions is considered along with the importance of radical ions as reaction intermediates.  38 Refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2HZUqmmzuuLVg90H21EOLACvtfcHk0lgrtIOocVyqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xit1Cgsb0%253D&md5=6d2bb6c2880c9cfb5c6765499b55e9dc</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2997172-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252997172-8%26sid%3Dliteratum%253Aachs%26aulast%3DWalling%26aufirst%3DC.%26atitle%3DSome%2520Properties%2520of%2520Radical%2520Reactions%2520Important%2520in%2520Synthesis%26jtitle%3DTetrahedron%26date%3D1985%26volume%3D41%26issue%3D19%26spage%3D3887%26epage%3D3900%26doi%3D10.1016%2FS0040-4020%2801%2997172-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McAtee, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClain, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, C. R. J.</span></span> <span> </span><span class="NLM_article-title">Illuminating Photoredox Catalysis</span>. <i>Trends Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/j.trechm.2019.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.trechm.2019.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1CqtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2019&pages=111-125&issue=1&author=R.+C.+McAteeauthor=E.+J.+McClainauthor=C.+R.+J.+Stephenson&title=Illuminating+Photoredox+Catalysis&doi=10.1016%2Fj.trechm.2019.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Illuminating Photoredox Catalysis</span></div><div class="casAuthors">McAtee, Rory C.; McClain, Edward J.; Stephenson, Corey R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-125</span>CODEN:
                <span class="NLM_cas:coden">TCRHBQ</span>;
        ISSN:<span class="NLM_cas:issn">2589-5974</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Over the past decade, photoredox catalysis has risen to the forefront of synthetic org. chem. as an indispensable tool for selective small-mol. activation and chem.-bond formation.  This cutting-edge platform allows photosensitizers to convert visible light into chem. energy, prompting generation of reactive radical intermediates.  In this , we highlight some of the recent key contributions in the field, including elucidating the impact of the chosen light arrays, promoting fundamental cross-coupling steps, selectively functionalizing aliph. amines, engaging complementary mechanistic paradigms, and applications in industry.  With such a wide breadth of reactivity already realized, the presence of photoredox catalysis in all sectors of org. chem. is expected for years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjQ-TKUkBDa7Vg90H21EOLACvtfcHk0libZNMoL8G--Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1CqtL%252FK&md5=45ffb329a2d146cc8caa3a75b4b5a6d1</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.trechm.2019.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trechm.2019.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DMcAtee%26aufirst%3DR.%2BC.%26aulast%3DMcClain%26aufirst%3DE.%2BJ.%26aulast%3DStephenson%26aufirst%3DC.%2BR.%2BJ.%26atitle%3DIlluminating%2520Photoredox%2520Catalysis%26jtitle%3DTrends%2520Chem.%26date%3D2019%26volume%3D1%26issue%3D1%26spage%3D111%26epage%3D125%26doi%3D10.1016%2Fj.trechm.2019.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">13230</span>– <span class="NLM_lpage">13319</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00397</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00397" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1WntbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=13230-13319&issue=21&author=M.+Yanauthor=Y.+Kawamataauthor=P.+S.+Baran&title=Synthetic+Organic+Electrochemical+Methods+Since+2000%3A+On+the+Verge+of+a+Renaissance&doi=10.1021%2Facs.chemrev.7b00397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance</span></div><div class="casAuthors">Yan, Ming; Kawamata, Yu; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13230-13319</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review discusses advances in synthetic org. electrochem. since 2000.  Enabling methods and synthetic applications are analyzed alongside innate advantages as well as future challenges of electroorg. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoosmLKvAW1Z7Vg90H21EOLACvtfcHk0libZNMoL8G--Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1WntbzJ&md5=21205e55da92db4e7d27aa393fed486d</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00397%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DM.%26aulast%3DKawamata%26aufirst%3DY.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DSynthetic%2520Organic%2520Electrochemical%2520Methods%2520Since%25202000%253A%2520On%2520the%2520Verge%2520of%2520a%2520Renaissance%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26issue%3D21%26spage%3D13230%26epage%3D13319%26doi%3D10.1021%2Facs.chemrev.7b00397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samanta, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percec, V.</span></span> <span> </span><span class="NLM_article-title">Single Electron Transfer in Radical Ion and Radical-Mediated Organic, Materials and Polymer Synthesis</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5848</span>– <span class="NLM_lpage">5958</span>, <span class="refDoi"> DOI: 10.1021/cr400689s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400689s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=5848-5958&issue=11&author=N.+Zhangauthor=S.+R.+Samantaauthor=B.+M.+Rosenauthor=V.+Percec&title=Single+Electron+Transfer+in+Radical+Ion+and+Radical-Mediated+Organic%2C+Materials+and+Polymer+Synthesis&doi=10.1021%2Fcr400689s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Single Electron Transfer in Radical Ion and Radical-Mediated Organic, Materials and Polymer Synthesis</span></div><div class="casAuthors">Zhang, Na; Samanta, Shampa R.; Rosen, Brad M.; Percec, Virgil</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5848-5958</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This review attempts to provide a compact but comprehensive discussion of old, never reviewed, almost forgotten, and new SET methodologies and mechanisms employed in org., materials, and macromol. synthesis as well as in the synthesis of functional building blocks relevant for supramol. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFLE8VO4i2obVg90H21EOLACvtfcHk0libZNMoL8G--Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWgurc%253D&md5=8632a41e0a6c0007c9b2a5bad94ec858</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fcr400689s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400689s%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DSamanta%26aufirst%3DS.%2BR.%26aulast%3DRosen%26aufirst%3DB.%2BM.%26aulast%3DPercec%26aufirst%3DV.%26atitle%3DSingle%2520Electron%2520Transfer%2520in%2520Radical%2520Ion%2520and%2520Radical-Mediated%2520Organic%252C%2520Materials%2520and%2520Polymer%2520Synthesis%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26issue%3D11%26spage%3D5848%26epage%3D5958%26doi%3D10.1021%2Fcr400689s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGruyter, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Alkyl Sulfinates: Radical Precursors Enabling Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2256</span>– <span class="NLM_lpage">2264</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01303</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01303" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVaqtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2256-2264&issue=5&author=J.+M.+Smithauthor=J.+A.+Dixonauthor=J.+N.+DeGruyterauthor=P.+S.+Baran&title=Alkyl+Sulfinates%3A+Radical+Precursors+Enabling+Drug+Discovery&doi=10.1021%2Facs.jmedchem.8b01303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Alkyl Sulfinates: Radical Precursors Enabling Drug Discovery</span></div><div class="casAuthors">Smith, Joel M.; Dixon, Janice A.; deGruyter, Justine N.; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2256-2264</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The modern constraints of drug discovery demand a rigorous validation process of all new reactions prior to widespread implementation.  To this end, sulfinates (now marketed as Diversinates) have seen alacritous adoption by the medicinal chem. community, as evidenced by the recent outpour of both patent and primary reports.  Featuring more than 50 examples, this review seeks to highlight those particularly compelling cases published in the past 5 years, with an eye toward the identification of robust and predictable trends in reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7GM4tNW5QcLVg90H21EOLACvtfcHk0li_KLWSeM9GWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVaqtL3I&md5=2c10a6e03d53de995f00614fb8c4bd85</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01303%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BM.%26aulast%3DDixon%26aufirst%3DJ.%2BA.%26aulast%3DDeGruyter%26aufirst%3DJ.%2BN.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DAlkyl%2520Sulfinates%253A%2520Radical%2520Precursors%2520Enabling%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D5%26spage%3D2256%26epage%3D2264%26doi%3D10.1021%2Facs.jmedchem.8b01303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antos, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, M. B.</span></span> <span> </span><span class="NLM_article-title">Chemoselective Tryptophan Labeling with Rhodium Carbenoids at Mild PH</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">6301</span>– <span class="NLM_lpage">6308</span>, <span class="refDoi"> DOI: 10.1021/ja900094h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja900094h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksV2isrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=6301-6308&issue=17&author=J.+M.+Antosauthor=J.+M.+McFarlandauthor=A.+T.+Iavaroneauthor=M.+B.+Francis&title=Chemoselective+Tryptophan+Labeling+with+Rhodium+Carbenoids+at+Mild+PH&doi=10.1021%2Fja900094h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective Tryptophan Labeling with Rhodium Carbenoids at Mild pH</span></div><div class="casAuthors">Antos, John M.; McFarland, Jesse M.; Iavarone, Anthony T.; Francis, Matthew B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6301-6308</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant improvements have been made to a previously reported tryptophan modification method using rhodium carbenoids in aq. soln., allowing the reaction to proceed at pH 6-7.  This technique is based on the discovery that N-(tert-butyl)hydroxylamine promotes indole modification with rhodium carbenoids over a broad pH range (2-7).  This methodol. was demonstrated on peptide and protein substrates, generally yielding 40-60% conversion with excellent tryptophan chemoselectivity.  The solvent accessibility of the indole side chains was a key factor in successful carbenoid addn., as demonstrated by conducting the reaction at temps. high enough to cause thermal denaturation of the protein substrate.  Progress toward the expression of proteins bearing solvent accessible tryptophan residues as reactive handles for modification with rhodium carbenoids is also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLPkOMINZJ9LVg90H21EOLACvtfcHk0li_KLWSeM9GWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksV2isrw%253D&md5=5c14c7fa813430af98264d990d2103ba</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fja900094h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja900094h%26sid%3Dliteratum%253Aachs%26aulast%3DAntos%26aufirst%3DJ.%2BM.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DIavarone%26aufirst%3DA.%2BT.%26aulast%3DFrancis%26aufirst%3DM.%2BB.%26atitle%3DChemoselective%2520Tryptophan%2520Labeling%2520with%2520Rhodium%2520Carbenoids%2520at%2520Mild%2520PH%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26issue%3D17%26spage%3D6301%26epage%3D6308%26doi%3D10.1021%2Fja900094h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verhoog, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khotavivattana, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersemans, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tredwell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouverneur, V.</span></span> <span> </span><span class="NLM_article-title">18 F-Trifluoromethylation of Unmodified Peptides with 5- 18 F-(Trifluoromethyl)Dibenzothiophenium Trifluoromethanesulfonate</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1572</span>– <span class="NLM_lpage">1575</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b10227</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b10227" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksVOitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=1572-1575&issue=5&author=S.+Verhoogauthor=C.+W.+Keeauthor=Y.+Wangauthor=T.+Khotavivattanaauthor=T.+C.+Wilsonauthor=V.+Kersemansauthor=S.+Smartauthor=M.+Tredwellauthor=B.+G.+Davisauthor=V.+Gouverneur&title=18+F-Trifluoromethylation+of+Unmodified+Peptides+with+5-+18+F-%28Trifluoromethyl%29Dibenzothiophenium+Trifluoromethanesulfonate&doi=10.1021%2Fjacs.7b10227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">18F-Trifluoromethylation of unmodified peptides with 5-18F-(trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate</span></div><div class="casAuthors">Verhoog, Stefan; Kee, Choon Wee; Wang, Yanlan; Khotavivattana, Tanatorn; Wilson, Thomas C.; Kersemans, Veerle; Smart, Sean; Tredwell, Matthew; Davis, Benjamin G.; Gouverneur, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1572-1575</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 18F-labeling of 5-(trifluoromethyl)-dibenzothiophenium trifluoromethanesulfonate, commonly referred to as the Umemoto reagent, has been accomplished applying a halogen exchange 18F-fluorination with 18F-fluoride, followed by oxidative cyclization with oxone and trifluoromethanesulfonic anhydride.  This new 18F-reagent allows for the direct chemoselective 18F-labeling of unmodified peptides at the thiol cysteine residue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB7gxj53dPK7Vg90H21EOLACvtfcHk0li3-7a_3Fu22A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksVOitw%253D%253D&md5=edd3cfce918a01f083c176ec95f4ef2d</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b10227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b10227%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoog%26aufirst%3DS.%26aulast%3DKee%26aufirst%3DC.%2BW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKhotavivattana%26aufirst%3DT.%26aulast%3DWilson%26aufirst%3DT.%2BC.%26aulast%3DKersemans%26aufirst%3DV.%26aulast%3DSmart%26aufirst%3DS.%26aulast%3DTredwell%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DB.%2BG.%26aulast%3DGouverneur%26aufirst%3DV.%26atitle%3D18%2520F-Trifluoromethylation%2520of%2520Unmodified%2520Peptides%2520with%25205-%252018%2520F-%2528Trifluoromethyl%2529Dibenzothiophenium%2520Trifluoromethanesulfonate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D5%26spage%3D1572%26epage%3D1575%26doi%3D10.1021%2Fjacs.7b10227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, M. L.</span></span> <span> </span><span class="NLM_article-title">Laser-Initiated Radical Trifluoromethylation of Peptides and Proteins: Application to Mass-Spectrometry-Based Protein Footprinting</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">14007</span>– <span class="NLM_lpage">14010</span>, <span class="refDoi"> DOI: 10.1002/anie.201706697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fanie.201706697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1WhtrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=14007-14010&issue=45&author=M.+Chengauthor=B.+Zhangauthor=W.+Cuiauthor=M.+L.+Gross&title=Laser-Initiated+Radical+Trifluoromethylation+of+Peptides+and+Proteins%3A+Application+to+Mass-Spectrometry-Based+Protein+Footprinting&doi=10.1002%2Fanie.201706697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Laser-Initiated Radical Trifluoromethylation of Peptides and Proteins: Application to Mass-Spectrometry-Based Protein Footprinting</span></div><div class="casAuthors">Cheng, Ming; Zhang, Bojie; Cui, Weidong; Gross, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">14007-14010</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Described is a novel, laser-initiated radical trifluoromethylation for protein footprinting and its broad residue coverage.  *CF3 reacts with 18 of the 20 common amino acids, including Gly, Ala, Ser, Thr, Asp, and Glu, which are relatively silent with regard to .OH.  This new approach to footprinting is a bridge between trifluoromethylation in materials and medicinal chem. and structural biol. and biotechnol.  Its application to a membrane protein and to myoglobin show that the approach is sensitive to protein conformational change and solvent accessibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK2o0BEvspCLVg90H21EOLACvtfcHk0li3-7a_3Fu22A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1WhtrnN&md5=5e5d3da20ecf869914284959d8feb96a</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706697%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DGross%26aufirst%3DM.%2BL.%26atitle%3DLaser-Initiated%2520Radical%2520Trifluoromethylation%2520of%2520Peptides%2520and%2520Proteins%253A%2520Application%2520to%2520Mass-Spectrometry-Based%2520Protein%2520Footprinting%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26issue%3D45%26spage%3D14007%26epage%3D14010%26doi%3D10.1002%2Fanie.201706697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labroo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labroo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, L.</span></span> <span> </span><span class="NLM_article-title">Direct Photochemical Trifluoromethylation of Histidine-Containing Peptides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">40</span>),  <span class="NLM_fpage">5705</span>– <span class="NLM_lpage">5708</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)97937-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS0040-4039%2800%2997937-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaK3MXisVGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1990&pages=5705-5708&issue=40&author=V.+Labrooauthor=R.+Labrooauthor=L.+Cohen&title=Direct+Photochemical+Trifluoromethylation+of+Histidine-Containing+Peptides&doi=10.1016%2FS0040-4039%2800%2997937-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Direct photochemical trifluoromethylation of histidine-containing peptides</span></div><div class="casAuthors">Labroo, V. M.; Labroo, R. B.; Cohen, L. A.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">5705-8</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">Photochem. trifluoromethylation of the imidazole ring of histidine in the tripeptide Glp-His-Pro-NH2 has been achieved to furnish a mixt. of imidazole trifluoromethylated isomers, which have been sepd. by reverse-phase HPLC and characterized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBUyL9nIxfs7Vg90H21EOLACvtfcHk0li3-7a_3Fu22A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXisVGruw%253D%253D&md5=972dbf43e25be716d0bddbe5d1f1f930</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2997937-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252997937-1%26sid%3Dliteratum%253Aachs%26aulast%3DLabroo%26aufirst%3DV.%26aulast%3DLabroo%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DL.%26atitle%3DDirect%2520Photochemical%2520Trifluoromethylation%2520of%2520Histidine-Containing%2520Peptides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1990%26volume%3D31%26issue%3D40%26spage%3D5705%26epage%3D5708%26doi%3D10.1016%2FS0040-4039%2800%2997937-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichiishi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streckfuss, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S. W.</span></span> <span> </span><span class="NLM_article-title">Protecting Group Free Radical C-H Trifluoromethylation of Peptides</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">4168</span>– <span class="NLM_lpage">4175</span>, <span class="refDoi"> DOI: 10.1039/C8SC00368H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC8SC00368H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=29780547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1emsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4168-4175&issue=17&author=N.+Ichiishiauthor=J.+P.+Caldwellauthor=M.+Linauthor=W.+Zhongauthor=X.+Zhuauthor=E.+Streckfussauthor=H.-Y.+Kimauthor=C.+A.+Parishauthor=S.+W.+Krska&title=Protecting+Group+Free+Radical+C-H+Trifluoromethylation+of+Peptides&doi=10.1039%2FC8SC00368H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Protecting group free radical C-H trifluoromethylation of peptides</span></div><div class="casAuthors">Ichiishi, Naoko; Caldwell, John P.; Lin, Melissa; Zhong, Wendy; Zhu, Xiaohong; Streckfuss, Eric; Kim, Hai-Young; Parish, Craig A.; Krska, Shane W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4168-4175</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Two radical-based approaches have been developed to effect the trifluoromethylation of aryl C-H bonds in native peptides either using stoichiometric oxidant or visible light photoredox catalysis.  The reported methods are able to derivatize tyrosine and tryptophan sidechains under biocompatible conditions, and a no. of examples are reported involving fully unprotected peptides with up to 51 amino acids.  The development of this chem. adds to the growing array of chem. methods for selectively modifying amino acid residues in the context of complex peptides.  The direct incorporation of trifluoromethyl groups into biopolymers enables the study of a range of biol. and biochem. systems, and preliminary results indicate this method can be extended to the incorporation of other fluoroalkyl groups for bioconjugation applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ2NGwSJKIdbVg90H21EOLACvtfcHk0lgupe7wkokfsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1emsbY%253D&md5=4bb4306ad9e207a5d8f0b196203b9577</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1039%2FC8SC00368H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8SC00368H%26sid%3Dliteratum%253Aachs%26aulast%3DIchiishi%26aufirst%3DN.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DStreckfuss%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DH.-Y.%26aulast%3DParish%26aufirst%3DC.%2BA.%26aulast%3DKrska%26aufirst%3DS.%2BW.%26atitle%3DProtecting%2520Group%2520Free%2520Radical%2520C-H%2520Trifluoromethylation%2520of%2520Peptides%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26issue%3D17%26spage%3D4168%26epage%3D4175%26doi%3D10.1039%2FC8SC00368H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lecocq, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vlaeminck, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanssens, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Huyvetter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyvaerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keyaerts, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devoogdt, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breckpot, K.</span></span> <span> </span><span class="NLM_article-title">Theranostics in Immuno-Oncology Using Nanobody Derivatives</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">7772</span>– <span class="NLM_lpage">7791</span>, <span class="refDoi"> DOI: 10.7150/thno.34941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.7150%2Fthno.34941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31695800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFamsrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=7772-7791&issue=25&author=Q.+Lecocqauthor=Y.+De+Vlaeminckauthor=H.+Hanssensauthor=M.+D%E2%80%99Huyvetterauthor=G.+Raesauthor=C.+Goyvaertsauthor=M.+Keyaertsauthor=N.+Devoogdtauthor=K.+Breckpot&title=Theranostics+in+Immuno-Oncology+Using+Nanobody+Derivatives&doi=10.7150%2Fthno.34941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostics in immuno-oncology using nanobody derivatives</span></div><div class="casAuthors">Lecocq, Quentin; De Vlaeminck, Yannick; Hanssens, Heleen; D'Huyvetter, Matthias; Raes, Geert; Goyvaerts, Cleo; Keyaerts, Marleen; Devoogdt, Nick; Breckpot, Karine</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7772-7791</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">A review.  Targeted therapy and immunotherapy have become mainstream in cancer treatment.  However, only patient subsets benefit from these expensive therapies, and often responses are short-lived or coincide with side effects.  A growing modality in precision oncol. is the development of theranostics, as this enables patient selection, treatment and monitoring.  In this approach, labeled compds. and an imaging technol. are used to diagnose patients and select the best treatment option, whereas for therapy, related compds. are used to target cancer cells or the tumor stroma.  In this context, nanobodies and nanobody-directed therapeutics have gained interest.  This interest stems from their high antigen specificity, small size, ease of labeling and engineering, allowing specific imaging and design of therapies targeting antigens on tumor cells, immune cells as well as proteins in the tumor environment.  This review provides a comprehensive overview on the state-of-the-art regarding the use of nanobodies as theranostics, and their importance in the emerging field of personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1OXs1AtDOArVg90H21EOLACvtfcHk0lgupe7wkokfsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFamsrfM&md5=7f00635de3529747d425124004cfe568</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.7150%2Fthno.34941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.34941%26sid%3Dliteratum%253Aachs%26aulast%3DLecocq%26aufirst%3DQ.%26aulast%3DDe%2BVlaeminck%26aufirst%3DY.%26aulast%3DHanssens%26aufirst%3DH.%26aulast%3DD%25E2%2580%2599Huyvetter%26aufirst%3DM.%26aulast%3DRaes%26aufirst%3DG.%26aulast%3DGoyvaerts%26aufirst%3DC.%26aulast%3DKeyaerts%26aufirst%3DM.%26aulast%3DDevoogdt%26aufirst%3DN.%26aulast%3DBreckpot%26aufirst%3DK.%26atitle%3DTheranostics%2520in%2520Immuno-Oncology%2520Using%2520Nanobody%2520Derivatives%26jtitle%3DTheranostics%26date%3D2019%26volume%3D9%26issue%3D25%26spage%3D7772%26epage%3D7791%26doi%3D10.7150%2Fthno.34941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brasino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbse, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, A. P.</span></span> <span> </span><span class="NLM_article-title">Anti-EGFR Affibodies with Site-Specific Photo-Cross-Linker Incorporation Show Both Directed Target-Specific Photoconjugation and Increased Retention in Tumors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">11820</span>– <span class="NLM_lpage">11828</span>, <span class="refDoi"> DOI: 10.1021/jacs.8b07601</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b07601" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1OltbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=11820-11828&issue=37&author=M.+Brasinoauthor=S.+Royauthor=A.+H.+Erbseauthor=L.+Heauthor=C.+Maoauthor=W.+Parkauthor=J.+N.+Chaauthor=A.+P.+Goodwin&title=Anti-EGFR+Affibodies+with+Site-Specific+Photo-Cross-Linker+Incorporation+Show+Both+Directed+Target-Specific+Photoconjugation+and+Increased+Retention+in+Tumors&doi=10.1021%2Fjacs.8b07601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-EGFR Affibodies with Site-Specific Photo-Cross-Linker Incorporation Show Both Directed Target-Specific Photoconjugation and Increased Retention in Tumors</span></div><div class="casAuthors">Brasino, Michael; Roy, Shambojit; Erbse, Annette H.; He, Liangcan; Mao, Chenchen; Park, Wounjhang; Cha, Jennifer N.; Goodwin, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11820-11828</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A significant challenge for solid tumor treatment is ensuring that a sufficient concn. of therapeutic agent is delivered to the tumor site at doses that can be tolerated by the patient.  Biomol. targeting can bias accumulation in tumors by taking advantage of specific interactions with receptors overexpressed on cancerous cells.  However, while antibody-based immunoconjugates show high binding to specific cells, their low dissocn. consts. (KD) and large Stokes radii hinder their ability to penetrate deep into tumor tissue, leading to incomplete cell killing and tumor recurrence.  To address this, we demonstrate the design and prodn. of a photo-crosslinkable affibody that can form a covalent bond to epidermal growth factor receptor (EGFR) under near UV irradn.  Twelve cysteine mutations were created of an EGFR affibody and conjugated with maleimide-benzophenone.  Of these only one exhibited photoconjugation to EGFR, as demonstrated by SDS-PAGE and Western blot.  Next this modified affibody was shown to not only bind EGFR expressing cells but also show enhanced retention in a 3D tumor spheroid model, with minimal loss up to 24 h as compared to either unmodified EGFR-binding affibodies or nonbinding, photo-crosslinkable affibodies.  Finally, in order to show utility of photo-crosslinking at clin. relevant wavelengths, upconverting nanoparticles (UCNPs) were synthesized that could convert 980 nm light to UV and blue light.  In the presence of UCNPs, both direct photoconjugation to EGFR and enhanced retention in tumor spheroids could be obtained using near-IR illumination.  Thus, the photoactive affibodies developed here may be utilized as a platform technol. for engineering new therapy conjugates that can penetrate deep into tumor tissue and be retained long enough for effective tumor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWO3Sgl4zZTbVg90H21EOLACvtfcHk0lgupe7wkokfsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1OltbbF&md5=5962a8ee95361b4442433b9be5d367fa</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b07601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b07601%26sid%3Dliteratum%253Aachs%26aulast%3DBrasino%26aufirst%3DM.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DErbse%26aufirst%3DA.%2BH.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DW.%26aulast%3DCha%26aufirst%3DJ.%2BN.%26aulast%3DGoodwin%26aufirst%3DA.%2BP.%26atitle%3DAnti-EGFR%2520Affibodies%2520with%2520Site-Specific%2520Photo-Cross-Linker%2520Incorporation%2520Show%2520Both%2520Directed%2520Target-Specific%2520Photoconjugation%2520and%2520Increased%2520Retention%2520in%2520Tumors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D37%26spage%3D11820%26epage%3D11828%26doi%3D10.1021%2Fjacs.8b07601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelemen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A.</span></span> <span> </span><span class="NLM_article-title">A Precise Chemical Strategy To Alter the Receptor Specificity of the Adeno-Associated Virus</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">10645</span>– <span class="NLM_lpage">10649</span>, <span class="refDoi"> DOI: 10.1002/anie.201604067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fanie.201604067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygtrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=10645-10649&issue=36&author=R.+E.+Kelemenauthor=R.+Mukherjeeauthor=X.+Caoauthor=S.+B.+Ericksonauthor=Y.+Zhengauthor=A.+Chatterjee&title=A+Precise+Chemical+Strategy+To+Alter+the+Receptor+Specificity+of+the+Adeno-Associated+Virus&doi=10.1002%2Fanie.201604067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">A Precise Chemical Strategy To Alter the Receptor Specificity of the Adeno-Associated Virus</span></div><div class="casAuthors">Kelemen, Rachel E.; Mukherjee, Raja; Cao, Xiaofu; Erickson, Sarah B.; Zheng, Yunan; Chatterjee, Abhishek</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">10645-10649</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The ability to target the adeno-assocd. virus (AAV) to specific types of cells, by altering the cell-surface receptor it binds, is desirable to generate safe and efficient therapeutic vectors.  Chem. attachment of receptor-targeting agents onto the AAV capsid holds potential to alter its tropism, but is limited by the lack of site specificity of available conjugation strategies.  The development of an AAV prodn. platform is reported that enables incorporation of unnatural amino acids (UAAs) into specific sites on the virus capsid.  Incorporation of an azido-UAA enabled site-specific attachment of a cyclic-RGD peptide onto the capsid, retargeting the virus to the αvβ3 integrin receptors, which are overexpressed in tumor vasculature.  Retargeting ability was site-dependent, underscoring the importance of achieving site-selective capsid modification.  This work provides a general chem. approach to introduce various receptor binding agents onto the AAV capsid with site selectivity to generate optimized vectors with engineered infectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLClkgH43sNrVg90H21EOLACvtfcHk0lg0C0jNnA2CdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygtrzE&md5=51cfd0c9c1866856ce8a926a760e4b98</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1002%2Fanie.201604067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201604067%26sid%3Dliteratum%253Aachs%26aulast%3DKelemen%26aufirst%3DR.%2BE.%26aulast%3DMukherjee%26aufirst%3DR.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DErickson%26aufirst%3DS.%2BB.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DChatterjee%26aufirst%3DA.%26atitle%3DA%2520Precise%2520Chemical%2520Strategy%2520To%2520Alter%2520the%2520Receptor%2520Specificity%2520of%2520the%2520Adeno-Associated%2520Virus%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D36%26spage%3D10645%26epage%3D10649%26doi%3D10.1002%2Fanie.201604067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greineder, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiseleva, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hood, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoshnejad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warden-Rothman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsourkas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzykantov, V. R.</span></span> <span> </span><span class="NLM_article-title">Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.7b00592</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.7b00592" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFSlu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=56-66&issue=1&author=C.+F.+Greinederauthor=C.+H.+Villaauthor=L.+R.+Walshauthor=R.+Y.+Kiselevaauthor=E.+D.+Hoodauthor=M.+Khoshnejadauthor=R.+Warden-Rothmanauthor=A.+Tsourkasauthor=V.+R.+Muzykantov&title=Site-Specific+Modification+of+Single-Chain+Antibody+Fragments+for+Bioconjugation+and+Vascular+Immunotargeting&doi=10.1021%2Facs.bioconjchem.7b00592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting</span></div><div class="casAuthors">Greineder, Colin F.; Villa, Carlos H.; Walsh, Landis R.; Kiseleva, Raisa Y.; Hood, Elizabeth D.; Khoshnejad, Makan; Warden-Rothman, Robert; Tsourkas, Andrew; Muzykantov, Vladimir R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-66</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The conjugation of antibodies to drugs and drug carriers improves delivery to target tissues.  Widespread implementation and effective translation of this pharmacol. strategy awaits the development of affinity ligands capable of a defined degree of modification and highly efficient bioconjugation without loss of affinity.  To date, such ligands are lacking for the targeting of therapeutics to vascular endothelial cells.  To enable site-specific, click-chem. conjugation to therapeutic cargo, we used the bacterial transpeptidase, sortase A, to attach short azidolysine contg. peptides to three endothelial-specific single chain antibody fragments (scFv).  While direct fusion of a recognition motif (sortag) to the scFv C-terminus generally resulted in low levels of sortase-mediated modification, improved reaction efficiency was obsd. for one protein, in which two amino acids had been introduced during cloning.  This prompted insertion of a short, semi-rigid linker between scFv and sortag.  The linker significantly enhanced modification of all three proteins, to the extent that unmodified scFv could no longer be detected.  As proof of principle, purified, azide-modified scFv was conjugated to the antioxidant enzyme, catalase, resulting in robust endothelial targeting of functional cargo in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEmdRfJrqe2rVg90H21EOLACvtfcHk0lg0C0jNnA2CdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFSlu7nN&md5=3f42501c7ac155e564de0e98a5f49c49</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.7b00592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.7b00592%26sid%3Dliteratum%253Aachs%26aulast%3DGreineder%26aufirst%3DC.%2BF.%26aulast%3DVilla%26aufirst%3DC.%2BH.%26aulast%3DWalsh%26aufirst%3DL.%2BR.%26aulast%3DKiseleva%26aufirst%3DR.%2BY.%26aulast%3DHood%26aufirst%3DE.%2BD.%26aulast%3DKhoshnejad%26aufirst%3DM.%26aulast%3DWarden-Rothman%26aufirst%3DR.%26aulast%3DTsourkas%26aufirst%3DA.%26aulast%3DMuzykantov%26aufirst%3DV.%2BR.%26atitle%3DSite-Specific%2520Modification%2520of%2520Single-Chain%2520Antibody%2520Fragments%2520for%2520Bioconjugation%2520and%2520Vascular%2520Immunotargeting%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26issue%3D1%26spage%3D56%26epage%3D66%26doi%3D10.1021%2Facs.bioconjchem.7b00592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Usami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, T.</span></span> <span> </span><span class="NLM_article-title">The Effect of PH, Hydrogen Peroxide and Temperature on the Stability of Human Monoclonal Antibody</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">8–10</span>),  <span class="NLM_fpage">1133</span>– <span class="NLM_lpage">1140</span>, <span class="refDoi"> DOI: 10.1016/S0731-7085(96)01721-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS0731-7085%2896%2901721-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=8818025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaK28Xks1Sjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1996&pages=1133-1140&issue=8%E2%80%9310&author=A.+Usamiauthor=A.+Ohtsuauthor=S.+Takahamaauthor=T.+Fujii&title=The+Effect+of+PH%2C+Hydrogen+Peroxide+and+Temperature+on+the+Stability+of+Human+Monoclonal+Antibody&doi=10.1016%2FS0731-7085%2896%2901721-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of pH, hydrogen peroxide and temperature on the stability of human monoclonal antibody</span></div><div class="casAuthors">Usami, A.; Ohtsu, A.; Takahama, S.; Fujii, T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8-10</span>),
    <span class="NLM_cas:pages">1133-1140</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The stability of human monoclonal antibody (C23), which is being developed as a passive immunotherapeutic agent against human cytomegalovirus, was investigated.  C23 (about 2 mg mL-1) was incubated under sterile conditions for 14 days in buffers with different pH values (ranging from 4-10), in hydrogen peroxide solns. with different concns. (0.01% or 0.1%), and in saline at 8° or 37°.  Samples were collected on days 0, 3, 7 and 14, and various physicochem. or biol. methods were used to det. the changes in C23.  These methods included turbidity (absorbance at 408 nm and transmittance at 580 nm), pH, size-exclusion high performance liq. chromatog. (HPLC), hydroxyapatite HPLC, SDS-PAGE, isoelec. focusing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry, and virus neutralization assay.  Using these methods, the possible degrdn. process of C23 was initially characterized.  Deamidation, oxidn., fragmentation, covalent cross-links, and aggregation were obsd. as major degrdn. routes.  These results gave useful information for the manufg. process and quality control of C23.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrHyS9jlOR5LVg90H21EOLACvtfcHk0liQu64cc30u8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xks1Sjt7o%253D&md5=ce517512515a0f8dcb5e48ef5588e64c</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2FS0731-7085%2896%2901721-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0731-7085%252896%252901721-9%26sid%3Dliteratum%253Aachs%26aulast%3DUsami%26aufirst%3DA.%26aulast%3DOhtsu%26aufirst%3DA.%26aulast%3DTakahama%26aufirst%3DS.%26aulast%3DFujii%26aufirst%3DT.%26atitle%3DThe%2520Effect%2520of%2520PH%252C%2520Hydrogen%2520Peroxide%2520and%2520Temperature%2520on%2520the%2520Stability%2520of%2520Human%2520Monoclonal%2520Antibody%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D1996%26volume%3D14%26issue%3D8%25E2%2580%259310%26spage%3D1133%26epage%3D1140%26doi%3D10.1016%2FS0731-7085%2896%2901721-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muyldermans, S.</span></span> <span> </span><span class="NLM_article-title">Nanobodies: Natural Single-Domain Antibodies</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">797</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-063011-092449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1146%2Fannurev-biochem-063011-092449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=23495938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOqsrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2013&pages=775-797&author=S.+Muyldermans&title=Nanobodies%3A+Natural+Single-Domain+Antibodies&doi=10.1146%2Fannurev-biochem-063011-092449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Nanobodies: natural single-domain antibodies</span></div><div class="casAuthors">Muyldermans, Serge</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">775-797</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Sera of camelids contain both conventional heterotetrameric antibodies and unique functional heavy (H)-chain antibodies (HCAbs).  The H chain of these homodimeric antibodies consists of one antigen-binding domain, the VHH, and two const. domains.  HCAbs fail to incorporate light (L) chains owing to the deletion of the first const. domain and a reshaped surface at the VHH side, which normally assocs. with L chains in conventional antibodies.  The genetic elements composing HCAbs have been identified, but the in vivo generation of these antibodies from their dedicated genes into antigen-specific and affinity-matured bona fide antibodies remains largely underinvestigated.  However, the facile identification of antigen-specific VHHs and their beneficial biochem. and economic properties (size, affinity, specificity, stability, prodn. cost) supported by multiple crystal structures have encouraged antibody engineering of these single-domain antibodies for use as a research tool and in biotechnol. and medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsTs-PnfjncbVg90H21EOLACvtfcHk0liQu64cc30u8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOqsrrJ&md5=19a7b3600cdefafdb5c771d40f661cd4</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-063011-092449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-063011-092449%26sid%3Dliteratum%253Aachs%26aulast%3DMuyldermans%26aufirst%3DS.%26atitle%3DNanobodies%253A%2520Natural%2520Single-Domain%2520Antibodies%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2013%26volume%3D82%26spage%3D775%26epage%3D797%26doi%3D10.1146%2Fannurev-biochem-063011-092449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sisso, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boit, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeForest, C. A.</span></span> <span> </span><span class="NLM_article-title">Self-healing Injectable Gelatin Hydrogels for Localized Therapeutic Cell Delivery</span>. <i>J. Biomed. Mater. Res., Part A</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1121</span>, <span class="refDoi"> DOI: 10.1002/jbm.a.36886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fjbm.a.36886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31971330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFKmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2020&pages=1112-1121&issue=5&author=A.+M.+Sissoauthor=M.+O.+Boitauthor=C.+A.+DeForest&title=Self-healing+Injectable+Gelatin+Hydrogels+for+Localized+Therapeutic+Cell+Delivery&doi=10.1002%2Fjbm.a.36886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Self-healing injectable gelatin hydrogels for localized therapeutic cell delivery</span></div><div class="casAuthors">Sisso, Arbel M.; Boit, Mary O.; De Forest, Cole A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Materials Research, Part A</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1112-1121</span>CODEN:
                <span class="NLM_cas:coden">JBMRCH</span>;
        ISSN:<span class="NLM_cas:issn">1549-3296</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Self-healing injectable hydrogel biomaterials uniquely enable precise therapeutic deposition and deployment at specific bodily locations through versatile and minimally invasive processes that can preserve cargo integrity and cell viability.  Despite the distinct advantages that injectable hydrogels offer in tissue engineering and therapeutic delivery, exceptionally few have been created using components naturally present in the cellular niche.  In this work, we introduce a shear-thinning hydrogel based on guest-host complexation of gelatin.  As a biocompatible, biodegradable, and nonimmunogenic biopolymer derived from the most abundant extracellular matrix protein (collagen), gelatin offers great utility as the structural component of biomaterials.  Taking advantage of reversible guest-host interactions between β-cyclodextrin (CD) and adamantane (AD) on modified gelatins, we report the first strategy to afford a self-healing material based solely on a functionalized extracellular matrix protein.  By varying the initial material formulation, hydrogels were synthesized with variable moduli and shear-thinability across a broad range.  Gels were demonstrated to exhibit shear-thinning and self-healing properties, supporting protection of clin. relevant stem-cell-derived cardiomyocytes during injection.  These materials are expected to expand clin. opportunities in cell delivery for in vivo tissue regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkGrzqvT3BArVg90H21EOLACvtfcHk0liQu64cc30u8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFKmtbc%253D&md5=d040e79d5a05da6f859fc58185ae676a</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1002%2Fjbm.a.36886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbm.a.36886%26sid%3Dliteratum%253Aachs%26aulast%3DSisso%26aufirst%3DA.%2BM.%26aulast%3DBoit%26aufirst%3DM.%2BO.%26aulast%3DDeForest%26aufirst%3DC.%2BA.%26atitle%3DSelf-healing%2520Injectable%2520Gelatin%2520Hydrogels%2520for%2520Localized%2520Therapeutic%2520Cell%2520Delivery%26jtitle%3DJ.%2520Biomed.%2520Mater.%2520Res.%252C%2520Part%2520A%26date%3D2020%26volume%3D108%26issue%3D5%26spage%3D1112%26epage%3D1121%26doi%3D10.1002%2Fjbm.a.36886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercadante, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikić, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemke, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gräter, F.</span></span> <span> </span><span class="NLM_article-title">Origin of Orthogonality of Strain-Promoted Click Reactions</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">35</span>),  <span class="NLM_fpage">12431</span>– <span class="NLM_lpage">12435</span>, <span class="refDoi"> DOI: 10.1002/chem.201501727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fchem.201501727" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26178299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOrtL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=12431-12435&issue=35&author=J.+A.+Wagnerauthor=D.+Mercadanteauthor=I.+Niki%C4%87author=E.+A.+Lemkeauthor=F.+Gr%C3%A4ter&title=Origin+of+Orthogonality+of+Strain-Promoted+Click+Reactions&doi=10.1002%2Fchem.201501727"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Origin of Orthogonality of Strain-Promoted Click Reactions</span></div><div class="casAuthors">Wagner, Johannes A.; Mercadante, Davide; Nikic, Ivana; Lemke, Edward A.; Graeter, Frauke</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">12431-12435</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Site-specific labeling of biomols. is rapidly advancing due to the discovery of novel mutually orthogonal reactions.  Quantum chem. studies have also increased our understanding of their relative rates, although these have until now been based on highly simplified reactants.  Here we examine a set of strain-promoted click-type cycloaddn. reactions of Pr azide, 3-benzyltetrazine and 3-benzyl-6-Me tetrazine with cyclooctenes/ynes, in which we aim to address all relevant structural details of the reactants.  Our calcns. have included the obligatory handles used to attach the label and biomol. as these can critically influence the stereochem. and electron demand of the reaction.  We systematically computed orbital gaps, activation and distortion energies using d. functional theory and detd. exptl. rates for validation.  Our results challenge the current paradigm of the inverse electron demand for this class of reactions.  We found that the ubiquitous handles, when next to the triple bond of cyclooctynes, can switch the Diels-Alder type ligations to normal electron demand, a class we term as SPINEDAC reactions.  Electron donating substituents on tetrazine can enhance normal demand but also increase distortion penalties.  The presence and isomeric configuration of handles thus det. the reaction speed and regioselectivity.  Our findings can be directly utilized in engineering genuine cycloaddn. click chemistries for biol. labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0544mlTLfCbVg90H21EOLACvtfcHk0lghwX-3LCV_Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOrtL%252FL&md5=9477aa024da2867baab6c23ce82f4a23</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1002%2Fchem.201501727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201501727%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DJ.%2BA.%26aulast%3DMercadante%26aufirst%3DD.%26aulast%3DNiki%25C4%2587%26aufirst%3DI.%26aulast%3DLemke%26aufirst%3DE.%2BA.%26aulast%3DGr%25C3%25A4ter%26aufirst%3DF.%26atitle%3DOrigin%2520of%2520Orthogonality%2520of%2520Strain-Promoted%2520Click%2520Reactions%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26issue%3D35%26spage%3D12431%26epage%3D12435%26doi%3D10.1002%2Fchem.201501727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narayanam, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houk, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of New Mutually Orthogonal Bioorthogonal Cycloaddition Pairs through Computational Screening</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1257</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1039/C5SC03259H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC5SC03259H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=29910881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVSgtb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1257-1261&issue=2&author=M.+K.+Narayanamauthor=Y.+Liangauthor=K.+N.+Houkauthor=J.+M.+Murphy&title=Discovery+of+New+Mutually+Orthogonal+Bioorthogonal+Cycloaddition+Pairs+through+Computational+Screening&doi=10.1039%2FC5SC03259H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of new mutually orthogonal bioorthogonal cycloaddition pairs through computational screening</span></div><div class="casAuthors">Narayanam, Maruthi Kumar; Liang, Yong; Houk, K. N.; Murphy, Jennifer M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1257-1261</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">D. functional theory (DFT) calcns. and expts. in tandem led to discoveries of new reactivities and selectivities involving bioorthogonal sydnone cycloaddns.  Dibenzocyclooctyne derivs. (DIBAC and BARAC) were identified to be esp. reactive dipolarophiles, which undergo the [3+2] cycloaddns. with N-Ph sydnone with the rate const. of up to 1.46 M-1 s-1.  Most significantly, the sydnone-dibenzocyclooctyne and norbornene-tetrazine cycloaddns. were predicted to be mutually orthogonal.  This was validated exptl. and used for highly selective fluorescence labeling of two proteins simultaneously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxbCgL7hhGkbVg90H21EOLACvtfcHk0lghwX-3LCV_Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVSgtb%252FF&md5=0d5cf273fb4552e14c19a1e3c6fed4b8</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1039%2FC5SC03259H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC03259H%26sid%3Dliteratum%253Aachs%26aulast%3DNarayanam%26aufirst%3DM.%2BK.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26aulast%3DMurphy%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%2520of%2520New%2520Mutually%2520Orthogonal%2520Bioorthogonal%2520Cycloaddition%2520Pairs%2520through%2520Computational%2520Screening%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26issue%3D2%26spage%3D1257%26epage%3D1261%26doi%3D10.1039%2FC5SC03259H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strumillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltrao, P.</span></span> <span> </span><span class="NLM_article-title">Towards the Computational Design of Protein Post-Translational Regulation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2877</span>– <span class="NLM_lpage">2882</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.04.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.bmc.2015.04.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=25956846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntlWlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2877-2882&issue=12&author=M.+Strumilloauthor=P.+Beltrao&title=Towards+the+Computational+Design+of+Protein+Post-Translational+Regulation&doi=10.1016%2Fj.bmc.2015.04.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Towards the computational design of protein post-translational regulation</span></div><div class="casAuthors">Strumillo, Marta; Beltrao, Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2877-2882</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein post-translational modifications (PTMs) are a fast and versatility mechanism used by the cell to regulate the function of proteins in response to changing conditions.  PTMs can alter the activity of proteins by allosteric regulation or by controlling protein interactions, localization and abundance.  Recent advances in proteomics revealed the extent of regulation by PTMs and the different mechanisms used in nature to exert control over protein function via PTMs.  These developments can serve as the foundation for the rational design of protein regulation.  Here the authors review the advances in methods to det. the function of PTMs, protein allosteric control and examples of rational design of PTM regulation.  These advances create an opportunity to move synthetic biol. forward by making use of a level of regulation that is of yet unexplored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob-snvpoICObVg90H21EOLACvtfcHk0lgJ03nMaqtI8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntlWlsLg%253D&md5=8ad88090f5738c1a53f048574ef47273</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.04.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.04.056%26sid%3Dliteratum%253Aachs%26aulast%3DStrumillo%26aufirst%3DM.%26aulast%3DBeltrao%26aufirst%3DP.%26atitle%3DTowards%2520the%2520Computational%2520Design%2520of%2520Protein%2520Post-Translational%2520Regulation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26issue%3D12%26spage%3D2877%26epage%3D2882%26doi%3D10.1016%2Fj.bmc.2015.04.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletti, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.-C.</span></span> <span> </span><span class="NLM_article-title">Chemoselective Peptide Modification via Photocatalytic Tryptophan β-Position Conjugation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">6797</span>– <span class="NLM_lpage">6800</span>, <span class="refDoi"> DOI: 10.1021/jacs.8b03973</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b03973" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVCiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=6797-6800&issue=22&author=Y.+Yuauthor=L.-K.+Zhangauthor=A.+V.+Buevichauthor=G.+Liauthor=H.+Tangauthor=P.+Vachalauthor=S.+L.+Collettiauthor=Z.-C.+Shi&title=Chemoselective+Peptide+Modification+via+Photocatalytic+Tryptophan+%CE%B2-Position+Conjugation&doi=10.1021%2Fjacs.8b03973"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective Peptide Modification via Photocatalytic Tryptophan β-Position Conjugation</span></div><div class="casAuthors">Yu, Younong; Zhang, Li-Kang; Buevich, Alexei V.; Li, Guoqing; Tang, Haiqun; Vachal, Petr; Colletti, Steven L.; Shi, Zhi-Cai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6797-6800</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeting tryptophan is a promising strategy to achieve high levels of selectivity for peptide or protein modification.  A chemoselective peptide modification method via photocatalytic tryptophan β-position conjugation has been discovered.  This transformation has good substrate scope for both peptide and Michael acceptor, and has good chemoselectivity vs. other amino acid residues.  The endogenous peptides, glucagon and GLP-1 amide, were both successfully conjugated at the tryptophan β-position.  Insulin was studied as a nontryptophan control mol., resulting in exclusive B-chain C-terminal-selective decarboxylative conjugation.  This transformation provides a novel approach toward peptide modification to support the discovery of new therapeutic peptides, protein labeling and bioconjugation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWz6oczGRAMLVg90H21EOLACvtfcHk0lgJ03nMaqtI8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVCiurY%253D&md5=35c3a0aff03bd3795ae48ff5df6debe9</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b03973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b03973%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.-K.%26aulast%3DBuevich%26aufirst%3DA.%2BV.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DColletti%26aufirst%3DS.%2BL.%26aulast%3DShi%26aufirst%3DZ.-C.%26atitle%3DChemoselective%2520Peptide%2520Modification%2520via%2520Photocatalytic%2520Tryptophan%2520%25CE%25B2-Position%2520Conjugation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D22%26spage%3D6797%26epage%3D6800%26doi%3D10.1021%2Fjacs.8b03973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in the Molecular Design of Synthetic Vaccines</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">952</span>– <span class="NLM_lpage">960</span>, <span class="refDoi"> DOI: 10.1038/nchem.2396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnchem.2396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26587710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFensLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=952-960&issue=12&author=L.+H.+Jones&title=Recent+Advances+in+the+Molecular+Design+of+Synthetic+Vaccines&doi=10.1038%2Fnchem.2396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the molecular design of synthetic vaccines</span></div><div class="casAuthors">Jones, Lyn H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">952-960</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Vaccines have typically been prepd. using whole organisms.  These are normally either attenuated bacteria or viruses that are live but have been altered to reduce their virulence, or pathogens that have been inactivated and effectively killed through exposure to heat or formaldehyde.  However, using whole organisms to elicit an immune response introduces the potential for infections arising from a reversion to a virulent form in live pathogens, unproductive reactions to vaccine components or batch-to-batch variability.  Synthetic vaccines, in which a mol. antigen is conjugated to a carrier protein, offer the opportunity to circumvent these problems.  This Perspective will highlight the progress that has been achieved in developing synthetic vaccines using a variety of mol. antigens.  In particular, the different approaches used to develop conjugate vaccines using peptide/proteins, carbohydrates and other small mol. haptens as antigens are compared.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphbKFn6TlnhrVg90H21EOLACvtfcHk0lgJ03nMaqtI8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFensLfL&md5=16e5d0b22ef8b5a66e104883f31385af</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2396%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Molecular%2520Design%2520of%2520Synthetic%2520Vaccines%26jtitle%3DNat.%2520Chem.%26date%3D2015%26volume%3D7%26issue%3D12%26spage%3D952%26epage%3D960%26doi%3D10.1038%2Fnchem.2396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veiseh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabikian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahrami, S.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veiseh, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackman, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravanpay, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusuma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sze, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenbogen, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. M.</span></span> <span> </span><span class="NLM_article-title">Tumor Paint: A Chlorotoxin:Cy5.5 Bioconjugate for Intraoperative Visualization of Cancer Foci</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">6882</span>– <span class="NLM_lpage">6888</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-3948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1158%2F0008-5472.CAN-06-3948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=17638899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslOisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6882-6888&issue=14&author=M.+Veisehauthor=P.+Gabikianauthor=S.-B.+Bahramiauthor=O.+Veisehauthor=M.+Zhangauthor=R.+C.+Hackmanauthor=A.+C.+Ravanpayauthor=M.+R.+Stroudauthor=Y.+Kusumaauthor=S.+J.+Hansenauthor=D.+Kwokauthor=N.+M.+Munozauthor=R.+W.+Szeauthor=W.+M.+Gradyauthor=N.+M.+Greenbergauthor=R.+G.+Ellenbogenauthor=J.+M.+Olson&title=Tumor+Paint%3A+A+Chlorotoxin%3ACy5.5+Bioconjugate+for+Intraoperative+Visualization+of+Cancer+Foci&doi=10.1158%2F0008-5472.CAN-06-3948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Paint: A Chlorotoxin:Cy5.5 Bioconjugate for Intraoperative Visualization of Cancer Foci</span></div><div class="casAuthors">Veiseh, Mandana; Gabikian, Patrik; Bahrami, S-Bahram; Veiseh, Omid; Zhang, Miqin; Hackman, Robert C.; Ravanpay, Ali C.; Stroud, Mark R.; Kusuma, Yumiko; Hansen, Stacey J.; Kwok, Deborah; Munoz, Nina M.; Sze, Raymond W.; Grady, William M.; Greenberg, Norman M.; Ellenbogen, Richard G.; Olson, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6882-6888</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Toward the goal of developing an optical imaging contrast agent that will enable surgeons to intraoperatively distinguish cancer foci from adjacent normal tissue, we developed a chlorotoxin:Cy5.5 (CTX:Cy5.5) bioconjugate that emits near-IR fluorescent signal.  The probe delineates malignant glioma, medulloblastoma, prostate cancer, intestinal cancer, and sarcoma from adjacent non-neoplastic tissue in mouse models.  Metastatic cancer foci as small as a few hundred cells were detected in lymph channels.  Specific binding to cancer cells is facilitated by matrix metalloproteinase-2 (MMP-2) as evidenced by redn. of CTX:Cy5.5 binding in vitro and in vivo by a pharmacol. blocker of MMP-2 and induction of CTX:Cy5.5 binding in MCF-7 cells following transfection with a plasmid encoding MMP-2.  Mouse studies revealed that CTX:Cy5.5 has favorable biodistribution and toxicity profiles.  These studies show that CTX:Cy5.5 has the potential to fundamentally improve intraoperative detection and resection of malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo04sI0a6cQdLVg90H21EOLACvtfcHk0li7zvOBbo1bfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslOisb8%253D&md5=9f9bbe1bf8df8b3ef12fa79df5e671e0</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-3948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-3948%26sid%3Dliteratum%253Aachs%26aulast%3DVeiseh%26aufirst%3DM.%26aulast%3DGabikian%26aufirst%3DP.%26aulast%3DBahrami%26aufirst%3DS.-B.%26aulast%3DVeiseh%26aufirst%3DO.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHackman%26aufirst%3DR.%2BC.%26aulast%3DRavanpay%26aufirst%3DA.%2BC.%26aulast%3DStroud%26aufirst%3DM.%2BR.%26aulast%3DKusuma%26aufirst%3DY.%26aulast%3DHansen%26aufirst%3DS.%2BJ.%26aulast%3DKwok%26aufirst%3DD.%26aulast%3DMunoz%26aufirst%3DN.%2BM.%26aulast%3DSze%26aufirst%3DR.%2BW.%26aulast%3DGrady%26aufirst%3DW.%2BM.%26aulast%3DGreenberg%26aufirst%3DN.%2BM.%26aulast%3DEllenbogen%26aufirst%3DR.%2BG.%26aulast%3DOlson%26aufirst%3DJ.%2BM.%26atitle%3DTumor%2520Paint%253A%2520A%2520Chlorotoxin%253ACy5.5%2520Bioconjugate%2520for%2520Intraoperative%2520Visualization%2520of%2520Cancer%2520Foci%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D14%26spage%3D6882%26epage%3D6888%26doi%3D10.1158%2F0008-5472.CAN-06-3948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patil, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittle, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nufer, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrnes-Blake, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrish-Novak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prow, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamelak, A. N.</span></span> <span> </span><span class="NLM_article-title">Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas</span>. <i>Neurosurgery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">E641</span>– <span class="NLM_lpage">E649</span>, <span class="refDoi"> DOI: 10.1093/neuros/nyz125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1093%2Fneuros%2Fnyz125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31069381" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2019&pages=E641-E649&issue=4&author=C.+G.+Patilauthor=D.+G.+Walkerauthor=D.+M.+Millerauthor=P.+Butteauthor=B.+Morrisonauthor=D.+S.+Kittleauthor=S.+J.+Hansenauthor=K.+L.+Nuferauthor=K.+A.+Byrnes-Blakeauthor=M.+Yamadaauthor=L.+L.+Linauthor=K.+Phamauthor=J.+Perryauthor=J.+Parrish-Novakauthor=L.+Ishakauthor=T.+Prowauthor=K.+Blackauthor=A.+N.+Mamelak&title=Phase+1+Safety%2C+Pharmacokinetics%2C+and+Fluorescence+Imaging+Study+of+Tozuleristide+%28BLZ-100%29+in+Adults+With+Newly+Diagnosed+or+Recurrent+Gliomas&doi=10.1093%2Fneuros%2Fnyz125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1093%2Fneuros%2Fnyz125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuros%252Fnyz125%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DC.%2BG.%26aulast%3DWalker%26aufirst%3DD.%2BG.%26aulast%3DMiller%26aufirst%3DD.%2BM.%26aulast%3DButte%26aufirst%3DP.%26aulast%3DMorrison%26aufirst%3DB.%26aulast%3DKittle%26aufirst%3DD.%2BS.%26aulast%3DHansen%26aufirst%3DS.%2BJ.%26aulast%3DNufer%26aufirst%3DK.%2BL.%26aulast%3DByrnes-Blake%26aufirst%3DK.%2BA.%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DL.%2BL.%26aulast%3DPham%26aufirst%3DK.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DParrish-Novak%26aufirst%3DJ.%26aulast%3DIshak%26aufirst%3DL.%26aulast%3DProw%26aufirst%3DT.%26aulast%3DBlack%26aufirst%3DK.%26aulast%3DMamelak%26aufirst%3DA.%2BN.%26atitle%3DPhase%25201%2520Safety%252C%2520Pharmacokinetics%252C%2520and%2520Fluorescence%2520Imaging%2520Study%2520of%2520Tozuleristide%2520%2528BLZ-100%2529%2520in%2520Adults%2520With%2520Newly%2520Diagnosed%2520or%2520Recurrent%2520Gliomas%26jtitle%3DNeurosurgery%26date%3D2019%26volume%3D85%26issue%3D4%26spage%3DE641%26epage%3DE649%26doi%3D10.1093%2Fneuros%2Fnyz125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khademhosseini, A.</span></span> <span> </span><span class="NLM_article-title">Advances in Engineering Hydrogels</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>356</i></span> (<span class="NLM_issue">6337</span>), <span class="NLM_elocation-id">eaaf3627</span> <span class="refDoi"> DOI: 10.1126/science.aaf3627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1126%2Fscience.aaf3627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=28473537" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2017&issue=6337&author=Y.+S.+Zhangauthor=A.+Khademhosseini&title=Advances+in+Engineering+Hydrogels&doi=10.1126%2Fscience.aaf3627"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaf3627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaf3627%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BS.%26aulast%3DKhademhosseini%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520Engineering%2520Hydrogels%26jtitle%3DScience%26date%3D2017%26volume%3D356%26issue%3D6337%26doi%3D10.1126%2Fscience.aaf3627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glazier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span> <span> </span><span class="NLM_article-title">Chemical Synthesis and Biological Application of Modified Oligonucleotides</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1213</span>– <span class="NLM_lpage">1233</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.0c00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.0c00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFCisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=1213-1233&issue=5&author=D.+A.+Glazierauthor=J.+Liaoauthor=B.+L.+Robertsauthor=X.+Liauthor=K.+Yangauthor=C.+M.+Stevensauthor=W.+Tang&title=Chemical+Synthesis+and+Biological+Application+of+Modified+Oligonucleotides&doi=10.1021%2Facs.bioconjchem.0c00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Synthesis and Biological Application of Modified Oligonucleotides</span></div><div class="casAuthors">Glazier, Daniel A.; Liao, Junzhuo; Roberts, Brett L.; Li, Xiaolei; Yang, Ka; Stevens, Christopher M.; Tang, Weiping</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1213-1233</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with refs.  RNA plays a myriad of roles in the body including the coding, decoding, regulation and expression of genes.  RNA oligonucleotides have garnered significant interest as therapeutics via antisense oligonucleotides or small interfering RNA strategies for the treatment of diseases ranging from hyperlipidemia, HCV, and others.  Addnl., the recently developed CRISPR-Cas9 mediated gene editing strategy also relies on Cas9-assocd. RNA strands.  However, RNA presents numerous challenges as both a synthetic target and a potential therapeutic.  RNA is inherently unstable, difficult to deliver into cells, and potentially immunogenic by itself or upon modification.  Despite these challenges, with the help of chem. modified oligonucleotides, multiple RNA based drugs have been approved by the FDA.  The progress is made possible due to the nature of chem. modified oligonucleotides bearing advantages of nuclease stability, stronger binding affinity and some other unique properties.  This review will focus on the chem. synthesis of RNA and its modified versions.  How chem. modifications of the ribose units and of the phosphatediester backbone address the inherent issues with using native RNA for biol. applications will be discussed along the way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ2I6IUYiuE7Vg90H21EOLACvtfcHk0lh8x3gw4cl_oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFCisbo%253D&md5=d52334a8bb55d61413e1c68aa2420c01</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.0c00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.0c00060%26sid%3Dliteratum%253Aachs%26aulast%3DGlazier%26aufirst%3DD.%2BA.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DB.%2BL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DC.%2BM.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DChemical%2520Synthesis%2520and%2520Biological%2520Application%2520of%2520Modified%2520Oligonucleotides%26jtitle%3DBioconjugate%2520Chem.%26date%3D2020%26volume%3D31%26issue%3D5%26spage%3D1213%26epage%3D1233%26doi%3D10.1021%2Facs.bioconjchem.0c00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nair, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willoughby, J. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charisse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoekstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandasamy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kel’in, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taneja, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaikh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Sluis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akinc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutabarat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchimanchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Berkel, T. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajeev, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, M.</span></span> <span> </span><span class="NLM_article-title">Multivalent N -Acetylgalactosamine-Conjugated SiRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">49</span>),  <span class="NLM_fpage">16958</span>– <span class="NLM_lpage">16961</span>, <span class="refDoi"> DOI: 10.1021/ja505986a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja505986a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSju7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=16958-16961&issue=49&author=J.+K.+Nairauthor=J.+L.+S.+Willoughbyauthor=A.+Chanauthor=K.+Charisseauthor=M.+R.+Alamauthor=Q.+Wangauthor=M.+Hoekstraauthor=P.+Kandasamyauthor=A.+V.+Kel%E2%80%99inauthor=S.+Milsteinauthor=N.+Tanejaauthor=J.+O%E2%80%99Sheaauthor=S.+Shaikhauthor=L.+Zhangauthor=R.+J.+van+der+Sluisauthor=M.+E.+Jungauthor=A.+Akincauthor=R.+Hutabaratauthor=S.+Kuchimanchiauthor=K.+Fitzgeraldauthor=T.+Zimmermannauthor=T.+J.+C.+van+Berkelauthor=M.+A.+Maierauthor=K.+G.+Rajeevauthor=M.+Manoharan&title=Multivalent+N+-Acetylgalactosamine-Conjugated+SiRNA+Localizes+in+Hepatocytes+and+Elicits+Robust+RNAi-Mediated+Gene+Silencing&doi=10.1021%2Fja505986a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing</span></div><div class="casAuthors">Nair, Jayaprakash K.; Willoughby, Jennifer L. S.; Chan, Amy; Charisse, Klaus; Alam, Md. Rowshon; Wang, Qianfan; Hoekstra, Menno; Kandasamy, Pachamuthu; Kel'in, Alexander V.; Milstein, Stuart; Taneja, Nate; O'Shea, Jonathan; Shaikh, Sarfraz; Zhang, Ligang; van der Sluis, Ronald J.; Jung, Michael E.; Akinc, Akin; Hutabarat, Renta; Kuchimanchi, Satya; Fitzgerald, Kevin; Zimmermann, Tracy; van Berkel, Theo J. C.; Maier, Martin A.; Rajeev, Kallanthottathil G.; Manoharan, Muthiah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">16958-16961</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Conjugation of small interfering RNA (siRNA) to an asialoglycoprotein receptor ligand derived from N-acetylgalactosamine (GalNAc) facilitates targeted delivery of the siRNA to hepatocytes in vitro and in vivo.  The ligands derived from GalNAc are compatible with solid-phase oligonucleotide synthesis and deprotection conditions, with synthesis yields comparable to those of std. oligonucleotides.  S.c. (SC) administration of siRNA-GalNAc conjugates resulted in robust RNAi-mediated gene silencing in liver.  Refinement of the siRNA chem. achieved a 5-fold improvement in efficacy over the parent design in vivo with a median ED (ED50) of 1 mg/kg following a single dose.  This enabled the SC administration of siRNA-GalNAc conjugates at therapeutically relevant doses and, importantly, at dose vols. of ≤1 mL.  Chronic weekly dosing resulted in sustained dose-dependent gene silencing for over 9 mo with no adverse effects in rodents.  The optimally chem. modified siRNA-GalNAc conjugates are hepatotropic and long-acting and have the potential to treat a wide range of diseases involving liver-expressed genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocTUVgPLEx2LVg90H21EOLACvtfcHk0lh8x3gw4cl_oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSju7vJ&md5=d47cb552873ffdaa46ed17d8d1fb4116</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Fja505986a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja505986a%26sid%3Dliteratum%253Aachs%26aulast%3DNair%26aufirst%3DJ.%2BK.%26aulast%3DWilloughby%26aufirst%3DJ.%2BL.%2BS.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DCharisse%26aufirst%3DK.%26aulast%3DAlam%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHoekstra%26aufirst%3DM.%26aulast%3DKandasamy%26aufirst%3DP.%26aulast%3DKel%25E2%2580%2599in%26aufirst%3DA.%2BV.%26aulast%3DMilstein%26aufirst%3DS.%26aulast%3DTaneja%26aufirst%3DN.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%26aulast%3DShaikh%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BSluis%26aufirst%3DR.%2BJ.%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DAkinc%26aufirst%3DA.%26aulast%3DHutabarat%26aufirst%3DR.%26aulast%3DKuchimanchi%26aufirst%3DS.%26aulast%3DFitzgerald%26aufirst%3DK.%26aulast%3DZimmermann%26aufirst%3DT.%26aulast%3Dvan%2BBerkel%26aufirst%3DT.%2BJ.%2BC.%26aulast%3DMaier%26aufirst%3DM.%2BA.%26aulast%3DRajeev%26aufirst%3DK.%2BG.%26aulast%3DManoharan%26aufirst%3DM.%26atitle%3DMultivalent%2520N%2520-Acetylgalactosamine-Conjugated%2520SiRNA%2520Localizes%2520in%2520Hepatocytes%2520and%2520Elicits%2520Robust%2520RNAi-Mediated%2520Gene%2520Silencing%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26issue%3D49%26spage%3D16958%26epage%3D16961%26doi%3D10.1021%2Fja505986a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coote, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valley, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhym, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bihler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mense, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCaffrey, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, W.</span></span> <span> </span><span class="NLM_article-title">Chemical Modifications of Adenine Base Editor MRNA and Guide RNA Expand Its Application Scope</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1979</span>, <span class="refDoi"> DOI: 10.1038/s41467-020-15892-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fs41467-020-15892-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=32332735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXot1amtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1979&issue=1&author=T.+Jiangauthor=J.+M.+Hendersonauthor=K.+Cooteauthor=Y.+Chengauthor=H.+C.+Valleyauthor=X.-O.+Zhangauthor=Q.+Wangauthor=L.+H.+Rhymauthor=Y.+Caoauthor=G.+A.+Newbyauthor=H.+Bihlerauthor=M.+Menseauthor=Z.+Wengauthor=D.+G.+Andersonauthor=A.+P.+McCaffreyauthor=D.+R.+Liuauthor=W.+Xue&title=Chemical+Modifications+of+Adenine+Base+Editor+MRNA+and+Guide+RNA+Expand+Its+Application+Scope&doi=10.1038%2Fs41467-020-15892-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope</span></div><div class="casAuthors">Jiang, Tingting; Henderson, Jordana M.; Coote, Kevin; Cheng, Yi; Valley, Hillary C.; Zhang, Xiao-Ou; Wang, Qin; Rhym, Luke H.; Cao, Yueying; Newby, Gregory A.; Bihler, Hermann; Mense, Martin; Weng, Zhiping; Anderson, Daniel G.; McCaffrey, Anton P.; Liu, David R.; Xue, Wen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1979</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">CRISPR-Cas9-assocd. base editing is a promising tool to correct pathogenic single nucleotide mutations in research or therapeutic settings.  Efficient base editing requires cellular exposure to levels of base editors that can be difficult to attain in hard-to-transfect cells or in vivo.  Here we engineer a chem. modified mRNA-encoded adenine base editor that mediates robust editing at various cellular genomic sites together with moderately modified guide RNA, and show its therapeutic potential in correcting pathogenic single nucleotide mutations in cell and animal models of diseases.  The optimized chem. modifications of adenine base editor mRNA and guide RNA expand the applicability of CRISPR-assocd. gene editing tools in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH03B3BbFdtbVg90H21EOLACvtfcHk0liMWvAwTHxFLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXot1amtLg%253D&md5=5a0c59eb0ee2f7f53121e5e77a74a811</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-15892-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-15892-8%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DHenderson%26aufirst%3DJ.%2BM.%26aulast%3DCoote%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DValley%26aufirst%3DH.%2BC.%26aulast%3DZhang%26aufirst%3DX.-O.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DRhym%26aufirst%3DL.%2BH.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DNewby%26aufirst%3DG.%2BA.%26aulast%3DBihler%26aufirst%3DH.%26aulast%3DMense%26aufirst%3DM.%26aulast%3DWeng%26aufirst%3DZ.%26aulast%3DAnderson%26aufirst%3DD.%2BG.%26aulast%3DMcCaffrey%26aufirst%3DA.%2BP.%26aulast%3DLiu%26aufirst%3DD.%2BR.%26aulast%3DXue%26aufirst%3DW.%26atitle%3DChemical%2520Modifications%2520of%2520Adenine%2520Base%2520Editor%2520MRNA%2520and%2520Guide%2520RNA%2520Expand%2520Its%2520Application%2520Scope%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D1979%26doi%3D10.1038%2Fs41467-020-15892-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarfò, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidts, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guirguis, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Słabicki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouffard, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castano, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kann, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinshpun, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sievers, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maus, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, B. L.</span></span> <span> </span><span class="NLM_article-title">Reversible ON- and OFF-Switch Chimeric Antigen Receptors Controlled by Lenalidomide</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">575</span>), <span class="NLM_elocation-id">eabb6295</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.abb6295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1126%2Fscitranslmed.abb6295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=33408186" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2021&issue=575&author=M.+Janauthor=I.+Scarf%C3%B2author=R.+C.+Larsonauthor=A.+Walkerauthor=A.+Schmidtsauthor=A.+A.+Guirguisauthor=J.+A.+Gasserauthor=M.+S%C5%82abickiauthor=A.+A.+Bouffardauthor=A.+P.+Castanoauthor=M.+C.+Kannauthor=M.+L.+Cabralauthor=A.+Tepperauthor=D.+E.+Grinshpunauthor=A.+S.+Sperlingauthor=T.+Kyungauthor=Q.+L.+Sieversauthor=M.+E.+Birnbaumauthor=M.+V.+Mausauthor=B.+L.+Ebert&title=Reversible+ON-+and+OFF-Switch+Chimeric+Antigen+Receptors+Controlled+by+Lenalidomide&doi=10.1126%2Fscitranslmed.abb6295"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.abb6295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.abb6295%26sid%3Dliteratum%253Aachs%26aulast%3DJan%26aufirst%3DM.%26aulast%3DScarf%25C3%25B2%26aufirst%3DI.%26aulast%3DLarson%26aufirst%3DR.%2BC.%26aulast%3DWalker%26aufirst%3DA.%26aulast%3DSchmidts%26aufirst%3DA.%26aulast%3DGuirguis%26aufirst%3DA.%2BA.%26aulast%3DGasser%26aufirst%3DJ.%2BA.%26aulast%3DS%25C5%2582abicki%26aufirst%3DM.%26aulast%3DBouffard%26aufirst%3DA.%2BA.%26aulast%3DCastano%26aufirst%3DA.%2BP.%26aulast%3DKann%26aufirst%3DM.%2BC.%26aulast%3DCabral%26aufirst%3DM.%2BL.%26aulast%3DTepper%26aufirst%3DA.%26aulast%3DGrinshpun%26aufirst%3DD.%2BE.%26aulast%3DSperling%26aufirst%3DA.%2BS.%26aulast%3DKyung%26aufirst%3DT.%26aulast%3DSievers%26aufirst%3DQ.%2BL.%26aulast%3DBirnbaum%26aufirst%3DM.%2BE.%26aulast%3DMaus%26aufirst%3DM.%2BV.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26atitle%3DReversible%2520ON-%2520and%2520OFF-Switch%2520Chimeric%2520Antigen%2520Receptors%2520Controlled%2520by%2520Lenalidomide%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2021%26volume%3D13%26issue%3D575%26doi%3D10.1126%2Fscitranslmed.abb6295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oakes, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rishi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadler, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doudna, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savage, D. F.</span></span> <span> </span><span class="NLM_article-title">CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">254</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.11.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.cell.2018.11.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=30633905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFyqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=254-267&issue=1%E2%80%932&author=B.+L.+Oakesauthor=C.+Fellmannauthor=H.+Rishiauthor=K.+L.+Taylorauthor=S.+M.+Renauthor=D.+C.+Nadlerauthor=R.+Yokooauthor=A.+P.+Arkinauthor=J.+A.+Doudnaauthor=D.+F.+Savage&title=CRISPR-Cas9+Circular+Permutants+as+Programmable+Scaffolds+for+Genome+Modification&doi=10.1016%2Fj.cell.2018.11.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">CRISPR-Cas9 circular permutants as programmable scaffolds for genome modification</span></div><div class="casAuthors">Oakes, Benjamin L.; Fellmann, Christof; Rishi, Harneet; Taylor, Kian L.; Ren, Shawn M.; Nadler, Dana C.; Yokoo, Rayka; Arkin, Adam P.; Doudna, Jennifer A.; Savage, David F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">254-267.e16</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The ability to engineer natural proteins is pivotal to a future, pragmatic biol.  CRISPR proteins have revolutionized genome modification, yet the CRISPR-Cas9 scaffold is not ideal for fusions or activation by cellular triggers.  Here, we show that a topol. rearrangement of Cas9 using circular permutation provides an advanced platform for RNA-guided genome modification and protection.  Through systematic interrogation, we find that protein termini can be positioned adjacent to bound DNA, offering a straightforward mechanism for strategically fusing functional domains.  Addnl., circular permutation enabled protease-sensing Cas9s (ProCas9s), a unique class of single-mol. effectors possessing programmable inputs and outputs.  ProCas9s can sense a wide range of proteases, and we demonstrate that ProCas9 can orchestrate a cellular response to pathogen-assocd. protease activity.  Together, these results provide a toolkit of safer and more efficient genome-modifying enzymes and mol. recorders for the advancement of precision genome engineering in research, agriculture, and biomedicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGdpuiMdxuyrVg90H21EOLACvtfcHk0ljLnY41A5vsug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFyqtQ%253D%253D&md5=1c85a526c0c6b4c5574652b348454547</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.11.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.11.052%26sid%3Dliteratum%253Aachs%26aulast%3DOakes%26aufirst%3DB.%2BL.%26aulast%3DFellmann%26aufirst%3DC.%26aulast%3DRishi%26aufirst%3DH.%26aulast%3DTaylor%26aufirst%3DK.%2BL.%26aulast%3DRen%26aufirst%3DS.%2BM.%26aulast%3DNadler%26aufirst%3DD.%2BC.%26aulast%3DYokoo%26aufirst%3DR.%26aulast%3DArkin%26aufirst%3DA.%2BP.%26aulast%3DDoudna%26aufirst%3DJ.%2BA.%26aulast%3DSavage%26aufirst%3DD.%2BF.%26atitle%3DCRISPR-Cas9%2520Circular%2520Permutants%2520as%2520Programmable%2520Scaffolds%2520for%2520Genome%2520Modification%26jtitle%3DCell%26date%3D2019%26volume%3D176%26issue%3D1%25E2%2580%25932%26spage%3D254%26epage%3D267%26doi%3D10.1016%2Fj.cell.2018.11.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogan, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Replogle, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adriaens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramadoss, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samelson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogson, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kampmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hovestadt, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, J. S.</span></span> <span> </span><span class="NLM_article-title">Genome-Wide Programmable Transcriptional Memory by CRISPR-Based Epigenome Editing</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">2503</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2021.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.cell.2021.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=33838111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3MXovV2itLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2021&pages=2503&author=J.+K.+Nu%C3%B1ezauthor=J.+Chenauthor=G.+C.+Pommierauthor=J.+Z.+Coganauthor=J.+M.+Replogleauthor=C.+Adriaensauthor=G.+N.+Ramadossauthor=Q.+Shiauthor=K.+L.+Hungauthor=A.+J.+Samelsonauthor=A.+N.+Pogsonauthor=J.+Y.+S.+Kimauthor=A.+Chungauthor=M.+D.+Leonettiauthor=H.+Y.+Changauthor=M.+Kampmannauthor=B.+E.+Bernsteinauthor=V.+Hovestadtauthor=L.+A.+Gilbertauthor=J.+S.+Weissman&title=Genome-Wide+Programmable+Transcriptional+Memory+by+CRISPR-Based+Epigenome+Editing&doi=10.1016%2Fj.cell.2021.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing</span></div><div class="casAuthors">Nunez, James K.; Chen, Jin; Pommier, Greg C.; Cogan, J. Zachery; Replogle, Joseph M.; Adriaens, Carmen; Ramadoss, Gokul N.; Shi, Quanming; Hung, King L.; Samelson, Avi J.; Pogson, Angela N.; Kim, James Y. S.; Chung, Amanda; Leonetti, Manuel D.; Chang, Howard Y.; Kampmann, Martin; Bernstein, Bradley E.; Hovestadt, Volker; Gilbert, Luke A.; Weissman, Jonathan S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2503-2519.e17</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A general approach for heritably altering gene expression has the potential to enable many discovery and therapeutic efforts.  Here, we present CRISPRoff-a programmable epigenetic memory writer consisting of a single dead Cas9 fusion protein that establishes DNA methylation and repressive histone modifications.  Transient CRISPRoff expression initiates highly specific DNA methylation and gene repression that is maintained through cell division and differentiation of stem cells to neurons.  Pairing CRISPRoff with genome-wide screens and anal. of chromatin marks establishes rules for heritable gene silencing.  We identify single guide RNAs (sgRNAs) capable of silencing the large majority of genes including those lacking canonical CpG islands (CGIs) and reveal a wide targeting window extending beyond annotated CGIs.  The broad ability of CRISPRoff to initiate heritable gene silencing even outside of CGIs expands the canonical model of methylation-based silencing and enables diverse applications including genome-wide screens, multiplexed cell engineering, enhancer silencing, and mechanistic exploration of epigenetic inheritance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ajVY0_DHaLVg90H21EOLACvtfcHk0ljLnY41A5vsug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXovV2itLY%253D&md5=cb2b0767e563c575c6f58de8f4f15be3</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2021.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2021.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DNu%25C3%25B1ez%26aufirst%3DJ.%2BK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DPommier%26aufirst%3DG.%2BC.%26aulast%3DCogan%26aufirst%3DJ.%2BZ.%26aulast%3DReplogle%26aufirst%3DJ.%2BM.%26aulast%3DAdriaens%26aufirst%3DC.%26aulast%3DRamadoss%26aufirst%3DG.%2BN.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DHung%26aufirst%3DK.%2BL.%26aulast%3DSamelson%26aufirst%3DA.%2BJ.%26aulast%3DPogson%26aufirst%3DA.%2BN.%26aulast%3DKim%26aufirst%3DJ.%2BY.%2BS.%26aulast%3DChung%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DM.%2BD.%26aulast%3DChang%26aufirst%3DH.%2BY.%26aulast%3DKampmann%26aufirst%3DM.%26aulast%3DBernstein%26aufirst%3DB.%2BE.%26aulast%3DHovestadt%26aufirst%3DV.%26aulast%3DGilbert%26aufirst%3DL.%2BA.%26aulast%3DWeissman%26aufirst%3DJ.%2BS.%26atitle%3DGenome-Wide%2520Programmable%2520Transcriptional%2520Memory%2520by%2520CRISPR-Based%2520Epigenome%2520Editing%26jtitle%3DCell%26date%3D2021%26volume%3D184%26spage%3D2503%26doi%3D10.1016%2Fj.cell.2021.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/medium/jm1c00294_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/large/jm1c00294_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00294&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/medium/jm1c00294_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/large/jm1c00294_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Milestone achievements in small molecules synthesis and drug development,<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref6 ref7 ref8 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref6 ref7 ref8 ref10 ref11 ref12 ref13">(1−4,6−8,10−13)</a> and likewise transformative events in molecular biology and biotechnological therapeutics.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18 ref19 ref20">(14−20)</a> Graphical illustration of human insulin was generated using data of Timofeev et al. (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7Y">3E7Y</a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/large/jm1c00294_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00294&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/medium/jm1c00294_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/large/jm1c00294_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical post-translational modification strategies targeting native protein residues: advantages, disadvantages, and examples of validated substrates illustrating the scope of use. Left: commonly used methods from the realm of “classical”, closed-shell chemistry.<a onclick="showRef(event, 'ref36 ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref36 ref61 ref62 ref63">(36,61−63)</a> Right: examples of emerging strategies using novel, “open-shell” technology.<a onclick="showRef(event, 'ref54 ref55 ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref64 ref65 ref66">(54,55,64−66)</a> (The protein depicted in the center is a gelsolin nanobody, (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4S11">4S11</a>) and is used for graphical purposes only.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> We do not suggest that the displayed reactions will be successful on this substrate.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00294/20210602/images/large/jm1c00294_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00294&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i5">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 125 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wöhler, F.</span></span> <span> </span><span class="NLM_article-title">Ueber Künstliche Bildung des Harnstoffs</span>. <i>Ann. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1828</span>,  <span class="NLM_volume"><i>88</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1002/andp.18280880206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fandp.18280880206" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1828&pages=253-256&issue=2&author=F.+W%C3%B6hler&title=Ueber+K%C3%BCnstliche+Bildung+des+Harnstoffs&doi=10.1002%2Fandp.18280880206"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fandp.18280880206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fandp.18280880206%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25B6hler%26aufirst%3DF.%26atitle%3DUeber%2520K%25C3%25BCnstliche%2520Bildung%2520des%2520Harnstoffs%26jtitle%3DAnn.%2520Phys.%26date%3D1828%26volume%3D88%26issue%3D2%26spage%3D253%26epage%3D256%26doi%3D10.1002%2Fandp.18280880206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolbe, H.</span></span> <span> </span><span class="NLM_article-title">Beiträge zur Kenntniss der Gepaarten Verbindungen</span>. <i>Ann. der Chemie und Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1845</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1002/jlac.18450540202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fjlac.18450540202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1845&pages=145-188&issue=2&author=H.+Kolbe&title=Beitr%C3%A4ge+zur+Kenntniss+der+Gepaarten+Verbindungen&doi=10.1002%2Fjlac.18450540202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fjlac.18450540202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.18450540202%26sid%3Dliteratum%253Aachs%26aulast%3DKolbe%26aufirst%3DH.%26atitle%3DBeitr%25C3%25A4ge%2520zur%2520Kenntniss%2520der%2520Gepaarten%2520Verbindungen%26jtitle%3DAnn.%2520der%2520Chemie%2520und%2520Pharm.%26date%3D1845%26volume%3D54%26issue%3D2%26spage%3D145%26epage%3D188%26doi%3D10.1002%2Fjlac.18450540202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aftalion, F.</span></span> <i>History of the International Chemical Industry</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Chemical Heritage Foundation</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=F.+Aftalion&title=History+of+the+International+Chemical+Industry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAftalion%26aufirst%3DF.%26btitle%3DHistory%2520of%2520the%2520International%2520Chemical%2520Industry%26pub%3DChemical%2520Heritage%2520Foundation%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jack, D. B.</span></span> <span> </span><span class="NLM_article-title">One Hundred Years of Aspirin</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>350</i></span> (<span class="NLM_issue">9075</span>),  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(97)07087-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS0140-6736%2897%2907087-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=9259670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A280%3ADyaK2svgs1ajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1997&pages=437-439&issue=9075&author=D.+B.+Jack&title=One+Hundred+Years+of+Aspirin&doi=10.1016%2FS0140-6736%2897%2907087-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">One hundred years of aspirin</span></div><div class="casAuthors">Jack D B</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">9075</span>),
    <span class="NLM_cas:pages">437-9</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTk-z6HyUUaGNbHMBt0mMIXfW6udTcc2ebttCngtdy4P7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2svgs1ajtQ%253D%253D&md5=97a39f30327b2b083f15310dd7c0c266</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2897%2907087-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252897%252907087-6%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DD.%2BB.%26atitle%3DOne%2520Hundred%2520Years%2520of%2520Aspirin%26jtitle%3DLancet%26date%3D1997%26volume%3D350%26issue%3D9075%26spage%3D437%26epage%3D439%26doi%3D10.1016%2FS0140-6736%2897%2907087-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolbe, H.</span></span> <span> </span><span class="NLM_article-title">Ueber Synthese der Salicylsäure</span>. <i>Ann. der Chemie und Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1860</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1002/jlac.18601130120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fjlac.18601130120" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1860&pages=125-127&issue=1&author=H.+Kolbe&title=Ueber+Synthese+der+Salicyls%C3%A4ure&doi=10.1002%2Fjlac.18601130120"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fjlac.18601130120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.18601130120%26sid%3Dliteratum%253Aachs%26aulast%3DKolbe%26aufirst%3DH.%26atitle%3DUeber%2520Synthese%2520der%2520Salicyls%25C3%25A4ure%26jtitle%3DAnn.%2520der%2520Chemie%2520und%2520Pharm.%26date%3D1860%26volume%3D113%26issue%3D1%26spage%3D125%26epage%3D127%26doi%3D10.1002%2Fjlac.18601130120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, R. B.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in the Chemistry of Natural Products</span>. <i>Pure Appl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1351/pac196817030519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1351%2Fpac196817030519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=5729287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaE3cXktFCksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1968&pages=519-547&issue=3%E2%80%934&author=R.+B.+Woodward&title=Recent+Advances+in+the+Chemistry+of+Natural+Products&doi=10.1351%2Fpac196817030519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry of natural products</span></div><div class="casAuthors">Woodward, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Pure and Applied Chemistry</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">519-47</span>CODEN:
                <span class="NLM_cas:coden">PACHAS</span>;
        ISSN:<span class="NLM_cas:issn">0033-4545</span>.
    </div><div class="casAbstract">A review of the current state of research in the synthesis of vitamin B12 with 1 ref.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUA2YUJjo-1LVg90H21EOLACvtfcHk0lifalsHfNnuhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXktFCksb4%253D&md5=d657880d680dc964900bbeff91343cdf</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1351%2Fpac196817030519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac196817030519%26sid%3Dliteratum%253Aachs%26aulast%3DWoodward%26aufirst%3DR.%2BB.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Chemistry%2520of%2520Natural%2520Products%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D1968%26volume%3D17%26issue%3D3%25E2%2580%25934%26spage%3D519%26epage%3D547%26doi%3D10.1351%2Fpac196817030519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eschenmoser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wintner, C.</span></span> <span> </span><span class="NLM_article-title">Natural Product Synthesis and Vitamin B12</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>196</i></span> (<span class="NLM_issue">4297</span>),  <span class="NLM_fpage">1410</span>– <span class="NLM_lpage">1420</span>, <span class="refDoi"> DOI: 10.1126/science.867037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1126%2Fscience.867037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=867037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaE2sXlvVCgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=1977&pages=1410-1420&issue=4297&author=A.+Eschenmoserauthor=C.+Wintner&title=Natural+Product+Synthesis+and+Vitamin+B12&doi=10.1126%2Fscience.867037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product synthesis and vitamin B12</span></div><div class="casAuthors">Eschenmoser, Albert; Wintner, Claude E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">4297</span>),
    <span class="NLM_cas:pages">1410-20</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 54 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpVOu70RpD2rVg90H21EOLACvtfcHk0liJSIdm9km1ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXlvVCgurk%253D&md5=687c932371867890753555ca177ef64a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.867037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.867037%26sid%3Dliteratum%253Aachs%26aulast%3DEschenmoser%26aufirst%3DA.%26aulast%3DWintner%26aufirst%3DC.%26atitle%3DNatural%2520Product%2520Synthesis%2520and%2520Vitamin%2520B12%26jtitle%3DScience%26date%3D1977%26volume%3D196%26issue%3D4297%26spage%3D1410%26epage%3D1420%26doi%3D10.1126%2Fscience.867037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marko, I. E.</span></span> <span> </span><span class="NLM_article-title">Natural Product Synthesis: The Art of Total Synthesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">5548</span>),  <span class="NLM_fpage">1842</span>– <span class="NLM_lpage">1843</span>, <span class="refDoi"> DOI: 10.1126/science.1067545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1126%2Fscience.1067545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=11729290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFSqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=1842-1843&issue=5548&author=I.+E.+Marko&title=Natural+Product+Synthesis%3A+The+Art+of+Total+Synthesis&doi=10.1126%2Fscience.1067545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product synthesis: the art of total synthesis</span></div><div class="casAuthors">Marko, Istvan E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">5548</span>),
    <span class="NLM_cas:pages">1842-1843</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review on the prepn. of complex natural products.  Emphasis is on Hirama's prepn. of ciguatoxin CTX3C in 77% yield via the selective acetalization of the two halves followed by a challenging metathesis reaction to install the final C-C bond and complete the whole skeleton of ciguatoxin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGRGB7W8uLf7Vg90H21EOLACvtfcHk0liJSIdm9km1ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFSqt7w%253D&md5=671388b5b9b2f516eabe010776c7f8bf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1067545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1067545%26sid%3Dliteratum%253Aachs%26aulast%3DMarko%26aufirst%3DI.%2BE.%26atitle%3DNatural%2520Product%2520Synthesis%253A%2520The%2520Art%2520of%2520Total%2520Synthesis%26jtitle%3DScience%26date%3D2001%26volume%3D294%26issue%3D5548%26spage%3D1842%26epage%3D1843%26doi%3D10.1126%2Fscience.1067545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, W. R.</span></span> <span> </span><span class="NLM_article-title">In Praise of Remarkably Powerful Centamolecular Therapeutic Agents</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1094</span>– <span class="NLM_lpage">1097</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlylsL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1094-1097&issue=8&author=N.+A.+Meanwellauthor=W.+R.+Ewing&title=In+Praise+of+Remarkably+Powerful+Centamolecular+Therapeutic+Agents&doi=10.1021%2Facsmedchemlett.9b00286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">In Praise of Remarkably Powerful Centamolecular Therapeutic Agents</span></div><div class="casAuthors">Meanwell, Nicholas A.; Ewing, William R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1094-1097</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  While biol. medications have addressed many challenging therapeutic targets, the pharmacopeia is still dominated by centamols.  In this viewpoint, we illustrate the impact of centamol. drugs on mortality and morbidity due to chronic viral infections and present select examples from other disease areas that highlight some of their remarkably powerful biochem. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofRNASt4Snv7Vg90H21EOLACvtfcHk0liJSIdm9km1ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlylsL3F&md5=16a78cfdc956392783a087a86bec8888</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00286%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26atitle%3DIn%2520Praise%2520of%2520Remarkably%2520Powerful%2520Centamolecular%2520Therapeutic%2520Agents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26issue%3D8%26spage%3D1094%26epage%3D1097%26doi%3D10.1021%2Facsmedchemlett.9b00286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicolaou, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nantermet, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claiborne, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couladouros, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulvannan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, E. J.</span></span> <span> </span><span class="NLM_article-title">Total Synthesis of Taxol</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>367</i></span> (<span class="NLM_issue">6464</span>),  <span class="NLM_fpage">630</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1038/367630a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2F367630a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=7906395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaK2cXksFOksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=1994&pages=630-634&issue=6464&author=K.+C.+Nicolaouauthor=Z.+Yangauthor=J.+J.+Liuauthor=H.+Uenoauthor=P.+G.+Nantermetauthor=R.+K.+Guyauthor=C.+F.+Claiborneauthor=J.+Renaudauthor=E.+A.+Couladourosauthor=K.+Paulvannanauthor=E.+J.+Sorensen&title=Total+Synthesis+of+Taxol&doi=10.1038%2F367630a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Total synthesis of taxol</span></div><div class="casAuthors">Nicolaou, K. C.; Yang, Z.; Liu, J. J.; Ueno, H.; Nantermet, P. G.; Guy, R. K.; Claiborne, C. F.; Renaud, J.; Couladouros, E. A.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">6464</span>),
    <span class="NLM_cas:pages">630-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The total synthesis of taxol (I) from the benzofuranone II by a convergent strategy, which opens a chem. pathway for the prodn. of both I and a variety of designed taxoids is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpntORbDeDdrbVg90H21EOLACvtfcHk0ljSJrNz8iLA6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFOksLc%253D&md5=d5ac12f78c2b2d62f145f25258961a2f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F367630a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F367630a0%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26aulast%3DClaiborne%26aufirst%3DC.%2BF.%26aulast%3DRenaud%26aufirst%3DJ.%26aulast%3DCouladouros%26aufirst%3DE.%2BA.%26aulast%3DPaulvannan%26aufirst%3DK.%26aulast%3DSorensen%26aufirst%3DE.%2BJ.%26atitle%3DTotal%2520Synthesis%2520of%2520Taxol%26jtitle%3DNature%26date%3D1994%26volume%3D367%26issue%3D6464%26spage%3D630%26epage%3D634%26doi%3D10.1038%2F367630a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marks, L.</span></span> <i>Sexual Chemistry: A History of the Contraceptive Pill</i>; <span class="NLM_publisher-name">Yale University Press</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=L.+Marks&title=Sexual+Chemistry%3A+A+History+of+the+Contraceptive+Pill"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DL.%26btitle%3DSexual%2520Chemistry%253A%2520A%2520History%2520of%2520the%2520Contraceptive%2520Pill%26pub%3DYale%2520University%2520Press%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denis, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueritte-Voegelein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangatal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, P.</span></span> <span> </span><span class="NLM_article-title">Highly Efficient, Practical Approach to Natural Taxol</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">5917</span>– <span class="NLM_lpage">5919</span>, <span class="refDoi"> DOI: 10.1021/ja00225a063</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00225a063" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaL1cXkvFegtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=5917-5919&issue=17&author=J.+N.+Denisauthor=A.+E.+Greeneauthor=D.+Guenardauthor=F.+Gueritte-Voegeleinauthor=L.+Mangatalauthor=P.+Potier&title=Highly+Efficient%2C+Practical+Approach+to+Natural+Taxol&doi=10.1021%2Fja00225a063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Highly efficient, practical approach to natural taxol</span></div><div class="casAuthors">Denis, Jean Noel; Greene, Andrew E.; Guenard, Daniel; Gueritte-Voegelein, Francoise; Mangatal, Lydie; Potier, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5917-19</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Taxol (I), a promising but difficultly accessible cancer chemotherapeutic agent isolated from yew bark, was efficiently synthesized in 4 steps from readily available congener II.  The synthesis should alleviate the current shortage and provide a reliable future source of this natural product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLI98SsnXembVg90H21EOLACvtfcHk0ljSJrNz8iLA6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXkvFegtL0%253D&md5=df78d2b2fddae985c666f836e19208e4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fja00225a063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00225a063%26sid%3Dliteratum%253Aachs%26aulast%3DDenis%26aufirst%3DJ.%2BN.%26aulast%3DGreene%26aufirst%3DA.%2BE.%26aulast%3DGuenard%26aufirst%3DD.%26aulast%3DGueritte-Voegelein%26aufirst%3DF.%26aulast%3DMangatal%26aufirst%3DL.%26aulast%3DPotier%26aufirst%3DP.%26atitle%3DHighly%2520Efficient%252C%2520Practical%2520Approach%2520to%2520Natural%2520Taxol%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26issue%3D17%26spage%3D5917%26epage%3D5919%26doi%3D10.1021%2Fja00225a063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holton, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biediger, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boatman, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span> <span> </span><span class="NLM_article-title">First Total Synthesis of Taxol. 1. Functionalization of the B Ring</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1597</span>– <span class="NLM_lpage">1598</span>, <span class="refDoi"> DOI: 10.1021/ja00083a066</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00083a066" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaK2cXhtlCrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=1597-1598&issue=4&author=R.+A.+Holtonauthor=C.+Somozaauthor=H.+B.+Kimauthor=F.+Liangauthor=R.+J.+Biedigerauthor=P.+D.+Boatmanauthor=M.+Shindoauthor=C.+C.+Smithauthor=S.+Kim&title=First+Total+Synthesis+of+Taxol.+1.+Functionalization+of+the+B+Ring&doi=10.1021%2Fja00083a066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">First total synthesis of taxol. 1. Functionalization of the B ring</span></div><div class="casAuthors">Holton, Robert A.; Somoza, Carmen; Kim, Hyeong Baik; Liang, Feng; Biediger, Ronald J.; Boatman, P. Douglas; Shindo, Mitsuru; Smith, Chase C.; Kim, Soekchan; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1597-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Beginning stages of a total synthesis of the anti-tumor agent taxol were described.  These stages result in the prepn. of an intermediate having three rings in which 6 stereocenters of the natural product are set.  The key feature of this part of the total synthesis is control of conformation and reactivity in the bicyclo[5.3.1]undecane ring system.  Thus, the diol I, a taxusin intermediate readily available from camphor, was transformed to the lactone carbonate II in 12 steps and 40% overall yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0YnV7x4JcZrVg90H21EOLACvtfcHk0lhdSjhXL1tOiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtlCrtLs%253D&md5=ff0f016854e9d02e755c7f053fe668ab</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fja00083a066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00083a066%26sid%3Dliteratum%253Aachs%26aulast%3DHolton%26aufirst%3DR.%2BA.%26aulast%3DSomoza%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DH.%2BB.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DBiediger%26aufirst%3DR.%2BJ.%26aulast%3DBoatman%26aufirst%3DP.%2BD.%26aulast%3DShindo%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DC.%2BC.%26aulast%3DKim%26aufirst%3DS.%26atitle%3DFirst%2520Total%2520Synthesis%2520of%2520Taxol.%25201.%2520Functionalization%2520of%2520the%2520B%2520Ring%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1994%26volume%3D116%26issue%3D4%26spage%3D1597%26epage%3D1598%26doi%3D10.1021%2Fja00083a066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, P.</span></span> <span> </span><span class="NLM_article-title">Biochemical Method for Inserting New Genetic Information into DNA of Simian Virus 40: Circular SV40 DNA Molecules Containing Lambda Phage Genes and the Galactose Operon of Escherichia Coli</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2904</span>– <span class="NLM_lpage">2909</span>, <span class="refDoi"> DOI: 10.1073/pnas.69.10.2904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1073%2Fpnas.69.10.2904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=4342968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaE3sXhslCh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1972&pages=2904-2909&issue=10&author=D.+A.+Jacksonauthor=R.+H.+Symonsauthor=P.+Berg&title=Biochemical+Method+for+Inserting+New+Genetic+Information+into+DNA+of+Simian+Virus+40%3A+Circular+SV40+DNA+Molecules+Containing+Lambda+Phage+Genes+and+the+Galactose+Operon+of+Escherichia+Coli&doi=10.1073%2Fpnas.69.10.2904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical method for inserting new genetic information into DNA of Simian Virus 40.  Circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli</span></div><div class="casAuthors">Jackson, David A.; Symons, Robert H.; Berg, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2904-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Methods for covalently joining duplex DNA mols. to one another have been developed and used to construct circular dimers of SV40 DNA and to insert a DNA segment contg. λ-phage genes and the galactose operon of E. coli into SV40 DNA.  The method involves:  (a) converting circular SV40 DNA to a linear form, (b) adding single-stranded homodeoxypolymeric extensions of defined compn. and length to the 3' ends of 1 of the DNA strands with the enzyme terminal deoxynucleotidyl transferase, (c) adding complementary homodeoxypolymeric extensions to the other DNA strand, (d) annealing the 2 DNA mols. to form a circular duplex structure, and (e) filling the gaps and sealing nicks in this structure with E. coli DNA polymerase and DNA ligase to form a covalently closed-circular DNA mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoslA6E7DpaFLVg90H21EOLACvtfcHk0lhdSjhXL1tOiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhslCh&md5=4afd92e56449c5d8cced628f9e174429</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.69.10.2904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.69.10.2904%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DD.%2BA.%26aulast%3DSymons%26aufirst%3DR.%2BH.%26aulast%3DBerg%26aufirst%3DP.%26atitle%3DBiochemical%2520Method%2520for%2520Inserting%2520New%2520Genetic%2520Information%2520into%2520DNA%2520of%2520Simian%2520Virus%252040%253A%2520Circular%2520SV40%2520DNA%2520Molecules%2520Containing%2520Lambda%2520Phage%2520Genes%2520and%2520the%2520Galactose%2520Operon%2520of%2520Escherichia%2520Coli%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1972%26volume%3D69%26issue%3D10%26spage%3D2904%26epage%3D2909%26doi%3D10.1073%2Fpnas.69.10.2904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nadler, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stashenko, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Button, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufe, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antman, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlossman, S. F.</span></span> <span> </span><span class="NLM_article-title">Serotherapy of a Patient with a Monoclonal Antibody Directed against a Human Lymphoma-Associated Antigen</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3147</span>– <span class="NLM_lpage">3154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=7427932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A280%3ADyaL3M%252Fkt1SlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1980&pages=3147-3154&issue=9&author=L.+M.+Nadlerauthor=P.+Stashenkoauthor=R.+Hardyauthor=W.+D.+Kaplanauthor=L.+N.+Buttonauthor=D.+W.+Kufeauthor=K.+H.+Antmanauthor=S.+F.+Schlossman&title=Serotherapy+of+a+Patient+with+a+Monoclonal+Antibody+Directed+against+a+Human+Lymphoma-Associated+Antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen</span></div><div class="casAuthors">Nadler L M; Stashenko P; Hardy R; Kaplan W D; Button L N; Kufe D W; Antman K H; Schlossman S F</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3147-54</span>
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">A preliminary serotherapeutic trial was undertaken with a monoclonal antibody designated antibody 89 (Ab 89) directed against a lymphoma-associated antigen.  In vitro studies demonstrated that Ab 89 could mediate complement-dependent lysis and macrophage adherence but not antibody-dependent cell-mediated cytotoxicity.  To evaluate toxicity and therapeutic efficacy, two courses of Ab 89 were administered to a patient with an Ab 89-reactive tumor.  Transient decreases in the number of circulating tumor cells and the appearance of circulating dead cells were noted with the infusion of Ab 89.  Following administration of 150 mg or more of Ab 89, small amounts of antibody could be demonstrated on circulating tumor cells at a time when no free antibody was found in the serum.  The inability to deliver a significant amount of Ab 89 to tumor cells in vivo is thought to be secondary to a circulating tumor antigen.  Following each infusion, the amount of this blocking antigen decreased but could not be entirely cleared from the serum.  This study provides preliminary evidence for the lack of clinical toxicity of a monoclonal antibody and identifies circulating blocking antigens as a significant obstacle to serotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPNHhFXNucGe98rul4nhSdfW6udTcc2eZTkaHuHqzcPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3M%252Fkt1SlsA%253D%253D&md5=3490ac2a7f42fb531ecfc19bcb5fa649</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNadler%26aufirst%3DL.%2BM.%26aulast%3DStashenko%26aufirst%3DP.%26aulast%3DHardy%26aufirst%3DR.%26aulast%3DKaplan%26aufirst%3DW.%2BD.%26aulast%3DButton%26aufirst%3DL.%2BN.%26aulast%3DKufe%26aufirst%3DD.%2BW.%26aulast%3DAntman%26aufirst%3DK.%2BH.%26aulast%3DSchlossman%26aufirst%3DS.%2BF.%26atitle%3DSerotherapy%2520of%2520a%2520Patient%2520with%2520a%2520Monoclonal%2520Antibody%2520Directed%2520against%2520a%2520Human%2520Lymphoma-Associated%2520Antigen%26jtitle%3DCancer%2520Res.%26date%3D1980%26volume%3D40%26issue%3D9%26spage%3D3147%26epage%3D3154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span> </span><span class="NLM_article-title">Human Insulin Receives FDA Approval</span>.  <i>FDA
Drug Bull.</i>, <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume">12</span> (<span class="NLM_issue">3</span>)  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">19</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=6762312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A280%3ADyaL3s7lvVGqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Human+Insulin+Receives+FDA+Approval.+FDA%0ADrug+Bull.%2C+1982%2C+12+%283%29+18%E2%80%9319."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Human insulin receives FDA approval</span></div><div class="casAuthors">Anonymous</div><div class="citationInfo"><span class="NLM_cas:title">FDA drug bulletin</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">18-9</span>
        ISSN:<span class="NLM_cas:issn">0361-4344</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9uBV65_Tx8Djk2McQZ6XmfW6udTcc2eZTkaHuHqzcPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s7lvVGqsg%253D%253D&md5=217b5e4f1f31b5988da77d3a5734fb5d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DHuman%2520Insulin%2520Receives%2520FDA%2520Approval%26jtitle%3DFDA%250ADrug%2520Bull.%26date%3D1982%26volume%3D12%26issue%3D3%26spage%3D18%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span> </span><span class="NLM_article-title">Rapid-Acting Insulin Approved for Marketing</span>.  <i>Am. J. Health-Syst. Pharm.</i>, <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume">53</span> (<span class="NLM_issue">19</span>)  <span class="NLM_fpage">2250</span>. <span class="refDoi"> DOI: 10.1093/ajhp/53.19.2250</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1093%2Fajhp%2F53.19.2250a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Rapid-Acting+Insulin+Approved+for+Marketing.+Am.+J.+Health-Syst.+Pharm.%2C+1996%2C+53+%2819%29+2250.+10.1093%2Fajhp%2F53.19.2250."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fajhp%2F53.19.2250a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajhp%252F53.19.2250a%26sid%3Dliteratum%253Aachs%26atitle%3DRapid-Acting%2520Insulin%2520Approved%2520for%2520Marketing%26jtitle%3DAm.%2520J.%2520Health-Syst.%2520Pharm.%26date%3D1996%26volume%3D53%26issue%3D19%26spage%3D2250%26doi%3D10.1093%2Fajhp%2F53.19.2250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bross, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beitz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridhara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdur, R.</span></span> <span> </span><span class="NLM_article-title">Approval Summary: Gemtuzumab Ozogamicin in Relapsed Acute Myeloid Leukemia</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1490</span>– <span class="NLM_lpage">1496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=11410481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltV2iu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=1490-1496&issue=6&author=P.+F.+Brossauthor=J.+Beitzauthor=G.+Chenauthor=X.+H.+Chenauthor=E.+Duffyauthor=L.+Kiefferauthor=S.+Royauthor=R.+Sridharaauthor=A.+Rahmanauthor=G.+Williamsauthor=R.+Pazdur&title=Approval+Summary%3A+Gemtuzumab+Ozogamicin+in+Relapsed+Acute+Myeloid+Leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Approval summary: Gemtuzumab ozogamicin in relapsed acute myeloid leukemia</span></div><div class="casAuthors">Bross, Peter F.; Beitz, Julie; Chen, Gang; Chen, Xiao Hong; Duffy, Eric; Kieffer, Lydia; Roy, Sandip; Sridhara, Rajeshwari; Rahman, Atiqur; Williams, Grant; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1490-1496</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review with refs.  Gemtuzumab ozogamicin (Mylotarg; Wyeth Labs., Philadelphia, PA) consists of a semisynthetic deriv. of calicheamicin, a cytotoxic antibiotic linked to a recombinant monoclonal antibody directed against the CD33 antigen present on leukemic myeloblasts in most patients with acute myeloid leukemia (AML).  In this study, we review the preclin. and clin. profiles of this immuno-conjugate and the regulatory review that led to marketing approval by the United States Food and Drug Administration.  From the literature and manufacturer's data, we review the activity, tolerability, and pharmacokinetics of gemtuzumab ozogamicin in preclin. and Phase I studies and its activity, efficacy, and side effects in three Phase 2 trials of 142 patients with relapsed AML.  In Phase I studies, the major toxicity was myelosuppression, esp. neutropenia and thrombocytopenia, resulting from the expression of CD33 on myeloid progenitor cells.  The Phase 2 dose was 9 mg/m2 infused i.v. over 4 h, repeated on day 14.  A minority of patients experienced acute infusion-related symptoms, usually transient and occasionally requiring hospitalization.  The complete response (CR) rate with full recovery of hematopoiesis was 16%.  A subset of patients [CRs with incomplete platelet recovery (CRps)] was identified with blast clearance and neutrophil recovery but incomplete platelet recovery.  The duration of responses of CRps appeared to be similar to those of the CRs, although the nos. were small.  The question of the equivalence of these response groups was a central issue in the review of this new drug application (NDA).  After considerable discussion, the Oncol. Drugs Advisory Committee recommended allowing inclusion of CRps resulting in an overall response rate in the Phase 2 studies of 30%.  In the subgroup of patients over 60 yr of age, the overall response rate was 26%.  Response duration was difficult to establish because of the high prevalence of postremission therapies.  Tolerability and ease of administration may be improved compared with conventional chemotherapy, except for hepatotoxicity, with 31% of patients exhibiting abnormal liver enzymes.  One patient died of liver failure in the Phase 2 trials.  Marketing approval of gemtuzumab ozogamicin was granted on May 17, 2000 by the United States Food and Drug Administration under the Accelerated Approval regulations.  Gemtuzumab ozogamicin is indicated for the treatment of patients with CD33 pos. AML in first relapse who are 60 yr of age or older and who are not considered candidates for cytotoxic chemotherapy.  The approved dose was 9 mg/m2 i.v. over 4 h and repeated in 14 days.  Completion of the ongoing studies of gemtuzumab ozogamicin in relapsed AML and initiation of randomized clin. trials comparing the effects of gemtuzumab ozogamicin in combination with conventional induction chemotherapy to conventional chemotherapy alone on survival are mandated to confirm clin. benefit under the accelerated approval Subpart H regulations.  Postmarketing reports of fatal anaphylaxis, adult respiratory distress syndrome (ARDS), and hepatotoxicity, esp. venoocclusive disease (VOD) in patients treated with gemtuzumab ozogamicin, with and without assocd. hematopoietic stem cell transplantation (HSCT), have required labeling revisions and the initiation of a registration surveillance program.  Tumor lysis and ARDS have been reported in patients with leukocytes above 30,000/mL treated with gemtuzumab ozogamicin; therefore, the redn. of leukocyte counts to below 30,000/mL is recommended prior to treatment.  Patients should be carefully monitored for acute hypersensitivity, hypoxia, and delayed hepatotoxicity following treatment with gemtuzumab ozogamicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxE3VNYYST67Vg90H21EOLACvtfcHk0ljWR6ibJ0RN1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltV2iu78%253D&md5=8a85e32e3113034e98f05dfbd119110b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBross%26aufirst%3DP.%2BF.%26aulast%3DBeitz%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DX.%2BH.%26aulast%3DDuffy%26aufirst%3DE.%26aulast%3DKieffer%26aufirst%3DL.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DSridhara%26aufirst%3DR.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DApproval%2520Summary%253A%2520Gemtuzumab%2520Ozogamicin%2520in%2520Relapsed%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26issue%3D6%26spage%3D1490%26epage%3D1496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">The
Lancet</span> <span> </span><span class="NLM_article-title">CAR T-Cells: An Exciting
Frontier in Cancer Therapy</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span> (<span class="NLM_issue">10099</span>),  <span class="NLM_fpage">1006</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(17)32395-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS0140-6736%2817%2932395-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=1006&issue=10099&author=The%0ALancet&title=CAR+T-Cells%3A+An+Exciting%0AFrontier+in+Cancer+Therapy&doi=10.1016%2FS0140-6736%2817%2932395-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2932395-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252932395-4%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DCAR%2520T-Cells%253A%2520An%2520Exciting%250AFrontier%2520in%2520Cancer%2520Therapy%26jtitle%3DLancet%26date%3D2017%26volume%3D390%26issue%3D10099%26spage%3D1006%26doi%3D10.1016%2FS0140-6736%2817%2932395-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gargano, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClung, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos-Outcalt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mbaeyi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dooling, K.</span></span> <span> </span><span class="NLM_article-title">The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020</span>. <i>MMWR. Morb. Mortal. Wkly. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">50</span>),  <span class="NLM_fpage">1922</span>– <span class="NLM_lpage">1924</span>, <span class="refDoi"> DOI: 10.15585/mmwr.mm6950e2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.15585%2Fmmwr.mm6950e2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=33332292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3MXltF2nuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2020&pages=1922-1924&issue=50&author=S.+E.+Oliverauthor=J.+W.+Garganoauthor=M.+Marinauthor=M.+Wallaceauthor=K.+G.+Curranauthor=M.+Chamberlandauthor=N.+McClungauthor=D.+Campos-Outcaltauthor=R.+L.+Morganauthor=S.+Mbaeyiauthor=J.+R.+Romeroauthor=H.+K.+Talbotauthor=G.+M.+Leeauthor=B.+P.+Bellauthor=K.+Dooling&title=The+Advisory+Committee+on+Immunization+Practices%E2%80%99+Interim+Recommendation+for+Use+of+Pfizer-BioNTech+COVID-19+Vaccine+-+United+States%2C+December+2020&doi=10.15585%2Fmmwr.mm6950e2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The advisory committee on immunization practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine - United States, December 2020</span></div><div class="casAuthors">Oliver, Sara E.; Gargano, Julia W.; Marin, Mona; Wallace, Megan; Curran, Kathryn G.; Chamberland, Mary; McClung, Nancy; Campos-Outcalt, Doug; Morgan, Rebecca L.; Mbaeyi, Sarah; Romero, Jose R.; Talbot, H. Keipp; Lee, Grace M.; Bell, Beth P.; Dooling, Kathleen</div><div class="citationInfo"><span class="NLM_cas:title">Morbidity and Mortality Weekly Report</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">1922-1924</span>CODEN:
                <span class="NLM_cas:coden">MMWRC7</span>;
        ISSN:<span class="NLM_cas:issn">1545-861X</span>.
    
            (<span class="NLM_cas:orgname">Centers for Disease Control and Prevention</span>)
        </div><div class="casAbstract">What is already known about this topic.  On Dec. 11, 2020, the Food and Drug Administration issued an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine.  What is added by this report.  On Dec. 12, 2020, after an explicit, evidence-based review of all available data, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years for the prevention of COVID-19.  What are the implications for public health practice.  The recommendation for the Pfizer-BioNTech COVID-19 vaccine should be implemented in conjunction with ACIP's interim recommendation for allocating initial supplies of COVID-19 vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj4Zl10Ay0TbVg90H21EOLACvtfcHk0ljWR6ibJ0RN1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXltF2nuw%253D%253D&md5=c155ec652cf8d1bfa3a3faaef9e35cdd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.15585%2Fmmwr.mm6950e2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15585%252Fmmwr.mm6950e2%26sid%3Dliteratum%253Aachs%26aulast%3DOliver%26aufirst%3DS.%2BE.%26aulast%3DGargano%26aufirst%3DJ.%2BW.%26aulast%3DMarin%26aufirst%3DM.%26aulast%3DWallace%26aufirst%3DM.%26aulast%3DCurran%26aufirst%3DK.%2BG.%26aulast%3DChamberland%26aufirst%3DM.%26aulast%3DMcClung%26aufirst%3DN.%26aulast%3DCampos-Outcalt%26aufirst%3DD.%26aulast%3DMorgan%26aufirst%3DR.%2BL.%26aulast%3DMbaeyi%26aufirst%3DS.%26aulast%3DRomero%26aufirst%3DJ.%2BR.%26aulast%3DTalbot%26aufirst%3DH.%2BK.%26aulast%3DLee%26aufirst%3DG.%2BM.%26aulast%3DBell%26aufirst%3DB.%2BP.%26aulast%3DDooling%26aufirst%3DK.%26atitle%3DThe%2520Advisory%2520Committee%2520on%2520Immunization%2520Practices%25E2%2580%2599%2520Interim%2520Recommendation%2520for%2520Use%2520of%2520Pfizer-BioNTech%2520COVID-19%2520Vaccine%2520-%2520United%2520States%252C%2520December%25202020%26jtitle%3DMMWR.%2520Morb.%2520Mortal.%2520Wkly.%2520Rep.%26date%3D2020%26volume%3D69%26issue%3D50%26spage%3D1922%26epage%3D1924%26doi%3D10.15585%2Fmmwr.mm6950e2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Timofeev, V. I.</span>; <span class="NLM_string-name">Baidus, A. N.</span>; <span class="NLM_string-name">Kislitsyn, Y. A.</span>; <span class="NLM_string-name">Kuranova, I. P.</span></span> <span> </span><span class="NLM_article-title">Structure of Human Insulin (PDB ID: 3E7Y); RSC PDB,</span> <span class="NLM_year" style="font-weight: bold;">2008</span>. <span class="refDoi"> DOI: 10.2210/pdb3E7Y/pdb</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.2210%2Fpdb3E7Y%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=V.+I.+Timofeev&author=A.+N.+Baidus&author=Y.+A.+Kislitsyn&author=I.+P.+Kuranova&title=Structure+of+Human+Insulin+%28PDB+ID%3A+3E7Y%29%3B+RSC+PDB%2C&doi=10.2210%2Fpdb3E7Y%2Fpdb"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2210%2Fpdb3E7Y%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2210%252Fpdb3E7Y%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DTimofeev%26aufirst%3DV.%2BI.%26atitle%3DStructure%2520of%2520Human%2520Insulin%2520%2528PDB%2520ID%253A%25203E7Y%2529%253B%2520RSC%2520PDB%252C%26date%3D2008%26doi%3D10.2210%2Fpdb3E7Y%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lartigue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noskov, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, R.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algire, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benders, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montague, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moodie, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merryman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vashee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnakumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assad-Garcia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews-Pfannkoch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denisova, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Z.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segall-Shapiro, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvey, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchison, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venter, J. C.</span></span> <span> </span><span class="NLM_article-title">Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>329</i></span> (<span class="NLM_issue">5987</span>),  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1126/science.1190719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1126%2Fscience.1190719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=20488990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVeqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2010&pages=52-56&issue=5987&author=D.+G.+Gibsonauthor=J.+I.+Glassauthor=C.+Lartigueauthor=V.+N.+Noskovauthor=R.-Y.+Chuangauthor=M.+A.+Algireauthor=G.+A.+Bendersauthor=M.+G.+Montagueauthor=L.+Maauthor=M.+M.+Moodieauthor=C.+Merrymanauthor=S.+Vasheeauthor=R.+Krishnakumarauthor=N.+Assad-Garciaauthor=C.+Andrews-Pfannkochauthor=E.+A.+Denisovaauthor=L.+Youngauthor=Z.-Q.+Qiauthor=T.+H.+Segall-Shapiroauthor=C.+H.+Calveyauthor=P.+P.+Parmarauthor=C.+A.+Hutchisonauthor=H.+O.+Smithauthor=J.+C.+Venter&title=Creation+of+a+Bacterial+Cell+Controlled+by+a+Chemically+Synthesized+Genome&doi=10.1126%2Fscience.1190719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Creation of a bacterial cell controlled by a chemically synthesized genome</span></div><div class="casAuthors">Gibson, Daniel G.; Glass, John I.; Lartigue, Carole; Noskov, Vladimir N.; Chuang, Ray-Yuan; Algire, Mikkel A.; Benders, Gwynedd A.; Montague, Michael G.; Ma, Li; Moodie, Monzia M.; Merryman, Chuck; Vashee, Sanjay; Krishnakumar, Radha; Assad-Garcia, Nacyra; Andrews-Pfannkoch, Cynthia; Denisova, Evgeniya A.; Young, Lei; Qi, Zhi-Qing; Segall-Shapiro, Thomas H.; Calvey, Christopher H.; Parmar, Prashanth P.; Hutchison, Clyde A., III; Smith, Hamilton O.; Venter, J. Craig</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">5987</span>),
    <span class="NLM_cas:pages">52-56</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We report the design, synthesis, and assembly of the 1.08-mega-base pair Mycoplasma mycoides JCVI-syn1.0 genome starting from digitized genome sequence information and its transplantation into a M. capricolum recipient cell to create new M. mycoides cells that are controlled only by the synthetic chromosome.  The only DNA in the cells is the designed synthetic DNA sequence, including "watermark" sequences and other designed gene deletions and polymorphisms, and mutations acquired during the building process.  The new cells have expected phenotypic properties and are capable of continuous self-replication.  The complete, annotated synthetic genome sequence is deposited in GenBank/EMBL/DDBJ with accession no. CP002027.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPBfMgKBs4-7Vg90H21EOLACvtfcHk0lgIh-Mx5DESdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVeqsLg%253D&md5=f978c98f3e5c3c9b14bd4c7d8a1eecc7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscience.1190719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1190719%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DD.%2BG.%26aulast%3DGlass%26aufirst%3DJ.%2BI.%26aulast%3DLartigue%26aufirst%3DC.%26aulast%3DNoskov%26aufirst%3DV.%2BN.%26aulast%3DChuang%26aufirst%3DR.-Y.%26aulast%3DAlgire%26aufirst%3DM.%2BA.%26aulast%3DBenders%26aufirst%3DG.%2BA.%26aulast%3DMontague%26aufirst%3DM.%2BG.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DMoodie%26aufirst%3DM.%2BM.%26aulast%3DMerryman%26aufirst%3DC.%26aulast%3DVashee%26aufirst%3DS.%26aulast%3DKrishnakumar%26aufirst%3DR.%26aulast%3DAssad-Garcia%26aufirst%3DN.%26aulast%3DAndrews-Pfannkoch%26aufirst%3DC.%26aulast%3DDenisova%26aufirst%3DE.%2BA.%26aulast%3DYoung%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DZ.-Q.%26aulast%3DSegall-Shapiro%26aufirst%3DT.%2BH.%26aulast%3DCalvey%26aufirst%3DC.%2BH.%26aulast%3DParmar%26aufirst%3DP.%2BP.%26aulast%3DHutchison%26aufirst%3DC.%2BA.%26aulast%3DSmith%26aufirst%3DH.%2BO.%26aulast%3DVenter%26aufirst%3DJ.%2BC.%26atitle%3DCreation%2520of%2520a%2520Bacterial%2520Cell%2520Controlled%2520by%2520a%2520Chemically%2520Synthesized%2520Genome%26jtitle%3DScience%26date%3D2010%26volume%3D329%26issue%3D5987%26spage%3D52%26epage%3D56%26doi%3D10.1126%2Fscience.1190719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malyshev, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavergne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrêa, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romesberg, F. E.</span></span> <span> </span><span class="NLM_article-title">A Semi-Synthetic Organism with an Expanded Genetic Alphabet</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>509</i></span> (<span class="NLM_issue">7500</span>),  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1038/nature13314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnature13314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=24805238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVyqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=509&publication_year=2014&pages=385-388&issue=7500&author=D.+A.+Malyshevauthor=K.+Dhamiauthor=T.+Lavergneauthor=T.+Chenauthor=N.+Daiauthor=J.+M.+Fosterauthor=I.+R.+Corr%C3%AAaauthor=F.+E.+Romesberg&title=A+Semi-Synthetic+Organism+with+an+Expanded+Genetic+Alphabet&doi=10.1038%2Fnature13314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A semi-synthetic organism with an expanded genetic alphabet</span></div><div class="casAuthors">Malyshev, Denis A.; Dhami, Kirandeep; Lavergne, Thomas; Chen, Tingjian; Dai, Nan; Foster, Jeremy M.; Correa, Ivan R.; Romesberg, Floyd E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">509</span>
        (<span class="NLM_cas:issue">7500</span>),
    <span class="NLM_cas:pages">385-388</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Organisms are defined by the information encoded in their genomes, and since the origin of life this information has been encoded using a two-base-pair genetic alphabet (A-T and G-C).  In vitro, the alphabet has been expanded to include several unnatural base pairs (UBPs).  We have developed a class of UBPs formed between nucleotides bearing hydrophobic nucleobases, exemplified by the pair formed between d5SICS and dNaM (d5SICS-dNaM), which is efficiently PCR-amplified and transcribed in vitro, and whose unique mechanism of replication has been characterized.  However, expansion of an organism's genetic alphabet presents new and unprecedented challenges: the unnatural nucleoside triphosphates must be available inside the cell; endogenous polymerases must be able to use the unnatural triphosphates to faithfully replicate DNA contg. the UBP within the complex cellular milieu; and finally, the UBP must be stable in the presence of pathways that maintain the integrity of DNA.  Here we show that an exogenously expressed algal nucleotide triphosphate transporter efficiently imports the triphosphates of both d5SICS and dNaM (d5SICSTP and dNaMTP) into Escherichia coli, and that the endogenous replication machinery uses them to accurately replicate a plasmid contg. d5SICS-dNaM.  Neither the presence of the unnatural triphosphates nor the replication of the UBP introduces a notable growth burden.  Lastly, we find that the UBP is not efficiently excised by DNA repair pathways.  Thus, the resulting bacterium is the first organism to propagate stably an expanded genetic alphabet.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgwP1p83TK1LVg90H21EOLACvtfcHk0lgIh-Mx5DESdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVyqtb8%253D&md5=97b4b184cda52cc809b1705e5e88ad8e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature13314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13314%26sid%3Dliteratum%253Aachs%26aulast%3DMalyshev%26aufirst%3DD.%2BA.%26aulast%3DDhami%26aufirst%3DK.%26aulast%3DLavergne%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DN.%26aulast%3DFoster%26aufirst%3DJ.%2BM.%26aulast%3DCorr%25C3%25AAa%26aufirst%3DI.%2BR.%26aulast%3DRomesberg%26aufirst%3DF.%2BE.%26atitle%3DA%2520Semi-Synthetic%2520Organism%2520with%2520an%2520Expanded%2520Genetic%2520Alphabet%26jtitle%3DNature%26date%3D2014%26volume%3D509%26issue%3D7500%26spage%3D385%26epage%3D388%26doi%3D10.1038%2Fnature13314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Powell, K.</span></span> <span> </span><span class="NLM_article-title">How Biologists Are Creating Life-like Cells from Scratch</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>563</i></span> (<span class="NLM_issue">7730</span>),  <span class="NLM_fpage">172</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1038/d41586-018-07289-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fd41586-018-07289-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=30405232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFejsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=563&publication_year=2018&pages=172-175&issue=7730&author=K.+Powell&title=How+Biologists+Are+Creating+Life-like+Cells+from+Scratch&doi=10.1038%2Fd41586-018-07289-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">How biologists are creating life-like cells from scratch</span></div><div class="casAuthors">Powell, Kendall</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">563</span>
        (<span class="NLM_cas:issue">7730</span>),
    <span class="NLM_cas:pages">172-175</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Built from the bottom up, synthetic cells and other creations are starting to come together and could soon test the boundaries of life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMM6QE2kl8ErVg90H21EOLACvtfcHk0ljdePXAis1bsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFejsbbF&md5=43ad5b99be3137e9bae225f6a88c031e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fd41586-018-07289-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fd41586-018-07289-x%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DK.%26atitle%3DHow%2520Biologists%2520Are%2520Creating%2520Life-like%2520Cells%2520from%2520Scratch%26jtitle%3DNature%26date%3D2018%26volume%3D563%26issue%3D7730%26spage%3D172%26epage%3D175%26doi%3D10.1038%2Fd41586-018-07289-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, M. H.</span></span> <span> </span><span class="NLM_article-title">A Completely De Novo ATPase from Combinatorial Protein Design</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">15230</span>– <span class="NLM_lpage">15234</span>, <span class="refDoi"> DOI: 10.1021/jacs.0c02954</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.0c02954" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1GrsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2020&pages=15230-15234&issue=36&author=M.+S.+Wangauthor=M.+H.+Hecht&title=A+Completely+De+Novo+ATPase+from+Combinatorial+Protein+Design&doi=10.1021%2Fjacs.0c02954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A completely de novo ATPase from combinatorial protein design</span></div><div class="casAuthors">Wang, Michael S.; Hecht, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">15230-15234</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Our understanding of biol. chem. is shaped by the observation that all life comes from other life-as Pasteur put it, omne vivum ex vivo.  A key step in expanding our biochem. vocabulary is to recapitulate biogenic catalysis using non-natural sequences that did not arise from common ancestry.  Here we describe an enzyme designed completely de novo that hydrolyzes ATP.  This protein was designed to lack β-sheet structure and is competitively inhibited by magnesium, two traits that are unlike natural ATPases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtlrIZve8BA7Vg90H21EOLACvtfcHk0ljdePXAis1bsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1GrsLjE&md5=976aa54a0e80422b8a195c50a0ee2010</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjacs.0c02954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.0c02954%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%2BS.%26aulast%3DHecht%26aufirst%3DM.%2BH.%26atitle%3DA%2520Completely%2520De%2520Novo%2520ATPase%2520from%2520Combinatorial%2520Protein%2520Design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2020%26volume%3D142%26issue%3D36%26spage%3D15230%26epage%3D15234%26doi%3D10.1021%2Fjacs.0c02954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, D.</span>; <span class="NLM_string-name">Pazdernik, N.</span></span> <i>Biotechnology</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Academic Cell</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+Clark&author=N.+Pazdernik&title=Biotechnology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%26btitle%3DBiotechnology%26pub%3DAcademic%2520Cell%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maini, R. N.</span></span> <span> </span><span class="NLM_article-title">TNF Defined as a Therapeutic Target for Rheumatoid Arthritis and Other Autoimmune Diseases</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1245</span>– <span class="NLM_lpage">1250</span>, <span class="refDoi"> DOI: 10.1038/nm939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnm939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=14520364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1Cksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=1245-1250&issue=10&author=M.+Feldmannauthor=R.+N.+Maini&title=TNF+Defined+as+a+Therapeutic+Target+for+Rheumatoid+Arthritis+and+Other+Autoimmune+Diseases&doi=10.1038%2Fnm939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases</span></div><div class="casAuthors">Feldmann, Marc; Maini, Ravinder N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1245-1250</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVrPP8cx-5NrVg90H21EOLACvtfcHk0ljdePXAis1bsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1Cksr0%253D&md5=5a47a0d9196b0be19eb25cdab5d17b9e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnm939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm939%26sid%3Dliteratum%253Aachs%26aulast%3DFeldmann%26aufirst%3DM.%26aulast%3DMaini%26aufirst%3DR.%2BN.%26atitle%3DTNF%2520Defined%2520as%2520a%2520Therapeutic%2520Target%2520for%2520Rheumatoid%2520Arthritis%2520and%2520Other%2520Autoimmune%2520Diseases%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26issue%3D10%26spage%3D1245%26epage%3D1250%26doi%3D10.1038%2Fnm939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Regulation of Tumour Necrosis Factor Signalling: Live or Let Die</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1038/nri3834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnri3834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26008591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=362-374&issue=6&author=D.+Brennerauthor=H.+Blaserauthor=T.+W.+Mak&title=Regulation+of+Tumour+Necrosis+Factor+Signalling%3A+Live+or+Let+Die&doi=10.1038%2Fnri3834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of tumour necrosis factor signalling: live or let die</span></div><div class="casAuthors">Brenner, Dirk; Blaser, Heiko; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">362-374</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is a pro-inflammatory cytokine that has important roles in mammalian immunity and cellular homeostasis.  Deregulation of TNF receptor (TNFR) signalling is assocd. with many inflammatory disorders, including various types of arthritis and inflammatory bowel disease, and targeting TNF has been an effective therapeutic strategy in these diseases.  This Review focuses on the recent advances that have been made in understanding TNFR signalling and the consequences of its deregulation for cellular survival, apoptosis and regulated necrosis.  We discuss how TNF-induced survival signals are distinguished from those that lead to cell death.  Finally, we provide a brief overview of the role of TNF in inflammatory and autoimmune diseases, and we discuss up-to-date and future treatment strategies for these disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwd5YDL8raprVg90H21EOLACvtfcHk0lgegJ9zl1lNRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7jJ&md5=adc251b8af3f6e4d5fc04262c597f67f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnri3834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3834%26sid%3Dliteratum%253Aachs%26aulast%3DBrenner%26aufirst%3DD.%26aulast%3DBlaser%26aufirst%3DH.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DRegulation%2520of%2520Tumour%2520Necrosis%2520Factor%2520Signalling%253A%2520Live%2520or%2520Let%2520Die%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26issue%3D6%26spage%3D362%26epage%3D374%26doi%3D10.1038%2Fnri3834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinarello, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Meer, J. W. M.</span></span> <span> </span><span class="NLM_article-title">Treating Inflammation by Blocking Interleukin-1 in a Broad Spectrum of Diseases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1038/nrd3800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnrd3800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=22850787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=633-652&issue=8&author=C.+A.+Dinarelloauthor=A.+Simonauthor=J.+W.+M.+van+der+Meer&title=Treating+Inflammation+by+Blocking+Interleukin-1+in+a+Broad+Spectrum+of+Diseases&doi=10.1038%2Fnrd3800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases</span></div><div class="casAuthors">Dinarello, Charles A.; Simon, Anna; van der Meer, Jos W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">633-652</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Interleukin-1 (IL-1) is a highly active pro-inflammatory cytokine that lowers pain thresholds and damages tissues.  Monotherapy blocking IL-1 activity in autoinflammatory syndromes results in a rapid and sustained redn. in disease severity, including reversal of inflammation-mediated loss of sight, hearing and organ function.  This approach can therefore be effective in treating common conditions such as post-infarction heart failure, and trials targeting a broad spectrum of new indications are underway.  So far, three IL-1-targeted agents have been approved: the IL-1 receptor antagonist anakinra, the sol. decoy receptor rilonacept and the neutralizing monoclonal anti-IL-1β antibody canakinumab.  In addn., a monoclonal antibody directed against the IL-1 receptor and a neutralizing anti-IL-1α antibody are in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6wcqDUVKRhLVg90H21EOLACvtfcHk0lgegJ9zl1lNRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmtrfJ&md5=9297c8530f9d2c75da0880a7df7c1fe2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnrd3800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3800%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%2BM.%26atitle%3DTreating%2520Inflammation%2520by%2520Blocking%2520Interleukin-1%2520in%2520a%2520Broad%2520Spectrum%2520of%2520Diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26issue%3D8%26spage%3D633%26epage%3D652%26doi%3D10.1038%2Fnrd3800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.9b01285</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.9b01285" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXks1Cmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2020&pages=770-803&issue=3&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+Products+as+Sources+of+New+Drugs+over+the+Nearly+Four+Decades+from+01%2F1981+to+09%2F2019&doi=10.1021%2Facs.jnatprod.9b01285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">770-803</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">This review is an updated and expanded version of the five prior reviews that were published in this journal in 1997, 2003, 2007, 2012, and 2016.  For all approved therapeutic agents, the time frame has been extended to cover the almost 39 years from the first of Jan. 1981 to the 30th of Sept. 2019 for all diseases worldwide and from ∼1946 (earliest so far identified) to the 30th of Sept. 2019 for all approved antitumor drugs worldwide.  As in earlier reviews, only the first approval of any drug is counted, irresp. of how many "biosimilars" or added approvals were subsequently identified.  As in the 2012 and 2016 reviews, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions, and the designation "natural product botanical", or "NB", to cover those botanical "defined mixts." now recognized as drug entities by the FDA (and similar organizations).  From the data presented in this review, the utilization of natural products and/or synthetic variations using their novel structures, in order to discover and develop the final drug entity, is still alive and well.  For example, in the area of cancer, over the time frame from 1946 to 1980, of the 75 small mols., 40, or 53.3%, are N or ND.  In the 1981 to date time frame the equiv. figures for the N* compds. of the 185 small mols. are 62, or 33.5%, though to these can be added the 58 S* and S*/NMs, bringing the figure to 64.9%.  In other areas, the influence of natural product structures is quite marked with, as expected from prior information, the anti-infective area being dependent on natural products and their structures, though as can be seen in the review there are still disease areas (shown in Table 2) for which there are no drugs derived from natural products.  Although combinatorial chem. techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are still able to identify only two de novo combinatorial compds. (one of which is a little speculative) approved as drugs in this 39-yr time frame, though there is also one drug that was developed using the "fragment-binding methodol." and approved in 2012.  We have also added a discussion of candidate drug entities currently in clin. trials as "warheads" and some very interesting preliminary reports on sources of novel antibiotics from Nature due to the abs. requirement for new agents to combat plasmid-borne resistance genes now in the general populace.  We continue to draw the attention of readers to the recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated"; thus we consider that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9vVZR4nleEbVg90H21EOLACvtfcHk0lhQcO64sEb6fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXks1Cmsrw%253D&md5=2c10c2aef98042d8bd772b6280b51d2b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.9b01285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.9b01285%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520Products%2520as%2520Sources%2520of%2520New%2520Drugs%2520over%2520the%2520Nearly%2520Four%2520Decades%2520from%252001%252F1981%2520to%252009%252F2019%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2020%26volume%3D83%26issue%3D3%26spage%3D770%26epage%3D803%26doi%3D10.1021%2Facs.jnatprod.9b01285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIsaac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wren, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. T.</span></span> <span> </span><span class="NLM_article-title">Market Share and Costs of Biologic Therapies for Inflammatory Bowel Disease in the USA</span>. <i>Aliment. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.1111/apt.14430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1111%2Fapt.14430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=29164650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmt1elsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=364-370&issue=3&author=H.+Yuauthor=D.+MacIsaacauthor=J.+J.+Wongauthor=Z.+M.+Sellersauthor=A.+A.+Wrenauthor=R.+Bensenauthor=C.+Kinauthor=K.+T.+Park&title=Market+Share+and+Costs+of+Biologic+Therapies+for+Inflammatory+Bowel+Disease+in+the+USA&doi=10.1111%2Fapt.14430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Market share and costs of biologic therapies for inflammatory bowel disease in the USA</span></div><div class="casAuthors">Yu, H.; MacIsaac, D.; Wong, J. J.; Sellers, Z. M.; Wren, A. A.; Bensen, R.; Kin, C.; Park, K. T.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">364-370</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Background : Real-world data quantifying the costs of increasing use of biologics in inflammatory bowel disease (IBD) are unknown.  Aim : To det. the outpatient IBD drug utilization trends, relative market share, and costs in the USA during a 9-yr period.  Methods : The Truven MarketScan Database was analyzed for patients with Crohn's disease (CD) and ulcerative colitis (UC) during 2007-2015.  National drug codes were used to identify prescription drugs; Healthcare Common Procedure Coding System J-codes were used to capture biol. out-patient infusions.  Proportion of drug usage, relative market share and per-member per-yr (PMPY) costs were analyzed for biologics, immunomodulators, 5-ASAs and corticosteroids.  Results : In 415 405 patients (188 842 CD; 195 183 UC; 31 380 indeterminate colitis; 54.67% female), utilization trends show a consistent rise in the market share of biologics during the 9-yr study period.  The proportion of patients using biologics increased from 21.8% to 43.8% for CD and 5.1%-16.2% for UC.  This contrasts a small decrease in immunomodulator and 5-ASA use for CD and relative constancy of other classes including corticosteroids-only use as primary IBD medication from 2007 to 2015.  The av. biol.-taking patient accounted for 25 275 PMPY in 2007 and 36 051 PMPY in 2015.  The av. paediatric biol.-taking patient accounted for 23 616 PMPY in 2007 and 41 109 PMPY in 2015.  In all patients, the share of costs for biologics increased from 72.9% in 2007 to 85.7% in 2015 (81.7% in 2007 to 94.9% in 2015 in paediatrics).  Conclusion : The vast majority of costs allocated to out-patient IBD medications in the USA is attributed to increasing use of biol. therapies despite the relative minority of biol.-taking patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdJoBG67JeN7Vg90H21EOLACvtfcHk0lhQcO64sEb6fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmt1elsg%253D%253D&md5=bc8bb2062cef56a3c2b6ec7343060353</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fapt.14430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fapt.14430%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DMacIsaac%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DJ.%2BJ.%26aulast%3DSellers%26aufirst%3DZ.%2BM.%26aulast%3DWren%26aufirst%3DA.%2BA.%26aulast%3DBensen%26aufirst%3DR.%26aulast%3DKin%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DK.%2BT.%26atitle%3DMarket%2520Share%2520and%2520Costs%2520of%2520Biologic%2520Therapies%2520for%2520Inflammatory%2520Bowel%2520Disease%2520in%2520the%2520USA%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2018%26volume%3D47%26issue%3D3%26spage%3D364%26epage%3D370%26doi%3D10.1111%2Fapt.14430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulman, K. A.</span></span> <span> </span><span class="NLM_article-title">The Impact Of Specialty Pharmaceuticals As Drivers Of Health Care Costs</span>. <i>Health Aff.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1714</span>– <span class="NLM_lpage">1720</span>, <span class="refDoi"> DOI: 10.1377/hlthaff.2014.0558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1377%2Fhlthaff.2014.0558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A280%3ADC%252BC2M7otVKjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=1714-1720&issue=10&author=B.+R.+Hirschauthor=S.+Baluauthor=K.+A.+Schulman&title=The+Impact+Of+Specialty+Pharmaceuticals+As+Drivers+Of+Health+Care+Costs&doi=10.1377%2Fhlthaff.2014.0558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of specialty pharmaceuticals as drivers of health care costs</span></div><div class="casAuthors">Hirsch Bradford R; Balu Suresh; Schulman Kevin A</div><div class="citationInfo"><span class="NLM_cas:title">Health affairs (Project Hope)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1714-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pharmaceutical industry is shifting its focus from blockbuster small molecules to specialty pharmaceuticals.  Specialty pharmaceuticals are novel drugs and biologic agents that require special handling and ongoing monitoring, are administered by injection or infusion, and are sold in the marketplace by a small number of distributors.  They are frequently identified by having a cost to payers and patients of $600 or more per treatment.  The total costs of the new agents are likely to have a substantial impact on overall health care costs and on patients during the next decade, unless steps are taken to align competing interests.  We examine the economic and policy issues related to specialty pharmaceuticals, taking care to consider the impact on patients.  We assess the role of cost-sharing provisions, legislation that is promoting realignment within the market, the role of biosimilars in price competition, and the potential for novel drug development paradigms to help bend the cost curve.  The economic aspects of this analysis highlight the need for a far-reaching discussion of potential novel approaches to innovation pathways in our quest for both affordability and new technology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRjBxt52rBKcJZoeNcnHOQ9fW6udTcc2eYEz3BGEnm9Vbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7otVKjug%253D%253D&md5=1cecaafff39d7069104b734d5f06f6cc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1377%2Fhlthaff.2014.0558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1377%252Fhlthaff.2014.0558%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch%26aufirst%3DB.%2BR.%26aulast%3DBalu%26aufirst%3DS.%26aulast%3DSchulman%26aufirst%3DK.%2BA.%26atitle%3DThe%2520Impact%2520Of%2520Specialty%2520Pharmaceuticals%2520As%2520Drivers%2520Of%2520Health%2520Care%2520Costs%26jtitle%3DHealth%2520Aff.%26date%3D2014%26volume%3D33%26issue%3D10%26spage%3D1714%26epage%3D1720%26doi%3D10.1377%2Fhlthaff.2014.0558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespi-Lofton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skelton, J. B.</span></span> <span> </span><span class="NLM_article-title">The Growing Role of Biologics and Biosimilars in the United States: Perspectives from the APhA Biologics and Biosimilars Stakeholder Conference</span>. <i>J. Am. Pharm. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">e15</span>– <span class="NLM_lpage">e27</span>, <span class="refDoi"> DOI: 10.1016/j.japh.2017.05.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.japh.2017.05.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=e15-e27&issue=5&author=J.+Crespi-Loftonauthor=J.+B.+Skelton&title=The+Growing+Role+of+Biologics+and+Biosimilars+in+the+United+States%3A+Perspectives+from+the+APhA+Biologics+and+Biosimilars+Stakeholder+Conference&doi=10.1016%2Fj.japh.2017.05.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.japh.2017.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.japh.2017.05.014%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi-Lofton%26aufirst%3DJ.%26aulast%3DSkelton%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520Growing%2520Role%2520of%2520Biologics%2520and%2520Biosimilars%2520in%2520the%2520United%2520States%253A%2520Perspectives%2520from%2520the%2520APhA%2520Biologics%2520and%2520Biosimilars%2520Stakeholder%2520Conference%26jtitle%3DJ.%2520Am.%2520Pharm.%2520Assoc.%26date%3D2017%26volume%3D57%26issue%3D5%26spage%3De15%26epage%3De27%26doi%3D10.1016%2Fj.japh.2017.05.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D.</span></span> <span> </span><span class="NLM_article-title">Rise of the Biologics</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1039/C7MD90046E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC7MD90046E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=30108898" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=10-11&issue=1&author=D.+Lowe&title=Rise+of+the+Biologics&doi=10.1039%2FC7MD90046E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2FC7MD90046E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD90046E%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DD.%26atitle%3DRise%2520of%2520the%2520Biologics%26jtitle%3DMedChemComm%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D10%26epage%3D11%26doi%3D10.1039%2FC7MD90046E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span> <i>Principles and Applications of Fermentation Technology</i>, <span class="NLM_contrib-group"><span class="NLM_string-name">Kuila, A.</span>; <span class="NLM_string-name">Sharma, V.</span></span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ, USA</span>, <span class="NLM_year">2018</span>. <span class="refDoi"> DOI: 10.1002/9781119460381</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2F9781119460381" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=A.+Kuila&author=V.+Sharma&title=Principles+and+Applications+of+Fermentation+Technology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2F9781119460381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781119460381%26sid%3Dliteratum%253Aachs%26btitle%3DPrinciples%2520and%2520Applications%2520of%2520Fermentation%2520Technology%26aulast%3DKuila%26aufirst%3DA.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2018%26doi%3D10.1002%2F9781119460381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Cruz, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutureira, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, G. J. L.</span></span> <span> </span><span class="NLM_article-title">Site-Selective Protein-Modification Chemistry for Basic Biology and Drug Development</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1038/nchem.2393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnchem.2393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26791892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFemsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=103-113&issue=2&author=N.+Krallauthor=F.+P.+da+Cruzauthor=O.+Boutureiraauthor=G.+J.+L.+Bernardes&title=Site-Selective+Protein-Modification+Chemistry+for+Basic+Biology+and+Drug+Development&doi=10.1038%2Fnchem.2393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Site-selective protein-modification chemistry for basic biology and drug development</span></div><div class="casAuthors">Krall, Nikolaus; da Cruz, Filipa P.; Boutureira, Omar; Bernardes, Goncalo J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">103-113</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nature has produced intricate machinery to covalently diversify the structure of proteins after their synthesis in the ribosome.  In an attempt to mimic nature, chemists have developed a large set of reactions that enable post-expression modification of proteins at pre-detd. sites.  These reactions are now used to selectively install particular modifications on proteins for many biol. and therapeutic applications.  For example, they provide an opportunity to install post-translational modifications on proteins to det. their exact biol. roles.  Labeling of proteins in live cells with fluorescent dyes allows protein uptake and intracellular trafficking to be tracked and also enables physiol. parameters to be measured optically.  Through the conjugation of potent cytotoxicants to antibodies, novel anti-cancer drugs with improved efficacy and reduced side effects may be obtained.  In this Perspective, we highlight the most exciting current and future applications of chem. site-selective protein modification and consider which hurdles still need to be overcome for more widespread use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCXe9yoL2S-bVg90H21EOLACvtfcHk0lgl_WMz6vQJCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFemsbrI&md5=9a8f675a512f1286c5d88c6692d8773c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2393%26sid%3Dliteratum%253Aachs%26aulast%3DKrall%26aufirst%3DN.%26aulast%3Dda%2BCruz%26aufirst%3DF.%2BP.%26aulast%3DBoutureira%26aufirst%3DO.%26aulast%3DBernardes%26aufirst%3DG.%2BJ.%2BL.%26atitle%3DSite-Selective%2520Protein-Modification%2520Chemistry%2520for%2520Basic%2520Biology%2520and%2520Drug%2520Development%26jtitle%3DNat.%2520Chem.%26date%3D2016%26volume%3D8%26issue%3D2%26spage%3D103%26epage%3D113%26doi%3D10.1038%2Fnchem.2393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adamo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutureira, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, G. J. L.</span></span> <span> </span><span class="NLM_article-title">Synthetically Defined Glycoprotein Vaccines: Current Status and Future Directions</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2995</span>– <span class="NLM_lpage">3008</span>, <span class="refDoi"> DOI: 10.1039/c3sc50862e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2Fc3sc50862e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=25893089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVehs7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2995-3008&issue=8&author=R.+Adamoauthor=A.+Niloauthor=B.+Castagnerauthor=O.+Boutureiraauthor=F.+Bertiauthor=G.+J.+L.+Bernardes&title=Synthetically+Defined+Glycoprotein+Vaccines%3A+Current+Status+and+Future+Directions&doi=10.1039%2Fc3sc50862e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetically defined glycoprotein vaccines: current status and future directions</span></div><div class="casAuthors">Adamo, Roberto; Nilo, Alberto; Castagner, Bastien; Boutureira, Omar; Berti, Francesco; Bernardes, Goncalo J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2995-3008</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Primary examples in vaccine design have shown good levels of carbohydrate-specific antibody generation when raised using extd. or fully synthetic capsular polysaccharide glycans covalently coupled to a protein carrier.  Herein, the authors cover recent clin. developments of carbohydrate-based vaccines and describe how novel cutting-edge methodol. for the total synthesis of oligosaccharides and for the precise placement of carbohydrates at pre-detd. sites within a protein may be used to further improve the safety and efficacy of glycovaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhC--VhdicaLVg90H21EOLACvtfcHk0lgl_WMz6vQJCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVehs7jN&md5=eb09336f0a6302efb364de7539fd94a4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2Fc3sc50862e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3sc50862e%26sid%3Dliteratum%253Aachs%26aulast%3DAdamo%26aufirst%3DR.%26aulast%3DNilo%26aufirst%3DA.%26aulast%3DCastagner%26aufirst%3DB.%26aulast%3DBoutureira%26aufirst%3DO.%26aulast%3DBerti%26aufirst%3DF.%26aulast%3DBernardes%26aufirst%3DG.%2BJ.%2BL.%26atitle%3DSynthetically%2520Defined%2520Glycoprotein%2520Vaccines%253A%2520Current%2520Status%2520and%2520Future%2520Directions%26jtitle%3DChem.%2520Sci.%26date%3D2013%26volume%3D4%26issue%3D8%26spage%3D2995%26epage%3D3008%26doi%3D10.1039%2Fc3sc50862e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span></span> <span> </span><span class="NLM_article-title">From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">836</span>– <span class="NLM_lpage">863</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(20000303)39:5<836::AID-ANIE836>3.0.CO;2-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2F%28SICI%291521-3773%2820000303%2939%3A5%3C836%3A%3AAID-ANIE836%3E3.0.CO%3B2-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFSns7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=836-863&issue=5&author=S.+J.+Danishefskyauthor=J.+R.+Allen&title=From+the+Laboratory+to+the+Clinic%3A+A+Retrospective+on+Fully+Synthetic+Carbohydrate-Based+Anticancer+Vaccines&doi=10.1002%2F%28SICI%291521-3773%2820000303%2939%3A5%3C836%3A%3AAID-ANIE836%3E3.0.CO%3B2-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">From the laboratory to the clinic: a retrospective on fully synthetic carbohydrate-based anticancer vaccines</span></div><div class="casAuthors">Danishefsky, Samuel J.; Allen, Jennifer R.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">836-863</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A review with many refs. on authors' explorations into oligosaccharide and glycoconjugate construction for the creation and evaluation of vaccines based on carbohydrate-centered tumor antigens.  The starting point was the known tendency of transformed cells to express selective carbohydrate motifs in the form of glycoproteins or glycolipids.  Anticancer vaccines derived from carbohydrate-based antigens could be effective targets for immune recognition and attack.  Obtaining significant quantities of such structures from natural sources is extremely difficult.  With the total synthesis of tumor-assocd. carbohydrate antigens accomplished, the evaluation at the clin. level was initiated whether the human immune system can respond to such fully synthetic antigens in a focused and useful way.  Toward this goal the resources of chem. and immunol. in an attack on the problem were merged.  The synthesis and immunoconjugation of various tumor-assocd. carbohydrate antigens and the results of such constructs in mice vaccinations are described.  For fashioning an effective vaccine, conjugation to a suitable immunogenic carrier was necessary and conjugates of keyhole limpet cyanin have consistently demonstrated the relevant immunogenicity.  Preclin. and clin. studies with synthetic conjugate carbohydrate vaccines show induction of IgM- and IgG-antibody responses.  Another approach to anticancer vaccines involves the use of clustered glycopeptides as targets for immune attack.  Initial attention has been directed to mucin-related O-linked glycopeptides.  Synthetic trimeric clusters of glycoepitopes derived from the Tn-, TF- and Lewisy-antigens, appropriately bioconjugated, have been demonstrated to be immunogenic.  The hope is that patients immunized in an adjuvant manner with synthetic carbohydrate vaccines would produce antibodies reactive with cancer cells and that the prodn. of such antibodies would mitigate against tumor spread, thereby enabling a more favorable survival and "quality of life" prognosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj1D_JGqYFi7Vg90H21EOLACvtfcHk0li6DPCri0KohQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFSns7s%253D&md5=0a800658fba553abe968b57db53ce28e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2820000303%2939%3A5%3C836%3A%3AAID-ANIE836%3E3.0.CO%3B2-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252820000303%252939%253A5%253C836%253A%253AAID-ANIE836%253E3.0.CO%253B2-I%26sid%3Dliteratum%253Aachs%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DFrom%2520the%2520Laboratory%2520to%2520the%2520Clinic%253A%2520A%2520Retrospective%2520on%2520Fully%2520Synthetic%2520Carbohydrate-Based%2520Anticancer%2520Vaccines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2000%26volume%3D39%26issue%3D5%26spage%3D836%26epage%3D863%26doi%3D10.1002%2F%28SICI%291521-3773%2820000303%2939%3A5%3C836%3A%3AAID-ANIE836%3E3.0.CO%3B2-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelegri-O’Day, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, E.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maynard, H. D.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Protein-Polymer Conjugates: Advancing Beyond PEGylation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">14323</span>– <span class="NLM_lpage">14332</span>, <span class="refDoi"> DOI: 10.1021/ja504390x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja504390x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFCjsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=14323-14332&issue=41&author=E.+M.+Pelegri-O%E2%80%99Dayauthor=E.-W.+Linauthor=H.+D.+Maynard&title=Therapeutic+Protein-Polymer+Conjugates%3A+Advancing+Beyond+PEGylation&doi=10.1021%2Fja504390x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Protein-Polymer Conjugates: Advancing Beyond PEGylation</span></div><div class="casAuthors">Pelegri-O'Day, Emma M.; Lin, En-Wei; Maynard, Heather D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">14323-14332</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Protein-polymer conjugates are widely used as therapeutics.  All Food and Drug Administration (FDA)-approved protein conjugates are covalently linked to poly(ethylene glycol) (PEG).  These PEGylated drugs have longer half-lives in the bloodstream, leading to less frequent dosing, which is a significant advantage for patients.  However, there are some potential drawbacks to PEG that are driving the development of alternatives.  Polymers that display enhanced pharmacokinetic properties along with addnl. advantages such as improved stability or degradability will be important to advance the field of protein therapeutics.  This perspective presents a summary of protein-PEG conjugates for therapeutic use and alternative technologies in various stages of development as well as suggestions for future directions.  Established methods of producing protein-PEG conjugates and new approaches utilizing controlled radical polymn. are also covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO4BZRwq_slrVg90H21EOLACvtfcHk0li6DPCri0KohQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCjsLfI&md5=784f96a81f2c6f6bfba8b4dadb31bdcb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja504390x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja504390x%26sid%3Dliteratum%253Aachs%26aulast%3DPelegri-O%25E2%2580%2599Day%26aufirst%3DE.%2BM.%26aulast%3DLin%26aufirst%3DE.-W.%26aulast%3DMaynard%26aufirst%3DH.%2BD.%26atitle%3DTherapeutic%2520Protein-Polymer%2520Conjugates%253A%2520Advancing%2520Beyond%2520PEGylation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26issue%3D41%26spage%3D14323%26epage%3D14332%26doi%3D10.1021%2Fja504390x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkenblit, A.</span></span> <span> </span><span class="NLM_article-title">Antibody-Drug Conjugates for Cancer Treatment</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1146/annurev-med-061516-121357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1146%2Fannurev-med-061516-121357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=29414262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVCns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2018&pages=191-207&issue=1&author=J.+M.+Lambertauthor=A.+Berkenblit&title=Antibody-Drug+Conjugates+for+Cancer+Treatment&doi=10.1146%2Fannurev-med-061516-121357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-Drug Conjugates for Cancer Treatment</span></div><div class="casAuthors">Lambert, John M.; Berkenblit, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191-207</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The concept of exploiting the specific binding properties of monoclonal antibodies as a mechanism for selective delivery of cytotoxic agents to tumor cells is an attractive soln. to the challenge of increasing the therapeutic index of cell-killing agents for treating cancer.  All three parts of an antibody-drug conjugate (ADC)-the antibody, the cytotoxic payload, and the linker chem. that joins them together-as well as the biol. properties of the cell-surface target antigen are important in designing an effective anticancer agent.  The approval of brentuximab vedotin in 2011 for treating relapsed Hodgkin's lymphoma and systemic anaplastic large cell lymphoma, and the approval of ado-trastuzumab emtansine in 2013 for treating HER2-pos. metastatic breast cancer, have sparked vigorous research in the field, with >65 ADCs currently in clin. evaluation.  This review highlights the ADCs that are approved for marketing, in pivotal clin. trials, or in at least phase II clin. development for treating both hematol. malignancies and solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_IOG6MLM3DbVg90H21EOLACvtfcHk0li6DPCri0KohQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVCns7o%253D&md5=2b1ef573a3a0949af32103053bb71be2</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-061516-121357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-061516-121357%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DJ.%2BM.%26aulast%3DBerkenblit%26aufirst%3DA.%26atitle%3DAntibody-Drug%2520Conjugates%2520for%2520Cancer%2520Treatment%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2018%26volume%3D69%26issue%3D1%26spage%3D191%26epage%3D207%26doi%3D10.1146%2Fannurev-med-061516-121357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choyke, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span> <span> </span><span class="NLM_article-title">New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2620</span>– <span class="NLM_lpage">2640</span>, <span class="refDoi"> DOI: 10.1021/cr900263j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900263j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGhtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=2620-2640&issue=5&author=H.+Kobayashiauthor=M.+Ogawaauthor=R.+Alfordauthor=P.+L.+Choykeauthor=Y.+Urano&title=New+Strategies+for+Fluorescent+Probe+Design+in+Medical+Diagnostic+Imaging&doi=10.1021%2Fcr900263j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging</span></div><div class="casAuthors">Kobayashi, Hisataka; Ogawa, Mikako; Alford, Raphael; Choyke, Peter L.; Urano, Yasuteru</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2620-2640</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review including major sections entitled Introduction, History of Fluorescent Probes in Medical Imaging, General Requirements for Fluorescent Probes in Medical Imaging, Classification of Fluorophores, Advanced Applications of Fluorescent Probes in Medical Imaging, and Addnl. Signaling Mechanisms Using Fluorescent Probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPWrMbju05UrVg90H21EOLACvtfcHk0li6DPCri0KohQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGhtbzP&md5=af8dc6331e8d0e311e8fc5cb5c1d6736</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fcr900263j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900263j%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DAlford%26aufirst%3DR.%26aulast%3DChoyke%26aufirst%3DP.%2BL.%26aulast%3DUrano%26aufirst%3DY.%26atitle%3DNew%2520Strategies%2520for%2520Fluorescent%2520Probe%2520Design%2520in%2520Medical%2520Diagnostic%2520Imaging%26jtitle%3DChem.%2520Rev.%26date%3D2010%26volume%3D110%26issue%3D5%26spage%3D2620%26epage%3D2640%26doi%3D10.1021%2Fcr900263j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykstra, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagarajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S. W.</span></span> <span> </span><span class="NLM_article-title">The Medicinal Chemist’s Toolbox for Late Stage Functionalization of Drug-like Molecules</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1039/C5CS00628G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC5CS00628G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26507237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslams7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=546-576&issue=3&author=T.+Cernakauthor=K.+D.+Dykstraauthor=S.+Tyagarajanauthor=P.+Vachalauthor=S.+W.+Krska&title=The+Medicinal+Chemist%E2%80%99s+Toolbox+for+Late+Stage+Functionalization+of+Drug-like+Molecules&doi=10.1039%2FC5CS00628G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The medicinal chemist's toolbox for late stage functionalization of drug-like molecules</span></div><div class="casAuthors">Cernak, Tim; Dykstra, Kevin D.; Tyagarajan, Sriram; Vachal, Petr; Krska, Shane W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">546-576</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The advent of modern C-H functionalization chemistries has enabled medicinal chemists to consider a synthetic strategy, late stage functionalization (LSF), which utilizes the C-H bonds of drug leads as points of diversification for generating new analogs.  LSF approaches offer the promise of rapid exploration of structure activity relationships (SAR), the generation of oxidized metabolites, the blocking of metabolic hot spots and the prepn. of biol. probes.  This review details a toolbox of intermol. C-H functionalization chemistries with proven applicability to drug-like mols., classified by regioselectivity patterns, and gives guidance on how to systematically develop LSF strategies using these patterns and other considerations.  In addn., a no. of examples illustrate how LSF approaches have been used to impact actual drug discovery and chem. biol. efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7N9sPaaVAQbVg90H21EOLACvtfcHk0lhh5GvwEffiLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslams7nN&md5=a52fc5692f5515e5cadab0f2746fd6f7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2FC5CS00628G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00628G%26sid%3Dliteratum%253Aachs%26aulast%3DCernak%26aufirst%3DT.%26aulast%3DDykstra%26aufirst%3DK.%2BD.%26aulast%3DTyagarajan%26aufirst%3DS.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DKrska%26aufirst%3DS.%2BW.%26atitle%3DThe%2520Medicinal%2520Chemist%25E2%2580%2599s%2520Toolbox%2520for%2520Late%2520Stage%2520Functionalization%2520of%2520Drug-like%2520Molecules%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26issue%3D3%26spage%3D546%26epage%3D576%26doi%3D10.1039%2FC5CS00628G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mennen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhambra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barberis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berritt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castañón, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damon, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eugenio
de Diego, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Cerrada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Losada, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitch, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobben, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacMillan, D. W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInturff, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monfette, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitter, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strambeanu, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twilton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zajac, M. A.</span></span> <span> </span><span class="NLM_article-title">The Evolution of High-Throughput Experimentation in Pharmaceutical Development and Perspectives on the Future</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1213</span>– <span class="NLM_lpage">1242</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.9b00140</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.9b00140" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptFyhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2019&pages=1213-1242&issue=6&author=S.+M.+Mennenauthor=C.+Alhambraauthor=C.+L.+Allenauthor=M.+Barberisauthor=S.+Berrittauthor=T.+A.+Brandtauthor=A.+D.+Campbellauthor=J.+Casta%C3%B1%C3%B3nauthor=A.+H.+Cherneyauthor=M.+Christensenauthor=D.+B.+Damonauthor=J.+Eugenio%0Ade+Diegoauthor=S.+Garc%C3%ADa-Cerradaauthor=P.+Garc%C3%ADa-Losadaauthor=R.+Haroauthor=J.+Janeyauthor=D.+C.+Leitchauthor=L.+Liauthor=F.+Liuauthor=P.+C.+Lobbenauthor=D.+W.+C.+MacMillanauthor=J.+Maganoauthor=E.+McInturffauthor=S.+Monfetteauthor=R.+J.+Postauthor=D.+Schultzauthor=B.+J.+Sitterauthor=J.+M.+Stevensauthor=I.+I.+Strambeanuauthor=J.+Twiltonauthor=K.+Wangauthor=M.+A.+Zajac&title=The+Evolution+of+High-Throughput+Experimentation+in+Pharmaceutical+Development+and+Perspectives+on+the+Future&doi=10.1021%2Facs.oprd.9b00140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Evolution of High-Throughput Experimentation in Pharmaceutical Development and Perspectives on the Future</span></div><div class="casAuthors">Mennen, Steven M.; Alhambra, Carolina; Allen, C. Liana; Barberis, Mario; Berritt, Simon; Brandt, Thomas A.; Campbell, Andrew D.; Castanon, Jesus; Cherney, Alan H.; Christensen, Melodie; Damon, David B.; Eugenio de Diego, J.; Garcia-Cerrada, Susana; Garcia-Losada, Pablo; Haro, Ruben; Janey, Jacob; Leitch, David C.; Li, Ling; Liu, Fangfang; Lobben, Paul C.; MacMillan, David W. C.; Magano, Javier; McInturff, Emma; Monfette, Sebastien; Post, Ronald J.; Schultz, Danielle; Sitter, Barbara J.; Stevens, Jason M.; Strambeanu, Iulia I.; Twilton, Jack; Wang, Ke; Zajac, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1213-1242</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  High-throughput experimentation (HTE) has revolutionized the pharmaceutical industry, most notably allowing for rapid screening of compd. libraries against therapeutic targets.  The past decade has also witnessed the extension of HTE principles toward the realm of small-mol. process chem.  Today, most major pharmaceutical companies have created dedicated HTE groups within their process development teams, invested in automation technol. to accelerate screening, or both.  The industry's commitment to accelerating process development has led to rapid innovations in the HTE space.  This review will deliver an overview of the latest best practices currently taking place within our teams in process chem. by sharing frequently studied transformations, our perspective for the next several years in the field, and manual and automated tools to enable experimentation.  A series of case studies are presented to exemplify state-of-the-art workflows developed within our labs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGv9Mgw1B12bVg90H21EOLACvtfcHk0lhh5GvwEffiLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptFyhsrc%253D&md5=e00d87520ba1f3498e3667e25c62dfe4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.9b00140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.9b00140%26sid%3Dliteratum%253Aachs%26aulast%3DMennen%26aufirst%3DS.%2BM.%26aulast%3DAlhambra%26aufirst%3DC.%26aulast%3DAllen%26aufirst%3DC.%2BL.%26aulast%3DBarberis%26aufirst%3DM.%26aulast%3DBerritt%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DT.%2BA.%26aulast%3DCampbell%26aufirst%3DA.%2BD.%26aulast%3DCasta%25C3%25B1%25C3%25B3n%26aufirst%3DJ.%26aulast%3DCherney%26aufirst%3DA.%2BH.%26aulast%3DChristensen%26aufirst%3DM.%26aulast%3DDamon%26aufirst%3DD.%2BB.%26aulast%3DEugenio%2Bde%2BDiego%26aufirst%3DJ.%26aulast%3DGarc%25C3%25ADa-Cerrada%26aufirst%3DS.%26aulast%3DGarc%25C3%25ADa-Losada%26aufirst%3DP.%26aulast%3DHaro%26aufirst%3DR.%26aulast%3DJaney%26aufirst%3DJ.%26aulast%3DLeitch%26aufirst%3DD.%2BC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DLobben%26aufirst%3DP.%2BC.%26aulast%3DMacMillan%26aufirst%3DD.%2BW.%2BC.%26aulast%3DMagano%26aufirst%3DJ.%26aulast%3DMcInturff%26aufirst%3DE.%26aulast%3DMonfette%26aufirst%3DS.%26aulast%3DPost%26aufirst%3DR.%2BJ.%26aulast%3DSchultz%26aufirst%3DD.%26aulast%3DSitter%26aufirst%3DB.%2BJ.%26aulast%3DStevens%26aufirst%3DJ.%2BM.%26aulast%3DStrambeanu%26aufirst%3DI.%2BI.%26aulast%3DTwilton%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DZajac%26aufirst%3DM.%2BA.%26atitle%3DThe%2520Evolution%2520of%2520High-Throughput%2520Experimentation%2520in%2520Pharmaceutical%2520Development%2520and%2520Perspectives%2520on%2520the%2520Future%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2019%26volume%3D23%26issue%3D6%26spage%3D1213%26epage%3D1242%26doi%3D10.1021%2Facs.oprd.9b00140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanathan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, C. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Peptides: Technological Advances Driving Peptides into Development</span>. <i>Curr. Opin. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.1016/j.copbio.2006.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.copbio.2006.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=17049837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eqs7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=638-642&issue=6&author=A.+K.+Satoauthor=M.+Viswanathanauthor=R.+B.+Kentauthor=C.+R.+Wood&title=Therapeutic+Peptides%3A+Technological+Advances+Driving+Peptides+into+Development&doi=10.1016%2Fj.copbio.2006.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic peptides: Technological advances driving peptides into development</span></div><div class="casAuthors">Sato, Aaron K.; Viswanathan, Malini; Kent, Rachel B.; Wood, Clive R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">638-642</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  As potential therapeutics, peptides offer several advantages over small mols. (increased specificity) and antibodies (small size).  Nevertheless, a no. of key issues have hampered their use as drug candidates.  A series of new technologies have recently been developed that allow peptides to be viable drug candidates in areas usually restricted to protein therapeutics, such as monoclonal antibodies.  These include the development of various types of peptide-conjugates that have lower rates of clearance and hence the potential to increase the exposure of peptide drug candidates in chronic diseases.  Structural addns. were also made to peptides, including the use of unnatural amino acids, main-chain modifications, and other novel substitutions, which have helped to improve peptide stability and further their therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiwe4yE4GqUbVg90H21EOLACvtfcHk0lii6EC7SDW_pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eqs7zL&md5=c29eae8a5bbf2e0bb5fb3c67211be0d5</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2006.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2006.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DA.%2BK.%26aulast%3DViswanathan%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DR.%2BB.%26aulast%3DWood%26aufirst%3DC.%2BR.%26atitle%3DTherapeutic%2520Peptides%253A%2520Technological%2520Advances%2520Driving%2520Peptides%2520into%2520Development%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2006%26volume%3D17%26issue%3D6%26spage%3D638%26epage%3D642%26doi%3D10.1016%2Fj.copbio.2006.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Strategic Approaches to Optimizing Peptide ADME Properties</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">143</span>, <span class="refDoi"> DOI: 10.1208/s12248-014-9687-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1208%2Fs12248-014-9687-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=25366889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSnurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=134-143&issue=1&author=L.+Di&title=Strategic+Approaches+to+Optimizing+Peptide+ADME+Properties&doi=10.1208%2Fs12248-014-9687-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Strategic Approaches to Optimizing Peptide ADME Properties</span></div><div class="casAuthors">Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-143</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Development of peptide drugs is challenging but also quite rewarding.  Five blockbuster peptide drugs are currently on the market, and six new peptides received first marketing approval as new mol. entities in 2012.  Although peptides only represent 2% of the drug market, the market is growing twice as quickly and might soon occupy a larger niche.  Natural peptides typically have poor absorption, distribution, metab., and excretion (ADME) properties with rapid clearance, short half-life, low permeability, and sometimes low soly.  Strategies have been developed to improve peptide drugability through enhancing permeability, reducing proteolysis and renal clearance, and prolonging half-life.  In vivo, in vitro, and in silico tools are available to evaluate ADME properties of peptides, and structural modification strategies are in place to improve peptide developability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDLDsR-Zk0OLVg90H21EOLACvtfcHk0lii6EC7SDW_pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSnurvJ&md5=530597d3719d65509105096f433fee0a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1208%2Fs12248-014-9687-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-014-9687-3%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26atitle%3DStrategic%2520Approaches%2520to%2520Optimizing%2520Peptide%2520ADME%2520Properties%26jtitle%3DAAPS%2520J.%26date%3D2015%26volume%3D17%26issue%3D1%26spage%3D134%26epage%3D143%26doi%3D10.1208%2Fs12248-014-9687-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Werle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernkop-Schnürch, A.</span></span> <span> </span><span class="NLM_article-title">Strategies to Improve Plasma Half Life Time of Peptide and Protein Drugs</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1007/s00726-005-0289-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1007%2Fs00726-005-0289-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=16622600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD28Xls1egsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=351-367&issue=4&author=M.+Werleauthor=A.+Bernkop-Schn%C3%BCrch&title=Strategies+to+Improve+Plasma+Half+Life+Time+of+Peptide+and+Protein+Drugs&doi=10.1007%2Fs00726-005-0289-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies to improve plasma half life time of peptide and protein drugs</span></div><div class="casAuthors">Werle, M.; Bernkop-Schnuerch, A.</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">Springer Wien</span>)
        </div><div class="casAbstract">A review.  Due to the obvious advantages of long-acting peptide and protein drugs, strategies to prolong blood plasma half life time of such compds. are highly on demand.  Short plasma half life times are commonly due to fast renal clearance as well as to enzymic degrdn. occurring during systemic circulation.  Modifications of the peptide/protein can lead to prolonged plasma half life times.  By shortening the overall amino acid amt. of somatostatin and replacing L-analog amino acids with D-amino acids, plasma half life time of the derivate octreotide was 1.5 h in comparison to only few minutes of somatostatin.  A PEG2,40K conjugate of INF-α-2b exhibited a 330-fold prolonged plasma half life time compared to the native protein.  It was the aim of this review to provide an overview of possible strategies to prolong plasma half life time such as modification of N- and C-terminus or PEGylation as well as methods to evaluate the effectiveness of drug modifications.  Furthermore, fundamental data about most important proteolytic enzymes of human blood, liver, and kidney as well as their cleavage specificity and inhibitors for them are provided to predict enzymic cleavage of peptide and protein drugs during systemic circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovVKc2VODC97Vg90H21EOLACvtfcHk0lii6EC7SDW_pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xls1egsrw%253D&md5=2e286c53028f38cfe33deef26bb160d0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs00726-005-0289-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-005-0289-3%26sid%3Dliteratum%253Aachs%26aulast%3DWerle%26aufirst%3DM.%26aulast%3DBernkop-Schn%25C3%25BCrch%26aufirst%3DA.%26atitle%3DStrategies%2520to%2520Improve%2520Plasma%2520Half%2520Life%2520Time%2520of%2520Peptide%2520and%2520Protein%2520Drugs%26jtitle%3DAmino%2520Acids%26date%3D2006%26volume%3D30%26issue%3D4%26spage%3D351%26epage%3D367%26doi%3D10.1007%2Fs00726-005-0289-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rand, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khunte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiowetz, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span> <span> </span><span class="NLM_article-title">Optimizing PK Properties of Cyclic Peptides: The Effect of Side Chain Substitutions on Permeability and Clearance</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1282</span>– <span class="NLM_lpage">1289</span>, <span class="refDoi"> DOI: 10.1039/C2MD20203D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC2MD20203D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=23133740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWns7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1282-1289&issue=10&author=A.+C.+Randauthor=S.+S.+F.+Leungauthor=H.+Engauthor=C.+J.+Rotterauthor=R.+Sharmaauthor=A.+S.+Kalgutkarauthor=Y.+Zhangauthor=M.+V.+Varmaauthor=K.+A.+Farleyauthor=B.+Khunteauthor=C.+Limberakisauthor=D.+A.+Priceauthor=S.+Lirasauthor=A.+M.+Mathiowetzauthor=M.+P.+Jacobsonauthor=R.+S.+Lokey&title=Optimizing+PK+Properties+of+Cyclic+Peptides%3A+The+Effect+of+Side+Chain+Substitutions+on+Permeability+and+Clearance&doi=10.1039%2FC2MD20203D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance</span></div><div class="casAuthors">Rand, Arthur C.; Leung, Siegfried S. F.; Eng, Heather; Rotter, Charles J.; Sharma, Raman; Kalgutkar, Amit S.; Zhang, Yizhong; Varma, Manthena V.; Farley, Kathleen A.; Khunte, Bhagyashree; Limberakis, Chris; Price, David A.; Liras, Spiros; Mathiowetz, Alan M.; Jacobson, Matthew P.; Lokey, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1282-1289</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of cyclic peptides were designed and prepd. to investigate the physicochem. properties that affect oral bioavailability of this chemotype in rats.  In particular, the ionization state of the peptide was examd. by the incorporation of naturally occurring amino acid residues that are charged in differing regions of the gut.  In addn., data was generated in a variety of in vitro assays and the usefulness of this data in predicting the subsequent oral bioavailability obsd. in the rat is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr-tYW5ziK7bVg90H21EOLACvtfcHk0likxhtSbGkLcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWns7%252FM&md5=fe1c9f3c7c3e6d48e4e11ee4b5818ef7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1039%2FC2MD20203D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2MD20203D%26sid%3Dliteratum%253Aachs%26aulast%3DRand%26aufirst%3DA.%2BC.%26aulast%3DLeung%26aufirst%3DS.%2BS.%2BF.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DRotter%26aufirst%3DC.%2BJ.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DFarley%26aufirst%3DK.%2BA.%26aulast%3DKhunte%26aufirst%3DB.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DMathiowetz%26aufirst%3DA.%2BM.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26atitle%3DOptimizing%2520PK%2520Properties%2520of%2520Cyclic%2520Peptides%253A%2520The%2520Effect%2520of%2520Side%2520Chain%2520Substitutions%2520on%2520Permeability%2520and%2520Clearance%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26issue%3D10%26spage%3D1282%26epage%3D1289%26doi%3D10.1039%2FC2MD20203D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. J.</span></span> <span> </span><span class="NLM_article-title">Potent Antibody Therapeutics by Design</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1038/nri1837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnri1837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=16622479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslOhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=343-357&issue=5&author=P.+J.+Carter&title=Potent+Antibody+Therapeutics+by+Design&doi=10.1038%2Fnri1837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Potent antibody therapeutics by design</span></div><div class="casAuthors">Carter, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">343-357</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibodies constitute the most rapidly growing class of human therapeutics and the second largest class of drugs after vaccines.  The generation of potent antibody therapeutics, reviewed here by the author, is an iterative design process that involves the generation and optimization of antibodies to improve their clin. potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnBlEa3XkH-rVg90H21EOLACvtfcHk0likxhtSbGkLcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslOhu7o%253D&md5=e7d506c0300d3700aefe04f2336878e2</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnri1837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1837%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DP.%2BJ.%26atitle%3DPotent%2520Antibody%2520Therapeutics%2520by%2520Design%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2006%26volume%3D6%26issue%3D5%26spage%3D343%26epage%3D357%26doi%3D10.1038%2Fnri1837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vasserot, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huse, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchester, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, J. D.</span></span> <span> </span><span class="NLM_article-title">Optimization of Protein Therapeutics by Directed Evolution</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(02)02590-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS1359-6446%2802%2902590-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=12568781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlyhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=118-126&issue=3&author=A.+P.+Vasserotauthor=C.+D.+Dickinsonauthor=Y.+Tangauthor=W.+D.+Huseauthor=K.+S.+Manchesterauthor=J.+D.+Watkins&title=Optimization+of+Protein+Therapeutics+by+Directed+Evolution&doi=10.1016%2FS1359-6446%2802%2902590-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of protein therapeutics by directed evolution</span></div><div class="casAuthors">Vasserot, Alain P.; Dickinson, Craig D.; Tang, Ying; Huse, William D.; Manchester, Keith S.; Watkins, Jeffry D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">118-126</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Directed evolution is a broadly applicable technol. platform that is ideally suited to address the need for protein optimization and to fully exploit the therapeutic potential of biologics.  The approach takes advantage of the remarkable structural and functional plasticity of proteins and permits the rapid remodeling of biologics into new entities with improved functions.  The ability to ameliorate virtually any characteristic of a protein can translate into significant clin. benefits, including decreased immunogenicity, higher potency, greater efficacy and improved safety profile, and can considerably increase the probability of successfully developing and commercializing biotherapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGritEbuoIROIrVg90H21EOLACvtfcHk0likxhtSbGkLcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlyhsg%253D%253D&md5=fc95c8f73ca12de4355a1cc9f55e29a8</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2802%2902590-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252802%252902590-4%26sid%3Dliteratum%253Aachs%26aulast%3DVasserot%26aufirst%3DA.%2BP.%26aulast%3DDickinson%26aufirst%3DC.%2BD.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DHuse%26aufirst%3DW.%2BD.%26aulast%3DManchester%26aufirst%3DK.%2BS.%26aulast%3DWatkins%26aufirst%3DJ.%2BD.%26atitle%3DOptimization%2520of%2520Protein%2520Therapeutics%2520by%2520Directed%2520Evolution%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26issue%3D3%26spage%3D118%26epage%3D126%26doi%3D10.1016%2FS1359-6446%2802%2902590-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaberc-Porekar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zore, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podobnik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menart, V.</span></span> <span> </span><span class="NLM_article-title">Obstacles and Pitfalls in the PEGylation of Therapeutic Proteins</span>. <i>Curr. Opin. Drug Discovery Devel.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">242</span>– <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=18283612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFektr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=242-250&issue=2&author=V.+Gaberc-Porekarauthor=I.+Zoreauthor=B.+Podobnikauthor=V.+Menart&title=Obstacles+and+Pitfalls+in+the+PEGylation+of+Therapeutic+Proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Obstacles and pitfalls in the PEGylation of therapeutic proteins</span></div><div class="casAuthors">Gaberc-Porekar, Vladka; Zore, Irena; Podobnik, Barbara; Menart, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">242-250</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  In recent years, PEGylation has become widely used as a post-prodn. modification methodol. for improving the biomedical efficacy and physicochem. properties of therapeutic proteins.  Several marketed drugs that have already been in use for more than a decade have proved the applicability and safety of this technol. and, with the successes already achieved, it is expected that PEGylation will be applied to other potential therapeutic proteins.  The non-biodegradable nature of PEG, however, may become a limiting factor for the next generation of protein pharmaceuticals, for which use in high concns. and in the long term is the aim, esp. considering the trend for the use of branched and high mol. mass PEGs.  This review addresses various obstacles and pitfalls in the prodn. of PEGylated biopharmaceuticals, in particular, the specificity of PEGylation reactions, sepn. and purifn. issues, the anal. of inherently polydisperse PEG reagents and PEGylated products, the consistency of products and processes, and the accurate detn. of pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzMDn_6Ri_tLVg90H21EOLACvtfcHk0likxhtSbGkLcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFektr8%253D&md5=01d9ff6b0f69299ea8cf1ed2b2db74a7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaberc-Porekar%26aufirst%3DV.%26aulast%3DZore%26aufirst%3DI.%26aulast%3DPodobnik%26aufirst%3DB.%26aulast%3DMenart%26aufirst%3DV.%26atitle%3DObstacles%2520and%2520Pitfalls%2520in%2520the%2520PEGylation%2520of%2520Therapeutic%2520Proteins%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Devel.%26date%3D2008%26volume%3D11%26issue%3D2%26spage%3D242%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dozier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distefano, M.</span></span> <span> </span><span class="NLM_article-title">Site-Specific PEGylation of Therapeutic Proteins</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">25831</span>– <span class="NLM_lpage">25864</span>, <span class="refDoi"> DOI: 10.3390/ijms161025831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.3390%2Fijms161025831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26516849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFaltrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=25831-25864&issue=10&author=J.+Dozierauthor=M.+Distefano&title=Site-Specific+PEGylation+of+Therapeutic+Proteins&doi=10.3390%2Fijms161025831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific pegylation of therapeutic proteins</span></div><div class="casAuthors">Dozier, Jonathan K.; Distefano, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">25831-25864</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The use of proteins as therapeutics has a long history and is becoming ever more common in modern medicine.  While the no. of protein-based drugs is growing every year, significant problems still remain with their use.  Among these problems are rapid degrdn. and excretion from patients, thus requiring frequent dosing, which in turn increases the chances for an immunol. response as well as increasing the cost of therapy.  One of the main strategies to alleviate these problems is to link a polyethylene glycol (PEG) group to the protein of interest.  This process, called PEGylation, has grown dramatically in recent years resulting in several approved drugs.  Installing a single PEG chain at a defined site in a protein is challenging.  Recently, there is has been considerable research into various methods for the site-specific PEGylation of proteins.  This review seeks to summarize that work and provide background and context for how site-specific PEGylation is performed.  After introducing the topic of site-specific PEGylation, recent developments using chem. methods are described.  That is followed by a more extensive discussion of bioorthogonal reactions and enzymic labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqamy1V2rUeIbVg90H21EOLACvtfcHk0liWw45efGTDDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFaltrfF&md5=e07d153e16a67da1e929964ec7ba01bf</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3390%2Fijms161025831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms161025831%26sid%3Dliteratum%253Aachs%26aulast%3DDozier%26aufirst%3DJ.%26aulast%3DDistefano%26aufirst%3DM.%26atitle%3DSite-Specific%2520PEGylation%2520of%2520Therapeutic%2520Proteins%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2015%26volume%3D16%26issue%3D10%26spage%3D25831%26epage%3D25864%26doi%3D10.3390%2Fijms161025831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cal, P. M. S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, G. J. L.</span></span> <span> </span><span class="NLM_article-title">Contemporary Approaches to Site-Selective Protein Modification</span>. <i>Nat. Rev. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1038/s41570-019-0079-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fs41570-019-0079-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsFCks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2019&pages=147-171&issue=3&author=E.+A.+Hoytauthor=P.+M.+S.+D.+Calauthor=B.+L.+Oliveiraauthor=G.+J.+L.+Bernardes&title=Contemporary+Approaches+to+Site-Selective+Protein+Modification&doi=10.1038%2Fs41570-019-0079-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Contemporary approaches to site-selective protein modification</span></div><div class="casAuthors">Hoyt, Emily A.; Cal, Pedro M. S. D.; Oliveira, Bruno L.; Bernardes, Goncalo J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">147-171</span>CODEN:
                <span class="NLM_cas:coden">NRCAF7</span>;
        ISSN:<span class="NLM_cas:issn">2397-3358</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Proteins constitute the majority of nature's worker biomols.  Designed for specific functions, complex tertiary structures make proteins ideal candidates for analyzing natural systems and creating novel biol. tools.  Owing to both their large size and the need for proper folding, de novo synthesis of proteins has been quite a challenge, leading scientists to focus on modifying protein templates already provided by nature.  Recently developed methods for protein modification fall into two broad categories: those that can modify the natural protein template directly and those that require genetic manipulation of the amino acid sequence before modification.  The goal of this Review is not only to provide a window through which to view the many opportunities created by novel protein modification techniques, but also to act as an initial guide to help scientists find direction and form ideas in an ever-growing field.  In addn. to highlighting methods reported in the past 5 years, we aim to provide a broader sense of the goals and outcomes of protein modification and bioconjugation in general.  While the main body of this paper comprises reactions involving the direct modification of expressed proteins, some further functionalization strategies as well as biol. applications are also acknowledged.  The discussion concludes by speculating which trends and discoveries will most likely come next in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt5DtfV3-IWbVg90H21EOLACvtfcHk0liWw45efGTDDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsFCks7o%253D&md5=b08dabd1a572061e988c0ee1d64d71d2</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fs41570-019-0079-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41570-019-0079-1%26sid%3Dliteratum%253Aachs%26aulast%3DHoyt%26aufirst%3DE.%2BA.%26aulast%3DCal%26aufirst%3DP.%2BM.%2BS.%2BD.%26aulast%3DOliveira%26aufirst%3DB.%2BL.%26aulast%3DBernardes%26aufirst%3DG.%2BJ.%2BL.%26atitle%3DContemporary%2520Approaches%2520to%2520Site-Selective%2520Protein%2520Modification%26jtitle%3DNat.%2520Rev.%2520Chem.%26date%3D2019%26volume%3D3%26issue%3D3%26spage%3D147%26epage%3D171%26doi%3D10.1038%2Fs41570-019-0079-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">deGruyter, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malins, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Residue-Specific Peptide Modification: A Chemist’s Guide</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">30</span>),  <span class="NLM_fpage">3863</span>– <span class="NLM_lpage">3873</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.7b00536</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.7b00536" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKisLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=3863-3873&issue=30&author=J.+N.+deGruyterauthor=L.+R.+Malinsauthor=P.+S.+Baran&title=Residue-Specific+Peptide+Modification%3A+A+Chemist%E2%80%99s+Guide&doi=10.1021%2Facs.biochem.7b00536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Residue-Specific Peptide Modification: A Chemist's Guide</span></div><div class="casAuthors">deGruyter, Justine N.; Malins, Lara R.; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">3863-3873</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Advances in bioconjugation and native protein modification are appearing at a blistering pace, making it increasingly time consuming for practitioners to identify the best chem. method to modify a specific amino acid residue in a complex setting.  The purpose of this perspective is to provide an informative, graphically rich manual highlighting significant advances in the field over the past decade.  This guide will help triage candidate methods for peptide alteration, and will serve as a starting point for those seeking to solve longstanding challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqGLA9b0u-FbVg90H21EOLACvtfcHk0liWw45efGTDDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKisLfK&md5=cb0a794b5077461762fd9fa43f4f39c2</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.7b00536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.7b00536%26sid%3Dliteratum%253Aachs%26aulast%3DdeGruyter%26aufirst%3DJ.%2BN.%26aulast%3DMalins%26aufirst%3DL.%2BR.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DResidue-Specific%2520Peptide%2520Modification%253A%2520A%2520Chemist%25E2%2580%2599s%2520Guide%26jtitle%3DBiochemistry%26date%3D2017%26volume%3D56%26issue%3D30%26spage%3D3863%26epage%3D3873%26doi%3D10.1021%2Facs.biochem.7b00536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kölmel, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacMillan, D. W. C.</span></span> <span> </span><span class="NLM_article-title">Decarboxylative Alkylation for Site-Selective Bioconjugation of Native Proteins via Oxidation Potentials</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1038/nchem.2888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnchem.2888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=29359756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=205-211&issue=2&author=S.+Bloomauthor=C.+Liuauthor=D.+K.+K%C3%B6lmelauthor=J.+X.+Qiaoauthor=Y.+Zhangauthor=M.+A.+Possauthor=W.+R.+Ewingauthor=D.+W.+C.+MacMillan&title=Decarboxylative+Alkylation+for+Site-Selective+Bioconjugation+of+Native+Proteins+via+Oxidation+Potentials&doi=10.1038%2Fnchem.2888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Decarboxylative alkylation for site-selective bioconjugation of native proteins via oxidation potentials</span></div><div class="casAuthors">Bloom, Steven; Liu, Chun; Kolmel, Dominik K.; Qiao, Jennifer X.; Zhang, Yong; Poss, Michael A.; Ewing, William R.; MacMillan, David W. C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-211</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The advent of antibody-drug conjugates as pharmaceuticals has fueled a need for reliable methods of site-selective protein modification that furnish homogeneous adducts.  Although bioorthogonal methods that use engineered amino acids often provide an elegant soln. to the question of selective functionalization, achieving homogeneity using native amino acids remains a challenge.  Here, the authors explore visible-light-mediated single-electron transfer as a mechanism towards enabling site- and chemoselective bioconjugation.  Specifically, the authors demonstrate the use of photoredox catalysis as a platform to selectivity wherein the discrepancy in oxidn. potentials between internal vs. C-terminal carboxylates can be exploited towards obtaining C-terminal functionalization exclusively.  This oxidn. potential-gated technol. is amenable to endogenous peptides and has been successfully demonstrated on the protein insulin.  As a fundamentally new approach to bioconjugation this methodol. provides a blueprint toward the development of photoredox catalysis as a generic platform to target other redox-active side chains for native conjugation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiy7-ViSoLeLVg90H21EOLACvtfcHk0lihHy0DzacqwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsrjJ&md5=a5f8b7f701329a625221c77280243746</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2888%26sid%3Dliteratum%253Aachs%26aulast%3DBloom%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DK%25C3%25B6lmel%26aufirst%3DD.%2BK.%26aulast%3DQiao%26aufirst%3DJ.%2BX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26aulast%3DMacMillan%26aufirst%3DD.%2BW.%2BC.%26atitle%3DDecarboxylative%2520Alkylation%2520for%2520Site-Selective%2520Bioconjugation%2520of%2520Native%2520Proteins%2520via%2520Oxidation%2520Potentials%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26issue%3D2%26spage%3D205%26epage%3D211%26doi%3D10.1038%2Fnchem.2888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imiołek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karunanithy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouverneur, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span> <span> </span><span class="NLM_article-title">Selective Radical Trifluoromethylation of Native Residues in Proteins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1568</span>– <span class="NLM_lpage">1571</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b10230</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b10230" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksVOitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=1568-1571&issue=5&author=M.+Imio%C5%82ekauthor=G.+Karunanithyauthor=W.-L.+Ngauthor=A.+J.+Baldwinauthor=V.+Gouverneurauthor=B.+G.+Davis&title=Selective+Radical+Trifluoromethylation+of+Native+Residues+in+Proteins&doi=10.1021%2Fjacs.7b10230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Radical Trifluoromethylation of Native Residues in Proteins</span></div><div class="casAuthors">Imiolek, Mateusz; Karunanithy, Gogulan; Ng, Wai-Lung; Baldwin, Andrew J.; Gouverneur, Veronique; Davis, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1568-1571</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The incorporation of fluorine can not only significantly facilitate the study of proteins but also potentially modulate their function.  Though some biosynthetic methods allow global residue-replacement, post-translational fluorine incorporation would constitute a fast and efficient alternative.  Here, the authors reveal a mild method for direct protein radical trifluoromethylation at native residues as a strategy for sym.-multifluorine incorporation on mg scales with high recoveries.  High selectivity toward tryptophan residues enhanced the utility of this direct trifluoromethylation technique allowing ready study of fluorinated protein constructs using 19F-NMR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh-m_zVIPb8bVg90H21EOLACvtfcHk0lihHy0DzacqwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksVOitQ%253D%253D&md5=87aeeae802829e661c71ab37374edda4</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b10230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b10230%26sid%3Dliteratum%253Aachs%26aulast%3DImio%25C5%2582ek%26aufirst%3DM.%26aulast%3DKarunanithy%26aufirst%3DG.%26aulast%3DNg%26aufirst%3DW.-L.%26aulast%3DBaldwin%26aufirst%3DA.%2BJ.%26aulast%3DGouverneur%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DB.%2BG.%26atitle%3DSelective%2520Radical%2520Trifluoromethylation%2520of%2520Native%2520Residues%2520in%2520Proteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D5%26spage%3D1568%26epage%3D1571%26doi%3D10.1021%2Fjacs.7b10230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vantourout, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adusumalli, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knouse, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flood, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padial, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istrate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maziarz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGruyter, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deery, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastgate, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, G. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Serine-Selective Bioconjugation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">17236</span>– <span class="NLM_lpage">17242</span>, <span class="refDoi"> DOI: 10.1021/jacs.0c05595</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.0c05595" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvV2ns7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2020&pages=17236-17242&issue=41&author=J.+C.+Vantouroutauthor=S.+R.+Adusumalliauthor=K.+W.+Knouseauthor=D.+T.+Floodauthor=A.+Ramirezauthor=N.+M.+Padialauthor=A.+Istrateauthor=K.+Maziarzauthor=J.+N.+DeGruyterauthor=R.+R.+Merchantauthor=J.+X.+Qiaoauthor=M.+A.+Schmidtauthor=M.+J.+Deeryauthor=M.+D.+Eastgateauthor=P.+E.+Dawsonauthor=G.+J.+L.+Bernardesauthor=P.+S.+Baran&title=Serine-Selective+Bioconjugation&doi=10.1021%2Fjacs.0c05595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Serine-Selective Bioconjugation</span></div><div class="casAuthors">Vantourout, Julien C.; Adusumalli, Srinivasa Rao; Knouse, Kyle W.; Flood, Dillon T.; Ramirez, Antonio; Padial, Natalia M.; Istrate, Alena; Maziarz, Katarzyna; deGruyter, Justine N.; Merchant, Rohan R.; Qiao, Jennifer X.; Schmidt, Michael A.; Deery, Michael J.; Eastgate, Martin D.; Dawson, Philip E.; Bernardes, Goncalo J. L.; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">17236-17242</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This Communication reports the first general method for rapid, chemoselective, and modular functionalization of serine residues in native polypeptides, which uses a reagent platform based on the P(V) oxidn. state.  This redox-economical approach can be used to append nearly any kind of cargo onto serine, generating a stable, benign, and hydrophilic phosphorothioate linkage.  The method tolerates all other known nucleophilic functional groups of naturally occurring proteinogenic amino acids.  A variety of applications can be envisaged by this expansion of the toolbox of site-selective bioconjugation methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolJdbCZc8hFrVg90H21EOLACvtfcHk0lihHy0DzacqwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvV2ns7%252FF&md5=82cfa0521bc91128872572324af57553</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjacs.0c05595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.0c05595%26sid%3Dliteratum%253Aachs%26aulast%3DVantourout%26aufirst%3DJ.%2BC.%26aulast%3DAdusumalli%26aufirst%3DS.%2BR.%26aulast%3DKnouse%26aufirst%3DK.%2BW.%26aulast%3DFlood%26aufirst%3DD.%2BT.%26aulast%3DRamirez%26aufirst%3DA.%26aulast%3DPadial%26aufirst%3DN.%2BM.%26aulast%3DIstrate%26aufirst%3DA.%26aulast%3DMaziarz%26aufirst%3DK.%26aulast%3DDeGruyter%26aufirst%3DJ.%2BN.%26aulast%3DMerchant%26aufirst%3DR.%2BR.%26aulast%3DQiao%26aufirst%3DJ.%2BX.%26aulast%3DSchmidt%26aufirst%3DM.%2BA.%26aulast%3DDeery%26aufirst%3DM.%2BJ.%26aulast%3DEastgate%26aufirst%3DM.%2BD.%26aulast%3DDawson%26aufirst%3DP.%2BE.%26aulast%3DBernardes%26aufirst%3DG.%2BJ.%2BL.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DSerine-Selective%2520Bioconjugation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2020%26volume%3D142%26issue%3D41%26spage%3D17236%26epage%3D17242%26doi%3D10.1021%2Fjacs.0c05595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhanjee, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buslov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windsor, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raines, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentelute, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">Palladium-Protein Oxidative Addition Complexes by Amine-Selective Acylation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">21237</span>– <span class="NLM_lpage">21242</span>, <span class="refDoi"> DOI: 10.1021/jacs.0c09180</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.0c09180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFOmurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2020&pages=21237-21242&issue=51&author=H.+H.+Dhanjeeauthor=I.+Buslovauthor=I.+W.+Windsorauthor=R.+T.+Rainesauthor=B.+L.+Penteluteauthor=S.+L.+Buchwald&title=Palladium-Protein+Oxidative+Addition+Complexes+by+Amine-Selective+Acylation&doi=10.1021%2Fjacs.0c09180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Protein Oxidative Addition Complexes by Amine-Selective Acylation</span></div><div class="casAuthors">Dhanjee, Heemal H.; Buslov, Ivan; Windsor, Ian W.; Raines, Ronald T.; Pentelute, Bradley L.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">21237-21242</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Palladium oxidative addn. complexes (OACs) are traditionally accessed by treating an aryl halide-contg. substrate with a palladium(0) source.  Here, a new strategy to selectively prep. stable OACs from amino groups on native proteins is presented.  The approach relies on an amine-selective acylation reaction that occurs without modification of a preformed palladium(II)-aryl group.  Once transferred onto a protein substrate, the palladium(II)-aryl group facilitates conjugation by undergoing reaction with a second, cysteine-contg. protein.  This operationally simple method is applicable to native, nonengineered enzymes as well as antibodies and is carried out in an aq. setting and open to air.  The resulting Pd-protein OACs are stable, storable reagents that retain biol. activity and can be used to achieve protein-protein cross-coupling at nanomolar concns. within hours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8uh91DRqw-LVg90H21EOLACvtfcHk0lhqXaIbpx2MtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFOmurvK&md5=290e986b0af0ed723d03bf24f29a3ce9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjacs.0c09180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.0c09180%26sid%3Dliteratum%253Aachs%26aulast%3DDhanjee%26aufirst%3DH.%2BH.%26aulast%3DBuslov%26aufirst%3DI.%26aulast%3DWindsor%26aufirst%3DI.%2BW.%26aulast%3DRaines%26aufirst%3DR.%2BT.%26aulast%3DPentelute%26aufirst%3DB.%2BL.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-Protein%2520Oxidative%2520Addition%2520Complexes%2520by%2520Amine-Selective%2520Acylation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2020%26volume%3D142%26issue%3D51%26spage%3D21237%26epage%3D21242%26doi%3D10.1021%2Fjacs.0c09180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
la Torre, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J. W.</span></span> <span> </span><span class="NLM_article-title">Reprogramming the Genetic Code</span>. <i>Nat. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1038/s41576-020-00307-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fs41576-020-00307-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=33318706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXis1SgsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2021&pages=169-184&issue=3&author=D.+de%0Ala+Torreauthor=J.+W.+Chin&title=Reprogramming+the+Genetic+Code&doi=10.1038%2Fs41576-020-00307-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Reprogramming the genetic code</span></div><div class="casAuthors">de la Torre, Daniel; Chin, Jason W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-184</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The encoded biosynthesis of proteins provides the ultimate paradigm for high-fidelity synthesis of long polymers of defined sequence and compn., but it is limited to polymg. the canonical amino acids.  Recent advances have built on genetic code expansion - which commonly permits the cellular incorporation of one type of non-canonical amino acid into a protein - to enable the encoded incorporation of several distinct non-canonical amino acids.  Developments include strategies to read quadruplet codons, use non-natural DNA base pairs, synthesize completely recoded genomes and create orthogonal translational components with reprogrammed specificities.  These advances may enable the genetically encoded synthesis of non-canonical biopolymers and provide a platform for transforming the discovery and evolution of new materials and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJFC6TSU507rVg90H21EOLACvtfcHk0lhqXaIbpx2MtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXis1SgsrfF&md5=a39d44aec6176822c98b73c20053d0f6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fs41576-020-00307-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41576-020-00307-7%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Bla%2BTorre%26aufirst%3DD.%26aulast%3DChin%26aufirst%3DJ.%2BW.%26atitle%3DReprogramming%2520the%2520Genetic%2520Code%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2021%26volume%3D22%26issue%3D3%26spage%3D169%26epage%3D184%26doi%3D10.1038%2Fs41576-020-00307-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, J. W.</span></span> <span> </span><span class="NLM_article-title">Cellular Incorporation of Unnatural Amino Acids and Bioorthogonal Labeling of Proteins</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4764</span>– <span class="NLM_lpage">4806</span>, <span class="refDoi"> DOI: 10.1021/cr400355w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400355w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslamtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=4764-4806&issue=9&author=K.+Langauthor=J.+W.+Chin&title=Cellular+Incorporation+of+Unnatural+Amino+Acids+and+Bioorthogonal+Labeling+of+Proteins&doi=10.1021%2Fcr400355w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Incorporation of Unnatural Amino Acids and Bioorthogonal Labeling of Proteins</span></div><div class="casAuthors">Lang, Kathrin; Chin, Jason W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4764-4806</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A range of bioorthogonal reactions are described and methods discussed include the cellular cotranslational incorporation of unnatural amino acids bearing bioorthogonal functionalities into proteins via residue-specific or site-specific approaches.  Applications of residue-specific incorporation and labeling and developments of site-specific incorporation and labeling are outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf78CtJ7B0jbVg90H21EOLACvtfcHk0lhVtvjcbNZ_wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslamtrY%253D&md5=bbb5b3099d3fccf801262e6b0d51676b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fcr400355w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400355w%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DK.%26aulast%3DChin%26aufirst%3DJ.%2BW.%26atitle%3DCellular%2520Incorporation%2520of%2520Unnatural%2520Amino%2520Acids%2520and%2520Bioorthogonal%2520Labeling%2520of%2520Proteins%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26issue%3D9%26spage%3D4764%26epage%3D4806%26doi%3D10.1021%2Fcr400355w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suazo, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distefano, M. D.</span></span> <span> </span><span class="NLM_article-title">Recent Progress in Enzymatic Protein Labelling Techniques and Their Applications</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">9106</span>– <span class="NLM_lpage">9136</span>, <span class="refDoi"> DOI: 10.1039/C8CS00537K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC8CS00537K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=30259933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWhur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=9106-9136&issue=24&author=Y.+Zhangauthor=K.-Y.+Parkauthor=K.+F.+Suazoauthor=M.+D.+Distefano&title=Recent+Progress+in+Enzymatic+Protein+Labelling+Techniques+and+Their+Applications&doi=10.1039%2FC8CS00537K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in enzymatic protein labelling techniques and their applications</span></div><div class="casAuthors">Zhang, Yi; Park, Keun-Young; Suazo, Kiall F.; Distefano, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9106-9136</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Protein-based conjugates are valuable constructs for a variety of applications.  Conjugation of proteins to fluorophores is commonly used to study their cellular localization and the protein-protein interactions.  Modification of therapeutic proteins with either polymers or cytotoxic moieties greatly enhances their pharmacokinetics or potency.  To label a protein of interest, conventional direct chem. reaction with the side-chains of native amino acids often yields heterogeneously modified products.  This renders their characterization complicated, requires difficult sepn. steps and may impact protein function.  Although modification can also be achieved via the insertion of unnatural amino acids bearing bioorthogonal functional groups, these methods can have lower protein expression yields, limiting large scale prodn.  As a site-specific modification method, enzymic protein labeling is highly efficient and robust under mild reaction conditions.  Significant progress has been made over the last five years in modifying proteins using enzymic methods for numerous applications, including the creation of clin. relevant conjugates with polymers, cytotoxins or imaging agents, fluorescent or affinity probes to study complex protein interaction networks, and protein-linked materials for biosensing.  This review summarizes developments in enzymic protein labeling over the last five years for a panel of ten enzymes, including sortase A, subtiligase, microbial transglutaminase, farnesyltransferase, N-myristoyltransferase, phosphopantetheinyl transferases, tubulin tyrosin ligase, lipoic acid ligase, biotin ligase and formylglycine generating enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSxSaDWbYK87Vg90H21EOLACvtfcHk0lhVtvjcbNZ_wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWhur7L&md5=4b7ebe718b06c70590cbeb8e96819a72</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1039%2FC8CS00537K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CS00537K%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DK.-Y.%26aulast%3DSuazo%26aufirst%3DK.%2BF.%26aulast%3DDistefano%26aufirst%3DM.%2BD.%26atitle%3DRecent%2520Progress%2520in%2520Enzymatic%2520Protein%2520Labelling%2520Techniques%2520and%2520Their%2520Applications%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2018%26volume%3D47%26issue%3D24%26spage%3D9106%26epage%3D9136%26doi%3D10.1039%2FC8CS00537K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disotuar, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, D. H.-C.</span></span> <span> </span><span class="NLM_article-title">Selective N-Terminal Functionalization of Native Peptides and Proteins</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">2717</span>– <span class="NLM_lpage">2722</span>, <span class="refDoi"> DOI: 10.1039/C6SC04744K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC6SC04744K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=28553506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltlCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=2717-2722&issue=4&author=D.+Chenauthor=M.+M.+Disotuarauthor=X.+Xiongauthor=Y.+Wangauthor=D.+H.-C.+Chou&title=Selective+N-Terminal+Functionalization+of+Native+Peptides+and+Proteins&doi=10.1039%2FC6SC04744K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Selective N-terminal functionalization of native peptides and proteins</span></div><div class="casAuthors">Chen, Diao; Disotuar, Maria M.; Xiong, Xiaochun; Wang, Yuanxiang; Chou, Danny Hung-Chieh</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2717-2722</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report an efficient, highly selective modification on the N-terminal amines of peptides and proteins using aldehyde derivs. via reductive alkylation.  After modification of a library of unprotected peptides XYSKEASAL (X varies over 20 natural amino acids) by benzaldehyde at room temp., pH 6.1 resulted in excellent N-terminal selectivity (α-amino/ε-amino: >99 : 1) and high reaction conversion for 19 out of the 20 peptides.  Under similar conditions, highly selective N-terminal modifications were achieved with a variety of aldehydes.  Furthermore, N-termini of native peptides and proteins could be selectively modified under the same conditions to introduce bioorthogonal functional groups.  Using human insulin as an example, we further demonstrated that preserving the pos. charge in the N-terminus using reductive alkylation instead of acylation leads to a 5-fold increase in bioactivity.  In summary, our reported method provides a universal strategy for site-selective N-terminal functionalization in native peptides and proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomrguLnvsfDbVg90H21EOLACvtfcHk0lhVtvjcbNZ_wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltlCgtQ%253D%253D&md5=3d3b5a3c8b73f72d0526fda0145a78f0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1039%2FC6SC04744K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC04744K%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DDisotuar%26aufirst%3DM.%2BM.%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChou%26aufirst%3DD.%2BH.-C.%26atitle%3DSelective%2520N-Terminal%2520Functionalization%2520of%2520Native%2520Peptides%2520and%2520Proteins%26jtitle%3DChem.%2520Sci.%26date%3D2017%26volume%3D8%26issue%3D4%26spage%3D2717%26epage%3D2722%26doi%3D10.1039%2FC6SC04744K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petter, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arduini, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brickelmaier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepinsky, R. B.</span></span> <span> </span><span class="NLM_article-title">N-Terminally PEGylated Human Interferon-β-1a with Improved Pharmacokinetic Properties and in Vivo Efficacy in a Melanoma Angiogenesis Model</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1021/bc050237q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc050237q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1KktrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=179-188&issue=1&author=D.+P.+Bakerauthor=E.+Y.+Linauthor=K.+Linauthor=M.+Pellegriniauthor=R.+C.+Petterauthor=L.+L.+Chenauthor=R.+M.+Arduiniauthor=M.+Brickelmaierauthor=D.+Wenauthor=D.+M.+Hessauthor=L.+Chenauthor=D.+Grantauthor=A.+Whittyauthor=A.+Gillauthor=D.+J.+Lindnerauthor=R.+B.+Pepinsky&title=N-Terminally+PEGylated+Human+Interferon-%CE%B2-1a+with+Improved+Pharmacokinetic+Properties+and+in+Vivo+Efficacy+in+a+Melanoma+Angiogenesis+Model&doi=10.1021%2Fbc050237q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">N-Terminally PEGylated Human Interferon-β-1a with Improved Pharmacokinetic Properties and in Vivo Efficacy in a Melanoma Angiogenesis Model</span></div><div class="casAuthors">Baker, Darren P.; Lin, Edward Y.; Lin, KoChung; Pellegrini, Maria; Petter, Russell C.; Chen, Ling Ling; Arduini, Robert M.; Brickelmaier, Margot; Wen, Dingyi; Hess, Donna M.; Chen, Liqing; Grant, Donna; Whitty, Adrian; Gill, Alan; Lindner, Daniel J.; Pepinsky, R. Blake</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-188</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PEGylation of IFN-α has been used successfully to improve the pharmacokinetic properties and efficacy of the drug.  To prep. a PEGylated form of human interferon-β-1a (IFN-β-1a) suitable for testing in vivo, the authors have synthesized 20 kDa mPEG-O-2-methylpropionaldehyde and used it to modify the N-terminal α-amino group of the cytokine.  The PEGylated protein retained ∼50% of the activity of the unmodified protein and had significantly improved pharmacokinetic properties following i.v. administration in rats.  The clearance and vol. of distribution at steady state were reduced ∼30-fold and ∼4-fold, resp., resulting in a significant increase in systemic exposure as detd. by the area under the curve.  The elimination half-life of the PEGylated protein was ∼13-fold greater than for the unmodified protein.  The unmodified and PEGylated proteins were tested for their ability to inhibit the formation of radially oriented blood vessels entering the periphery of human SK-MEL-1 melanoma tumors in athymic nude homozygous (nu/nu) mice.  In a single dose comparison study, administration of 1×106 units of unmodified IFN-β-1a resulted in a 29% redn. in vessel no., while 1×106 units of PEGylated IFN-β-1a resulted in a 58% redn.  Both treatments resulted in statistically significant redns. in mean vessel no. as compared to the vehicle (control)-treated mice, with the PEGylated IFN-β-1a-treated mice showing a statistically significantly greater redn. in mean vessel no. as compared to the unmodified IFN-β-1a-treated mice.  In a multiple vs. single dose comparison study, daily administration of 1×106 units of unmodified IFN-β-1a for 9 days resulted in a 51% redn. in vessel no., while a single dose of 1×106 units of the PEGylated protein resulted in a 66% redn.  Both treatments resulted in statistically significant redns. in mean vessel no. as compared to the vehicle-treated mice, with the PEGylated IFN-β-1a-treated mice showing a statistically significantly greater redn. in mean vessel no. as compared to the unmodified IFN-β-1a-treated mice.  Therefore, the improved pharmacokinetic properties of the modified protein translated into improved efficacy.  Since unmodified IFN-β is used for the treatment of multiple sclerosis and hepatitis C virus infection, a PEGylated form of the protein such as 20 kDa mPEG-O-2-methylpropionaldehyde-modified IFN-β-1a may serve as a useful adjunct for the treatment of these diseases.  In addn., the antiangiogenic effects of PEGylated IFN-β-1a may be harnessed for the treatment of certain cancers, either as a sole agent or in combination with other antitumor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBICklCkZ7QLVg90H21EOLACvtfcHk0ljP_DcMlJIPUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1KktrrM&md5=20ca130e0d26f9f2b484379f4d870eef</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fbc050237q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc050237q%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DD.%2BP.%26aulast%3DLin%26aufirst%3DE.%2BY.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DPellegrini%26aufirst%3DM.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DChen%26aufirst%3DL.%2BL.%26aulast%3DArduini%26aufirst%3DR.%2BM.%26aulast%3DBrickelmaier%26aufirst%3DM.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DHess%26aufirst%3DD.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrant%26aufirst%3DD.%26aulast%3DWhitty%26aufirst%3DA.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DLindner%26aufirst%3DD.%2BJ.%26aulast%3DPepinsky%26aufirst%3DR.%2BB.%26atitle%3DN-Terminally%2520PEGylated%2520Human%2520Interferon-%25CE%25B2-1a%2520with%2520Improved%2520Pharmacokinetic%2520Properties%2520and%2520in%2520Vivo%2520Efficacy%2520in%2520a%2520Melanoma%2520Angiogenesis%2520Model%26jtitle%3DBioconjugate%2520Chem.%26date%3D2006%26volume%3D17%26issue%3D1%26spage%3D179%26epage%3D188%26doi%3D10.1021%2Fbc050237q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minus, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abernathy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, Z. T.</span></span> <span> </span><span class="NLM_article-title">Histidine-Directed Arylation/Alkenylation of Backbone N-H Bonds Mediated by Copper(II)</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7472</span>– <span class="NLM_lpage">7475</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b03390</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b03390" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVKrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=7472-7475&issue=24&author=J.+Ohataauthor=M.+B.+Minusauthor=M.+E.+Abernathyauthor=Z.+T.+Ball&title=Histidine-Directed+Arylation%2FAlkenylation+of+Backbone+N-H+Bonds+Mediated+by+Copper%28II%29&doi=10.1021%2Fjacs.6b03390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Histidine-directed arylation/alkenylation of backbone N-H bonds mediated by copper(II)</span></div><div class="casAuthors">Ohata, Jun; Minus, Matthew B.; Abernathy, Morgan E.; Ball, Zachary T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7472-7475</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chem. modification of proteins and peptides represents a challenge of reaction design as well as an important biol. tool.  In contrast to side-chain modification, synthetic methods to alter backbone structure are extremely limited.  In this communication, copper-mediated backbone N-alkenylation or N-arylation of peptides and proteins by direct modification of natural sequences is described.  Histidine residues direct oxidative coupling of boronic acids at the backbone NH of a neighboring amino acid.  The mild reaction conditions in common physiol. buffers, at ambient temp., are compatible with proteins and biol. systems.  This simple reaction demonstrates the potential for directed reactions in complex systems to allow modification of N-H bonds that directly affect polypeptide structure, stability, and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXQ-5qVYtGZ7Vg90H21EOLACvtfcHk0ljP_DcMlJIPUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVKrur4%253D&md5=fe5570c124808c522ec7fc886763c945</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b03390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b03390%26sid%3Dliteratum%253Aachs%26aulast%3DOhata%26aufirst%3DJ.%26aulast%3DMinus%26aufirst%3DM.%2BB.%26aulast%3DAbernathy%26aufirst%3DM.%2BE.%26aulast%3DBall%26aufirst%3DZ.%2BT.%26atitle%3DHistidine-Directed%2520Arylation%252FAlkenylation%2520of%2520Backbone%2520N-H%2520Bonds%2520Mediated%2520by%2520Copper%2528II%2529%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26issue%3D24%26spage%3D7472%26epage%3D7475%26doi%3D10.1021%2Fjacs.6b03390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, T.</span></span> <span> </span><span class="NLM_article-title">Photo-Induced Coupling Reactions of Tetrazoles with Carboxylic Acids in Aqueous Solution: Application in Protein Labelling</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">4702</span>– <span class="NLM_lpage">4705</span>, <span class="refDoi"> DOI: 10.1039/C5CC10445A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC5CC10445A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26953773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1ejs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=4702-4705&issue=25&author=S.+Zhaoauthor=J.+Daiauthor=M.+Huauthor=C.+Liuauthor=R.+Mengauthor=X.+Liuauthor=C.+Wangauthor=T.+Luo&title=Photo-Induced+Coupling+Reactions+of+Tetrazoles+with+Carboxylic+Acids+in+Aqueous+Solution%3A+Application+in+Protein+Labelling&doi=10.1039%2FC5CC10445A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Photo-induced coupling reactions of tetrazoles with carboxylic acids in aqueous solution: application in protein labeling</span></div><div class="casAuthors">Zhao, Shan; Dai, Jianye; Hu, Mo; Liu, Chang; Meng, Rong; Liu, Xiaoyun; Wang, Chu; Luo, Tuoping</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4702-4705</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The photo-induced reactions of diaryltetrazoles with carboxylic acids in aq. soln. were studied.  Besides measuring the apparent second-order rate const. and evaluating the functional group compatibility of these reactions, the authors further incorporated the tetrazoles into SAHA, leading to a new active-site-directed probe for labeling HDACs in both cell lysates and living cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF0HDgo-LCF7Vg90H21EOLACvtfcHk0lg47sI8goJ5Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1ejs78%253D&md5=09c69da8265c035f3dcd8000d298c0b8</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1039%2FC5CC10445A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC10445A%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMeng%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DT.%26atitle%3DPhoto-Induced%2520Coupling%2520Reactions%2520of%2520Tetrazoles%2520with%2520Carboxylic%2520Acids%2520in%2520Aqueous%2520Solution%253A%2520Application%2520in%2520Protein%2520Labelling%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26issue%3D25%26spage%3D4702%26epage%3D4705%26doi%3D10.1039%2FC5CC10445A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, A.</span></span> <span> </span><span class="NLM_article-title">Electrochemical Oxidation Induced Selective Tyrosine Bioconjugation for the Modification of Biomolecules</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">7982</span>– <span class="NLM_lpage">7987</span>, <span class="refDoi"> DOI: 10.1039/C9SC02218J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC9SC02218J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31673320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlaltrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=7982-7987&issue=34&author=C.+Songauthor=K.+Liuauthor=Z.+Wangauthor=B.+Dingauthor=S.+Wangauthor=Y.+Wengauthor=C.-W.+Chiangauthor=A.+Lei&title=Electrochemical+Oxidation+Induced+Selective+Tyrosine+Bioconjugation+for+the+Modification+of+Biomolecules&doi=10.1039%2FC9SC02218J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Electrochemical oxidation induced selective tyrosine bioconjugation for the modification of biomolecules</span></div><div class="casAuthors">Song, Chunlan; Liu, Kun; Wang, Zhongjie; Ding, Bo; Wang, Shengchun; Weng, Yue; Chiang, Chien-Wei; Lei, Aiwen</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7982-7987</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Directly introducing a beneficial functional group into biomols. under mild, clean and easy-to-handle conditions is of great importance in the field of chem. biol. and pharmacol.  Herein, we described an electrochem. strategy to perform the bioconjugation of tyrosine residues with phenothiazine derivs. in a rapid and simple manner.  In this electrochem. system, various polypeptides and proteins were successfully labeled with excellent site- and chemo-selectivity, and metals, oxidants or additives were also avoided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpARru4dpklgrVg90H21EOLACvtfcHk0lg47sI8goJ5Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlaltrrJ&md5=cceaefba850ea224cdff9a6276faedf8</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1039%2FC9SC02218J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9SC02218J%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWeng%26aufirst%3DY.%26aulast%3DChiang%26aufirst%3DC.-W.%26aulast%3DLei%26aufirst%3DA.%26atitle%3DElectrochemical%2520Oxidation%2520Induced%2520Selective%2520Tyrosine%2520Bioconjugation%2520for%2520the%2520Modification%2520of%2520Biomolecules%26jtitle%3DChem.%2520Sci.%26date%3D2019%26volume%3D10%26issue%3D34%26spage%3D7982%26epage%3D7987%26doi%3D10.1039%2FC9SC02218J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noisier, A. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knerr, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drury, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valeur, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malins, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalakrishnan, R.</span></span> <span> </span><span class="NLM_article-title">Late-Stage Functionalization of Histidine in Unprotected Peptides</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">52</span>),  <span class="NLM_fpage">19096</span>– <span class="NLM_lpage">19102</span>, <span class="refDoi"> DOI: 10.1002/anie.201910888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fanie.201910888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFant7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=19096-19102&issue=52&author=A.+F.+M.+Noisierauthor=M.+J.+Johanssonauthor=L.+Knerrauthor=M.+A.+Hayesauthor=W.+J.+Druryauthor=E.+Valeurauthor=L.+R.+Malinsauthor=R.+Gopalakrishnan&title=Late-Stage+Functionalization+of+Histidine+in+Unprotected+Peptides&doi=10.1002%2Fanie.201910888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Late-stage functionalization of histidine in unprotected peptides</span></div><div class="casAuthors">Noisier, Anais F. M.; Johansson, Magnus J.; Knerr, Laurent; Hayes, Martin A.; Drury, William J. III; Valeur, Eric; Malins, Lara R.; Gopalakrishnan, Ranganath</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">19096-19102</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The late-stage functionalization (LSF) of peptides represents a valuable strategy for the design of potent peptide pharmaceuticals by enabling rapid exploration of chem. diversity and offering novel opportunities for peptide conjugation.  While the C(sp2)-H activation of tryptophan (Trp) is well documented, the resurgence of radical chem. is opening new avenues for the C-H functionalization of other arom. side-chains.  Herein, we report the first example of LSF at C2 of histidine (His) utilizing a broad scope of aliph. sulfinate salts as radical precursors.  In this work, the exquisite selectivity for histidine functionalization was demonstrated through the alkylation of complex unprotected peptides in aq. media.  Finally, this methodol. was extended for the installation of a ketone handle, providing an unprecedented anchor for selective oxime/hydrazone conjugation at histidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXni3z_Jrfe7Vg90H21EOLACvtfcHk0ljQq1z_Zk4yFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFant7vE&md5=76bd2c854dfe039f866e87ee9aed69ff</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fanie.201910888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201910888%26sid%3Dliteratum%253Aachs%26aulast%3DNoisier%26aufirst%3DA.%2BF.%2BM.%26aulast%3DJohansson%26aufirst%3DM.%2BJ.%26aulast%3DKnerr%26aufirst%3DL.%26aulast%3DHayes%26aufirst%3DM.%2BA.%26aulast%3DDrury%26aufirst%3DW.%2BJ.%26aulast%3DValeur%26aufirst%3DE.%26aulast%3DMalins%26aufirst%3DL.%2BR.%26aulast%3DGopalakrishnan%26aufirst%3DR.%26atitle%3DLate-Stage%2520Functionalization%2520of%2520Histidine%2520in%2520Unprotected%2520Peptides%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26issue%3D52%26spage%3D19096%26epage%3D19102%26doi%3D10.1002%2Fanie.201910888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Overbeke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongsantichon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everaert, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwaenepoel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loonchanta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burtnick, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Ganck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochepied, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haigh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuvelier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derave, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettemans, J.</span></span> <span> </span><span class="NLM_article-title">An ER-Directed Gelsolin Nanobody Targets the First Step in Amyloid Formation in a Gelsolin Amyloidosis Mouse Model</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2492</span>– <span class="NLM_lpage">2507</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddv010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1093%2Fhmg%2Fddv010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=25601851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVyltLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=2492-2507&issue=9&author=W.+Van%0AOverbekeauthor=J.+Wongsantichonauthor=I.+Everaertauthor=A.+Verhelleauthor=O.+Zwaenepoelauthor=A.+Loonchantaauthor=L.+D.+Burtnickauthor=A.+De+Ganckauthor=T.+Hochepiedauthor=J.+Haighauthor=C.+Cuvelierauthor=W.+Deraveauthor=R.+C.+Robinsonauthor=J.+Gettemans&title=An+ER-Directed+Gelsolin+Nanobody+Targets+the+First+Step+in+Amyloid+Formation+in+a+Gelsolin+Amyloidosis+Mouse+Model&doi=10.1093%2Fhmg%2Fddv010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">An ER-directed gelsolin nanobody targets the first step in amyloid formation in a gelsolin amyloidosis mouse model</span></div><div class="casAuthors">Van Overbeke, Wouter; Wongsantichon, Jantana; Everaert, Inge; Verhelle, Adriaan; Zwaenepoel, Olivier; Loonchanta, Anantasak; Burtnick, Leslie D.; De Ganck, Ariane; Hochepied, Tino; Haigh, Jody; Cuvelier, Claude; Derave, Wim; Robinson, Robert C.; Gettemans, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2492-2507</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Hereditary gelsolin amyloidosis is an autosomal dominantly inherited amyloid disorder.  A point mutation in the GSN gene (G654A being the most common one) results in disturbed calcium binding by the second gelsolin domain (G2).  As a result, the folding of G2 is hampered, rendering the mutant plasma gelsolin susceptible to a proteolytic cascade.  Consecutive cleavage by furin and MT1-MMP-like proteases generates 8 and 5 kDa amyloidogenic peptides that cause neurol., ophthalmol. and dermatol. findings.  To this day, no specific treatment is available to counter the pathogenesis.  Using GSN nanobody 11 as a mol. chaperone, we aimed to protect mutant plasma gelsolin from furin proteolysis in the trans-Golgi network.  We report a transgenic, GSN nanobody 11 secreting mouse that was used for crossbreeding with gelsolin amyloidosis mice.  Insertion of the therapeutic nanobody gene into the gelsolin amyloidosis mouse genome resulted in improved muscle contractility.  X-ray crystal structure detn. of the gelsolin G2:Nb11 complex revealed that Nb11 does not directly block the furin cleavage site.  We conclude that nanobodies can be used to shield substrates from aberrant proteolysis and this approach might establish a novel therapeutic strategy in amyloid diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-aY9pOJNQxbVg90H21EOLACvtfcHk0ljQq1z_Zk4yFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVyltLfI&md5=46d05bff0cd01f07e0c075fc684c2816</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddv010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddv010%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BOverbeke%26aufirst%3DW.%26aulast%3DWongsantichon%26aufirst%3DJ.%26aulast%3DEveraert%26aufirst%3DI.%26aulast%3DVerhelle%26aufirst%3DA.%26aulast%3DZwaenepoel%26aufirst%3DO.%26aulast%3DLoonchanta%26aufirst%3DA.%26aulast%3DBurtnick%26aufirst%3DL.%2BD.%26aulast%3DDe%2BGanck%26aufirst%3DA.%26aulast%3DHochepied%26aufirst%3DT.%26aulast%3DHaigh%26aufirst%3DJ.%26aulast%3DCuvelier%26aufirst%3DC.%26aulast%3DDerave%26aufirst%3DW.%26aulast%3DRobinson%26aufirst%3DR.%2BC.%26aulast%3DGettemans%26aufirst%3DJ.%26atitle%3DAn%2520ER-Directed%2520Gelsolin%2520Nanobody%2520Targets%2520the%2520First%2520Step%2520in%2520Amyloid%2520Formation%2520in%2520a%2520Gelsolin%2520Amyloidosis%2520Mouse%2520Model%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2015%26volume%3D24%26issue%3D9%26spage%3D2492%26epage%3D2507%26doi%3D10.1093%2Fhmg%2Fddv010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spicer, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span> <span> </span><span class="NLM_article-title">Selective Chemical Protein Modification</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">4740</span>, <span class="refDoi"> DOI: 10.1038/ncomms5740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fncomms5740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=25190082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVeksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4740&issue=1&author=C.+D.+Spicerauthor=B.+G.+Davis&title=Selective+Chemical+Protein+Modification&doi=10.1038%2Fncomms5740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Selective chemical protein modification</span></div><div class="casAuthors">Spicer, Christopher D.; Davis, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4740</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The chem. modification of proteins is an important tool for probing natural systems and synthesizing novel conjugates.  Here, Spicer and Davis review the merits and limitations of the most useful methods for selective modification at both natural and unnatural amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZgjVcXZmMGbVg90H21EOLACvtfcHk0ljQq1z_Zk4yFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVeksb4%253D&md5=055c882ff0405b0bbb91edca3bcef8cb</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fncomms5740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms5740%26sid%3Dliteratum%253Aachs%26aulast%3DSpicer%26aufirst%3DC.%2BD.%26aulast%3DDavis%26aufirst%3DB.%2BG.%26atitle%3DSelective%2520Chemical%2520Protein%2520Modification%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26issue%3D1%26spage%3D4740%26doi%3D10.1038%2Fncomms5740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boutureira, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, G. J. L.</span></span> <span> </span><span class="NLM_article-title">Advances in Chemical Protein Modification</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2174</span>– <span class="NLM_lpage">2195</span>, <span class="refDoi"> DOI: 10.1021/cr500399p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500399p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtV2nu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=2174-2195&issue=5&author=O.+Boutureiraauthor=G.+J.+L.+Bernardes&title=Advances+in+Chemical+Protein+Modification&doi=10.1021%2Fcr500399p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Chemical Protein Modification</span></div><div class="casAuthors">Boutureira, Omar; Bernardes, Goncalo J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2174-2195</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Transition metal-free and -mediated approaches are covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptimHDGRGsWLVg90H21EOLACvtfcHk0ljBq2Dq2kripA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtV2nu7k%253D&md5=d21a5407a59a7e12346c16e5db75ab91</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fcr500399p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500399p%26sid%3Dliteratum%253Aachs%26aulast%3DBoutureira%26aufirst%3DO.%26aulast%3DBernardes%26aufirst%3DG.%2BJ.%2BL.%26atitle%3DAdvances%2520in%2520Chemical%2520Protein%2520Modification%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26issue%3D5%26spage%3D2174%26epage%3D2195%26doi%3D10.1021%2Fcr500399p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isenegger, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span> <span> </span><span class="NLM_article-title">Concepts of Catalysis in Site-Selective Protein Modifications</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>141</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8005</span>– <span class="NLM_lpage">8013</span>, <span class="refDoi"> DOI: 10.1021/jacs.8b13187</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b13187" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntlehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2019&pages=8005-8013&issue=20&author=P.+G.+Iseneggerauthor=B.+G.+Davis&title=Concepts+of+Catalysis+in+Site-Selective+Protein+Modifications&doi=10.1021%2Fjacs.8b13187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Concepts of Catalysis in Site-Selective Protein Modifications</span></div><div class="casAuthors">Isenegger, Patrick G.; Davis, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8005-8013</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The manipulation and modulation of biomols. has the potential to herald new modes of Biol. and Medicine through chem. "editing".  Key to the success of such processes will be the selectivities, reactivities and efficiencies that may be brought to bear in bond-formation and bond-cleavage in a benign manner.  In this Perspective, we use select examples, primarily from our own research, to examine the current opportunities, limitations and the particular potential of metal-mediated processes as exemplars of possible alternative catalytic modes and manifolds to those already found in nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq44tDJIQ-GT7Vg90H21EOLACvtfcHk0ljBq2Dq2kripA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntlehsb8%253D&md5=37e790585ed0d73fec6ab1303358abd0</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b13187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b13187%26sid%3Dliteratum%253Aachs%26aulast%3DIsenegger%26aufirst%3DP.%2BG.%26aulast%3DDavis%26aufirst%3DB.%2BG.%26atitle%3DConcepts%2520of%2520Catalysis%2520in%2520Site-Selective%2520Protein%2520Modifications%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2019%26volume%3D141%26issue%3D20%26spage%3D8005%26epage%3D8013%26doi%3D10.1021%2Fjacs.8b13187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetsch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumontet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvaïa, N.</span></span> <span> </span><span class="NLM_article-title">Strategies and Challenges for the next Generation of Antibody-Drug Conjugates</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnrd.2016.268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=28303026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1Onsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=315-337&issue=5&author=A.+Beckauthor=L.+Goetschauthor=C.+Dumontetauthor=N.+Corva%C3%AFa&title=Strategies+and+Challenges+for+the+next+Generation+of+Antibody-Drug+Conjugates&doi=10.1038%2Fnrd.2016.268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies and challenges for the next generation of antibody-drug conjugates</span></div><div class="casAuthors">Beck, Alain; Goetsch, Liliane; Dumontet, Charles; Corvaia, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">315-337</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibody-drug conjugates (ADCs) are one of the fastest growing classes of oncol. therapeutics.  After half a century of research, the approvals of brentuximab vedotin (in 2011) and trastuzumab emtansine (in 2013) have paved the way for ongoing clin. trials that are evaluating more than 60 further ADC candidates.  The limited success of first-generation ADCs (developed in the early 2000s) informed strategies to bring second-generation ADCs to the market, which have higher levels of cytotoxic drug conjugation, lower levels of naked antibodies and more-stable linkers between the drug and the antibody.  Furthermore, lessons learned during the past decade are now being used in the development of third-generation ADCs.  In this Review, we discuss strategies to select the best target antigens as well as suitable cytotoxic drugs; the design of optimized linkers; the discovery of bioorthogonal conjugation chemistries; and toxicity issues.  The selection and engineering of antibodies for site-specific drug conjugation, which will result in higher homogeneity and increased stability, as well as the quest for new conjugation chemistries and mechanisms of action, are priorities in ADC research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP7lV63Ws8rbVg90H21EOLACvtfcHk0liC0QjZ52blQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1Onsbc%253D&md5=7358b6080dd1aed1d21e98c078cd9ef1</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.268%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DA.%26aulast%3DGoetsch%26aufirst%3DL.%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DCorva%25C3%25AFa%26aufirst%3DN.%26atitle%3DStrategies%2520and%2520Challenges%2520for%2520the%2520next%2520Generation%2520of%2520Antibody-Drug%2520Conjugates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26issue%3D5%26spage%3D315%26epage%3D337%26doi%3D10.1038%2Fnrd.2016.268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labrijn, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buijsse, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den
Bremer, E. T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verwilligen, A. Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleeker, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killestein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polman, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aalberse, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuurman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Winkel, J. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parren, P. W. H. I.</span></span> <span> </span><span class="NLM_article-title">Therapeutic IgG4 Antibodies Engage in Fab-Arm Exchange with Endogenous Human IgG4 in Vivo</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">771</span>, <span class="refDoi"> DOI: 10.1038/nbt.1553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnbt.1553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=19620983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD1MXoslymt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=767-771&issue=8&author=A.+F.+Labrijnauthor=A.+O.+Buijsseauthor=E.+T.+J.+van+den%0ABremerauthor=A.+Y.+W.+Verwilligenauthor=W.+K.+Bleekerauthor=S.+J.+Thorpeauthor=J.+Killesteinauthor=C.+H.+Polmanauthor=R.+C.+Aalberseauthor=J.+Schuurmanauthor=J.+G.+J.+van+de+Winkelauthor=P.+W.+H.+I.+Parren&title=Therapeutic+IgG4+Antibodies+Engage+in+Fab-Arm+Exchange+with+Endogenous+Human+IgG4+in+Vivo&doi=10.1038%2Fnbt.1553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo</span></div><div class="casAuthors">Labrijn, Aran F.; Buijsse, Antonio Ortiz; van den Bremer, Ewald T. J.; Verwilligen, Annemiek Y. W.; Bleeker, Wim K.; Thorpe, Susan J.; Killestein, Joep; Polman, Chris H.; Aalberse, Rob C.; Schuurman, Janine; van de Winkel, Jan G. J.; Parren, Paul W. H. I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">767-771</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Two humanized IgG4 antibodies, natalizumab and gemtuzumab, are approved for human use, and several others, like TGN1412, are or have been in clin. development.  Although IgG4 antibodies can dynamically exchange half-mols., Fab-arm exchange with therapeutic antibodies has not been demonstrated in humans.  Here, the authors show that natalizumab exchanges Fab arms with endogenous human IgG4 in natalizumab-treated individuals.  Gemtuzumab, in contrast, contains an IgG4 core-hinge mutation that blocks Fab-arm exchange to undetectable levels both in vitro and in a mouse model.  The ability of IgG4 therapeutics to recombine with endogenous IgG4 may affect their pharmacokinetics and pharmacodynamics.  Although pharmacokinetic modeling lessens concerns about undesired crosslinking under normal conditions, unpredictability remains and mutations that completely prevent Fab-arm exchange in vivo should be considered when designing therapeutic IgG4 antibodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGn4nvTCj3-LVg90H21EOLACvtfcHk0liC0QjZ52blQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXoslymt7Y%253D&md5=c758d687c55c60f4dd18be713be8f892</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1553%26sid%3Dliteratum%253Aachs%26aulast%3DLabrijn%26aufirst%3DA.%2BF.%26aulast%3DBuijsse%26aufirst%3DA.%2BO.%26aulast%3Dvan%2Bden%2BBremer%26aufirst%3DE.%2BT.%2BJ.%26aulast%3DVerwilligen%26aufirst%3DA.%2BY.%2BW.%26aulast%3DBleeker%26aufirst%3DW.%2BK.%26aulast%3DThorpe%26aufirst%3DS.%2BJ.%26aulast%3DKillestein%26aufirst%3DJ.%26aulast%3DPolman%26aufirst%3DC.%2BH.%26aulast%3DAalberse%26aufirst%3DR.%2BC.%26aulast%3DSchuurman%26aufirst%3DJ.%26aulast%3Dvan%2Bde%2BWinkel%26aufirst%3DJ.%2BG.%2BJ.%26aulast%3DParren%26aufirst%3DP.%2BW.%2BH.%2BI.%26atitle%3DTherapeutic%2520IgG4%2520Antibodies%2520Engage%2520in%2520Fab-Arm%2520Exchange%2520with%2520Endogenous%2520Human%2520IgG4%2520in%2520Vivo%26jtitle%3DNat.%2520Biotechnol.%26date%3D2009%26volume%3D27%26issue%3D8%26spage%3D767%26epage%3D771%26doi%3D10.1038%2Fnbt.1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C. R.</span></span> <span> </span><span class="NLM_article-title">Site-Specific Antibody-Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1021/bc5004982</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc5004982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=176-192&issue=2&author=P.+Agarwalauthor=C.+R.+Bertozzi&title=Site-Specific+Antibody-Drug+Conjugates%3A+The+Nexus+of+Bioorthogonal+Chemistry%2C+Protein+Engineering%2C+and+Drug+Development&doi=10.1021%2Fbc5004982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Site-Specific Antibody-Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development</span></div><div class="casAuthors">Agarwal, Paresh; Bertozzi, Carolyn R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">176-192</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Antibody-drug conjugates (ADCs) combine the specificity of antibodies with the potency of small mols. to create targeted drugs.  Despite the simplicity of this concept, generation of clin. successful ADCs has been very difficult.  Over the past several decades, scientists have learned a great deal about the constraints on antibodies, linkers, and drugs as they relate to successful construction of ADCs.  Once these components are in hand, most ADCs are prepd. by nonspecific modification of antibody lysine or cysteine residues with drug-linker reagents, which results in heterogeneous product mixts. that cannot be further purified.  With advances in the fields of bioorthogonal chem. and protein engineering, there is growing interest in producing ADCs by site-specific conjugation to the antibody, yielding more homogeneous products that have demonstrated benefits over their heterogeneous counterparts in vivo.  Here, we chronicle the development of a multitude of site-specific conjugation strategies for assembly of ADCs and provide a comprehensive account of key advances and their roots in the fields of bioorthogonal chem. and protein engineering.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOcb0A3dT72bVg90H21EOLACvtfcHk0liC0QjZ52blQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrsrfK&md5=c3d822b0e53e5cdb074e5b63b8060ccf</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fbc5004982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc5004982%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DP.%26aulast%3DBertozzi%26aufirst%3DC.%2BR.%26atitle%3DSite-Specific%2520Antibody-Drug%2520Conjugates%253A%2520The%2520Nexus%2520of%2520Bioorthogonal%2520Chemistry%252C%2520Protein%2520Engineering%252C%2520and%2520Drug%2520Development%26jtitle%3DBioconjugate%2520Chem.%26date%3D2015%26volume%3D26%26issue%3D2%26spage%3D176%26epage%3D192%26doi%3D10.1021%2Fbc5004982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovee, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doronina, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duniho, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiske, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senter, P. D.</span></span> <span> </span><span class="NLM_article-title">Self-Hydrolyzing Maleimides Improve the Stability and Pharmacological Properties of Antibody-Drug Conjugates</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1059</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.1038/nbt.2968</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnbt.2968" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=25194818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKms7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=1059-1062&issue=10&author=R.+P.+Lyonauthor=J.+R.+Setterauthor=T.+D.+Boveeauthor=S.+O.+Doroninaauthor=J.+H.+Hunterauthor=M.+E.+Andersonauthor=C.+L.+Balasubramanianauthor=S.+M.+Dunihoauthor=C.+I.+Leiskeauthor=F.+Liauthor=P.+D.+Senter&title=Self-Hydrolyzing+Maleimides+Improve+the+Stability+and+Pharmacological+Properties+of+Antibody-Drug+Conjugates&doi=10.1038%2Fnbt.2968"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates</span></div><div class="casAuthors">Lyon, Robert P.; Setter, Jocelyn R.; Bovee, Tim D.; Doronina, Svetlana O.; Hunter, Joshua H.; Anderson, Martha E.; Balasubramanian, Cindy L.; Duniho, Steven M.; Leiske, Chris I.; Li, Fu; Senter, Peter D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1059-1062</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many antibody-drug conjugates (ADCs) are unstable in vivo because they are formed from maleimide-contg. components conjugated to reactive thiols.  These thiosuccinimide linkages undergo two competing reactions in plasma: elimination of the maleimide through a retro-Michael reaction, which results in loss of drug-linker from the ADC, and hydrolysis of the thiosuccinimide ring, which results in a deriv. that is resistant to the elimination reaction.  In an effort to create linker technologies with improved stability characteristics, we used diaminopropionic acid (DPR) to prep. a drug-linker incorporating a basic amino group adjacent to the maleimide, positioned to provide intramol. catalysis of thiosuccinimide ring hydrolysis.  This basic group induces the thiosuccinimide to undergo rapid hydrolysis at neutral pH and room temp.  Once hydrolyzed, the drug-linker is no longer subject to maleimide elimination reactions, preventing nonspecific deconjugation.  In vivo studies demonstrate that the increased stability characteristics can lead to improved ADC antitumor activity and reduced neutropenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOKvXMGRGxEbVg90H21EOLACvtfcHk0liWRmPYSM6mhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKms7jN&md5=96c3b19b856cc9c685cbdc704a842797</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2968%26sid%3Dliteratum%253Aachs%26aulast%3DLyon%26aufirst%3DR.%2BP.%26aulast%3DSetter%26aufirst%3DJ.%2BR.%26aulast%3DBovee%26aufirst%3DT.%2BD.%26aulast%3DDoronina%26aufirst%3DS.%2BO.%26aulast%3DHunter%26aufirst%3DJ.%2BH.%26aulast%3DAnderson%26aufirst%3DM.%2BE.%26aulast%3DBalasubramanian%26aufirst%3DC.%2BL.%26aulast%3DDuniho%26aufirst%3DS.%2BM.%26aulast%3DLeiske%26aufirst%3DC.%2BI.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DSenter%26aufirst%3DP.%2BD.%26atitle%3DSelf-Hydrolyzing%2520Maleimides%2520Improve%2520the%2520Stability%2520and%2520Pharmacological%2520Properties%2520of%2520Antibody-Drug%2520Conjugates%26jtitle%3DNat.%2520Biotechnol.%26date%3D2014%26volume%3D32%26issue%3D10%26spage%3D1059%26epage%3D1062%26doi%3D10.1038%2Fnbt.2968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strop, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaria, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foletti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witt, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasa-Moreno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorywalska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farias, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pios, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dushin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navaratnam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pons, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajpal, A.</span></span> <span> </span><span class="NLM_article-title">Site-Specific Conjugation Improves Therapeutic Index of Antibody Drug Conjugates with High Drug Loading</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">694</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1038/nbt.3274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnbt.3274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26154005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ensLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=694-696&issue=7&author=P.+Stropauthor=K.+Delariaauthor=D.+Folettiauthor=J.+M.+Wittauthor=A.+Hasa-Morenoauthor=K.+Poulsenauthor=M.+G.+Casasauthor=M.+Dorywalskaauthor=S.+Fariasauthor=A.+Piosauthor=V.+Luiauthor=R.+Dushinauthor=D.+Zhouauthor=T.+Navaratnamauthor=T.-T.+Tranauthor=J.+Suttonauthor=K.+C.+Lindquistauthor=B.+Hanauthor=S.-H.+Liuauthor=D.+L.+Sheltonauthor=J.+Ponsauthor=A.+Rajpal&title=Site-Specific+Conjugation+Improves+Therapeutic+Index+of+Antibody+Drug+Conjugates+with+High+Drug+Loading&doi=10.1038%2Fnbt.3274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loading</span></div><div class="casAuthors">Strop, Pavel; Delaria, Kathy; Foletti, Davide; Witt, Jody Melton; Hasa-Moreno, Adela; Poulsen, Kris; Casas, Meritxell Galindo; Dorywalska, Magdalena; Farias, Santiago; Pios, Ariel; Lui, Victor; Dushin, Russell; Zhou, Dahui; Navaratnam, Thayalan; Tran, Thomas-Toan; Sutton, Janette; Lindquist, Kevin C.; Han, Bora; Liu, Shu-Hui; Shelton, David L.; Pons, Jaume; Rajpal, Arvind</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">694-696</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt9y4CtErWAbVg90H21EOLACvtfcHk0liWRmPYSM6mhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ensLbK&md5=43b6c9f702e02a91887c3f27a5ab7353</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fnbt.3274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.3274%26sid%3Dliteratum%253Aachs%26aulast%3DStrop%26aufirst%3DP.%26aulast%3DDelaria%26aufirst%3DK.%26aulast%3DFoletti%26aufirst%3DD.%26aulast%3DWitt%26aufirst%3DJ.%2BM.%26aulast%3DHasa-Moreno%26aufirst%3DA.%26aulast%3DPoulsen%26aufirst%3DK.%26aulast%3DCasas%26aufirst%3DM.%2BG.%26aulast%3DDorywalska%26aufirst%3DM.%26aulast%3DFarias%26aufirst%3DS.%26aulast%3DPios%26aufirst%3DA.%26aulast%3DLui%26aufirst%3DV.%26aulast%3DDushin%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DTran%26aufirst%3DT.-T.%26aulast%3DSutton%26aufirst%3DJ.%26aulast%3DLindquist%26aufirst%3DK.%2BC.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DS.-H.%26aulast%3DShelton%26aufirst%3DD.%2BL.%26aulast%3DPons%26aufirst%3DJ.%26aulast%3DRajpal%26aufirst%3DA.%26atitle%3DSite-Specific%2520Conjugation%2520Improves%2520Therapeutic%2520Index%2520of%2520Antibody%2520Drug%2520Conjugates%2520with%2520High%2520Drug%2520Loading%26jtitle%3DNat.%2520Biotechnol.%26date%3D2015%26volume%3D33%26issue%3D7%26spage%3D694%26epage%3D696%26doi%3D10.1038%2Fnbt.3274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christie, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezabeh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimasi, N.</span></span> <span> </span><span class="NLM_article-title">Stabilization of Cysteine-Linked Antibody Drug Conjugates with N-Aryl Maleimides</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>220</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2015.09.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.jconrel.2015.09.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26387744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1SiurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=2015&pages=660-670&author=R.+J.+Christieauthor=R.+Flemingauthor=B.+Bezabehauthor=R.+Woodsauthor=S.+Maoauthor=J.+Harperauthor=A.+Josephauthor=Q.+Wangauthor=Z.-Q.+Xuauthor=H.+Wuauthor=C.+Gaoauthor=N.+Dimasi&title=Stabilization+of+Cysteine-Linked+Antibody+Drug+Conjugates+with+N-Aryl+Maleimides&doi=10.1016%2Fj.jconrel.2015.09.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides</span></div><div class="casAuthors">Christie, R. James; Fleming, Ryan; Bezabeh, Binyam; Woods, Rob; Mao, Shenlan; Harper, Jay; Joseph, Augustine; Wang, Qianli; Xu, Ze-Qi; Wu, Herren; Gao, Changshou; Dimasi, Nazzareno</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">660-670</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Maleimides are often used to covalently attach drugs to cysteine thiols for prodn. of antibody-drug conjugates (ADCs).  However, ADCs formed with traditional N-alkyl maleimides have variable stability in the bloodstream leading to loss of drug.  Here, we report that N-aryl maleimides form stable antibody conjugates under very mild conditions while also maintaining high conjugation efficiency.  Thiol-maleimide coupling and ADC stabilization via thiosuccinimide hydrolysis were accelerated by addn. of N-Ph or N-fluorophenyl groups to the ring-head nitrogen.  Cysteine-linked ADCs prepd. with N-aryl maleimides exhibited less than 20% deconjugation in both thiol-contg. buffer and serum when incubated at 37 °C over a period of 7 days, whereas the analogous ADCs prepd. with N-alkyl maleimides showed 35-67% deconjugation under the same conditions.  ADCs prepd. with the anticancer drug N-Ph maleimide monomethyl-auristatin-E (MMAE) maintained high cytotoxicity following long-term exposure to serum whereas the N-alkyl maleimide MMAE ADC lost potency over time.  These data demonstrate that N-aryl maleimides are a convenient and flexible platform to improve the stability of ADCs through manipulation of functional groups attached to the maleimide ring-head nitrogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP7jfO1qLzB7Vg90H21EOLACvtfcHk0lh1BdC_kW1xxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1SiurbK&md5=0d689828ce8d888cead593ff0dc3423f</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2015.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2015.09.032%26sid%3Dliteratum%253Aachs%26aulast%3DChristie%26aufirst%3DR.%2BJ.%26aulast%3DFleming%26aufirst%3DR.%26aulast%3DBezabeh%26aufirst%3DB.%26aulast%3DWoods%26aufirst%3DR.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DHarper%26aufirst%3DJ.%26aulast%3DJoseph%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DZ.-Q.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DC.%26aulast%3DDimasi%26aufirst%3DN.%26atitle%3DStabilization%2520of%2520Cysteine-Linked%2520Antibody%2520Drug%2520Conjugates%2520with%2520N-Aryl%2520Maleimides%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2015%26volume%3D220%26spage%3D660%26epage%3D670%26doi%3D10.1016%2Fj.jconrel.2015.09.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolodych, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koniev, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baatarkhuu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debaene, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianférani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dorsselaer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A.</span></span> <span> </span><span class="NLM_article-title">CBTF: New Amine-to-Thiol Coupling Reagent for Preparation of Antibody Conjugates with Increased Plasma Stability</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1021/bc500610g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc500610g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=197-200&issue=2&author=S.+Kolodychauthor=O.+Konievauthor=Z.+Baatarkhuuauthor=J.-Y.+Bonnefoyauthor=F.+Debaeneauthor=S.+Cianf%C3%A9raniauthor=A.+Van+Dorsselaerauthor=A.+Wagner&title=CBTF%3A+New+Amine-to-Thiol+Coupling+Reagent+for+Preparation+of+Antibody+Conjugates+with+Increased+Plasma+Stability&doi=10.1021%2Fbc500610g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">CBTF: New Amine-to-Thiol Coupling Reagent for Preparation of Antibody Conjugates with Increased Plasma Stability</span></div><div class="casAuthors">Kolodych, Sergii; Koniev, Oleksandr; Baatarkhuu, Zoljargal; Bonnefoy, Jean-Yves; Debaene, Francois; Cianferani, Sarah; Van Dorsselaer, Alain; Wagner, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-200</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amine-to-thiol coupling is the most common route for the prepn. of antibody-drug conjugates (ADC).  It is usually achieved by using heterobifunctional reagents possessing an activated ester at one end and a maleimide group at the other.  However, maleimide-based conjugates were recently revealed to have limited stability in blood circulation, which can compromise therapeutic efficacy of the conjugate.  To address this issue, we have developed a heterobifunctional reagent, sodium 4-((4-(cyanoethynyl)benzoyl)oxy)-2,3,5,6-tetrafluorobenzenesulfonate (CBTF), for amine-to-thiol coupling.  It comprises a recently described 3-arylpropionitrile (APN) function in replacement of maleimide and allows for the prepn. of remarkably stable conjugates.  A series of antibody-dye conjugates have been prepd. using this reagent and shown superior stability in human blood plasma compared to maleimide-derived conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTbOZ8qNf8brVg90H21EOLACvtfcHk0lh1BdC_kW1xxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWgu7w%253D&md5=1b3c24d458a79fe4c9d5b30a606c9248</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fbc500610g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc500610g%26sid%3Dliteratum%253Aachs%26aulast%3DKolodych%26aufirst%3DS.%26aulast%3DKoniev%26aufirst%3DO.%26aulast%3DBaatarkhuu%26aufirst%3DZ.%26aulast%3DBonnefoy%26aufirst%3DJ.-Y.%26aulast%3DDebaene%26aufirst%3DF.%26aulast%3DCianf%25C3%25A9rani%26aufirst%3DS.%26aulast%3DVan%2BDorsselaer%26aufirst%3DA.%26aulast%3DWagner%26aufirst%3DA.%26atitle%3DCBTF%253A%2520New%2520Amine-to-Thiol%2520Coupling%2520Reagent%2520for%2520Preparation%2520of%2520Antibody%2520Conjugates%2520with%2520Increased%2520Plasma%2520Stability%26jtitle%3DBioconjugate%2520Chem.%26date%3D2015%26volume%3D26%26issue%3D2%26spage%3D197%26epage%3D200%26doi%3D10.1021%2Fbc500610g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dovgan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolodych, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koniev, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A.</span></span> <span> </span><span class="NLM_article-title">2-(Maleimidomethyl)-1,3-Dioxanes (MD): A Serum-Stable Self-Hydrolysable Hydrophilic Alternative to Classical Maleimide Conjugation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">30835</span>, <span class="refDoi"> DOI: 10.1038/srep30835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fsrep30835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=27501860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCisbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=30835&issue=1&author=I.+Dovganauthor=S.+Kolodychauthor=O.+Konievauthor=A.+Wagner&title=2-%28Maleimidomethyl%29-1%2C3-Dioxanes+%28MD%29%3A+A+Serum-Stable+Self-Hydrolysable+Hydrophilic+Alternative+to+Classical+Maleimide+Conjugation&doi=10.1038%2Fsrep30835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">2-(Maleimidomethyl)-1,3-Dioxanes (MD): a Serum-Stable Self-hydrolysable Hydrophilic Alternative to Classical Maleimide Conjugation</span></div><div class="casAuthors">Dovgan, Igor; Kolodych, Sergii; Koniev, Oleksandr; Wagner, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30835</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The vast majority of antibody-drug conjugates (ADC) are prepd. through amine-to-thiol conjugation.  To date, N-Succinimidyl-4-(maleimidomethyl) cyclohexanecarboxylate (SMCC) has been one of the most frequently applied reagents for the prepn. of ADC and other functional conjugates.  However, SMCC-based conjugates suffer from limited stability in blood circulation and from a hydrophobic character of the linker, which may give rise to major pharmacokinetic implications.  To address this issue, we have developed a heterobifunctional analog of a SMCC reagent, i.e., sodium 4-((maleimidomethyl-1,3-dioxane-5-carbonyl)oxy)-2,3,5,6- tetrafluorobenzenesulfonate (MDTF) for amine-to-thiol conjugation.  By replacing the cyclohexyl ring in the SMCC structure with the 1,3-dioxane, we increased the hydrophilicity of the linker.  A FRET probe based on MD linker was prepd. and showed superior stability compared to the MCC linker in human plasma, as well as in a variety of aq. buffers.  A detailed investigation demonstrated an accelerated succinimide ring opening for MD linker, resulting in stabilized conjugates.  Finally, the MDTF reagent was applied for the prepn. of serum stable antibody-dye conjugate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwsmWEmS006LVg90H21EOLACvtfcHk0ljtXY16ehn6LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCisbbO&md5=6be2bf9187983ec52f6650841df724e3</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fsrep30835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep30835%26sid%3Dliteratum%253Aachs%26aulast%3DDovgan%26aufirst%3DI.%26aulast%3DKolodych%26aufirst%3DS.%26aulast%3DKoniev%26aufirst%3DO.%26aulast%3DWagner%26aufirst%3DA.%26atitle%3D2-%2528Maleimidomethyl%2529-1%252C3-Dioxanes%2520%2528MD%2529%253A%2520A%2520Serum-Stable%2520Self-Hydrolysable%2520Hydrophilic%2520Alternative%2520to%2520Classical%2520Maleimide%2520Conjugation%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26issue%3D1%26spage%3D30835%26doi%3D10.1038%2Fsrep30835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span>; <span class="NLM_string-name">Moore, K. N.</span>; <span class="NLM_string-name">Wang, J. S.</span>; <span class="NLM_string-name">Patel, M.</span>; <span class="NLM_string-name">Birrer, M. J.</span>; <span class="NLM_string-name">Hamilton, E.</span>; <span class="NLM_string-name">Barroilhet, L.</span>; <span class="NLM_string-name">Flanagan, W. M.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Garg, A.</span>; <span class="NLM_string-name">Lu, X.</span>; <span class="NLM_string-name">Vaze, A.</span>; <span class="NLM_string-name">Amin, D.</span>; <span class="NLM_string-name">Leipold, D.</span>; <span class="NLM_string-name">Commerford, S. R.</span>; <span class="NLM_string-name">Humke, E. W.</span>; <span class="NLM_string-name">Burris, H. A.</span></span> <span> </span><span class="NLM_article-title">Abstract CT009: Targeting MUC16 with the THIOMAB TM -Drug Conjugate DMUC4064A in Patients with Platinum-Resistant Ovarian Cancer: A Phase I Escalation Study</span>. In  <i>Clinical Trials</i>; <span class="NLM_publisher-name">American Association for Cancer Research</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">CT009</span>– <span class="NLM_lpage">CT009</span>. <span class="refDoi"> DOI: 10.1158/1538-7445.AM2017-CT009</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1158%2F1538-7445.AM2017-CT009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=CT009-CT009&author=J.+F.+Liu&author=K.+N.+Moore&author=J.+S.+Wang&author=M.+Patel&author=M.+J.+Birrer&author=E.+Hamilton&author=L.+Barroilhet&author=W.+M.+Flanagan&author=Y.+Wang&author=A.+Garg&author=X.+Lu&author=A.+Vaze&author=D.+Amin&author=D.+Leipold&author=S.+R.+Commerford&author=E.+W.+Humke&author=H.+A.+Burris&title=Clinical+Trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2017-CT009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1158%252F1538-7445.AM2017-CT009%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26atitle%3DAbstract%2520CT009%253A%2520Targeting%2520MUC16%2520with%2520the%2520THIOMAB%2520TM%2520-Drug%2520Conjugate%2520DMUC4064A%2520in%2520Patients%2520with%2520Platinum-Resistant%2520Ovarian%2520Cancer%253A%2520A%2520Phase%2520I%2520Escalation%2520Study%26btitle%3DClinical%2520Trials%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%26date%3D2017%26spage%3DCT009%26epage%3DCT009%26doi%3D10.1158%2F1538-7445.AM2017-CT009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erba, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Advani, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancet, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacsovics, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelo, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bixby, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faderl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jillella, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biddle-Snead, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, A. S.</span></span> <span> </span><span class="NLM_article-title">A Phase 1 Trial of Vadastuximab Talirine as Monotherapy in Patients with CD33-Positive Acute Myeloid Leukemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1182/blood-2017-06-789800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1182%2Fblood-2017-06-789800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=29196412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1CqsLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2018&pages=387-396&issue=4&author=E.+M.+Steinauthor=R.+B.+Walterauthor=H.+P.+Erbaauthor=A.+T.+Fathiauthor=A.+S.+Advaniauthor=J.+E.+Lancetauthor=F.+Ravandiauthor=T.+Kovacsovicsauthor=D.+J.+DeAngeloauthor=D.+Bixbyauthor=S.+Faderlauthor=A.+P.+Jillellaauthor=P.+A.+Hoauthor=M.+M.+O%E2%80%99Mearaauthor=B.+Zhaoauthor=C.+Biddle-Sneadauthor=A.+S.+Stein&title=A+Phase+1+Trial+of+Vadastuximab+Talirine+as+Monotherapy+in+Patients+with+CD33-Positive+Acute+Myeloid+Leukemia&doi=10.1182%2Fblood-2017-06-789800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia</span></div><div class="casAuthors">Stein, Eytan M.; Walter, Roland B.; Erba, Harry P.; Fathi, Amir T.; Advani, Anjali S.; Lancet, Jeffrey E.; Ravandi, Farhad; Kovacsovics, Tibor; DeAngelo, Daniel J.; Bixby, Dale; Faderl, Stefan; Jillella, Anand P.; Ho, Phoenix A.; O'Meara, Megan M.; Zhao, Baiteng; Biddle-Snead, Charles; Stein, Anthony S.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-396</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Vadastuximab talirine (SGN-CD33A, 33A) is an antibody-drug conjugate consisting of pyrrolobenzodiazepine dimers linked to a monoclonal antibody targeting CD33, which is expressed in the majority of acute myeloid leukemia (AML) patients.  This phase 1 study evaluated the safety, pharmacokinetics, and preliminary activity of vadastuximab talirine and detd. the recommended monotherapy dose in patients with relapsed or refractory AML.  Addnl. expansion cohorts tested vadastuximab talirine in specific subpopulations of relapsed AML, and in a cohort of older, treatment-naive patients.  Patients received vadastuximab talirine IV on day 1 (5-60μg/kg) or on days 1 and 4 (20μg/kg) of 21-day cycles.  A total of 131 patients (median age, 73 years [range, 26-89 years]) had intermediate I-II (48%) or adverse (34%) risk by European LeukemiaNet classification; 50% of patients had underlying myelodysplasia.  Two dose-limiting toxicities (grade 2 pulmonary embolism and grade 4 hypocellular marrow) occurred during dose finding.  Most adverse events (AEs) were consistent with myelosuppression; nonhematol. AEs included fatigue, nausea, and diarrhea.  The 30-day mortality was 8%.  At the recommended monotherapy dose of 40μg/kg, the complete remission + CRi rate was 28% (5 of 18 patients); 50% of patients who responded achieved minimal residual disease negativity.  In patients across dose levels who achieved CR or CRi, the median time to full count recovery was 6.4 wk for neutrophils (≥1000/mL) and 10.6 wk for platelets (≥100 × 109/L).  Vadastuximab talirine demonstrates activity and a tolerable safety profile as a single agent in patients with AML.  The recommended monotherapy dose of vadastuximab talirine is 40μg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrINNKMO7kyLLVg90H21EOLACvtfcHk0ljofd2HlNuuCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1CqsLvN&md5=31b796f7bf19c07dc37b88c6935308ee</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1182%2Fblood-2017-06-789800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2017-06-789800%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DE.%2BM.%26aulast%3DWalter%26aufirst%3DR.%2BB.%26aulast%3DErba%26aufirst%3DH.%2BP.%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DAdvani%26aufirst%3DA.%2BS.%26aulast%3DLancet%26aufirst%3DJ.%2BE.%26aulast%3DRavandi%26aufirst%3DF.%26aulast%3DKovacsovics%26aufirst%3DT.%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DBixby%26aufirst%3DD.%26aulast%3DFaderl%26aufirst%3DS.%26aulast%3DJillella%26aufirst%3DA.%2BP.%26aulast%3DHo%26aufirst%3DP.%2BA.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%2BM.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DBiddle-Snead%26aufirst%3DC.%26aulast%3DStein%26aufirst%3DA.%2BS.%26atitle%3DA%2520Phase%25201%2520Trial%2520of%2520Vadastuximab%2520Talirine%2520as%2520Monotherapy%2520in%2520Patients%2520with%2520CD33-Positive%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DBlood%26date%3D2018%26volume%3D131%26issue%3D4%26spage%3D387%26epage%3D396%26doi%3D10.1182%2Fblood-2017-06-789800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strop, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorywalska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaria, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dushin, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, W.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farias, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdiche, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekaran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samain, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaparro-Riggers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pons, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajpal, A.</span></span> <span> </span><span class="NLM_article-title">Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2013.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.chembiol.2013.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=23438745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=161-167&issue=2&author=P.+Stropauthor=S.-H.+Liuauthor=M.+Dorywalskaauthor=K.+Delariaauthor=R.+G.+Dushinauthor=T.-T.+Tranauthor=W.-H.+Hoauthor=S.+Fariasauthor=M.+G.+Casasauthor=Y.+Abdicheauthor=D.+Zhouauthor=R.+Chandrasekaranauthor=C.+Samainauthor=C.+Looauthor=A.+Rossiauthor=M.+Rickertauthor=S.+Krimmauthor=T.+Wongauthor=S.+M.+Chinauthor=J.+Yuauthor=J.+Dilleyauthor=J.+Chaparro-Riggersauthor=G.+F.+Filzenauthor=C.+J.+O%E2%80%99Donnellauthor=F.+Wangauthor=J.+S.+Myersauthor=J.+Ponsauthor=D.+L.+Sheltonauthor=A.+Rajpal&title=Location+Matters%3A+Site+of+Conjugation+Modulates+Stability+and+Pharmacokinetics+of+Antibody+Drug+Conjugates&doi=10.1016%2Fj.chembiol.2013.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates</span></div><div class="casAuthors">Strop, Pavel; Liu, Shu-Hui; Dorywalska, Magdalena; Delaria, Kathy; Dushin, Russell G.; Tran, Thomas-Toan; Ho, Wei-Hsien; Farias, Santiago; Casas, Meritxell Galindo; Abdiche, Yasmina; Zhou, Dahui; Chandrasekaran, Ramalakshmi; Samain, Caroline; Loo, Carole; Rossi, Andrea; Rickert, Mathias; Krimm, Stellanie; Wong, Teresa; Chin, Sherman Michael; Yu, Jessica; Dilley, Jeanette; Chaparro-Riggers, Javier; Filzen, Gary F.; O'Donnell, Christopher J.; Wang, Fang; Myers, Jeremy S.; Pons, Jaume; Shelton, David L.; Rajpal, Arvind</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-167</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Antibody drug conjugates (ADCs) are a therapeutic class offering promise for cancer therapy.  The attachment of cytotoxic drugs to antibodies can result in an effective therapy with better safety potential than nontargeted cytotoxics.  To understand the role of conjugation site, we developed an enzymic method for site-specific antibody drug conjugation using microbial transglutaminase.  This allowed us to attach diverse compds. at multiple positions and investigate how the site influences stability, toxicity, and efficacy.  We show that the conjugation site has significant impact on ADC stability and pharmacokinetics in a species-dependent manner.  These differences can be directly attributed to the position of the linkage rather than the chem. instability, as was obsd. with a maleimide linkage.  With this method, it is possible to produce homogeneous ADCs and tune their properties to maximize the therapeutic window.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIo4ZEVMFX2LVg90H21EOLACvtfcHk0lhehJK_Pnb70w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWht74%253D&md5=0b419848b5fd4dfa4863a29de0555cf4</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DStrop%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DS.-H.%26aulast%3DDorywalska%26aufirst%3DM.%26aulast%3DDelaria%26aufirst%3DK.%26aulast%3DDushin%26aufirst%3DR.%2BG.%26aulast%3DTran%26aufirst%3DT.-T.%26aulast%3DHo%26aufirst%3DW.-H.%26aulast%3DFarias%26aufirst%3DS.%26aulast%3DCasas%26aufirst%3DM.%2BG.%26aulast%3DAbdiche%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DChandrasekaran%26aufirst%3DR.%26aulast%3DSamain%26aufirst%3DC.%26aulast%3DLoo%26aufirst%3DC.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DKrimm%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DT.%26aulast%3DChin%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DDilley%26aufirst%3DJ.%26aulast%3DChaparro-Riggers%26aufirst%3DJ.%26aulast%3DFilzen%26aufirst%3DG.%2BF.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DMyers%26aufirst%3DJ.%2BS.%26aulast%3DPons%26aufirst%3DJ.%26aulast%3DShelton%26aufirst%3DD.%2BL.%26aulast%3DRajpal%26aufirst%3DA.%26atitle%3DLocation%2520Matters%253A%2520Site%2520of%2520Conjugation%2520Modulates%2520Stability%2520and%2520Pharmacokinetics%2520of%2520Antibody%2520Drug%2520Conjugates%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26issue%3D2%26spage%3D161%26epage%3D167%26doi%3D10.1016%2Fj.chembiol.2013.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ricart, A. D.</span></span> <span> </span><span class="NLM_article-title">Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6417</span>– <span class="NLM_lpage">6427</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-0486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1158%2F1078-0432.CCR-11-0486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=22003069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSksrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6417-6427&issue=20&author=A.+D.+Ricart&title=Antibody-Drug+Conjugates+of+Calicheamicin+Derivative%3A+Gemtuzumab+Ozogamicin+and+Inotuzumab+Ozogamicin&doi=10.1158%2F1078-0432.CCR-11-0486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin</span></div><div class="casAuthors">Ricart, Alejandro D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6417-6427</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Antibody-drug conjugates (ADC) are an attractive approach for the treatment of acute myeloid leukemia and non-Hodgkin lymphomas, which in most cases, are inherently sensitive to cytotoxic agents.  CD33 and CD22 are specific markers of myeloid leukemias and B-cell malignancies, resp.  These endocytic receptors are ideal for an ADC strategy because they can effectively carry the cytotoxic payload into the cell.  Gemtuzumab ozogamicin (GO, Mylotarg) and inotuzumab ozogamicin consist of a deriv. of calicheamicin (a potent DNA-binding cytotoxic antibiotic) linked to a humanized monoclonal IgG4 antibody directed against CD33 or CD22, resp.  Both of these ADCs have a target-mediated pharmacokinetic disposition.  GO was the first drug to prove the ADC concept in the clinic, specifically in phase II studies that included substantial proportions of older patients with relapsed acute myeloid leukemia.  In contrast, in phase III studies, it has thus far failed to show clin. benefit in first-line treatment in combination with std. chemotherapy.  Inotuzumab ozogamicin has shown remarkable clin. activity in relapsed/refractory B-cell non-Hodgkin lymphoma, and it has started phase III evaluation.  The safety profile of these ADCs includes reversible myelosuppression (esp. neutropenia and thrombocytopenia), elevated hepatic transaminases, and hyperbilirubinemia.  There have been postmarketing reports of hepatotoxicity, esp. veno-occlusive disease, assocd. with GO.  The incidence is ∼2%, but patients who undergo hematopoietic stem cell transplantation have an increased risk.  As we steadily move toward the goal of personalized medicine, these kinds of agents will provide a unique opportunity to treat selected patient subpopulations based on the expression of their specific tumor targets.  Clin Cancer Res; 17(20); 6417-27.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXhh65029iwbVg90H21EOLACvtfcHk0lhehJK_Pnb70w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSksrzF&md5=103b40cfe49632a86367414e0e97c011</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-0486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-0486%26sid%3Dliteratum%253Aachs%26aulast%3DRicart%26aufirst%3DA.%2BD.%26atitle%3DAntibody-Drug%2520Conjugates%2520of%2520Calicheamicin%2520Derivative%253A%2520Gemtuzumab%2520Ozogamicin%2520and%2520Inotuzumab%2520Ozogamicin%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26issue%3D20%26spage%3D6417%26epage%3D6427%26doi%3D10.1158%2F1078-0432.CCR-11-0486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krop, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welslau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baselga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diéras, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guardino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwell, K.</span></span> <span> </span><span class="NLM_article-title">Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">1783</span>– <span class="NLM_lpage">1791</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1209124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1056%2FNEJMoa1209124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=23020162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=1783-1791&issue=19&author=S.+Vermaauthor=D.+Milesauthor=L.+Gianniauthor=I.+E.+Kropauthor=M.+Welslauauthor=J.+Baselgaauthor=M.+Pegramauthor=D.-Y.+Ohauthor=V.+Di%C3%A9rasauthor=E.+Guardinoauthor=L.+Fangauthor=M.+W.+Luauthor=S.+Olsenauthor=K.+Blackwell&title=Trastuzumab+Emtansine+for+HER2-Positive+Advanced+Breast+Cancer&doi=10.1056%2FNEJMoa1209124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Trastuzumab emtansine for HER2-positive advanced breast cancer</span></div><div class="casAuthors">Verma, Sunil; Miles, David; Gianni, Luca; Krop, Ian E.; Welslau, Manfred; Baselga, Jose; Pegram, Mark; Oh, Do-Youn; Dieras, Veronique; Guardino, Ellie; Fang, Liang; Lu, Michael W.; Olsen, Steven; Blackwell, Kim</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1783-1791</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate incorporating the human epidermal growth factor receptor 2 (HER2)-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.  The antibody and the cytotoxic agent are conjugated by means of a stable linker.  METHODS: We randomly assigned patients with HER2-pos. advanced breast cancer, who had previously been treated with trastuzumab and a taxane, to T-DM1 or lapatinib plus capecitabine.  The primary end points were progression-free survival (as assessed by independent review), overall survival, and safety.  Secondary end points included progression-free survival (investigator-assessed), the objective response rate, and the time to symptom progression.  Two interim analyses of overall survival were conducted.  RESULTS: Among 991 randomly assigned patients, median progression-free survival as assessed by independent review was 9.6 mo with T-DM1 vs. 6.4 mo with lapatinib plus capecitabine (hazard ratio for progression or death from any cause, 0.65; 95% confidence interval [CI], 0.55 to 0.77; P<0.001), and median overall survival at the second interim anal. crossed the stopping boundary for efficacy (30.9 mo vs. 25.1 mo; hazard ratio for death from any cause, 0.68; 95% CI, 0.55 to 0.85; P<0.001).  The objective response rate was higher with T-DM1 (43.6%, vs. 30.8% with lapatinib plus capecitabine; P<0.001); results for all addnl. secondary end points favored T-DM1.  Rates of grade 3 or above were higher with lapatinib plus capecitabine than with T-DM1 (57% vs. 41%).  The incidences of thrombocytopenia and increased serum aminotransferase levels were higher with T-DM1, whereas the incidences of diarrhea, nausea, vomiting, and palmar-plantar erythrodysesthesia were higher with lapatinib plus capecitabine.  CONCLUSIONS: T-DM1 significantly prolonged progression-free and overall survival with less toxicity than lapatinib plus capecitabine in patients with HER2-pos. advanced breast cancer previously treated with trastuzumab and a taxane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGRhxRQ7JSJrVg90H21EOLACvtfcHk0lhUhd6CraJYEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt73M&md5=3be5bac27a81b530442dc8a6b4a1f82e</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1209124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1209124%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DS.%26aulast%3DMiles%26aufirst%3DD.%26aulast%3DGianni%26aufirst%3DL.%26aulast%3DKrop%26aufirst%3DI.%2BE.%26aulast%3DWelslau%26aufirst%3DM.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DPegram%26aufirst%3DM.%26aulast%3DOh%26aufirst%3DD.-Y.%26aulast%3DDi%25C3%25A9ras%26aufirst%3DV.%26aulast%3DGuardino%26aufirst%3DE.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DS.%26aulast%3DBlackwell%26aufirst%3DK.%26atitle%3DTrastuzumab%2520Emtansine%2520for%2520HER2-Positive%2520Advanced%2520Breast%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26issue%3D19%26spage%3D1783%26epage%3D1791%26doi%3D10.1056%2FNEJMoa1209124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bardia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vahdat, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolaney, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isakoff, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shaughnessy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroose, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santin, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramson, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugo, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenberg, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweidan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iannone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washkowitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharkey, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegener, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinsky, K.</span></span> <span> </span><span class="NLM_article-title">Sacituzumab Govitecan-Hziy in Refractory Metastatic Triple-Negative Breast Cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>380</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1814213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1056%2FNEJMoa1814213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=30786188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvVSjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2019&pages=741-751&issue=8&author=A.+Bardiaauthor=I.+A.+Mayerauthor=L.+T.+Vahdatauthor=S.+M.+Tolaneyauthor=S.+J.+Isakoffauthor=J.+R.+Diamondauthor=J.+O%E2%80%99Shaughnessyauthor=R.+L.+Morooseauthor=A.+D.+Santinauthor=V.+G.+Abramsonauthor=N.+C.+Shahauthor=H.+S.+Rugoauthor=D.+M.+Goldenbergauthor=A.+M.+Sweidanauthor=R.+Iannoneauthor=S.+Washkowitzauthor=R.+M.+Sharkeyauthor=W.+A.+Wegenerauthor=K.+Kalinsky&title=Sacituzumab+Govitecan-Hziy+in+Refractory+Metastatic+Triple-Negative+Breast+Cancer&doi=10.1056%2FNEJMoa1814213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer</span></div><div class="casAuthors">Bardia, A.; Mayer, I. A.; Vahdat, L. T.; Tolaney, S. M.; Isakoff, S. J.; Diamond, J. R.; O'Shaughnessy, J.; Moroose, R. L.; Santin, A. D.; Abramson, V. G.; Shah, N. C.; Rugo, H. S.; Goldenberg, D. M.; Sweidan, A. M.; Iannone, R.; Washkowitz, S.; Sharkey, R. M.; Wegener, W. A.; Kalinsky, K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">741-751</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background Std. chemotherapy is assocd. with low response rates and short progression-free survival among patients with pretreated metastatic triple-neg. breast cancer.  Sacituzumab govitecan-hziy is an antibody-drug conjugate that combines a humanized monoclonal antibody, which targets the human trophoblast cell-surface antigen 2 (Trop-2), with SN-38, which is conjugated to the antibody by a cleavable linker.  Sacituzumab govitecan-hziy enables delivery of high concns. of SN-38 to tumors.  Methods We conducted a phase 1/2 single-group, multicenter trial involving patients with advanced epithelial cancers who received sacituzumab govitecan-hziy i.v. on days 1 and 8 of each 21-day cycle until disease progression or unacceptable toxic effects.  A total of 108 patients received sacituzumab govitecan-hziy at a dose of 10 mg per kg of body wt. after receiving at least two previous anticancer therapies for metastatic triple-neg. breast cancer.  The end points included safety; the objective response rate (according to Response Evaluation Criteria in Solid Tumors, version 1.1), which was assessed locally; the duration of response; the clin. benefit rate (defined as a complete or partial response or stable disease for at least 6 mo); progression-free survival; and overall survival.  Post hoc analyses detd. the response rate and duration, which were assessed by blinded independent central review. results The 108 patients with triple-neg. breast cancer had received a median of 3 previous therapies (range, 2 to 10).  Four deaths occurred during treatment; 3 patients (2.8%) discontinued treatment because of adverse events.  Grade 3 or 4 adverse events (in ≥10% of the patients) included anemia and neutropenia; 10 patients (9.3%) had febrile neutropenia.  The response rate (3 complete and 33 partial responses) was 33.3% (95% confidence interval [CI], 24.6 to 43.1), and the median duration of response was 7.7 mo (95% CI, 4.9 to 10.8); as assessed by independent central review, these values were 34.3% and 9.1 mo, resp.  The clin. benefit rate was 45.4%.  Median progression-free survival was 5.5 mo (95% CI, 4.1 to 6.3), and overall survival was 13.0 mo (95% CI, 11.2 to 13.7).  Conclusions Sacituzumab govitecan-hziy was assocd. with durable objective responses in patients with heavily pretreated metastatic triple-neg. breast cancer.  Myelotoxic effects were the main adverse reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAgQWEPOcqfrVg90H21EOLACvtfcHk0lhUhd6CraJYEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvVSjs7w%253D&md5=75edc2c274aef0ab90dd2aaf230dabac</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1814213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1814213%26sid%3Dliteratum%253Aachs%26aulast%3DBardia%26aufirst%3DA.%26aulast%3DMayer%26aufirst%3DI.%2BA.%26aulast%3DVahdat%26aufirst%3DL.%2BT.%26aulast%3DTolaney%26aufirst%3DS.%2BM.%26aulast%3DIsakoff%26aufirst%3DS.%2BJ.%26aulast%3DDiamond%26aufirst%3DJ.%2BR.%26aulast%3DO%25E2%2580%2599Shaughnessy%26aufirst%3DJ.%26aulast%3DMoroose%26aufirst%3DR.%2BL.%26aulast%3DSantin%26aufirst%3DA.%2BD.%26aulast%3DAbramson%26aufirst%3DV.%2BG.%26aulast%3DShah%26aufirst%3DN.%2BC.%26aulast%3DRugo%26aufirst%3DH.%2BS.%26aulast%3DGoldenberg%26aufirst%3DD.%2BM.%26aulast%3DSweidan%26aufirst%3DA.%2BM.%26aulast%3DIannone%26aufirst%3DR.%26aulast%3DWashkowitz%26aufirst%3DS.%26aulast%3DSharkey%26aufirst%3DR.%2BM.%26aulast%3DWegener%26aufirst%3DW.%2BA.%26aulast%3DKalinsky%26aufirst%3DK.%26atitle%3DSacituzumab%2520Govitecan-Hziy%2520in%2520Refractory%2520Metastatic%2520Triple-Negative%2520Breast%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2019%26volume%3D380%26issue%3D8%26spage%3D741%26epage%3D751%26doi%3D10.1056%2FNEJMoa1814213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lonial, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trudel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nooka, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdallah, A.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callander, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lendvai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sborov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suvannasankha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libby, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnulf, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortüm, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Otero, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usmani, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quach, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voorhees, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piontek, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewell, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dettman, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposti, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opalinska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, A. D.</span></span> <span> </span><span class="NLM_article-title">Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma (DREAMM-2): A Two-Arm, Randomised, Open-Label, Phase 2 Study</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(19)30788-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS1470-2045%2819%2930788-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31859245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVajtLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=207-221&issue=2&author=S.+Lonialauthor=H.+C.+Leeauthor=A.+Badrosauthor=S.+Trudelauthor=A.+K.+Nookaauthor=A.+Chariauthor=A.-O.+Abdallahauthor=N.+Callanderauthor=N.+Lendvaiauthor=D.+Sborovauthor=A.+Suvannasankhaauthor=K.+Weiselauthor=L.+Karlinauthor=E.+Libbyauthor=B.+Arnulfauthor=T.+Faconauthor=C.+Hulinauthor=K.+M.+Kort%C3%BCmauthor=P.+Rodr%C3%ADguez-Oteroauthor=S.+Z.+Usmaniauthor=P.+Hariauthor=R.+Bazauthor=H.+Quachauthor=P.+Moreauauthor=P.+M.+Voorheesauthor=I.+Guptaauthor=A.+Hoosauthor=E.+Zhiauthor=J.+Baronauthor=T.+Piontekauthor=E.+Lewisauthor=R.+C.+Jewellauthor=E.+J.+Dettmanauthor=R.+Popatauthor=S.+D.+Espostiauthor=J.+Opalinskaauthor=P.+Richardsonauthor=A.+D.+Cohen&title=Belantamab+Mafodotin+for+Relapsed+or+Refractory+Multiple+Myeloma+%28DREAMM-2%29%3A+A+Two-Arm%2C+Randomised%2C+Open-Label%2C+Phase+2+Study&doi=10.1016%2FS1470-2045%2819%2930788-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study</span></div><div class="casAuthors">Lonial, Sagar; Lee, Hans C.; Badros, Ashraf; Trudel, Suzanne; Nooka, Ajay K.; Chari, Ajai; Abdallah, Al-Ola; Callander, Natalie; Lendvai, Nikoletta; Sborov, Douglas; Suvannasankha, Attaya; Weisel, Katja; Karlin, Lionel; Libby, Edward; Arnulf, Bertrand; Facon, Thierry; Hulin, Cyrille; Kortum, K. Martin; Rodriguez-Otero, Paula; Usmani, Saad Z.; Hari, Parameswaran; Baz, Rachid; Quach, Hang; Moreau, Philippe; Voorhees, Peter M.; Gupta, Ira; Hoos, Axel; Zhi, Eric; Baron, January; Piontek, Trisha; Lewis, Eric; Jewell, Roxanne C.; Dettman, Elisha J.; Popat, Rakesh; Esposti, Simona Degli; Opalinska, Joanna; Richardson, Paul; Cohen, Adam D.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-221</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Belantamab mafodotin (GSK2857916), an immunoconjugate targeting B-cell maturation antigen, showed single-agent activity in the phase 1 DREAMM-1 study in heavily pre-treated patients with relapsed or refractory multiple myeloma.  We further investigated the safety and activity of belantamab mafodotin in the DREAMM-2 study.  DREAMM-2 is an open-label, two-arm, phase 2 study done at 58 multiple myeloma specialty centers in eight countries.  Patients (aged ≥18 years) with relapsed or refractory multiple myeloma with disease progression after three or more lines of therapy and who were refractory to immunomodulatory drugs and proteasome inhibitors, and refractory or intolerant (or both) to an anti-CD38 monoclonal antibody with an Eastern Cooperative Oncol. Group performance status of 0-2 were recruited, centrally randomly assigned (1:1) with permuted blocks (block size 4), and stratified by previous lines of therapy (≤4 vs >4) and cytogenetic features to receive 2·5 mg/kg or 3·4 mg/kg belantamab mafodotin via i.v. infusion every 3 wk on day 1 of each cycle until disease progression or unacceptable toxicity.  The intention-to-treat population comprised all randomised patients, regardless of treatment administration.  The safety population comprised all patients who received at least one dose of belantamab mafodotin.  The primary outcome was the proportion of randomly assigned patients in the intention-to-treat population who achieved an overall response, as assessed by an independent review committee.  This study is registered with ClinicalTrials.gov, NCT03525678, and is ongoing.  Between June 18, 2018, and Jan 2, 2019, 293 patients were screened and 196 were included in the intention-to-treat population (97 in the 2·5 mg/kg cohort and 99 in the 3·4 mg/kg cohort).  As of June 21, 2019 (the primary anal. data cutoff date), 30 (31%; 97·5% CI 20·8-42·6) of 97 patients in the 2·5 mg/kg cohort and 34 (34%; 23·9-46·0) of 99 patients in the 3·4 mg/kg cohort achieved an overall response.  The most common grade 3-4 adverse events in the safety population were keratopathy (in 26 [27%] of 95 patients in the 2·5 mg/kg cohort and 21 [21%] of 99 patients in the 3·4 mg/kg cohort), thrombocytopenia (19 [20%] and 33 [33%]), and anemia (19 [20%] and 25 [25%]); 38 (40%) of 95 patients in the 2·5 mg/kg cohort and 47 (47%) of 99 in the 3·4 mg/kg cohort reported serious adverse events.  Two deaths were potentially treatment related (one case of sepsis in the 2·5 mg/kg cohort and one case of haemophagocytic lymphohistiocytosis in the 3·4 mg/kg cohort).  Single-agent belantamab mafodotin shows anti-myeloma activity with a manageable safety profile in patients with relapsed or refractory multiple myeloma.GlaxoSmithKline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX5xuk-7bebbVg90H21EOLACvtfcHk0lieVsU8BxthWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVajtLjN&md5=cef83b6e32d56ef8410f339855314db1</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2819%2930788-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252819%252930788-0%26sid%3Dliteratum%253Aachs%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DH.%2BC.%26aulast%3DBadros%26aufirst%3DA.%26aulast%3DTrudel%26aufirst%3DS.%26aulast%3DNooka%26aufirst%3DA.%2BK.%26aulast%3DChari%26aufirst%3DA.%26aulast%3DAbdallah%26aufirst%3DA.-O.%26aulast%3DCallander%26aufirst%3DN.%26aulast%3DLendvai%26aufirst%3DN.%26aulast%3DSborov%26aufirst%3DD.%26aulast%3DSuvannasankha%26aufirst%3DA.%26aulast%3DWeisel%26aufirst%3DK.%26aulast%3DKarlin%26aufirst%3DL.%26aulast%3DLibby%26aufirst%3DE.%26aulast%3DArnulf%26aufirst%3DB.%26aulast%3DFacon%26aufirst%3DT.%26aulast%3DHulin%26aufirst%3DC.%26aulast%3DKort%25C3%25BCm%26aufirst%3DK.%2BM.%26aulast%3DRodr%25C3%25ADguez-Otero%26aufirst%3DP.%26aulast%3DUsmani%26aufirst%3DS.%2BZ.%26aulast%3DHari%26aufirst%3DP.%26aulast%3DBaz%26aufirst%3DR.%26aulast%3DQuach%26aufirst%3DH.%26aulast%3DMoreau%26aufirst%3DP.%26aulast%3DVoorhees%26aufirst%3DP.%2BM.%26aulast%3DGupta%26aufirst%3DI.%26aulast%3DHoos%26aufirst%3DA.%26aulast%3DZhi%26aufirst%3DE.%26aulast%3DBaron%26aufirst%3DJ.%26aulast%3DPiontek%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DE.%26aulast%3DJewell%26aufirst%3DR.%2BC.%26aulast%3DDettman%26aufirst%3DE.%2BJ.%26aulast%3DPopat%26aufirst%3DR.%26aulast%3DEsposti%26aufirst%3DS.%2BD.%26aulast%3DOpalinska%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DCohen%26aufirst%3DA.%2BD.%26atitle%3DBelantamab%2520Mafodotin%2520for%2520Relapsed%2520or%2520Refractory%2520Multiple%2520Myeloma%2520%2528DREAMM-2%2529%253A%2520A%2520Two-Arm%252C%2520Randomised%252C%2520Open-Label%252C%2520Phase%25202%2520Study%26jtitle%3DLancet%2520Oncol.%26date%3D2020%26volume%3D21%26issue%3D2%26spage%3D207%26epage%3D221%26doi%3D10.1016%2FS1470-2045%2819%2930788-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Modi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsurutani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denduluri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aogi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, S.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurvitz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahidi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yver, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krop, I.</span></span> <span> </span><span class="NLM_article-title">Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>382</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">610</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1914510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1056%2FNEJMoa1914510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31825192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtlChur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2020&pages=610-621&issue=7&author=S.+Modiauthor=C.+Sauraauthor=T.+Yamashitaauthor=Y.+H.+Parkauthor=S.-B.+Kimauthor=K.+Tamuraauthor=F.+Andreauthor=H.+Iwataauthor=Y.+Itoauthor=J.+Tsurutaniauthor=J.+Sohnauthor=N.+Denduluriauthor=C.+Perrinauthor=K.+Aogiauthor=E.+Tokunagaauthor=S.-A.+Imauthor=K.+S.+Leeauthor=S.+A.+Hurvitzauthor=J.+Cortesauthor=C.+Leeauthor=S.+Chenauthor=L.+Zhangauthor=J.+Shahidiauthor=A.+Yverauthor=I.+Krop&title=Trastuzumab+Deruxtecan+in+Previously+Treated+HER2-Positive+Breast+Cancer&doi=10.1056%2FNEJMoa1914510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Trastuzumab deruxtecan in previously treated HER2-positive breast cancer</span></div><div class="casAuthors">Modi, S.; Saura, C.; Yamashita, T.; Park, Y. H.; Kim, S.-B.; Tamura, K.; Andre, F.; Iwata, H.; Ito, Y.; Tsurutani, J.; Sohn, J.; Denduluri, N.; Perrin, C.; Aogi, K.; Tokunaga, E.; Im, S.-A.; Lee, K. S.; Hurvitz, S. A.; Cortes, J.; Lee, C.; Chen, S.; Zhang, L.; Shahidi, J.; Yver, A.; Krop, I.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">610-621</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">In this two-part, open-label, single-group, multicenter, phase 2 study, we evaluated trastuzumab deruxtecan in adults with pathol. documented HER2-pos. metastatic breast cancer who had received previous treatment with trastuzumab emtansine.  In the first part of the study, we evaluated three different doses of trastuzumab deruxtecan to establish a recommended dose; in the second part, we evaluated the efficacy and safety of the recommended dose.  Key secondary end points were the disease-control rate, clin.-benefit rate, duration of response and progression-free survival, and safety. results Overall, 184 patients who had undergone a median of six previous treatments received the recommended dose of trastuzumab deruxtecan (5.4 mg per kg of body wt.).  During the study, the most common adverse events of grade 3 or higher were a decreased neutrophil count (in 20.7% of the patients), anemia (in 8.7%), and nausea (in 7.6%).  On independent adjudication, the trial drug was assocd. with interstitial lung disease in 13.6% of the patients (grade 1 or 2, 10.9%; grade 3 or 4, 0.5%; and grade 5, 2.2%). conclusions Trastuzumab deruxtecan showed durable antitumor activity in a pretreated patient population with HER2-pos. metastatic breast cancer.  In addn. to nausea and myelosuppression, interstitial lung disease was obsd. in a subgroup of patients and requires attention to pulmonary symptoms and careful monitoring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Uc2NDB76h7Vg90H21EOLACvtfcHk0lgR1dWL2yYnkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtlChur8%253D&md5=0b142802a47c4f50f0b2cdc82f22ce87</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1914510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1914510%26sid%3Dliteratum%253Aachs%26aulast%3DModi%26aufirst%3DS.%26aulast%3DSaura%26aufirst%3DC.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DY.%2BH.%26aulast%3DKim%26aufirst%3DS.-B.%26aulast%3DTamura%26aufirst%3DK.%26aulast%3DAndre%26aufirst%3DF.%26aulast%3DIwata%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DTsurutani%26aufirst%3DJ.%26aulast%3DSohn%26aufirst%3DJ.%26aulast%3DDenduluri%26aufirst%3DN.%26aulast%3DPerrin%26aufirst%3DC.%26aulast%3DAogi%26aufirst%3DK.%26aulast%3DTokunaga%26aufirst%3DE.%26aulast%3DIm%26aufirst%3DS.-A.%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DHurvitz%26aufirst%3DS.%2BA.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DShahidi%26aufirst%3DJ.%26aulast%3DYver%26aufirst%3DA.%26aulast%3DKrop%26aufirst%3DI.%26atitle%3DTrastuzumab%2520Deruxtecan%2520in%2520Previously%2520Treated%2520HER2-Positive%2520Breast%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2020%26volume%3D382%26issue%3D7%26spage%3D610%26epage%3D621%26doi%3D10.1056%2FNEJMoa1914510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balar, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galsky, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gartner, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinelli, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melhem-Bertrandt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrylak, D. P.</span></span> <span> </span><span class="NLM_article-title">Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">2592</span>– <span class="NLM_lpage">2600</span>, <span class="refDoi"> DOI: 10.1200/JCO.19.01140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1200%2FJCO.19.01140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31356140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovVSitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=2592-2600&issue=29&author=J.+E.+Rosenbergauthor=P.+H.+O%E2%80%99Donnellauthor=A.+V.+Balarauthor=B.+A.+McGregorauthor=E.+I.+Heathauthor=E.+Y.+Yuauthor=M.+D.+Galskyauthor=N.+M.+Hahnauthor=E.+M.+Gartnerauthor=J.+M.+Pinelliauthor=S.-Y.+Liangauthor=A.+Melhem-Bertrandtauthor=D.+P.+Petrylak&title=Pivotal+Trial+of+Enfortumab+Vedotin+in+Urothelial+Carcinoma+After+Platinum+and+Anti-Programmed+Death+1%2FProgrammed+Death+Ligand+1+Therapy&doi=10.1200%2FJCO.19.01140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Pivotal trial of enfortumab vedotin in urothelial carcinoma after platinum and anti-programmed death 1/programmed death ligand 1 therapy</span></div><div class="casAuthors">Rosenberg, Jonathan E.; O'Donnell, Peter H.; Balar, Arjun V.; McGregor, Bradley A.; Heath, Elisabeth I.; Yu, Evan Y.; Galsky, Matthew D.; Hahn, Noah M.; Gartner, Elaina M.; Pinelli, Juan M.; Liang, Shang-Ying; Melhem-Bertrandt, Amal; Petrylak, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">2592-2613</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">1527-7755</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">PURPOSE Locally advanced or metastatic urothelial carcinoma is an incurable disease with limited treatment options, esp. for patients who were previously treated with platinum and anti-programmed death 1 or anti-programmed death ligand 1 (PD-1/L1) therapy.  Enfortumab vedotin is an antibody-drug conjugate that targets Nectin-4, which is highly expressed in urothelial carcinoma.  METHODS EV-201 is a global, phase II, single-arm study of enfortumab vedotin 1.25mg/kg (i.v. on days 1, 8, and 15 of every 28-day cycle) in patients with locally advanced or metastatic urothelial carcinoma who were previously treated with platinum chemotherapy and anti-PD-1/L1 therapy.  The primary end point was objective response rate per Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 by blinded independent central review.  Key secondary end points were duration of response, progression-free survival, overall survival, safety, and tolerability.  RESULTS Enfortumab vedotin was administered to 125 patients with metastatic urothelial carcinoma.  Median follow-up was 10.2 mo (range, 0.5 to 16.5 mo).  Confirmed objective response rate was 44% (95% CI, 35.1% to 53.2%), including 12% complete responses.  Similar responses were obsd. in prespecified subgroups, such as those patients with liver metastases and those with no response to prior anti-PD-1/L1 therapy.  Median duration of response was 7.6 mo (range, 0.95 to 11.301 mo).  The most common treatment-related adverse events were fatigue (50%), any peripheral neuropathy (50%), alopecia (49%), any rash (48%), decreased appetite (44%), and dysgeusia (40%).  No single treatment-related adverse events grade 3 or greater occurred in 10% or more of patients.  CONCLUSION Enfortumab vedotin demonstrated a clin. meaningful response rate with a manageable and tolerable safety profile in patients with locally advanced or metastatic urothelial carcinoma who were previously treated with platinum and anti-PD-1/L1 therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSAj5iZGBZybVg90H21EOLACvtfcHk0lgR1dWL2yYnkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovVSitrc%253D&md5=01f8e50e459d254f0a687abc479da014</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1200%2FJCO.19.01140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.19.01140%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DP.%2BH.%26aulast%3DBalar%26aufirst%3DA.%2BV.%26aulast%3DMcGregor%26aufirst%3DB.%2BA.%26aulast%3DHeath%26aufirst%3DE.%2BI.%26aulast%3DYu%26aufirst%3DE.%2BY.%26aulast%3DGalsky%26aufirst%3DM.%2BD.%26aulast%3DHahn%26aufirst%3DN.%2BM.%26aulast%3DGartner%26aufirst%3DE.%2BM.%26aulast%3DPinelli%26aufirst%3DJ.%2BM.%26aulast%3DLiang%26aufirst%3DS.-Y.%26aulast%3DMelhem-Bertrandt%26aufirst%3DA.%26aulast%3DPetrylak%26aufirst%3DD.%2BP.%26atitle%3DPivotal%2520Trial%2520of%2520Enfortumab%2520Vedotin%2520in%2520Urothelial%2520Carcinoma%2520After%2520Platinum%2520and%2520Anti-Programmed%2520Death%25201%252FProgrammed%2520Death%2520Ligand%25201%2520Therapy%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2019%26volume%3D37%26issue%3D29%26spage%3D2592%26epage%3D2600%26doi%3D10.1200%2FJCO.19.01140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sehn, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flowers, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamdar, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMillan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assouline, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozcan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penuel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulson, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matasar, M. J.</span></span> <span> </span><span class="NLM_article-title">Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1200/JCO.19.00172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1200%2FJCO.19.00172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31693429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslSktb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2020&pages=155-165&issue=2&author=L.+H.+Sehnauthor=A.+F.+Herreraauthor=C.+R.+Flowersauthor=M.+K.+Kamdarauthor=A.+McMillanauthor=M.+Hertzbergauthor=S.+Assoulineauthor=T.+M.+Kimauthor=W.+S.+Kimauthor=M.+Ozcanauthor=J.+Hirataauthor=E.+Penuelauthor=J.+N.+Paulsonauthor=J.+Chengauthor=G.+Kuauthor=M.+J.+Matasar&title=Polatuzumab+Vedotin+in+Relapsed+or+Refractory+Diffuse+Large+B-Cell+Lymphoma&doi=10.1200%2FJCO.19.00172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma</span></div><div class="casAuthors">Sehn, Laurie H.; Herrera, Alex F.; Flowers, Christopher R.; Kaar, Manali K.; McMillan, Andrew; Hertzberg, Mark; Assouline, Sarit; Kim, Tae Min; Kim, Won Seog; Ozcan, Muhit; Hirata, Jamie; Penuel, Elicia; Paulson, Joseph N.; Cheng, Ji; Ku, Grace; Matasar, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-176</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">1527-7755</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Patients with transplantation-ineligible relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) fare poorly, with limited treatment options.  The antibody-drug conjugate polatuzumab vedotin targets CD79b, a B-cell receptor component.  Safety and efficacy of polatuzumab vedotin with bendamustine and obinutuzumab (pola-BG) was evaluated in a single-arm cohort.  Polatuzumab vedotin combined with bendamustine and rituximab (pola-BR) was compared with bendamustine and rituximab (BR) in a randomly assigned cohort of patients with transplantation-ineligible R/R DLBCL (primary end point: independent review committee [IRC] assessed complete response [CR] rate at the end of treatment).  Duration of response, progression-free survival (PFS), and overall survival (OS) were analyzed using Kaplan-Meier and Cox regression methods.  Pola-BG and pola-BR had a tolerable safety profile.  The phase Ib/II pola-BG cohort (n = 27) had a CR rate of 29.6% and a median OS of 10.8 mo (median follow-up, 27.0 mo).  In the randomly assigned cohort (n = 80; 40 per arm), pola-BR patients had a significantly higher IRC-assessed CR rate (40.0% v 17.5%; P = .026) and longer IRC-assessed PFS (median, 9.5 v 3.7 mo; hazard ratio [HR], 0.36, 95% CI, 0.21 to 0.63; P < .001) and OS (median, 12.4 v 4.7 mo; HR, 0.42; 95% CI, 0.24 to 0.75; P = .002; median follow-up, 22.3 mo).  Pola-BR patients had higher rates of grade 3-4 neutropenia (46.2% v 33.3%), anemia (28.2% v 17.9%), and thrombocytopenia (41% v 23.1%), but similar grade 3-4 infections (23.1% v 20.5%), vs. the BR group.  Peripheral neuropathy assocd. with polatuzumab vedotin (43.6% of patients) was grade 1-2 and resolved in most patients.  Polatuzumab vedotin combined with BR resulted in a significantly higher CR rate and reduced the risk of death by 58% compared with BR in patients with transplantation-ineligible R/R DLBCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUa_nOL1QFFLVg90H21EOLACvtfcHk0linHmU5hBGD3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslSktb3L&md5=3e8d91c5458d187b189615090441f029</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1200%2FJCO.19.00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.19.00172%26sid%3Dliteratum%253Aachs%26aulast%3DSehn%26aufirst%3DL.%2BH.%26aulast%3DHerrera%26aufirst%3DA.%2BF.%26aulast%3DFlowers%26aufirst%3DC.%2BR.%26aulast%3DKamdar%26aufirst%3DM.%2BK.%26aulast%3DMcMillan%26aufirst%3DA.%26aulast%3DHertzberg%26aufirst%3DM.%26aulast%3DAssouline%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DT.%2BM.%26aulast%3DKim%26aufirst%3DW.%2BS.%26aulast%3DOzcan%26aufirst%3DM.%26aulast%3DHirata%26aufirst%3DJ.%26aulast%3DPenuel%26aufirst%3DE.%26aulast%3DPaulson%26aufirst%3DJ.%2BN.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DKu%26aufirst%3DG.%26aulast%3DMatasar%26aufirst%3DM.%2BJ.%26atitle%3DPolatuzumab%2520Vedotin%2520in%2520Relapsed%2520or%2520Refractory%2520Diffuse%2520Large%2520B-Cell%2520Lymphoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2020%26volume%3D38%26issue%3D2%26spage%3D155%26epage%3D165%26doi%3D10.1200%2FJCO.19.00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Younes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sievers, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forero-Torres, A.</span></span> <span> </span><span class="NLM_article-title">Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>363</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">1812</span>– <span class="NLM_lpage">1821</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1002965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1056%2FNEJMoa1002965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=21047225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2gsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1812-1821&issue=19&author=A.+Younesauthor=N.+L.+Bartlettauthor=J.+P.+Leonardauthor=D.+A.+Kennedyauthor=C.+M.+Lynchauthor=E.+L.+Sieversauthor=A.+Forero-Torres&title=Brentuximab+Vedotin+%28SGN-35%29+for+Relapsed+CD30-Positive+Lymphomas&doi=10.1056%2FNEJMoa1002965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Brentuximab vedotin (SGN-35) for relapsed Cd30-positive lymphomas</span></div><div class="casAuthors">Younes, Anas; Bartlett, Nancy L.; Leonard, John P.; Kennedy, Dana A.; Lynch, Carmel M.; Sievers, Eric L.; Forero-Torres, Andres</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1812-1821</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Hodgkin's lymphoma and anaplastic large-cell lymphoma are the two most common tumors expressing CD30.  Previous attempts to target the CD30 antigen with monoclonal-based therapies have shown minimal activity.  To enhance the antitumor activity of CD30-directed therapy, the antitubulin agent monomethyl auristatin E (MMAE) was attached to a CD30-specific monoclonal antibody by an enzyme-cleavable linker, producing the antibody-drug conjugate brentuximab vedotin (SGN-35).  METHODS: In this phase 1, open-label, multicenter dose-escalation study, we administered brentuximab vedotin (at a dose of 0.1 to 3.6 mg per kg of body wt.) every 3 wk to 45 patients with relapsed or refractory CD30-pos. hematol.  Cancers, primarily Hodgkin's lymphoma and anaplastic large-cell lymphoma.  Patients had received a median of three previous chemotherapy regimens (range, one to seven), and 73% had undergone autologous stem-cell transplantation.  RESULTS: The max. tolerated dose was 1.8 mg per kg, administered every 3 wk.  Objective responses, including 11 complete remissions, were obsd. in 17 patients.  Of 12 patients who received the 1.8-mg-per-kilogram dose, 6 (50%) had an objective response.  The median duration of response was at least 9.7 mo.  Tumor regression was obsd. in 36 of 42 patients who could be evaluated (86%).  The most common adverse events were fatigue, pyrexia, diarrhea, nausea, neutropenia, and peripheral neuropathy.  CONCLUSIONS: Brentuximab vedotin induced durable objective responses and resulted in tumor regression for most patients with relapsed or refractory CD30-pos. lymphomas in this phase 1 study.  Treatment was assocd. primarily with grade 1 or 2 (mild-to-moderate) toxic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS4GvKk2Sw7bVg90H21EOLACvtfcHk0linHmU5hBGD3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2gsbbE&md5=d27d22f971143a6c5415090ab57fe01a</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1002965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1002965%26sid%3Dliteratum%253Aachs%26aulast%3DYounes%26aufirst%3DA.%26aulast%3DBartlett%26aufirst%3DN.%2BL.%26aulast%3DLeonard%26aufirst%3DJ.%2BP.%26aulast%3DKennedy%26aufirst%3DD.%2BA.%26aulast%3DLynch%26aufirst%3DC.%2BM.%26aulast%3DSievers%26aufirst%3DE.%2BL.%26aulast%3DForero-Torres%26aufirst%3DA.%26atitle%3DBrentuximab%2520Vedotin%2520%2528SGN-35%2529%2520for%2520Relapsed%2520CD30-Positive%2520Lymphomas%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26issue%3D19%26spage%3D1812%26epage%3D1821%26doi%3D10.1056%2FNEJMoa1002965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kreitman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dearden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinzani, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gladstone, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">le Coutre, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larratt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swords, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouabdallah, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breems, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortelezzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doubek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gjertsen, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepretre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloisel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravandi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousselot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadmor, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troussard, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saglio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roboz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balic, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standifer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, F.</span></span> <span> </span><span class="NLM_article-title">Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1768</span>– <span class="NLM_lpage">1777</span>, <span class="refDoi"> DOI: 10.1038/s41375-018-0210-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fs41375-018-0210-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=30030507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2jsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=1768-1777&issue=8&author=R.+J.+Kreitmanauthor=C.+Deardenauthor=P.+L.+Zinzaniauthor=J.+Delgadoauthor=L.+Karlinauthor=T.+Robakauthor=D.+E.+Gladstoneauthor=P.+le+Coutreauthor=S.+Dietrichauthor=M.+Goticauthor=L.+Larrattauthor=F.+Offnerauthor=G.+Schillerauthor=R.+Swordsauthor=L.+Baconauthor=M.+Bocchiaauthor=K.+Bouabdallahauthor=D.+A.+Breemsauthor=A.+Cortelezziauthor=S.+Dinnerauthor=M.+Doubekauthor=B.+T.+Gjertsenauthor=M.+Gobbiauthor=A.+Hellmannauthor=S.+Lepretreauthor=F.+Maloiselauthor=F.+Ravandiauthor=P.+Rousselotauthor=M.+Rummelauthor=T.+Siddiqiauthor=T.+Tadmorauthor=X.+Troussardauthor=C.+A.+Yiauthor=G.+Saglioauthor=G.+J.+Robozauthor=K.+Balicauthor=N.+Standiferauthor=P.+Heauthor=S.+Marshallauthor=W.+Wilsonauthor=I.+Pastanauthor=N.-S.+Yaoauthor=F.+Giles&title=Moxetumomab+Pasudotox+in+Relapsed%2FRefractory+Hairy+Cell+Leukemia&doi=10.1038%2Fs41375-018-0210-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia</span></div><div class="casAuthors">Kreitman, Robert J.; Dearden, Claire; Zinzani, Pier Luigi; Delgado, Julio; Karlin, Lionel; Robak, Tadeusz; Gladstone, Douglas E.; le Coutre, Philipp; Dietrich, Sascha; Gotic, Mirjana; Larratt, Loree; Offner, Fritz; Schiller, Gary; Swords, Ronan; Bacon, Larry; Bocchia, Monica; Bouabdallah, Krimo; Breems, Dimitri A.; Cortelezzi, Agostino; Dinner, Shira; Doubek, Michael; Gjertsen, Bjorn Tore; Gobbi, Marco; Hellmann, Andrzej; Lepretre, Stephane; Maloisel, Frederic; Ravandi, Farhad; Rousselot, Philippe; Rummel, Mathias; Siddiqi, Tanya; Tadmor, Tamar; Troussard, Xavier; Yi, Cecilia Arana; Saglio, Giuseppe; Roboz, Gail J.; Balic, Kemal; Standifer, Nathan; He, Peng; Marshall, Shannon; Wilson, Wyndham; Pastan, Ira; Yao, Nai-Shun; Giles, Francis</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1768-1777</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">This is a pivotal, multicenter, open-label study of moxetumomab pasudotox, a recombinant CD22-targeting immunotoxin, in hairy cell leukemia (HCL), a rare B cell malignancy with high CD22 expression.  The study enrolled patients with relapsed/refractory HCL who had ≥2 prior systemic therapies, including ≥1 purine nucleoside analog.  Patients received moxetumomab pasudotox 40μg/kg i.v. on days 1, 3, and 5 every 28 days for ≤6 cycles.  Blinded independent central review detd. disease response and minimal residual disease (MRD) status.  Among 80 patients (79% males; median age, 60.0 years), durable complete response (CR) rate was 30%, CR rate was 41%, and objective response rate (CR and partial response) was 75%; 64 patients (80%) achieved hematol. remission.  Among complete responders, 27 (85%) achieved MRD negativity by immunohistochem.  The most frequent adverse events (AEs) were peripheral edema (39%), nausea (35%), fatigue (34%), and headache (33%).  Treatment-related serious AEs of hemolytic uremic syndrome (7.5%) and capillary leak syndrome (5%) were reversible and generally manageable with supportive care and treatment discontinuation (6 patients; 7.5%).  Moxetumomab pasudotox treatment achieved a high rate of independently assessed durable response and MRD eradication in heavily pretreated patients with HCL, with acceptable tolerability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeY1R3pFu2G7Vg90H21EOLACvtfcHk0liygK1MzAlbpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2jsLfF&md5=99d890861536dbea09c65e49da58bfdd</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1038%2Fs41375-018-0210-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41375-018-0210-1%26sid%3Dliteratum%253Aachs%26aulast%3DKreitman%26aufirst%3DR.%2BJ.%26aulast%3DDearden%26aufirst%3DC.%26aulast%3DZinzani%26aufirst%3DP.%2BL.%26aulast%3DDelgado%26aufirst%3DJ.%26aulast%3DKarlin%26aufirst%3DL.%26aulast%3DRobak%26aufirst%3DT.%26aulast%3DGladstone%26aufirst%3DD.%2BE.%26aulast%3Dle%2BCoutre%26aufirst%3DP.%26aulast%3DDietrich%26aufirst%3DS.%26aulast%3DGotic%26aufirst%3DM.%26aulast%3DLarratt%26aufirst%3DL.%26aulast%3DOffner%26aufirst%3DF.%26aulast%3DSchiller%26aufirst%3DG.%26aulast%3DSwords%26aufirst%3DR.%26aulast%3DBacon%26aufirst%3DL.%26aulast%3DBocchia%26aufirst%3DM.%26aulast%3DBouabdallah%26aufirst%3DK.%26aulast%3DBreems%26aufirst%3DD.%2BA.%26aulast%3DCortelezzi%26aufirst%3DA.%26aulast%3DDinner%26aufirst%3DS.%26aulast%3DDoubek%26aufirst%3DM.%26aulast%3DGjertsen%26aufirst%3DB.%2BT.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DHellmann%26aufirst%3DA.%26aulast%3DLepretre%26aufirst%3DS.%26aulast%3DMaloisel%26aufirst%3DF.%26aulast%3DRavandi%26aufirst%3DF.%26aulast%3DRousselot%26aufirst%3DP.%26aulast%3DRummel%26aufirst%3DM.%26aulast%3DSiddiqi%26aufirst%3DT.%26aulast%3DTadmor%26aufirst%3DT.%26aulast%3DTroussard%26aufirst%3DX.%26aulast%3DYi%26aufirst%3DC.%2BA.%26aulast%3DSaglio%26aufirst%3DG.%26aulast%3DRoboz%26aufirst%3DG.%2BJ.%26aulast%3DBalic%26aufirst%3DK.%26aulast%3DStandifer%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DMarshall%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DW.%26aulast%3DPastan%26aufirst%3DI.%26aulast%3DYao%26aufirst%3DN.-S.%26aulast%3DGiles%26aufirst%3DF.%26atitle%3DMoxetumomab%2520Pasudotox%2520in%2520Relapsed%252FRefractory%2520Hairy%2520Cell%2520Leukemia%26jtitle%3DLeukemia%26date%3D2018%26volume%3D32%26issue%3D8%26spage%3D1768%26epage%3D1777%26doi%3D10.1038%2Fs41375-018-0210-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welborn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentelute, B. L.</span></span> <span> </span><span class="NLM_article-title">π-Clamp-Mediated Cysteine Conjugation</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1038/nchem.2413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnchem.2413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26791894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVygurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=120-128&issue=2&author=C.+Zhangauthor=M.+Welbornauthor=T.+Zhuauthor=N.+J.+Yangauthor=M.+S.+Santosauthor=T.+Van+Voorhisauthor=B.+L.+Pentelute&title=%CF%80-Clamp-Mediated+Cysteine+Conjugation&doi=10.1038%2Fnchem.2413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">π-Clamp-mediated cysteine conjugation</span></div><div class="casAuthors">Zhang, Chi; Welborn, Matthew; Zhu, Tianyu; Yang, Nicole J.; Santos, Michael S.; Van Voorhis, Troy; Pentelute, Bradley L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-128</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Site-selective functionalization of complex mols. is one of the most significant challenges in chem.  Typically, protecting groups or catalysts must be used to enable the selective modification of one site among many that are similarly reactive, and general strategies that selectively tune the local chem. environment around a target site are rare.  Here, the authors show a four-amino-acid sequence (Phe-Cys-Pro-Phe), which the authors call the π-clamp, that tunes the reactivity of its cysteine thiol for site-selective conjugation with perfluoroarom. reagents.  The authors use the π-clamp to selectively modify one cysteine site in proteins contg. multiple endogenous cysteine residues.  These examples include antibodies and cysteine-based enzymes that would be difficult to modify selectively using std. cysteine-based methods.  Antibodies modified using the π-clamp retained binding affinity to their targets, enabling the synthesis of site-specific antibody-drug conjugates for selective killing of HER2-pos. breast cancer cells.  The π-clamp is an unexpected approach to mediate site-selective chem. and provides new avenues to modify biomols. for research and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN7ymIedFQd7Vg90H21EOLACvtfcHk0liygK1MzAlbpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVygurzE&md5=8c3c367f6fd7c64237bd0ba3e9bd40b4</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2413%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWelborn%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DN.%2BJ.%26aulast%3DSantos%26aufirst%3DM.%2BS.%26aulast%3DVan%2BVoorhis%26aufirst%3DT.%26aulast%3DPentelute%26aufirst%3DB.%2BL.%26atitle%3D%25CF%2580-Clamp-Mediated%2520Cysteine%2520Conjugation%26jtitle%3DNat.%2520Chem.%26date%3D2016%26volume%3D8%26issue%3D2%26spage%3D120%26epage%3D128%26doi%3D10.1038%2Fnchem.2413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garbaccio, R. M.</span></span> <span> </span><span class="NLM_article-title">9.17 Chemistry of Antibody-Small Molecule Drug Conjugates</span>. In  <i>Comprehensive Organic Synthesis II</i>; <span class="NLM_publisher-name">Elsevier</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">462</span>. <span class="refDoi"> DOI: 10.1016/B978-0-08-097742-3.00942-3</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FB978-0-08-097742-3.00942-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=438-462&author=R.+M.+Garbaccio&title=Comprehensive+Organic+Synthesis+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2FB978-0-08-097742-3.00942-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-08-097742-3.00942-3%26sid%3Dliteratum%253Aachs%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26atitle%3D9.17%2520Chemistry%2520of%2520Antibody-Small%2520Molecule%2520Drug%2520Conjugates%26btitle%3DComprehensive%2520Organic%2520Synthesis%2520II%26pub%3DElsevier%26date%3D2014%26spage%3D438%26epage%3D462%26doi%3D10.1016%2FB978-0-08-097742-3.00942-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Radicals: Reactive Intermediates with Translational Potential</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">12692</span>– <span class="NLM_lpage">12714</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b08856</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b08856" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWqsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=12692-12714&issue=39&author=M.+Yanauthor=J.+C.+Loauthor=J.+T.+Edwardsauthor=P.+S.+Baran&title=Radicals%3A+Reactive+Intermediates+with+Translational+Potential&doi=10.1021%2Fjacs.6b08856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Radicals: Reactive Intermediates with Translational Potential</span></div><div class="casAuthors">Yan, Ming; Lo, Julian C.; Edwards, Jacob T.; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">12692-12714</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This Perspective illustrates the defining characteristics of free radical chem., beginning with its rich and storied history.  Studies from our lab. are discussed along with recent developments emanating from others in this burgeoning area.  The practicality and chemoselectivity of radical reactions enable rapid access to mols. of relevance to drug discovery, agrochem., material science, and other disciplines.  Thus, these reactive intermediates possess inherent translational potential, as they can be widely used to expedite scientific endeavors for the betterment of humankind.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4oRSlR3ztW7Vg90H21EOLACvtfcHk0lhXt2w6KjEVxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWqsbvM&md5=15c5593913c703235d22a5681ebd8413</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b08856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b08856%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DJ.%2BC.%26aulast%3DEdwards%26aufirst%3DJ.%2BT.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DRadicals%253A%2520Reactive%2520Intermediates%2520with%2520Translational%2520Potential%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26issue%3D39%26spage%3D12692%26epage%3D12714%26doi%3D10.1021%2Fjacs.6b08856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sletten, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C. R.</span></span> <span> </span><span class="NLM_article-title">Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">6974</span>– <span class="NLM_lpage">6998</span>, <span class="refDoi"> DOI: 10.1002/anie.200900942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fanie.200900942" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2ltrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6974-6998&issue=38&author=E.+M.+Slettenauthor=C.+R.+Bertozzi&title=Bioorthogonal+Chemistry%3A+Fishing+for+Selectivity+in+a+Sea+of+Functionality&doi=10.1002%2Fanie.200900942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality</span></div><div class="casAuthors">Sletten, Ellen M.; Bertozzi, Carolyn R.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">6974-6998</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The study of biomols. in their native environments is a challenging task because of the vast complexity of cellular systems.  Technologies developed in the last few years for the selective modification of biol. species in living systems have yielded new insights into cellular processes.  Key to these new techniques are bioorthogonal chem. reactions, whose components must react rapidly and selectively with each other under physiol. conditions in the presence of the plethora of functionality necessary to sustain life.  Herein the authors describe the bioorthogonal chem. reactions developed to date and how they can be used to study biomols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJibJXpsfxW7Vg90H21EOLACvtfcHk0lhXt2w6KjEVxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2ltrvK&md5=993199cb4deabc186848bae6fe81f605</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1002%2Fanie.200900942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200900942%26sid%3Dliteratum%253Aachs%26aulast%3DSletten%26aufirst%3DE.%2BM.%26aulast%3DBertozzi%26aufirst%3DC.%2BR.%26atitle%3DBioorthogonal%2520Chemistry%253A%2520Fishing%2520for%2520Selectivity%2520in%2520a%2520Sea%2520of%2520Functionality%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26issue%3D38%26spage%3D6974%26epage%3D6998%26doi%3D10.1002%2Fanie.200900942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walling, C.</span></span> <span> </span><span class="NLM_article-title">Some Properties of Radical Reactions Important in Synthesis</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">3887</span>– <span class="NLM_lpage">3900</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)97172-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS0040-4020%2801%2997172-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaL28Xit1Cgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1985&pages=3887-3900&issue=19&author=C.+Walling&title=Some+Properties+of+Radical+Reactions+Important+in+Synthesis&doi=10.1016%2FS0040-4020%2801%2997172-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Some properties of radical reactions important in synthesis</span></div><div class="casAuthors">Walling, Cheves</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3887-900</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">Properties of radical chain reactions are reviewed including propagating steps, lifetimes of chains, and choices of initiators.  Structure and reactivity relations in chain-propagation steps and their effects on regio- and stereochem. are discussed.  The utility of redox chains involving transition metal ions is considered along with the importance of radical ions as reaction intermediates.  38 Refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2HZUqmmzuuLVg90H21EOLACvtfcHk0lhXt2w6KjEVxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xit1Cgsb0%253D&md5=6d2bb6c2880c9cfb5c6765499b55e9dc</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2997172-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252997172-8%26sid%3Dliteratum%253Aachs%26aulast%3DWalling%26aufirst%3DC.%26atitle%3DSome%2520Properties%2520of%2520Radical%2520Reactions%2520Important%2520in%2520Synthesis%26jtitle%3DTetrahedron%26date%3D1985%26volume%3D41%26issue%3D19%26spage%3D3887%26epage%3D3900%26doi%3D10.1016%2FS0040-4020%2801%2997172-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McAtee, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClain, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, C. R. J.</span></span> <span> </span><span class="NLM_article-title">Illuminating Photoredox Catalysis</span>. <i>Trends Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/j.trechm.2019.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.trechm.2019.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1CqtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2019&pages=111-125&issue=1&author=R.+C.+McAteeauthor=E.+J.+McClainauthor=C.+R.+J.+Stephenson&title=Illuminating+Photoredox+Catalysis&doi=10.1016%2Fj.trechm.2019.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Illuminating Photoredox Catalysis</span></div><div class="casAuthors">McAtee, Rory C.; McClain, Edward J.; Stephenson, Corey R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-125</span>CODEN:
                <span class="NLM_cas:coden">TCRHBQ</span>;
        ISSN:<span class="NLM_cas:issn">2589-5974</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Over the past decade, photoredox catalysis has risen to the forefront of synthetic org. chem. as an indispensable tool for selective small-mol. activation and chem.-bond formation.  This cutting-edge platform allows photosensitizers to convert visible light into chem. energy, prompting generation of reactive radical intermediates.  In this , we highlight some of the recent key contributions in the field, including elucidating the impact of the chosen light arrays, promoting fundamental cross-coupling steps, selectively functionalizing aliph. amines, engaging complementary mechanistic paradigms, and applications in industry.  With such a wide breadth of reactivity already realized, the presence of photoredox catalysis in all sectors of org. chem. is expected for years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjQ-TKUkBDa7Vg90H21EOLACvtfcHk0liY7InWVMZPlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1CqtL%252FK&md5=45ffb329a2d146cc8caa3a75b4b5a6d1</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.trechm.2019.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trechm.2019.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DMcAtee%26aufirst%3DR.%2BC.%26aulast%3DMcClain%26aufirst%3DE.%2BJ.%26aulast%3DStephenson%26aufirst%3DC.%2BR.%2BJ.%26atitle%3DIlluminating%2520Photoredox%2520Catalysis%26jtitle%3DTrends%2520Chem.%26date%3D2019%26volume%3D1%26issue%3D1%26spage%3D111%26epage%3D125%26doi%3D10.1016%2Fj.trechm.2019.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">13230</span>– <span class="NLM_lpage">13319</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00397</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00397" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1WntbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=13230-13319&issue=21&author=M.+Yanauthor=Y.+Kawamataauthor=P.+S.+Baran&title=Synthetic+Organic+Electrochemical+Methods+Since+2000%3A+On+the+Verge+of+a+Renaissance&doi=10.1021%2Facs.chemrev.7b00397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance</span></div><div class="casAuthors">Yan, Ming; Kawamata, Yu; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13230-13319</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review discusses advances in synthetic org. electrochem. since 2000.  Enabling methods and synthetic applications are analyzed alongside innate advantages as well as future challenges of electroorg. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoosmLKvAW1Z7Vg90H21EOLACvtfcHk0liY7InWVMZPlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1WntbzJ&md5=21205e55da92db4e7d27aa393fed486d</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00397%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DM.%26aulast%3DKawamata%26aufirst%3DY.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DSynthetic%2520Organic%2520Electrochemical%2520Methods%2520Since%25202000%253A%2520On%2520the%2520Verge%2520of%2520a%2520Renaissance%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26issue%3D21%26spage%3D13230%26epage%3D13319%26doi%3D10.1021%2Facs.chemrev.7b00397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samanta, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percec, V.</span></span> <span> </span><span class="NLM_article-title">Single Electron Transfer in Radical Ion and Radical-Mediated Organic, Materials and Polymer Synthesis</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5848</span>– <span class="NLM_lpage">5958</span>, <span class="refDoi"> DOI: 10.1021/cr400689s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400689s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=5848-5958&issue=11&author=N.+Zhangauthor=S.+R.+Samantaauthor=B.+M.+Rosenauthor=V.+Percec&title=Single+Electron+Transfer+in+Radical+Ion+and+Radical-Mediated+Organic%2C+Materials+and+Polymer+Synthesis&doi=10.1021%2Fcr400689s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Single Electron Transfer in Radical Ion and Radical-Mediated Organic, Materials and Polymer Synthesis</span></div><div class="casAuthors">Zhang, Na; Samanta, Shampa R.; Rosen, Brad M.; Percec, Virgil</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5848-5958</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This review attempts to provide a compact but comprehensive discussion of old, never reviewed, almost forgotten, and new SET methodologies and mechanisms employed in org., materials, and macromol. synthesis as well as in the synthesis of functional building blocks relevant for supramol. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFLE8VO4i2obVg90H21EOLACvtfcHk0liY7InWVMZPlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWgurc%253D&md5=8632a41e0a6c0007c9b2a5bad94ec858</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fcr400689s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400689s%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DSamanta%26aufirst%3DS.%2BR.%26aulast%3DRosen%26aufirst%3DB.%2BM.%26aulast%3DPercec%26aufirst%3DV.%26atitle%3DSingle%2520Electron%2520Transfer%2520in%2520Radical%2520Ion%2520and%2520Radical-Mediated%2520Organic%252C%2520Materials%2520and%2520Polymer%2520Synthesis%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26issue%3D11%26spage%3D5848%26epage%3D5958%26doi%3D10.1021%2Fcr400689s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGruyter, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Alkyl Sulfinates: Radical Precursors Enabling Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2256</span>– <span class="NLM_lpage">2264</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01303</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01303" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVaqtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2256-2264&issue=5&author=J.+M.+Smithauthor=J.+A.+Dixonauthor=J.+N.+DeGruyterauthor=P.+S.+Baran&title=Alkyl+Sulfinates%3A+Radical+Precursors+Enabling+Drug+Discovery&doi=10.1021%2Facs.jmedchem.8b01303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Alkyl Sulfinates: Radical Precursors Enabling Drug Discovery</span></div><div class="casAuthors">Smith, Joel M.; Dixon, Janice A.; deGruyter, Justine N.; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2256-2264</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The modern constraints of drug discovery demand a rigorous validation process of all new reactions prior to widespread implementation.  To this end, sulfinates (now marketed as Diversinates) have seen alacritous adoption by the medicinal chem. community, as evidenced by the recent outpour of both patent and primary reports.  Featuring more than 50 examples, this review seeks to highlight those particularly compelling cases published in the past 5 years, with an eye toward the identification of robust and predictable trends in reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7GM4tNW5QcLVg90H21EOLACvtfcHk0liY7InWVMZPlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVaqtL3I&md5=2c10a6e03d53de995f00614fb8c4bd85</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01303%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BM.%26aulast%3DDixon%26aufirst%3DJ.%2BA.%26aulast%3DDeGruyter%26aufirst%3DJ.%2BN.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DAlkyl%2520Sulfinates%253A%2520Radical%2520Precursors%2520Enabling%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D5%26spage%3D2256%26epage%3D2264%26doi%3D10.1021%2Facs.jmedchem.8b01303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antos, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, M. B.</span></span> <span> </span><span class="NLM_article-title">Chemoselective Tryptophan Labeling with Rhodium Carbenoids at Mild PH</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">6301</span>– <span class="NLM_lpage">6308</span>, <span class="refDoi"> DOI: 10.1021/ja900094h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja900094h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksV2isrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=6301-6308&issue=17&author=J.+M.+Antosauthor=J.+M.+McFarlandauthor=A.+T.+Iavaroneauthor=M.+B.+Francis&title=Chemoselective+Tryptophan+Labeling+with+Rhodium+Carbenoids+at+Mild+PH&doi=10.1021%2Fja900094h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective Tryptophan Labeling with Rhodium Carbenoids at Mild pH</span></div><div class="casAuthors">Antos, John M.; McFarland, Jesse M.; Iavarone, Anthony T.; Francis, Matthew B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6301-6308</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant improvements have been made to a previously reported tryptophan modification method using rhodium carbenoids in aq. soln., allowing the reaction to proceed at pH 6-7.  This technique is based on the discovery that N-(tert-butyl)hydroxylamine promotes indole modification with rhodium carbenoids over a broad pH range (2-7).  This methodol. was demonstrated on peptide and protein substrates, generally yielding 40-60% conversion with excellent tryptophan chemoselectivity.  The solvent accessibility of the indole side chains was a key factor in successful carbenoid addn., as demonstrated by conducting the reaction at temps. high enough to cause thermal denaturation of the protein substrate.  Progress toward the expression of proteins bearing solvent accessible tryptophan residues as reactive handles for modification with rhodium carbenoids is also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLPkOMINZJ9LVg90H21EOLACvtfcHk0lht8HFQaN9row"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksV2isrw%253D&md5=5c14c7fa813430af98264d990d2103ba</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fja900094h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja900094h%26sid%3Dliteratum%253Aachs%26aulast%3DAntos%26aufirst%3DJ.%2BM.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DIavarone%26aufirst%3DA.%2BT.%26aulast%3DFrancis%26aufirst%3DM.%2BB.%26atitle%3DChemoselective%2520Tryptophan%2520Labeling%2520with%2520Rhodium%2520Carbenoids%2520at%2520Mild%2520PH%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26issue%3D17%26spage%3D6301%26epage%3D6308%26doi%3D10.1021%2Fja900094h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verhoog, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khotavivattana, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersemans, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tredwell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouverneur, V.</span></span> <span> </span><span class="NLM_article-title">18 F-Trifluoromethylation of Unmodified Peptides with 5- 18 F-(Trifluoromethyl)Dibenzothiophenium Trifluoromethanesulfonate</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1572</span>– <span class="NLM_lpage">1575</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b10227</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b10227" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksVOitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=1572-1575&issue=5&author=S.+Verhoogauthor=C.+W.+Keeauthor=Y.+Wangauthor=T.+Khotavivattanaauthor=T.+C.+Wilsonauthor=V.+Kersemansauthor=S.+Smartauthor=M.+Tredwellauthor=B.+G.+Davisauthor=V.+Gouverneur&title=18+F-Trifluoromethylation+of+Unmodified+Peptides+with+5-+18+F-%28Trifluoromethyl%29Dibenzothiophenium+Trifluoromethanesulfonate&doi=10.1021%2Fjacs.7b10227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">18F-Trifluoromethylation of unmodified peptides with 5-18F-(trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate</span></div><div class="casAuthors">Verhoog, Stefan; Kee, Choon Wee; Wang, Yanlan; Khotavivattana, Tanatorn; Wilson, Thomas C.; Kersemans, Veerle; Smart, Sean; Tredwell, Matthew; Davis, Benjamin G.; Gouverneur, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1572-1575</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 18F-labeling of 5-(trifluoromethyl)-dibenzothiophenium trifluoromethanesulfonate, commonly referred to as the Umemoto reagent, has been accomplished applying a halogen exchange 18F-fluorination with 18F-fluoride, followed by oxidative cyclization with oxone and trifluoromethanesulfonic anhydride.  This new 18F-reagent allows for the direct chemoselective 18F-labeling of unmodified peptides at the thiol cysteine residue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB7gxj53dPK7Vg90H21EOLACvtfcHk0lht8HFQaN9row"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksVOitw%253D%253D&md5=edd3cfce918a01f083c176ec95f4ef2d</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b10227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b10227%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoog%26aufirst%3DS.%26aulast%3DKee%26aufirst%3DC.%2BW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKhotavivattana%26aufirst%3DT.%26aulast%3DWilson%26aufirst%3DT.%2BC.%26aulast%3DKersemans%26aufirst%3DV.%26aulast%3DSmart%26aufirst%3DS.%26aulast%3DTredwell%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DB.%2BG.%26aulast%3DGouverneur%26aufirst%3DV.%26atitle%3D18%2520F-Trifluoromethylation%2520of%2520Unmodified%2520Peptides%2520with%25205-%252018%2520F-%2528Trifluoromethyl%2529Dibenzothiophenium%2520Trifluoromethanesulfonate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D5%26spage%3D1572%26epage%3D1575%26doi%3D10.1021%2Fjacs.7b10227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, M. L.</span></span> <span> </span><span class="NLM_article-title">Laser-Initiated Radical Trifluoromethylation of Peptides and Proteins: Application to Mass-Spectrometry-Based Protein Footprinting</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">14007</span>– <span class="NLM_lpage">14010</span>, <span class="refDoi"> DOI: 10.1002/anie.201706697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fanie.201706697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1WhtrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=14007-14010&issue=45&author=M.+Chengauthor=B.+Zhangauthor=W.+Cuiauthor=M.+L.+Gross&title=Laser-Initiated+Radical+Trifluoromethylation+of+Peptides+and+Proteins%3A+Application+to+Mass-Spectrometry-Based+Protein+Footprinting&doi=10.1002%2Fanie.201706697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Laser-Initiated Radical Trifluoromethylation of Peptides and Proteins: Application to Mass-Spectrometry-Based Protein Footprinting</span></div><div class="casAuthors">Cheng, Ming; Zhang, Bojie; Cui, Weidong; Gross, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">14007-14010</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Described is a novel, laser-initiated radical trifluoromethylation for protein footprinting and its broad residue coverage.  *CF3 reacts with 18 of the 20 common amino acids, including Gly, Ala, Ser, Thr, Asp, and Glu, which are relatively silent with regard to .OH.  This new approach to footprinting is a bridge between trifluoromethylation in materials and medicinal chem. and structural biol. and biotechnol.  Its application to a membrane protein and to myoglobin show that the approach is sensitive to protein conformational change and solvent accessibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK2o0BEvspCLVg90H21EOLACvtfcHk0ljk4oGuKqcKOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1WhtrnN&md5=5e5d3da20ecf869914284959d8feb96a</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706697%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DGross%26aufirst%3DM.%2BL.%26atitle%3DLaser-Initiated%2520Radical%2520Trifluoromethylation%2520of%2520Peptides%2520and%2520Proteins%253A%2520Application%2520to%2520Mass-Spectrometry-Based%2520Protein%2520Footprinting%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26issue%3D45%26spage%3D14007%26epage%3D14010%26doi%3D10.1002%2Fanie.201706697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labroo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labroo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, L.</span></span> <span> </span><span class="NLM_article-title">Direct Photochemical Trifluoromethylation of Histidine-Containing Peptides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">40</span>),  <span class="NLM_fpage">5705</span>– <span class="NLM_lpage">5708</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)97937-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS0040-4039%2800%2997937-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaK3MXisVGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1990&pages=5705-5708&issue=40&author=V.+Labrooauthor=R.+Labrooauthor=L.+Cohen&title=Direct+Photochemical+Trifluoromethylation+of+Histidine-Containing+Peptides&doi=10.1016%2FS0040-4039%2800%2997937-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Direct photochemical trifluoromethylation of histidine-containing peptides</span></div><div class="casAuthors">Labroo, V. M.; Labroo, R. B.; Cohen, L. A.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">5705-8</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">Photochem. trifluoromethylation of the imidazole ring of histidine in the tripeptide Glp-His-Pro-NH2 has been achieved to furnish a mixt. of imidazole trifluoromethylated isomers, which have been sepd. by reverse-phase HPLC and characterized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBUyL9nIxfs7Vg90H21EOLACvtfcHk0ljk4oGuKqcKOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXisVGruw%253D%253D&md5=972dbf43e25be716d0bddbe5d1f1f930</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2997937-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252997937-1%26sid%3Dliteratum%253Aachs%26aulast%3DLabroo%26aufirst%3DV.%26aulast%3DLabroo%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DL.%26atitle%3DDirect%2520Photochemical%2520Trifluoromethylation%2520of%2520Histidine-Containing%2520Peptides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1990%26volume%3D31%26issue%3D40%26spage%3D5705%26epage%3D5708%26doi%3D10.1016%2FS0040-4039%2800%2997937-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichiishi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streckfuss, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S. W.</span></span> <span> </span><span class="NLM_article-title">Protecting Group Free Radical C-H Trifluoromethylation of Peptides</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">4168</span>– <span class="NLM_lpage">4175</span>, <span class="refDoi"> DOI: 10.1039/C8SC00368H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC8SC00368H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=29780547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1emsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4168-4175&issue=17&author=N.+Ichiishiauthor=J.+P.+Caldwellauthor=M.+Linauthor=W.+Zhongauthor=X.+Zhuauthor=E.+Streckfussauthor=H.-Y.+Kimauthor=C.+A.+Parishauthor=S.+W.+Krska&title=Protecting+Group+Free+Radical+C-H+Trifluoromethylation+of+Peptides&doi=10.1039%2FC8SC00368H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Protecting group free radical C-H trifluoromethylation of peptides</span></div><div class="casAuthors">Ichiishi, Naoko; Caldwell, John P.; Lin, Melissa; Zhong, Wendy; Zhu, Xiaohong; Streckfuss, Eric; Kim, Hai-Young; Parish, Craig A.; Krska, Shane W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4168-4175</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Two radical-based approaches have been developed to effect the trifluoromethylation of aryl C-H bonds in native peptides either using stoichiometric oxidant or visible light photoredox catalysis.  The reported methods are able to derivatize tyrosine and tryptophan sidechains under biocompatible conditions, and a no. of examples are reported involving fully unprotected peptides with up to 51 amino acids.  The development of this chem. adds to the growing array of chem. methods for selectively modifying amino acid residues in the context of complex peptides.  The direct incorporation of trifluoromethyl groups into biopolymers enables the study of a range of biol. and biochem. systems, and preliminary results indicate this method can be extended to the incorporation of other fluoroalkyl groups for bioconjugation applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ2NGwSJKIdbVg90H21EOLACvtfcHk0ljk4oGuKqcKOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1emsbY%253D&md5=4bb4306ad9e207a5d8f0b196203b9577</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1039%2FC8SC00368H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8SC00368H%26sid%3Dliteratum%253Aachs%26aulast%3DIchiishi%26aufirst%3DN.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DStreckfuss%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DH.-Y.%26aulast%3DParish%26aufirst%3DC.%2BA.%26aulast%3DKrska%26aufirst%3DS.%2BW.%26atitle%3DProtecting%2520Group%2520Free%2520Radical%2520C-H%2520Trifluoromethylation%2520of%2520Peptides%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26issue%3D17%26spage%3D4168%26epage%3D4175%26doi%3D10.1039%2FC8SC00368H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lecocq, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vlaeminck, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanssens, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Huyvetter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyvaerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keyaerts, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devoogdt, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breckpot, K.</span></span> <span> </span><span class="NLM_article-title">Theranostics in Immuno-Oncology Using Nanobody Derivatives</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">7772</span>– <span class="NLM_lpage">7791</span>, <span class="refDoi"> DOI: 10.7150/thno.34941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.7150%2Fthno.34941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31695800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFamsrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=7772-7791&issue=25&author=Q.+Lecocqauthor=Y.+De+Vlaeminckauthor=H.+Hanssensauthor=M.+D%E2%80%99Huyvetterauthor=G.+Raesauthor=C.+Goyvaertsauthor=M.+Keyaertsauthor=N.+Devoogdtauthor=K.+Breckpot&title=Theranostics+in+Immuno-Oncology+Using+Nanobody+Derivatives&doi=10.7150%2Fthno.34941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostics in immuno-oncology using nanobody derivatives</span></div><div class="casAuthors">Lecocq, Quentin; De Vlaeminck, Yannick; Hanssens, Heleen; D'Huyvetter, Matthias; Raes, Geert; Goyvaerts, Cleo; Keyaerts, Marleen; Devoogdt, Nick; Breckpot, Karine</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7772-7791</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">A review.  Targeted therapy and immunotherapy have become mainstream in cancer treatment.  However, only patient subsets benefit from these expensive therapies, and often responses are short-lived or coincide with side effects.  A growing modality in precision oncol. is the development of theranostics, as this enables patient selection, treatment and monitoring.  In this approach, labeled compds. and an imaging technol. are used to diagnose patients and select the best treatment option, whereas for therapy, related compds. are used to target cancer cells or the tumor stroma.  In this context, nanobodies and nanobody-directed therapeutics have gained interest.  This interest stems from their high antigen specificity, small size, ease of labeling and engineering, allowing specific imaging and design of therapies targeting antigens on tumor cells, immune cells as well as proteins in the tumor environment.  This review provides a comprehensive overview on the state-of-the-art regarding the use of nanobodies as theranostics, and their importance in the emerging field of personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1OXs1AtDOArVg90H21EOLACvtfcHk0lgB3QF7x55hSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFamsrfM&md5=7f00635de3529747d425124004cfe568</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.7150%2Fthno.34941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.34941%26sid%3Dliteratum%253Aachs%26aulast%3DLecocq%26aufirst%3DQ.%26aulast%3DDe%2BVlaeminck%26aufirst%3DY.%26aulast%3DHanssens%26aufirst%3DH.%26aulast%3DD%25E2%2580%2599Huyvetter%26aufirst%3DM.%26aulast%3DRaes%26aufirst%3DG.%26aulast%3DGoyvaerts%26aufirst%3DC.%26aulast%3DKeyaerts%26aufirst%3DM.%26aulast%3DDevoogdt%26aufirst%3DN.%26aulast%3DBreckpot%26aufirst%3DK.%26atitle%3DTheranostics%2520in%2520Immuno-Oncology%2520Using%2520Nanobody%2520Derivatives%26jtitle%3DTheranostics%26date%3D2019%26volume%3D9%26issue%3D25%26spage%3D7772%26epage%3D7791%26doi%3D10.7150%2Fthno.34941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brasino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbse, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, A. P.</span></span> <span> </span><span class="NLM_article-title">Anti-EGFR Affibodies with Site-Specific Photo-Cross-Linker Incorporation Show Both Directed Target-Specific Photoconjugation and Increased Retention in Tumors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">11820</span>– <span class="NLM_lpage">11828</span>, <span class="refDoi"> DOI: 10.1021/jacs.8b07601</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b07601" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1OltbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=11820-11828&issue=37&author=M.+Brasinoauthor=S.+Royauthor=A.+H.+Erbseauthor=L.+Heauthor=C.+Maoauthor=W.+Parkauthor=J.+N.+Chaauthor=A.+P.+Goodwin&title=Anti-EGFR+Affibodies+with+Site-Specific+Photo-Cross-Linker+Incorporation+Show+Both+Directed+Target-Specific+Photoconjugation+and+Increased+Retention+in+Tumors&doi=10.1021%2Fjacs.8b07601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-EGFR Affibodies with Site-Specific Photo-Cross-Linker Incorporation Show Both Directed Target-Specific Photoconjugation and Increased Retention in Tumors</span></div><div class="casAuthors">Brasino, Michael; Roy, Shambojit; Erbse, Annette H.; He, Liangcan; Mao, Chenchen; Park, Wounjhang; Cha, Jennifer N.; Goodwin, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11820-11828</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A significant challenge for solid tumor treatment is ensuring that a sufficient concn. of therapeutic agent is delivered to the tumor site at doses that can be tolerated by the patient.  Biomol. targeting can bias accumulation in tumors by taking advantage of specific interactions with receptors overexpressed on cancerous cells.  However, while antibody-based immunoconjugates show high binding to specific cells, their low dissocn. consts. (KD) and large Stokes radii hinder their ability to penetrate deep into tumor tissue, leading to incomplete cell killing and tumor recurrence.  To address this, we demonstrate the design and prodn. of a photo-crosslinkable affibody that can form a covalent bond to epidermal growth factor receptor (EGFR) under near UV irradn.  Twelve cysteine mutations were created of an EGFR affibody and conjugated with maleimide-benzophenone.  Of these only one exhibited photoconjugation to EGFR, as demonstrated by SDS-PAGE and Western blot.  Next this modified affibody was shown to not only bind EGFR expressing cells but also show enhanced retention in a 3D tumor spheroid model, with minimal loss up to 24 h as compared to either unmodified EGFR-binding affibodies or nonbinding, photo-crosslinkable affibodies.  Finally, in order to show utility of photo-crosslinking at clin. relevant wavelengths, upconverting nanoparticles (UCNPs) were synthesized that could convert 980 nm light to UV and blue light.  In the presence of UCNPs, both direct photoconjugation to EGFR and enhanced retention in tumor spheroids could be obtained using near-IR illumination.  Thus, the photoactive affibodies developed here may be utilized as a platform technol. for engineering new therapy conjugates that can penetrate deep into tumor tissue and be retained long enough for effective tumor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWO3Sgl4zZTbVg90H21EOLACvtfcHk0lgB3QF7x55hSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1OltbbF&md5=5962a8ee95361b4442433b9be5d367fa</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b07601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b07601%26sid%3Dliteratum%253Aachs%26aulast%3DBrasino%26aufirst%3DM.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DErbse%26aufirst%3DA.%2BH.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DW.%26aulast%3DCha%26aufirst%3DJ.%2BN.%26aulast%3DGoodwin%26aufirst%3DA.%2BP.%26atitle%3DAnti-EGFR%2520Affibodies%2520with%2520Site-Specific%2520Photo-Cross-Linker%2520Incorporation%2520Show%2520Both%2520Directed%2520Target-Specific%2520Photoconjugation%2520and%2520Increased%2520Retention%2520in%2520Tumors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D37%26spage%3D11820%26epage%3D11828%26doi%3D10.1021%2Fjacs.8b07601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelemen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A.</span></span> <span> </span><span class="NLM_article-title">A Precise Chemical Strategy To Alter the Receptor Specificity of the Adeno-Associated Virus</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">10645</span>– <span class="NLM_lpage">10649</span>, <span class="refDoi"> DOI: 10.1002/anie.201604067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fanie.201604067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygtrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=10645-10649&issue=36&author=R.+E.+Kelemenauthor=R.+Mukherjeeauthor=X.+Caoauthor=S.+B.+Ericksonauthor=Y.+Zhengauthor=A.+Chatterjee&title=A+Precise+Chemical+Strategy+To+Alter+the+Receptor+Specificity+of+the+Adeno-Associated+Virus&doi=10.1002%2Fanie.201604067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">A Precise Chemical Strategy To Alter the Receptor Specificity of the Adeno-Associated Virus</span></div><div class="casAuthors">Kelemen, Rachel E.; Mukherjee, Raja; Cao, Xiaofu; Erickson, Sarah B.; Zheng, Yunan; Chatterjee, Abhishek</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">10645-10649</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The ability to target the adeno-assocd. virus (AAV) to specific types of cells, by altering the cell-surface receptor it binds, is desirable to generate safe and efficient therapeutic vectors.  Chem. attachment of receptor-targeting agents onto the AAV capsid holds potential to alter its tropism, but is limited by the lack of site specificity of available conjugation strategies.  The development of an AAV prodn. platform is reported that enables incorporation of unnatural amino acids (UAAs) into specific sites on the virus capsid.  Incorporation of an azido-UAA enabled site-specific attachment of a cyclic-RGD peptide onto the capsid, retargeting the virus to the αvβ3 integrin receptors, which are overexpressed in tumor vasculature.  Retargeting ability was site-dependent, underscoring the importance of achieving site-selective capsid modification.  This work provides a general chem. approach to introduce various receptor binding agents onto the AAV capsid with site selectivity to generate optimized vectors with engineered infectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLClkgH43sNrVg90H21EOLACvtfcHk0lhWGg1ToZCj3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygtrzE&md5=51cfd0c9c1866856ce8a926a760e4b98</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1002%2Fanie.201604067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201604067%26sid%3Dliteratum%253Aachs%26aulast%3DKelemen%26aufirst%3DR.%2BE.%26aulast%3DMukherjee%26aufirst%3DR.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DErickson%26aufirst%3DS.%2BB.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DChatterjee%26aufirst%3DA.%26atitle%3DA%2520Precise%2520Chemical%2520Strategy%2520To%2520Alter%2520the%2520Receptor%2520Specificity%2520of%2520the%2520Adeno-Associated%2520Virus%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D36%26spage%3D10645%26epage%3D10649%26doi%3D10.1002%2Fanie.201604067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greineder, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiseleva, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hood, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoshnejad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warden-Rothman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsourkas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzykantov, V. R.</span></span> <span> </span><span class="NLM_article-title">Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.7b00592</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.7b00592" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFSlu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=56-66&issue=1&author=C.+F.+Greinederauthor=C.+H.+Villaauthor=L.+R.+Walshauthor=R.+Y.+Kiselevaauthor=E.+D.+Hoodauthor=M.+Khoshnejadauthor=R.+Warden-Rothmanauthor=A.+Tsourkasauthor=V.+R.+Muzykantov&title=Site-Specific+Modification+of+Single-Chain+Antibody+Fragments+for+Bioconjugation+and+Vascular+Immunotargeting&doi=10.1021%2Facs.bioconjchem.7b00592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting</span></div><div class="casAuthors">Greineder, Colin F.; Villa, Carlos H.; Walsh, Landis R.; Kiseleva, Raisa Y.; Hood, Elizabeth D.; Khoshnejad, Makan; Warden-Rothman, Robert; Tsourkas, Andrew; Muzykantov, Vladimir R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-66</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The conjugation of antibodies to drugs and drug carriers improves delivery to target tissues.  Widespread implementation and effective translation of this pharmacol. strategy awaits the development of affinity ligands capable of a defined degree of modification and highly efficient bioconjugation without loss of affinity.  To date, such ligands are lacking for the targeting of therapeutics to vascular endothelial cells.  To enable site-specific, click-chem. conjugation to therapeutic cargo, we used the bacterial transpeptidase, sortase A, to attach short azidolysine contg. peptides to three endothelial-specific single chain antibody fragments (scFv).  While direct fusion of a recognition motif (sortag) to the scFv C-terminus generally resulted in low levels of sortase-mediated modification, improved reaction efficiency was obsd. for one protein, in which two amino acids had been introduced during cloning.  This prompted insertion of a short, semi-rigid linker between scFv and sortag.  The linker significantly enhanced modification of all three proteins, to the extent that unmodified scFv could no longer be detected.  As proof of principle, purified, azide-modified scFv was conjugated to the antioxidant enzyme, catalase, resulting in robust endothelial targeting of functional cargo in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEmdRfJrqe2rVg90H21EOLACvtfcHk0lhWGg1ToZCj3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFSlu7nN&md5=3f42501c7ac155e564de0e98a5f49c49</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.7b00592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.7b00592%26sid%3Dliteratum%253Aachs%26aulast%3DGreineder%26aufirst%3DC.%2BF.%26aulast%3DVilla%26aufirst%3DC.%2BH.%26aulast%3DWalsh%26aufirst%3DL.%2BR.%26aulast%3DKiseleva%26aufirst%3DR.%2BY.%26aulast%3DHood%26aufirst%3DE.%2BD.%26aulast%3DKhoshnejad%26aufirst%3DM.%26aulast%3DWarden-Rothman%26aufirst%3DR.%26aulast%3DTsourkas%26aufirst%3DA.%26aulast%3DMuzykantov%26aufirst%3DV.%2BR.%26atitle%3DSite-Specific%2520Modification%2520of%2520Single-Chain%2520Antibody%2520Fragments%2520for%2520Bioconjugation%2520and%2520Vascular%2520Immunotargeting%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26issue%3D1%26spage%3D56%26epage%3D66%26doi%3D10.1021%2Facs.bioconjchem.7b00592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Usami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, T.</span></span> <span> </span><span class="NLM_article-title">The Effect of PH, Hydrogen Peroxide and Temperature on the Stability of Human Monoclonal Antibody</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">8–10</span>),  <span class="NLM_fpage">1133</span>– <span class="NLM_lpage">1140</span>, <span class="refDoi"> DOI: 10.1016/S0731-7085(96)01721-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2FS0731-7085%2896%2901721-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=8818025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADyaK28Xks1Sjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1996&pages=1133-1140&issue=8%E2%80%9310&author=A.+Usamiauthor=A.+Ohtsuauthor=S.+Takahamaauthor=T.+Fujii&title=The+Effect+of+PH%2C+Hydrogen+Peroxide+and+Temperature+on+the+Stability+of+Human+Monoclonal+Antibody&doi=10.1016%2FS0731-7085%2896%2901721-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of pH, hydrogen peroxide and temperature on the stability of human monoclonal antibody</span></div><div class="casAuthors">Usami, A.; Ohtsu, A.; Takahama, S.; Fujii, T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8-10</span>),
    <span class="NLM_cas:pages">1133-1140</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The stability of human monoclonal antibody (C23), which is being developed as a passive immunotherapeutic agent against human cytomegalovirus, was investigated.  C23 (about 2 mg mL-1) was incubated under sterile conditions for 14 days in buffers with different pH values (ranging from 4-10), in hydrogen peroxide solns. with different concns. (0.01% or 0.1%), and in saline at 8° or 37°.  Samples were collected on days 0, 3, 7 and 14, and various physicochem. or biol. methods were used to det. the changes in C23.  These methods included turbidity (absorbance at 408 nm and transmittance at 580 nm), pH, size-exclusion high performance liq. chromatog. (HPLC), hydroxyapatite HPLC, SDS-PAGE, isoelec. focusing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry, and virus neutralization assay.  Using these methods, the possible degrdn. process of C23 was initially characterized.  Deamidation, oxidn., fragmentation, covalent cross-links, and aggregation were obsd. as major degrdn. routes.  These results gave useful information for the manufg. process and quality control of C23.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrHyS9jlOR5LVg90H21EOLACvtfcHk0li1UJXqhdCLQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xks1Sjt7o%253D&md5=ce517512515a0f8dcb5e48ef5588e64c</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2FS0731-7085%2896%2901721-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0731-7085%252896%252901721-9%26sid%3Dliteratum%253Aachs%26aulast%3DUsami%26aufirst%3DA.%26aulast%3DOhtsu%26aufirst%3DA.%26aulast%3DTakahama%26aufirst%3DS.%26aulast%3DFujii%26aufirst%3DT.%26atitle%3DThe%2520Effect%2520of%2520PH%252C%2520Hydrogen%2520Peroxide%2520and%2520Temperature%2520on%2520the%2520Stability%2520of%2520Human%2520Monoclonal%2520Antibody%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D1996%26volume%3D14%26issue%3D8%25E2%2580%259310%26spage%3D1133%26epage%3D1140%26doi%3D10.1016%2FS0731-7085%2896%2901721-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muyldermans, S.</span></span> <span> </span><span class="NLM_article-title">Nanobodies: Natural Single-Domain Antibodies</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">797</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-063011-092449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1146%2Fannurev-biochem-063011-092449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=23495938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOqsrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2013&pages=775-797&author=S.+Muyldermans&title=Nanobodies%3A+Natural+Single-Domain+Antibodies&doi=10.1146%2Fannurev-biochem-063011-092449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Nanobodies: natural single-domain antibodies</span></div><div class="casAuthors">Muyldermans, Serge</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">775-797</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Sera of camelids contain both conventional heterotetrameric antibodies and unique functional heavy (H)-chain antibodies (HCAbs).  The H chain of these homodimeric antibodies consists of one antigen-binding domain, the VHH, and two const. domains.  HCAbs fail to incorporate light (L) chains owing to the deletion of the first const. domain and a reshaped surface at the VHH side, which normally assocs. with L chains in conventional antibodies.  The genetic elements composing HCAbs have been identified, but the in vivo generation of these antibodies from their dedicated genes into antigen-specific and affinity-matured bona fide antibodies remains largely underinvestigated.  However, the facile identification of antigen-specific VHHs and their beneficial biochem. and economic properties (size, affinity, specificity, stability, prodn. cost) supported by multiple crystal structures have encouraged antibody engineering of these single-domain antibodies for use as a research tool and in biotechnol. and medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsTs-PnfjncbVg90H21EOLACvtfcHk0li1UJXqhdCLQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOqsrrJ&md5=19a7b3600cdefafdb5c771d40f661cd4</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-063011-092449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-063011-092449%26sid%3Dliteratum%253Aachs%26aulast%3DMuyldermans%26aufirst%3DS.%26atitle%3DNanobodies%253A%2520Natural%2520Single-Domain%2520Antibodies%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2013%26volume%3D82%26spage%3D775%26epage%3D797%26doi%3D10.1146%2Fannurev-biochem-063011-092449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sisso, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boit, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeForest, C. A.</span></span> <span> </span><span class="NLM_article-title">Self-healing Injectable Gelatin Hydrogels for Localized Therapeutic Cell Delivery</span>. <i>J. Biomed. Mater. Res., Part A</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1121</span>, <span class="refDoi"> DOI: 10.1002/jbm.a.36886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fjbm.a.36886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31971330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFKmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2020&pages=1112-1121&issue=5&author=A.+M.+Sissoauthor=M.+O.+Boitauthor=C.+A.+DeForest&title=Self-healing+Injectable+Gelatin+Hydrogels+for+Localized+Therapeutic+Cell+Delivery&doi=10.1002%2Fjbm.a.36886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Self-healing injectable gelatin hydrogels for localized therapeutic cell delivery</span></div><div class="casAuthors">Sisso, Arbel M.; Boit, Mary O.; De Forest, Cole A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Materials Research, Part A</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1112-1121</span>CODEN:
                <span class="NLM_cas:coden">JBMRCH</span>;
        ISSN:<span class="NLM_cas:issn">1549-3296</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Self-healing injectable hydrogel biomaterials uniquely enable precise therapeutic deposition and deployment at specific bodily locations through versatile and minimally invasive processes that can preserve cargo integrity and cell viability.  Despite the distinct advantages that injectable hydrogels offer in tissue engineering and therapeutic delivery, exceptionally few have been created using components naturally present in the cellular niche.  In this work, we introduce a shear-thinning hydrogel based on guest-host complexation of gelatin.  As a biocompatible, biodegradable, and nonimmunogenic biopolymer derived from the most abundant extracellular matrix protein (collagen), gelatin offers great utility as the structural component of biomaterials.  Taking advantage of reversible guest-host interactions between β-cyclodextrin (CD) and adamantane (AD) on modified gelatins, we report the first strategy to afford a self-healing material based solely on a functionalized extracellular matrix protein.  By varying the initial material formulation, hydrogels were synthesized with variable moduli and shear-thinability across a broad range.  Gels were demonstrated to exhibit shear-thinning and self-healing properties, supporting protection of clin. relevant stem-cell-derived cardiomyocytes during injection.  These materials are expected to expand clin. opportunities in cell delivery for in vivo tissue regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkGrzqvT3BArVg90H21EOLACvtfcHk0ljMj9WA78SiwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFKmtbc%253D&md5=d040e79d5a05da6f859fc58185ae676a</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1002%2Fjbm.a.36886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbm.a.36886%26sid%3Dliteratum%253Aachs%26aulast%3DSisso%26aufirst%3DA.%2BM.%26aulast%3DBoit%26aufirst%3DM.%2BO.%26aulast%3DDeForest%26aufirst%3DC.%2BA.%26atitle%3DSelf-healing%2520Injectable%2520Gelatin%2520Hydrogels%2520for%2520Localized%2520Therapeutic%2520Cell%2520Delivery%26jtitle%3DJ.%2520Biomed.%2520Mater.%2520Res.%252C%2520Part%2520A%26date%3D2020%26volume%3D108%26issue%3D5%26spage%3D1112%26epage%3D1121%26doi%3D10.1002%2Fjbm.a.36886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercadante, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikić, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemke, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gräter, F.</span></span> <span> </span><span class="NLM_article-title">Origin of Orthogonality of Strain-Promoted Click Reactions</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">35</span>),  <span class="NLM_fpage">12431</span>– <span class="NLM_lpage">12435</span>, <span class="refDoi"> DOI: 10.1002/chem.201501727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1002%2Fchem.201501727" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26178299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOrtL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=12431-12435&issue=35&author=J.+A.+Wagnerauthor=D.+Mercadanteauthor=I.+Niki%C4%87author=E.+A.+Lemkeauthor=F.+Gr%C3%A4ter&title=Origin+of+Orthogonality+of+Strain-Promoted+Click+Reactions&doi=10.1002%2Fchem.201501727"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Origin of Orthogonality of Strain-Promoted Click Reactions</span></div><div class="casAuthors">Wagner, Johannes A.; Mercadante, Davide; Nikic, Ivana; Lemke, Edward A.; Graeter, Frauke</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">12431-12435</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Site-specific labeling of biomols. is rapidly advancing due to the discovery of novel mutually orthogonal reactions.  Quantum chem. studies have also increased our understanding of their relative rates, although these have until now been based on highly simplified reactants.  Here we examine a set of strain-promoted click-type cycloaddn. reactions of Pr azide, 3-benzyltetrazine and 3-benzyl-6-Me tetrazine with cyclooctenes/ynes, in which we aim to address all relevant structural details of the reactants.  Our calcns. have included the obligatory handles used to attach the label and biomol. as these can critically influence the stereochem. and electron demand of the reaction.  We systematically computed orbital gaps, activation and distortion energies using d. functional theory and detd. exptl. rates for validation.  Our results challenge the current paradigm of the inverse electron demand for this class of reactions.  We found that the ubiquitous handles, when next to the triple bond of cyclooctynes, can switch the Diels-Alder type ligations to normal electron demand, a class we term as SPINEDAC reactions.  Electron donating substituents on tetrazine can enhance normal demand but also increase distortion penalties.  The presence and isomeric configuration of handles thus det. the reaction speed and regioselectivity.  Our findings can be directly utilized in engineering genuine cycloaddn. click chemistries for biol. labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0544mlTLfCbVg90H21EOLACvtfcHk0ljMj9WA78SiwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOrtL%252FL&md5=9477aa024da2867baab6c23ce82f4a23</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1002%2Fchem.201501727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201501727%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DJ.%2BA.%26aulast%3DMercadante%26aufirst%3DD.%26aulast%3DNiki%25C4%2587%26aufirst%3DI.%26aulast%3DLemke%26aufirst%3DE.%2BA.%26aulast%3DGr%25C3%25A4ter%26aufirst%3DF.%26atitle%3DOrigin%2520of%2520Orthogonality%2520of%2520Strain-Promoted%2520Click%2520Reactions%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26issue%3D35%26spage%3D12431%26epage%3D12435%26doi%3D10.1002%2Fchem.201501727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narayanam, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houk, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of New Mutually Orthogonal Bioorthogonal Cycloaddition Pairs through Computational Screening</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1257</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1039/C5SC03259H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1039%2FC5SC03259H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=29910881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVSgtb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1257-1261&issue=2&author=M.+K.+Narayanamauthor=Y.+Liangauthor=K.+N.+Houkauthor=J.+M.+Murphy&title=Discovery+of+New+Mutually+Orthogonal+Bioorthogonal+Cycloaddition+Pairs+through+Computational+Screening&doi=10.1039%2FC5SC03259H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of new mutually orthogonal bioorthogonal cycloaddition pairs through computational screening</span></div><div class="casAuthors">Narayanam, Maruthi Kumar; Liang, Yong; Houk, K. N.; Murphy, Jennifer M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1257-1261</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">D. functional theory (DFT) calcns. and expts. in tandem led to discoveries of new reactivities and selectivities involving bioorthogonal sydnone cycloaddns.  Dibenzocyclooctyne derivs. (DIBAC and BARAC) were identified to be esp. reactive dipolarophiles, which undergo the [3+2] cycloaddns. with N-Ph sydnone with the rate const. of up to 1.46 M-1 s-1.  Most significantly, the sydnone-dibenzocyclooctyne and norbornene-tetrazine cycloaddns. were predicted to be mutually orthogonal.  This was validated exptl. and used for highly selective fluorescence labeling of two proteins simultaneously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxbCgL7hhGkbVg90H21EOLACvtfcHk0ljMj9WA78SiwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVSgtb%252FF&md5=0d5cf273fb4552e14c19a1e3c6fed4b8</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1039%2FC5SC03259H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC03259H%26sid%3Dliteratum%253Aachs%26aulast%3DNarayanam%26aufirst%3DM.%2BK.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26aulast%3DMurphy%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%2520of%2520New%2520Mutually%2520Orthogonal%2520Bioorthogonal%2520Cycloaddition%2520Pairs%2520through%2520Computational%2520Screening%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26issue%3D2%26spage%3D1257%26epage%3D1261%26doi%3D10.1039%2FC5SC03259H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strumillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltrao, P.</span></span> <span> </span><span class="NLM_article-title">Towards the Computational Design of Protein Post-Translational Regulation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2877</span>– <span class="NLM_lpage">2882</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.04.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.bmc.2015.04.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=25956846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntlWlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2877-2882&issue=12&author=M.+Strumilloauthor=P.+Beltrao&title=Towards+the+Computational+Design+of+Protein+Post-Translational+Regulation&doi=10.1016%2Fj.bmc.2015.04.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Towards the computational design of protein post-translational regulation</span></div><div class="casAuthors">Strumillo, Marta; Beltrao, Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2877-2882</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein post-translational modifications (PTMs) are a fast and versatility mechanism used by the cell to regulate the function of proteins in response to changing conditions.  PTMs can alter the activity of proteins by allosteric regulation or by controlling protein interactions, localization and abundance.  Recent advances in proteomics revealed the extent of regulation by PTMs and the different mechanisms used in nature to exert control over protein function via PTMs.  These developments can serve as the foundation for the rational design of protein regulation.  Here the authors review the advances in methods to det. the function of PTMs, protein allosteric control and examples of rational design of PTM regulation.  These advances create an opportunity to move synthetic biol. forward by making use of a level of regulation that is of yet unexplored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob-snvpoICObVg90H21EOLACvtfcHk0livBflDcrCfXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntlWlsLg%253D&md5=8ad88090f5738c1a53f048574ef47273</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.04.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.04.056%26sid%3Dliteratum%253Aachs%26aulast%3DStrumillo%26aufirst%3DM.%26aulast%3DBeltrao%26aufirst%3DP.%26atitle%3DTowards%2520the%2520Computational%2520Design%2520of%2520Protein%2520Post-Translational%2520Regulation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26issue%3D12%26spage%3D2877%26epage%3D2882%26doi%3D10.1016%2Fj.bmc.2015.04.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletti, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.-C.</span></span> <span> </span><span class="NLM_article-title">Chemoselective Peptide Modification via Photocatalytic Tryptophan β-Position Conjugation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">6797</span>– <span class="NLM_lpage">6800</span>, <span class="refDoi"> DOI: 10.1021/jacs.8b03973</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b03973" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVCiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=6797-6800&issue=22&author=Y.+Yuauthor=L.-K.+Zhangauthor=A.+V.+Buevichauthor=G.+Liauthor=H.+Tangauthor=P.+Vachalauthor=S.+L.+Collettiauthor=Z.-C.+Shi&title=Chemoselective+Peptide+Modification+via+Photocatalytic+Tryptophan+%CE%B2-Position+Conjugation&doi=10.1021%2Fjacs.8b03973"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective Peptide Modification via Photocatalytic Tryptophan β-Position Conjugation</span></div><div class="casAuthors">Yu, Younong; Zhang, Li-Kang; Buevich, Alexei V.; Li, Guoqing; Tang, Haiqun; Vachal, Petr; Colletti, Steven L.; Shi, Zhi-Cai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6797-6800</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeting tryptophan is a promising strategy to achieve high levels of selectivity for peptide or protein modification.  A chemoselective peptide modification method via photocatalytic tryptophan β-position conjugation has been discovered.  This transformation has good substrate scope for both peptide and Michael acceptor, and has good chemoselectivity vs. other amino acid residues.  The endogenous peptides, glucagon and GLP-1 amide, were both successfully conjugated at the tryptophan β-position.  Insulin was studied as a nontryptophan control mol., resulting in exclusive B-chain C-terminal-selective decarboxylative conjugation.  This transformation provides a novel approach toward peptide modification to support the discovery of new therapeutic peptides, protein labeling and bioconjugation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWz6oczGRAMLVg90H21EOLACvtfcHk0livBflDcrCfXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVCiurY%253D&md5=35c3a0aff03bd3795ae48ff5df6debe9</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b03973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b03973%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.-K.%26aulast%3DBuevich%26aufirst%3DA.%2BV.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DColletti%26aufirst%3DS.%2BL.%26aulast%3DShi%26aufirst%3DZ.-C.%26atitle%3DChemoselective%2520Peptide%2520Modification%2520via%2520Photocatalytic%2520Tryptophan%2520%25CE%25B2-Position%2520Conjugation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D22%26spage%3D6797%26epage%3D6800%26doi%3D10.1021%2Fjacs.8b03973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in the Molecular Design of Synthetic Vaccines</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">952</span>– <span class="NLM_lpage">960</span>, <span class="refDoi"> DOI: 10.1038/nchem.2396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fnchem.2396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=26587710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFensLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=952-960&issue=12&author=L.+H.+Jones&title=Recent+Advances+in+the+Molecular+Design+of+Synthetic+Vaccines&doi=10.1038%2Fnchem.2396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the molecular design of synthetic vaccines</span></div><div class="casAuthors">Jones, Lyn H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">952-960</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Vaccines have typically been prepd. using whole organisms.  These are normally either attenuated bacteria or viruses that are live but have been altered to reduce their virulence, or pathogens that have been inactivated and effectively killed through exposure to heat or formaldehyde.  However, using whole organisms to elicit an immune response introduces the potential for infections arising from a reversion to a virulent form in live pathogens, unproductive reactions to vaccine components or batch-to-batch variability.  Synthetic vaccines, in which a mol. antigen is conjugated to a carrier protein, offer the opportunity to circumvent these problems.  This Perspective will highlight the progress that has been achieved in developing synthetic vaccines using a variety of mol. antigens.  In particular, the different approaches used to develop conjugate vaccines using peptide/proteins, carbohydrates and other small mol. haptens as antigens are compared.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphbKFn6TlnhrVg90H21EOLACvtfcHk0lggv_oXvarYPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFensLfL&md5=16e5d0b22ef8b5a66e104883f31385af</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2396%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Molecular%2520Design%2520of%2520Synthetic%2520Vaccines%26jtitle%3DNat.%2520Chem.%26date%3D2015%26volume%3D7%26issue%3D12%26spage%3D952%26epage%3D960%26doi%3D10.1038%2Fnchem.2396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veiseh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabikian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahrami, S.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veiseh, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackman, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravanpay, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusuma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sze, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenbogen, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. M.</span></span> <span> </span><span class="NLM_article-title">Tumor Paint: A Chlorotoxin:Cy5.5 Bioconjugate for Intraoperative Visualization of Cancer Foci</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">6882</span>– <span class="NLM_lpage">6888</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-3948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1158%2F0008-5472.CAN-06-3948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=17638899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslOisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6882-6888&issue=14&author=M.+Veisehauthor=P.+Gabikianauthor=S.-B.+Bahramiauthor=O.+Veisehauthor=M.+Zhangauthor=R.+C.+Hackmanauthor=A.+C.+Ravanpayauthor=M.+R.+Stroudauthor=Y.+Kusumaauthor=S.+J.+Hansenauthor=D.+Kwokauthor=N.+M.+Munozauthor=R.+W.+Szeauthor=W.+M.+Gradyauthor=N.+M.+Greenbergauthor=R.+G.+Ellenbogenauthor=J.+M.+Olson&title=Tumor+Paint%3A+A+Chlorotoxin%3ACy5.5+Bioconjugate+for+Intraoperative+Visualization+of+Cancer+Foci&doi=10.1158%2F0008-5472.CAN-06-3948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Paint: A Chlorotoxin:Cy5.5 Bioconjugate for Intraoperative Visualization of Cancer Foci</span></div><div class="casAuthors">Veiseh, Mandana; Gabikian, Patrik; Bahrami, S-Bahram; Veiseh, Omid; Zhang, Miqin; Hackman, Robert C.; Ravanpay, Ali C.; Stroud, Mark R.; Kusuma, Yumiko; Hansen, Stacey J.; Kwok, Deborah; Munoz, Nina M.; Sze, Raymond W.; Grady, William M.; Greenberg, Norman M.; Ellenbogen, Richard G.; Olson, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6882-6888</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Toward the goal of developing an optical imaging contrast agent that will enable surgeons to intraoperatively distinguish cancer foci from adjacent normal tissue, we developed a chlorotoxin:Cy5.5 (CTX:Cy5.5) bioconjugate that emits near-IR fluorescent signal.  The probe delineates malignant glioma, medulloblastoma, prostate cancer, intestinal cancer, and sarcoma from adjacent non-neoplastic tissue in mouse models.  Metastatic cancer foci as small as a few hundred cells were detected in lymph channels.  Specific binding to cancer cells is facilitated by matrix metalloproteinase-2 (MMP-2) as evidenced by redn. of CTX:Cy5.5 binding in vitro and in vivo by a pharmacol. blocker of MMP-2 and induction of CTX:Cy5.5 binding in MCF-7 cells following transfection with a plasmid encoding MMP-2.  Mouse studies revealed that CTX:Cy5.5 has favorable biodistribution and toxicity profiles.  These studies show that CTX:Cy5.5 has the potential to fundamentally improve intraoperative detection and resection of malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo04sI0a6cQdLVg90H21EOLACvtfcHk0lggv_oXvarYPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslOisb8%253D&md5=9f9bbe1bf8df8b3ef12fa79df5e671e0</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-3948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-3948%26sid%3Dliteratum%253Aachs%26aulast%3DVeiseh%26aufirst%3DM.%26aulast%3DGabikian%26aufirst%3DP.%26aulast%3DBahrami%26aufirst%3DS.-B.%26aulast%3DVeiseh%26aufirst%3DO.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHackman%26aufirst%3DR.%2BC.%26aulast%3DRavanpay%26aufirst%3DA.%2BC.%26aulast%3DStroud%26aufirst%3DM.%2BR.%26aulast%3DKusuma%26aufirst%3DY.%26aulast%3DHansen%26aufirst%3DS.%2BJ.%26aulast%3DKwok%26aufirst%3DD.%26aulast%3DMunoz%26aufirst%3DN.%2BM.%26aulast%3DSze%26aufirst%3DR.%2BW.%26aulast%3DGrady%26aufirst%3DW.%2BM.%26aulast%3DGreenberg%26aufirst%3DN.%2BM.%26aulast%3DEllenbogen%26aufirst%3DR.%2BG.%26aulast%3DOlson%26aufirst%3DJ.%2BM.%26atitle%3DTumor%2520Paint%253A%2520A%2520Chlorotoxin%253ACy5.5%2520Bioconjugate%2520for%2520Intraoperative%2520Visualization%2520of%2520Cancer%2520Foci%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D14%26spage%3D6882%26epage%3D6888%26doi%3D10.1158%2F0008-5472.CAN-06-3948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patil, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittle, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nufer, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrnes-Blake, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrish-Novak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prow, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamelak, A. N.</span></span> <span> </span><span class="NLM_article-title">Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas</span>. <i>Neurosurgery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">E641</span>– <span class="NLM_lpage">E649</span>, <span class="refDoi"> DOI: 10.1093/neuros/nyz125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1093%2Fneuros%2Fnyz125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=31069381" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2019&pages=E641-E649&issue=4&author=C.+G.+Patilauthor=D.+G.+Walkerauthor=D.+M.+Millerauthor=P.+Butteauthor=B.+Morrisonauthor=D.+S.+Kittleauthor=S.+J.+Hansenauthor=K.+L.+Nuferauthor=K.+A.+Byrnes-Blakeauthor=M.+Yamadaauthor=L.+L.+Linauthor=K.+Phamauthor=J.+Perryauthor=J.+Parrish-Novakauthor=L.+Ishakauthor=T.+Prowauthor=K.+Blackauthor=A.+N.+Mamelak&title=Phase+1+Safety%2C+Pharmacokinetics%2C+and+Fluorescence+Imaging+Study+of+Tozuleristide+%28BLZ-100%29+in+Adults+With+Newly+Diagnosed+or+Recurrent+Gliomas&doi=10.1093%2Fneuros%2Fnyz125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1093%2Fneuros%2Fnyz125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuros%252Fnyz125%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DC.%2BG.%26aulast%3DWalker%26aufirst%3DD.%2BG.%26aulast%3DMiller%26aufirst%3DD.%2BM.%26aulast%3DButte%26aufirst%3DP.%26aulast%3DMorrison%26aufirst%3DB.%26aulast%3DKittle%26aufirst%3DD.%2BS.%26aulast%3DHansen%26aufirst%3DS.%2BJ.%26aulast%3DNufer%26aufirst%3DK.%2BL.%26aulast%3DByrnes-Blake%26aufirst%3DK.%2BA.%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DL.%2BL.%26aulast%3DPham%26aufirst%3DK.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DParrish-Novak%26aufirst%3DJ.%26aulast%3DIshak%26aufirst%3DL.%26aulast%3DProw%26aufirst%3DT.%26aulast%3DBlack%26aufirst%3DK.%26aulast%3DMamelak%26aufirst%3DA.%2BN.%26atitle%3DPhase%25201%2520Safety%252C%2520Pharmacokinetics%252C%2520and%2520Fluorescence%2520Imaging%2520Study%2520of%2520Tozuleristide%2520%2528BLZ-100%2529%2520in%2520Adults%2520With%2520Newly%2520Diagnosed%2520or%2520Recurrent%2520Gliomas%26jtitle%3DNeurosurgery%26date%3D2019%26volume%3D85%26issue%3D4%26spage%3DE641%26epage%3DE649%26doi%3D10.1093%2Fneuros%2Fnyz125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khademhosseini, A.</span></span> <span> </span><span class="NLM_article-title">Advances in Engineering Hydrogels</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>356</i></span> (<span class="NLM_issue">6337</span>), <span class="NLM_elocation-id">eaaf3627</span> <span class="refDoi"> DOI: 10.1126/science.aaf3627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1126%2Fscience.aaf3627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=28473537" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2017&issue=6337&author=Y.+S.+Zhangauthor=A.+Khademhosseini&title=Advances+in+Engineering+Hydrogels&doi=10.1126%2Fscience.aaf3627"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaf3627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaf3627%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BS.%26aulast%3DKhademhosseini%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520Engineering%2520Hydrogels%26jtitle%3DScience%26date%3D2017%26volume%3D356%26issue%3D6337%26doi%3D10.1126%2Fscience.aaf3627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glazier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span> <span> </span><span class="NLM_article-title">Chemical Synthesis and Biological Application of Modified Oligonucleotides</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1213</span>– <span class="NLM_lpage">1233</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.0c00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.0c00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFCisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=1213-1233&issue=5&author=D.+A.+Glazierauthor=J.+Liaoauthor=B.+L.+Robertsauthor=X.+Liauthor=K.+Yangauthor=C.+M.+Stevensauthor=W.+Tang&title=Chemical+Synthesis+and+Biological+Application+of+Modified+Oligonucleotides&doi=10.1021%2Facs.bioconjchem.0c00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Synthesis and Biological Application of Modified Oligonucleotides</span></div><div class="casAuthors">Glazier, Daniel A.; Liao, Junzhuo; Roberts, Brett L.; Li, Xiaolei; Yang, Ka; Stevens, Christopher M.; Tang, Weiping</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1213-1233</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with refs.  RNA plays a myriad of roles in the body including the coding, decoding, regulation and expression of genes.  RNA oligonucleotides have garnered significant interest as therapeutics via antisense oligonucleotides or small interfering RNA strategies for the treatment of diseases ranging from hyperlipidemia, HCV, and others.  Addnl., the recently developed CRISPR-Cas9 mediated gene editing strategy also relies on Cas9-assocd. RNA strands.  However, RNA presents numerous challenges as both a synthetic target and a potential therapeutic.  RNA is inherently unstable, difficult to deliver into cells, and potentially immunogenic by itself or upon modification.  Despite these challenges, with the help of chem. modified oligonucleotides, multiple RNA based drugs have been approved by the FDA.  The progress is made possible due to the nature of chem. modified oligonucleotides bearing advantages of nuclease stability, stronger binding affinity and some other unique properties.  This review will focus on the chem. synthesis of RNA and its modified versions.  How chem. modifications of the ribose units and of the phosphatediester backbone address the inherent issues with using native RNA for biol. applications will be discussed along the way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ2I6IUYiuE7Vg90H21EOLACvtfcHk0lhV1vXedaomTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFCisbo%253D&md5=d52334a8bb55d61413e1c68aa2420c01</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.0c00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.0c00060%26sid%3Dliteratum%253Aachs%26aulast%3DGlazier%26aufirst%3DD.%2BA.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DB.%2BL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DC.%2BM.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DChemical%2520Synthesis%2520and%2520Biological%2520Application%2520of%2520Modified%2520Oligonucleotides%26jtitle%3DBioconjugate%2520Chem.%26date%3D2020%26volume%3D31%26issue%3D5%26spage%3D1213%26epage%3D1233%26doi%3D10.1021%2Facs.bioconjchem.0c00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nair, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willoughby, J. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charisse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoekstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandasamy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kel’in, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taneja, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaikh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Sluis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akinc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutabarat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchimanchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Berkel, T. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajeev, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, M.</span></span> <span> </span><span class="NLM_article-title">Multivalent N -Acetylgalactosamine-Conjugated SiRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">49</span>),  <span class="NLM_fpage">16958</span>– <span class="NLM_lpage">16961</span>, <span class="refDoi"> DOI: 10.1021/ja505986a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja505986a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSju7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=16958-16961&issue=49&author=J.+K.+Nairauthor=J.+L.+S.+Willoughbyauthor=A.+Chanauthor=K.+Charisseauthor=M.+R.+Alamauthor=Q.+Wangauthor=M.+Hoekstraauthor=P.+Kandasamyauthor=A.+V.+Kel%E2%80%99inauthor=S.+Milsteinauthor=N.+Tanejaauthor=J.+O%E2%80%99Sheaauthor=S.+Shaikhauthor=L.+Zhangauthor=R.+J.+van+der+Sluisauthor=M.+E.+Jungauthor=A.+Akincauthor=R.+Hutabaratauthor=S.+Kuchimanchiauthor=K.+Fitzgeraldauthor=T.+Zimmermannauthor=T.+J.+C.+van+Berkelauthor=M.+A.+Maierauthor=K.+G.+Rajeevauthor=M.+Manoharan&title=Multivalent+N+-Acetylgalactosamine-Conjugated+SiRNA+Localizes+in+Hepatocytes+and+Elicits+Robust+RNAi-Mediated+Gene+Silencing&doi=10.1021%2Fja505986a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing</span></div><div class="casAuthors">Nair, Jayaprakash K.; Willoughby, Jennifer L. S.; Chan, Amy; Charisse, Klaus; Alam, Md. Rowshon; Wang, Qianfan; Hoekstra, Menno; Kandasamy, Pachamuthu; Kel'in, Alexander V.; Milstein, Stuart; Taneja, Nate; O'Shea, Jonathan; Shaikh, Sarfraz; Zhang, Ligang; van der Sluis, Ronald J.; Jung, Michael E.; Akinc, Akin; Hutabarat, Renta; Kuchimanchi, Satya; Fitzgerald, Kevin; Zimmermann, Tracy; van Berkel, Theo J. C.; Maier, Martin A.; Rajeev, Kallanthottathil G.; Manoharan, Muthiah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">16958-16961</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Conjugation of small interfering RNA (siRNA) to an asialoglycoprotein receptor ligand derived from N-acetylgalactosamine (GalNAc) facilitates targeted delivery of the siRNA to hepatocytes in vitro and in vivo.  The ligands derived from GalNAc are compatible with solid-phase oligonucleotide synthesis and deprotection conditions, with synthesis yields comparable to those of std. oligonucleotides.  S.c. (SC) administration of siRNA-GalNAc conjugates resulted in robust RNAi-mediated gene silencing in liver.  Refinement of the siRNA chem. achieved a 5-fold improvement in efficacy over the parent design in vivo with a median ED (ED50) of 1 mg/kg following a single dose.  This enabled the SC administration of siRNA-GalNAc conjugates at therapeutically relevant doses and, importantly, at dose vols. of ≤1 mL.  Chronic weekly dosing resulted in sustained dose-dependent gene silencing for over 9 mo with no adverse effects in rodents.  The optimally chem. modified siRNA-GalNAc conjugates are hepatotropic and long-acting and have the potential to treat a wide range of diseases involving liver-expressed genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocTUVgPLEx2LVg90H21EOLACvtfcHk0lhV1vXedaomTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSju7vJ&md5=d47cb552873ffdaa46ed17d8d1fb4116</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Fja505986a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja505986a%26sid%3Dliteratum%253Aachs%26aulast%3DNair%26aufirst%3DJ.%2BK.%26aulast%3DWilloughby%26aufirst%3DJ.%2BL.%2BS.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DCharisse%26aufirst%3DK.%26aulast%3DAlam%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHoekstra%26aufirst%3DM.%26aulast%3DKandasamy%26aufirst%3DP.%26aulast%3DKel%25E2%2580%2599in%26aufirst%3DA.%2BV.%26aulast%3DMilstein%26aufirst%3DS.%26aulast%3DTaneja%26aufirst%3DN.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%26aulast%3DShaikh%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BSluis%26aufirst%3DR.%2BJ.%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DAkinc%26aufirst%3DA.%26aulast%3DHutabarat%26aufirst%3DR.%26aulast%3DKuchimanchi%26aufirst%3DS.%26aulast%3DFitzgerald%26aufirst%3DK.%26aulast%3DZimmermann%26aufirst%3DT.%26aulast%3Dvan%2BBerkel%26aufirst%3DT.%2BJ.%2BC.%26aulast%3DMaier%26aufirst%3DM.%2BA.%26aulast%3DRajeev%26aufirst%3DK.%2BG.%26aulast%3DManoharan%26aufirst%3DM.%26atitle%3DMultivalent%2520N%2520-Acetylgalactosamine-Conjugated%2520SiRNA%2520Localizes%2520in%2520Hepatocytes%2520and%2520Elicits%2520Robust%2520RNAi-Mediated%2520Gene%2520Silencing%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26issue%3D49%26spage%3D16958%26epage%3D16961%26doi%3D10.1021%2Fja505986a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coote, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valley, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhym, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bihler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mense, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCaffrey, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, W.</span></span> <span> </span><span class="NLM_article-title">Chemical Modifications of Adenine Base Editor MRNA and Guide RNA Expand Its Application Scope</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1979</span>, <span class="refDoi"> DOI: 10.1038/s41467-020-15892-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1038%2Fs41467-020-15892-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=32332735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3cXot1amtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1979&issue=1&author=T.+Jiangauthor=J.+M.+Hendersonauthor=K.+Cooteauthor=Y.+Chengauthor=H.+C.+Valleyauthor=X.-O.+Zhangauthor=Q.+Wangauthor=L.+H.+Rhymauthor=Y.+Caoauthor=G.+A.+Newbyauthor=H.+Bihlerauthor=M.+Menseauthor=Z.+Wengauthor=D.+G.+Andersonauthor=A.+P.+McCaffreyauthor=D.+R.+Liuauthor=W.+Xue&title=Chemical+Modifications+of+Adenine+Base+Editor+MRNA+and+Guide+RNA+Expand+Its+Application+Scope&doi=10.1038%2Fs41467-020-15892-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope</span></div><div class="casAuthors">Jiang, Tingting; Henderson, Jordana M.; Coote, Kevin; Cheng, Yi; Valley, Hillary C.; Zhang, Xiao-Ou; Wang, Qin; Rhym, Luke H.; Cao, Yueying; Newby, Gregory A.; Bihler, Hermann; Mense, Martin; Weng, Zhiping; Anderson, Daniel G.; McCaffrey, Anton P.; Liu, David R.; Xue, Wen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1979</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">CRISPR-Cas9-assocd. base editing is a promising tool to correct pathogenic single nucleotide mutations in research or therapeutic settings.  Efficient base editing requires cellular exposure to levels of base editors that can be difficult to attain in hard-to-transfect cells or in vivo.  Here we engineer a chem. modified mRNA-encoded adenine base editor that mediates robust editing at various cellular genomic sites together with moderately modified guide RNA, and show its therapeutic potential in correcting pathogenic single nucleotide mutations in cell and animal models of diseases.  The optimized chem. modifications of adenine base editor mRNA and guide RNA expand the applicability of CRISPR-assocd. gene editing tools in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH03B3BbFdtbVg90H21EOLACvtfcHk0lhEDaTwVkgdiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXot1amtLg%253D&md5=5a0c59eb0ee2f7f53121e5e77a74a811</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-15892-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-15892-8%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DHenderson%26aufirst%3DJ.%2BM.%26aulast%3DCoote%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DValley%26aufirst%3DH.%2BC.%26aulast%3DZhang%26aufirst%3DX.-O.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DRhym%26aufirst%3DL.%2BH.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DNewby%26aufirst%3DG.%2BA.%26aulast%3DBihler%26aufirst%3DH.%26aulast%3DMense%26aufirst%3DM.%26aulast%3DWeng%26aufirst%3DZ.%26aulast%3DAnderson%26aufirst%3DD.%2BG.%26aulast%3DMcCaffrey%26aufirst%3DA.%2BP.%26aulast%3DLiu%26aufirst%3DD.%2BR.%26aulast%3DXue%26aufirst%3DW.%26atitle%3DChemical%2520Modifications%2520of%2520Adenine%2520Base%2520Editor%2520MRNA%2520and%2520Guide%2520RNA%2520Expand%2520Its%2520Application%2520Scope%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D1979%26doi%3D10.1038%2Fs41467-020-15892-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarfò, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidts, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guirguis, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Słabicki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouffard, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castano, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kann, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinshpun, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sievers, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maus, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, B. L.</span></span> <span> </span><span class="NLM_article-title">Reversible ON- and OFF-Switch Chimeric Antigen Receptors Controlled by Lenalidomide</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">575</span>), <span class="NLM_elocation-id">eabb6295</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.abb6295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1126%2Fscitranslmed.abb6295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=33408186" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2021&issue=575&author=M.+Janauthor=I.+Scarf%C3%B2author=R.+C.+Larsonauthor=A.+Walkerauthor=A.+Schmidtsauthor=A.+A.+Guirguisauthor=J.+A.+Gasserauthor=M.+S%C5%82abickiauthor=A.+A.+Bouffardauthor=A.+P.+Castanoauthor=M.+C.+Kannauthor=M.+L.+Cabralauthor=A.+Tepperauthor=D.+E.+Grinshpunauthor=A.+S.+Sperlingauthor=T.+Kyungauthor=Q.+L.+Sieversauthor=M.+E.+Birnbaumauthor=M.+V.+Mausauthor=B.+L.+Ebert&title=Reversible+ON-+and+OFF-Switch+Chimeric+Antigen+Receptors+Controlled+by+Lenalidomide&doi=10.1126%2Fscitranslmed.abb6295"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.abb6295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.abb6295%26sid%3Dliteratum%253Aachs%26aulast%3DJan%26aufirst%3DM.%26aulast%3DScarf%25C3%25B2%26aufirst%3DI.%26aulast%3DLarson%26aufirst%3DR.%2BC.%26aulast%3DWalker%26aufirst%3DA.%26aulast%3DSchmidts%26aufirst%3DA.%26aulast%3DGuirguis%26aufirst%3DA.%2BA.%26aulast%3DGasser%26aufirst%3DJ.%2BA.%26aulast%3DS%25C5%2582abicki%26aufirst%3DM.%26aulast%3DBouffard%26aufirst%3DA.%2BA.%26aulast%3DCastano%26aufirst%3DA.%2BP.%26aulast%3DKann%26aufirst%3DM.%2BC.%26aulast%3DCabral%26aufirst%3DM.%2BL.%26aulast%3DTepper%26aufirst%3DA.%26aulast%3DGrinshpun%26aufirst%3DD.%2BE.%26aulast%3DSperling%26aufirst%3DA.%2BS.%26aulast%3DKyung%26aufirst%3DT.%26aulast%3DSievers%26aufirst%3DQ.%2BL.%26aulast%3DBirnbaum%26aufirst%3DM.%2BE.%26aulast%3DMaus%26aufirst%3DM.%2BV.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26atitle%3DReversible%2520ON-%2520and%2520OFF-Switch%2520Chimeric%2520Antigen%2520Receptors%2520Controlled%2520by%2520Lenalidomide%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2021%26volume%3D13%26issue%3D575%26doi%3D10.1126%2Fscitranslmed.abb6295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oakes, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rishi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadler, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doudna, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savage, D. F.</span></span> <span> </span><span class="NLM_article-title">CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">254</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.11.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.cell.2018.11.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=30633905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFyqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=254-267&issue=1%E2%80%932&author=B.+L.+Oakesauthor=C.+Fellmannauthor=H.+Rishiauthor=K.+L.+Taylorauthor=S.+M.+Renauthor=D.+C.+Nadlerauthor=R.+Yokooauthor=A.+P.+Arkinauthor=J.+A.+Doudnaauthor=D.+F.+Savage&title=CRISPR-Cas9+Circular+Permutants+as+Programmable+Scaffolds+for+Genome+Modification&doi=10.1016%2Fj.cell.2018.11.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">CRISPR-Cas9 circular permutants as programmable scaffolds for genome modification</span></div><div class="casAuthors">Oakes, Benjamin L.; Fellmann, Christof; Rishi, Harneet; Taylor, Kian L.; Ren, Shawn M.; Nadler, Dana C.; Yokoo, Rayka; Arkin, Adam P.; Doudna, Jennifer A.; Savage, David F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">254-267.e16</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The ability to engineer natural proteins is pivotal to a future, pragmatic biol.  CRISPR proteins have revolutionized genome modification, yet the CRISPR-Cas9 scaffold is not ideal for fusions or activation by cellular triggers.  Here, we show that a topol. rearrangement of Cas9 using circular permutation provides an advanced platform for RNA-guided genome modification and protection.  Through systematic interrogation, we find that protein termini can be positioned adjacent to bound DNA, offering a straightforward mechanism for strategically fusing functional domains.  Addnl., circular permutation enabled protease-sensing Cas9s (ProCas9s), a unique class of single-mol. effectors possessing programmable inputs and outputs.  ProCas9s can sense a wide range of proteases, and we demonstrate that ProCas9 can orchestrate a cellular response to pathogen-assocd. protease activity.  Together, these results provide a toolkit of safer and more efficient genome-modifying enzymes and mol. recorders for the advancement of precision genome engineering in research, agriculture, and biomedicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGdpuiMdxuyrVg90H21EOLACvtfcHk0lhEDaTwVkgdiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFyqtQ%253D%253D&md5=1c85a526c0c6b4c5574652b348454547</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.11.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.11.052%26sid%3Dliteratum%253Aachs%26aulast%3DOakes%26aufirst%3DB.%2BL.%26aulast%3DFellmann%26aufirst%3DC.%26aulast%3DRishi%26aufirst%3DH.%26aulast%3DTaylor%26aufirst%3DK.%2BL.%26aulast%3DRen%26aufirst%3DS.%2BM.%26aulast%3DNadler%26aufirst%3DD.%2BC.%26aulast%3DYokoo%26aufirst%3DR.%26aulast%3DArkin%26aufirst%3DA.%2BP.%26aulast%3DDoudna%26aufirst%3DJ.%2BA.%26aulast%3DSavage%26aufirst%3DD.%2BF.%26atitle%3DCRISPR-Cas9%2520Circular%2520Permutants%2520as%2520Programmable%2520Scaffolds%2520for%2520Genome%2520Modification%26jtitle%3DCell%26date%3D2019%26volume%3D176%26issue%3D1%25E2%2580%25932%26spage%3D254%26epage%3D267%26doi%3D10.1016%2Fj.cell.2018.11.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogan, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Replogle, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adriaens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramadoss, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samelson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogson, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kampmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hovestadt, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, J. S.</span></span> <span> </span><span class="NLM_article-title">Genome-Wide Programmable Transcriptional Memory by CRISPR-Based Epigenome Editing</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">2503</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2021.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=10.1016%2Fj.cell.2021.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=33838111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;key=1%3ACAS%3A528%3ADC%252BB3MXovV2itLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2021&pages=2503&author=J.+K.+Nu%C3%B1ezauthor=J.+Chenauthor=G.+C.+Pommierauthor=J.+Z.+Coganauthor=J.+M.+Replogleauthor=C.+Adriaensauthor=G.+N.+Ramadossauthor=Q.+Shiauthor=K.+L.+Hungauthor=A.+J.+Samelsonauthor=A.+N.+Pogsonauthor=J.+Y.+S.+Kimauthor=A.+Chungauthor=M.+D.+Leonettiauthor=H.+Y.+Changauthor=M.+Kampmannauthor=B.+E.+Bernsteinauthor=V.+Hovestadtauthor=L.+A.+Gilbertauthor=J.+S.+Weissman&title=Genome-Wide+Programmable+Transcriptional+Memory+by+CRISPR-Based+Epigenome+Editing&doi=10.1016%2Fj.cell.2021.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing</span></div><div class="casAuthors">Nunez, James K.; Chen, Jin; Pommier, Greg C.; Cogan, J. Zachery; Replogle, Joseph M.; Adriaens, Carmen; Ramadoss, Gokul N.; Shi, Quanming; Hung, King L.; Samelson, Avi J.; Pogson, Angela N.; Kim, James Y. S.; Chung, Amanda; Leonetti, Manuel D.; Chang, Howard Y.; Kampmann, Martin; Bernstein, Bradley E.; Hovestadt, Volker; Gilbert, Luke A.; Weissman, Jonathan S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2503-2519.e17</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A general approach for heritably altering gene expression has the potential to enable many discovery and therapeutic efforts.  Here, we present CRISPRoff-a programmable epigenetic memory writer consisting of a single dead Cas9 fusion protein that establishes DNA methylation and repressive histone modifications.  Transient CRISPRoff expression initiates highly specific DNA methylation and gene repression that is maintained through cell division and differentiation of stem cells to neurons.  Pairing CRISPRoff with genome-wide screens and anal. of chromatin marks establishes rules for heritable gene silencing.  We identify single guide RNAs (sgRNAs) capable of silencing the large majority of genes including those lacking canonical CpG islands (CGIs) and reveal a wide targeting window extending beyond annotated CGIs.  The broad ability of CRISPRoff to initiate heritable gene silencing even outside of CGIs expands the canonical model of methylation-based silencing and enables diverse applications including genome-wide screens, multiplexed cell engineering, enhancer silencing, and mechanistic exploration of epigenetic inheritance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ajVY0_DHaLVg90H21EOLACvtfcHk0ljgNAkauRGsFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXovV2itLY%253D&md5=cb2b0767e563c575c6f58de8f4f15be3</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2021.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2021.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DNu%25C3%25B1ez%26aufirst%3DJ.%2BK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DPommier%26aufirst%3DG.%2BC.%26aulast%3DCogan%26aufirst%3DJ.%2BZ.%26aulast%3DReplogle%26aufirst%3DJ.%2BM.%26aulast%3DAdriaens%26aufirst%3DC.%26aulast%3DRamadoss%26aufirst%3DG.%2BN.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DHung%26aufirst%3DK.%2BL.%26aulast%3DSamelson%26aufirst%3DA.%2BJ.%26aulast%3DPogson%26aufirst%3DA.%2BN.%26aulast%3DKim%26aufirst%3DJ.%2BY.%2BS.%26aulast%3DChung%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DM.%2BD.%26aulast%3DChang%26aufirst%3DH.%2BY.%26aulast%3DKampmann%26aufirst%3DM.%26aulast%3DBernstein%26aufirst%3DB.%2BE.%26aulast%3DHovestadt%26aufirst%3DV.%26aulast%3DGilbert%26aufirst%3DL.%2BA.%26aulast%3DWeissman%26aufirst%3DJ.%2BS.%26atitle%3DGenome-Wide%2520Programmable%2520Transcriptional%2520Memory%2520by%2520CRISPR-Based%2520Epigenome%2520Editing%26jtitle%3DCell%26date%3D2021%26volume%3D184%26spage%3D2503%26doi%3D10.1016%2Fj.cell.2021.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7Y" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E7Y','PDB','3E7Y'); return false;">PDB: 3E7Y</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4S11" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4S11','PDB','4S11'); return false;">PDB: 4S11</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00294&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-11%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00294%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00294" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994bacf8803c7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
